{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Paths with key players\n",
    "Analysis of key players that are involved in HemeMap and pathway databases (KEGG, Reactome and WikiPathways converted into BEL using PathMe python package).\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import sys\n",
    "import time\n",
    "import pybel\n",
    "import logging\n",
    "import pybel_tools\n",
    "\n",
    "from itertools import chain\n",
    "import pickle\n",
    "from pybel_jupyter import to_jupyter # Visualize network\n",
    "from pybel.struct.mutation import collapse_all_variants, collapse_to_genes\n",
    "import matplotlib.pyplot as plt\n",
    "from matplotlib_venn import venn2, venn3, venn2_unweighted, venn3_unweighted\n",
    "\n",
    "from bio2bel_kegg import Manager as KeggManager\n",
    "from bio2bel_reactome import Manager as ReactomeManager\n",
    "from bio2bel_wikipathways import Manager as WikipathwaysManager\n",
    "\n",
    "from networkx.algorithms import shortest_path, all_simple_paths # From a(MESH:Heme) to path(MESH:Thrombosis)\n",
    "import networkx as nx\n",
    "\n",
    "from pybel.constants import ANNOTATIONS, RELATION\n",
    "from collections import Counter, defaultdict\n",
    "\n",
    "import heme_knowledge"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'3.7.3 (default, Mar 27 2019, 17:13:21) [MSC v.1915 64 bit (AMD64)]'"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sys.version"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Fri Jun 21 08:58:51 2019'"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "time.asctime()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'0.13.2'"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pybel.get_version()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "logging.basicConfig(level=20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "merged_network = heme_knowledge.get_graph()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "pybel.struct.remove_associations(merged_network)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "collapse_to_genes(merged_network)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "#pybel.struct.mutation.remove_isolated_list_abundances(merged_network)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "#pybel.struct.mutation.remove_biological_processes(merged_network)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "#to_jupyter(merged_network)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Create a subgraph of path from heme to target node to find the key players in paths"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of simple paths for heme-Inflammation: 70488\n"
     ]
    }
   ],
   "source": [
    "def bel_to_simple_directed(graph):\n",
    "    \"\"\"BELGraph to directed NetworkX graph reducing redundant edges.\"\"\"\n",
    "    directed_graph = nx.DiGraph()\n",
    "    \n",
    "    for sub, obj in graph.edges():\n",
    "        directed_graph.add_edge(sub, obj)\n",
    "\n",
    "    return directed_graph\n",
    "\n",
    "merged_network_directed = bel_to_simple_directed(merged_network)\n",
    "\n",
    "#gives the paths from heme-thrombosis\n",
    "for node in merged_network_directed:\n",
    "        if 'name' in node and node.name == 'heme':\n",
    "            source_node = node\n",
    "        \n",
    "        elif 'name' in node and node.name == 'Inflammation':\n",
    "            target_node = node\n",
    "            \n",
    "#         if not source_node or not target_node:\n",
    "#             raise ValueError('One of the nodes was not found')\n",
    "\n",
    "data = nx.all_simple_paths(merged_network_directed, source_node, target_node, cutoff= 6)\n",
    "\n",
    "data = list(data)\n",
    "\n",
    "#Gives all the nodes present in the path\n",
    "all_nodes_in_paths = set(chain.from_iterable(data))\n",
    "\n",
    "print(f\"Number of simple paths for {source_node.name}-{target_node.name}: {len(data)}\")\n",
    "\n",
    "#Gives those which involoves the key_players in paths leading from heme-endpoints (thrombosis, inflammation, hemolysis)\n",
    "def via_paths(paths, node_name):\n",
    "    \n",
    "    via_key_players_list = []\n",
    "        \n",
    "    for path in paths:\n",
    "        for node in path:\n",
    "            if 'name' in node and node.name == node_name:\n",
    "                via_key_players_list.append(path)\n",
    "                \n",
    "    return via_key_players_list\n",
    "\n",
    "key_nodes = via_paths(data, 'TLR4')\n",
    "\n",
    "#flattens the list of list for graph generation\n",
    "def flatten_list(list_of_list):\n",
    "    \n",
    "    key_nodes_flat = list()\n",
    "    \n",
    "    for sublist in list_of_list:\n",
    "        for element in sublist:\n",
    "            \n",
    "            key_nodes_flat.append(element)\n",
    "            \n",
    "    return key_nodes_flat\n",
    "\n",
    "graph_nodes_key_players = flatten_list(key_nodes)\n",
    "\n",
    "# sub_graph generation from heme_network \n",
    "graph = pybel.struct.union([\n",
    "    merged_network.subgraph(graph_nodes_key_players)\n",
    "    \n",
    "])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/javascript": [
       "function init_d3_force(d3, graph, chart, width, height, function_colors) {\n",
       "    var focus_node = null;\n",
       "    var highlight_node = null;\n",
       "\n",
       "    // Highlight color variables\n",
       "\n",
       "    // Highlight color of the node boundering\n",
       "    const highlight_node_boundering = \"#4EB2D4\";\n",
       "\n",
       "    // Highlight color of the edge\n",
       "    const highlighted_link_color = \"#4EB2D4\";\n",
       "\n",
       "    // Text highlight color\n",
       "    const highlight_text = \"#4EB2D4\";\n",
       "\n",
       "    // Size when zooming scale\n",
       "    var size = d3.scalePow().exponent(1)\n",
       "        .domain([1, 100])\n",
       "        .range([8, 24]);\n",
       "\n",
       "    // Simulation parameters\n",
       "    const linkDistance = 100;\n",
       "    const fCharge = -1000;\n",
       "    const linkStrength = 0.7;\n",
       "    const collideStrength = 1;\n",
       "\n",
       "    // Simulation defined with variables\n",
       "    var simulation = d3.forceSimulation()\n",
       "        .force(\"link\", d3.forceLink()\n",
       "            .distance(linkDistance)\n",
       "            .strength(linkStrength)\n",
       "        )\n",
       "        .force(\"collide\", d3.forceCollide()\n",
       "            .radius(function (d) {\n",
       "                return d.r + 10\n",
       "            })\n",
       "            .strength(collideStrength)\n",
       "        )\n",
       "        .force(\"charge\", d3.forceManyBody()\n",
       "            .strength(fCharge)\n",
       "        )\n",
       "        .force(\"center\", d3.forceCenter(width / 2, height / 2))\n",
       "        .force(\"y\", d3.forceY(0))\n",
       "        .force(\"x\", d3.forceX(0));\n",
       "\n",
       "    // Pin down functionality\n",
       "    var node_drag = d3.drag()\n",
       "        .on(\"start\", dragstarted)\n",
       "        .on(\"drag\", dragged)\n",
       "        .on(\"end\", dragended);\n",
       "\n",
       "    function dragstarted(d) {\n",
       "        if (!d3.event.active) simulation.alphaTarget(0.3).restart();\n",
       "        d.fx = d.x;\n",
       "        d.fy = d.y;\n",
       "    }\n",
       "\n",
       "    function dragged(d) {\n",
       "        d.fx = d3.event.x;\n",
       "        d.fy = d3.event.y;\n",
       "    }\n",
       "\n",
       "    function dragended(d) {\n",
       "        if (!d3.event.active) simulation.alphaTarget(0);\n",
       "    }\n",
       "\n",
       "    function releasenode(d) {\n",
       "        d.fx = null;\n",
       "        d.fy = null;\n",
       "    }\n",
       "\n",
       "    //END Pin down functionality\n",
       "\n",
       "\n",
       "    /**\n",
       "     * Gets the best name for a node object\n",
       "     * @param {object} d object\n",
       "     * @returns {str} canonical name of the node\n",
       "     */\n",
       "    function getCanonicalName(d) {\n",
       "        if (d.name && !(d.variants || d.reactants || d.products || d.members)) {\n",
       "            return d.name\n",
       "        } else if (d.bel) {\n",
       "            return d.bel\n",
       "        } else {\n",
       "            console.log('Undefined node: ' + d);\n",
       "            return 'UNDEFINED'\n",
       "        }\n",
       "    }\n",
       "\n",
       "    const color_circunferencia = \"black\";\n",
       "    const default_link_color = \"#AAAAAA\";\n",
       "    const nominal_base_node_size = 8;\n",
       "\n",
       "    // Normal and highlighted stroke of the links (double the width of the link when highlighted)\n",
       "    const nominal_stroke = 1.5;\n",
       "\n",
       "    // Zoom variables\n",
       "    const min_zoom = 0.1;\n",
       "    const max_zoom = 10;\n",
       "\n",
       "    var svg = d3.select(chart).append(\"svg\")\n",
       "        .attr(\"width\", width)\n",
       "        .attr(\"height\", height);\n",
       "\n",
       "    // // Create definition for arrowhead.\n",
       "    svg.append(\"defs\").append(\"marker\")\n",
       "        .attr(\"id\", \"arrowhead\")\n",
       "        .attr(\"viewBox\", \"0 -5 10 10\")\n",
       "        .attr(\"refX\", 20)\n",
       "        .attr(\"refY\", 0)\n",
       "        .attr(\"markerUnits\", \"strokeWidth\")\n",
       "        .attr(\"markerWidth\", 6)\n",
       "        .attr(\"markerHeight\", 6)\n",
       "        .attr(\"orient\", \"auto\")\n",
       "        .append(\"path\")\n",
       "        .attr(\"d\", \"M0,-5L10,0L0,5\");\n",
       "\n",
       "    // // Create definition for stub.\n",
       "    svg.append(\"defs\").append(\"marker\")\n",
       "        .attr(\"id\", \"stub\")\n",
       "        .attr(\"viewBox\", \"-1 -5 2 10\")\n",
       "        .attr(\"refX\", 15)\n",
       "        .attr(\"refY\", 0)\n",
       "        .attr(\"markerUnits\", \"strokeWidth\")\n",
       "        .attr(\"markerWidth\", 6)\n",
       "        .attr(\"markerHeight\", 6)\n",
       "        .attr(\"orient\", \"auto\")\n",
       "        .append(\"path\")\n",
       "        .attr(\"d\", \"M 0,0 m -1,-5 L 1,-5 L 1,5 L -1,5 Z\");\n",
       "\n",
       "    // Background\n",
       "    svg.append(\"rect\")\n",
       "        .attr(\"width\", \"100%\")\n",
       "        .attr(\"height\", \"100%\")\n",
       "        .attr(\"fill\", \"#ffffff\")\n",
       "        .style(\"pointer-events\", \"all\")\n",
       "        // Zoom + panning functionality\n",
       "        .call(d3.zoom()\n",
       "            .scaleExtent([min_zoom, max_zoom])\n",
       "            .on(\"zoom\", zoomed))\n",
       "        .on(\"dblclick.zoom\", null);\n",
       "\n",
       "\n",
       "    function zoomed() {\n",
       "        g.attr(\"transform\", d3.event.transform);\n",
       "    }\n",
       "\n",
       "    // g = svg object where the graph will be appended\n",
       "    var g = svg.append(\"g\");\n",
       "\n",
       "    var linkedByIndex = {};\n",
       "    graph.links.forEach(function (d) {\n",
       "        linkedByIndex[d.source + \",\" + d.target] = true;\n",
       "    });\n",
       "\n",
       "    function isConnected(a, b) {\n",
       "        return linkedByIndex[a.index + \",\" + b.index] || linkedByIndex[b.index + \",\" + a.index] || a.index == b.index;\n",
       "    }\n",
       "\n",
       "    function ticked() {\n",
       "        link.attr(\"x1\", function (d) {\n",
       "            return d.source.x;\n",
       "        })\n",
       "            .attr(\"y1\", function (d) {\n",
       "                return d.source.y;\n",
       "            })\n",
       "            .attr(\"x2\", function (d) {\n",
       "                return d.target.x;\n",
       "            })\n",
       "            .attr(\"y2\", function (d) {\n",
       "                return d.target.y;\n",
       "            });\n",
       "\n",
       "        node\n",
       "            .attr(\"transform\", function (d) {\n",
       "                return \"translate(\" + d.x + \", \" + d.y + \")\";\n",
       "            });\n",
       "    }\n",
       "\n",
       "\n",
       "    simulation\n",
       "        .nodes(graph.nodes)\n",
       "        .on(\"tick\", ticked);\n",
       "\n",
       "    simulation.force(\"link\")\n",
       "        .links(graph.links);\n",
       "\n",
       "    // Definition of links nodes text...\n",
       "\n",
       "    var link = g.selectAll(\".link\")\n",
       "        .data(graph.links)\n",
       "        .enter().append(\"line\")\n",
       "        .style(\"stroke-width\", nominal_stroke)\n",
       "        .style(\"stroke\", default_link_color)\n",
       "        .style(\"stroke-dasharray\", function (d) {\n",
       "            if (['decreases', 'directlyDecreases', 'increases', 'directlyIncreases', 'negativeCorrelation',\n",
       "                'positiveCorrelation'].indexOf(d.relation) >= 0) {\n",
       "                return \"none\"\n",
       "            } else {\n",
       "                return \"4, 4\"\n",
       "            }\n",
       "        })\n",
       "        .attr(\"marker-start\", function (d) {\n",
       "            if ('positiveCorrelation' == d.relation) {\n",
       "                return \"url(#arrowhead)\"\n",
       "            }\n",
       "            else if ('negativeCorrelation' == d.relation) {\n",
       "                return \"url(#stub)\"\n",
       "            }\n",
       "            else {\n",
       "                return \"\"\n",
       "            }\n",
       "        })\n",
       "        .attr(\"marker-end\", function (d) {\n",
       "            if (['increases', 'directlyIncreases', 'positiveCorrelation', 'isA', 'partOf'].indexOf(d.relation) >= 0) {\n",
       "                return \"url(#arrowhead)\"\n",
       "            } else if (['decreases', 'directlyDecreases', 'negativeCorrelation'].indexOf(d.relation) >= 0) {\n",
       "                return \"url(#stub)\"\n",
       "            } else {\n",
       "                return \"\"\n",
       "            }\n",
       "        });\n",
       "\n",
       "    var node = g.selectAll(\".nodes\")\n",
       "        .data(graph.nodes)\n",
       "        .enter().append(\"g\")\n",
       "        .attr(\"class\", \"node\")\n",
       "        // Next two lines -> Pin down functionality\n",
       "        .on('dblclick', releasenode)\n",
       "        .call(node_drag);\n",
       "\n",
       "    var circle = node.append(\"path\")\n",
       "        .attr(\"d\", d3.symbol()\n",
       "            .size(function (d) {\n",
       "                return Math.PI * Math.pow(size(d.size) || nominal_base_node_size, 2);\n",
       "            })\n",
       "        )\n",
       "        .attr(\"class\", function (d) {\n",
       "            return d.function\n",
       "        })\n",
       "        .style('fill', function (d) {\n",
       "            return function_colors[d.function]\n",
       "        })\n",
       "        .style(\"stroke-width\", nominal_stroke)\n",
       "        .style(\"stroke\", color_circunferencia);\n",
       "\n",
       "    var text = node.append(\"text\")\n",
       "        .attr(\"class\", \"node-name\")\n",
       "        // .attr(\"id\", nodehashes[d])\n",
       "        .attr(\"fill\", \"black\")\n",
       "        .attr(\"dx\", 12)\n",
       "        .attr(\"dy\", \".35em\")\n",
       "        .text(function (d) {\n",
       "            return getCanonicalName(d)\n",
       "        });\n",
       "\n",
       "    // Highlight on mouseenter and back to normal on mouseout\n",
       "    node.on(\"mouseenter\", function (d) {\n",
       "        set_highlight(d);\n",
       "    })\n",
       "        .on(\"mousedown\", function () {\n",
       "            d3.event.stopPropagation();\n",
       "        }).on(\"mouseout\", function () {\n",
       "        exit_highlight();\n",
       "    });\n",
       "\n",
       "    function exit_highlight() {\n",
       "        highlight_node = null;\n",
       "        if (focus_node === null) {\n",
       "            if (highlight_node_boundering != color_circunferencia) {\n",
       "                circle.style(\"stroke\", color_circunferencia);\n",
       "                text.style(\"fill\", \"black\");\n",
       "                link.style(\"stroke\", default_link_color);\n",
       "            }\n",
       "        }\n",
       "    }\n",
       "\n",
       "    function set_highlight(d) {\n",
       "        if (focus_node !== null) d = focus_node;\n",
       "        highlight_node = d;\n",
       "\n",
       "        if (highlight_node_boundering != color_circunferencia) {\n",
       "            circle.style(\"stroke\", function (o) {\n",
       "                return isConnected(d, o) ? highlight_node_boundering : color_circunferencia;\n",
       "            });\n",
       "            text.style(\"fill\", function (o) {\n",
       "                return isConnected(d, o) ? highlight_text : \"black\";\n",
       "            });\n",
       "            link.style(\"stroke\", function (o) {\n",
       "                return o.source.index == d.index || o.target.index == d.index ? highlighted_link_color : default_link_color;\n",
       "            });\n",
       "        }\n",
       "    }\n",
       "\n",
       "\n",
       "    // Freeze the graph when space is pressed\n",
       "    function freezeGraph() {\n",
       "        // Space button Triggers STOP\n",
       "        if (d3.event.keyCode == 32) {\n",
       "            simulation.stop();\n",
       "        }\n",
       "    }\n",
       "\n",
       "    // Call freezeGraph when a key is pressed, freezeGraph checks whether this key is \"Space\" that triggers the freeze\n",
       "    d3.select(window).on(\"keydown\", freezeGraph);\n",
       "}\n",
       "\n",
       "require.config({\n",
       "    paths: {\n",
       "        d3: '//cdnjs.cloudflare.com/ajax/libs/d3/4.5.0/d3.min'\n",
       "    }\n",
       "});\n",
       "\n",
       "var elementInnerHTML = \"<div id='prcaembydgsjvozk'></div>\";\n",
       "\n",
       "element.append(elementInnerHTML);\n",
       "\n",
       "require(['d3'], function (d3) {\n",
       "    return init_d3_force(d3, {\"directed\": true, \"graph\": {\"annotation_list\": {}, \"annotation_pattern\": {\"Concentration\": \".*\", \"Species\": \".*\", \"TimePoint\": \".*\"}, \"annotation_url\": {\"Anatomy\": \"https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno\", \"Cell\": \"https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno\", \"CellLine\": \"https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno\", \"CellStructure\": \"https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno\", \"Confidence\": \"https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno\", \"Disease\": \"https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno\", \"Gender\": \"https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno\", \"MeSHAnatomy\": \"https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno\", \"MeSHDisease\": \"https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno\", \"Subgraph\": \"https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno\", \"TextLocation\": \"https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno\"}, \"document_metadata\": {\"authors\": \"Daniel Domingo-Fernández, Farah Humayun\", \"contact\": \"daniel.domingo.fernandez@scai.fraunhofer.de\", \"copyright\": \"Copyright © 2019 Fraunhofer SCAI, All rights reserved.\", \"description\": \"Mechanistic knowledge surrounding hemes\", \"licenses\": \"MIT License\", \"name\": \"Heme Curation\", \"version\": \"0.0.1-dev\"}, \"namespace_pattern\": {\"DBSNP\": \"rs[0-9]+\", \"HM\": \".*\", \"PUBCHEM\": \"^\\\\d+$\", \"TAXONOMY\": \"^\\\\d+$\", \"UNIPROT\": \"^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\\\.\\\\d+)?$\"}, \"namespace_url\": {\"CHEBI\": \"https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns\", \"CTO\": \"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns\", \"DO\": \"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns\", \"DRUGBANK\": \"https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns\", \"ECCODE\": \"https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns\", \"FPLX\": \"https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns\", \"GO\": \"https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns\", \"HBP\": \"https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/export/hbp-names.belns\", \"HGNC\": \"https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns\", \"HGNCGENEFAMILY\": \"https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns\", \"HP\": \"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns\", \"INTERPRO\": \"https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns\", \"MESH\": \"https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns\", \"MGI\": \"https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns\", \"MIRBASE\": \"https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns\", \"NCBIGENE\": \"https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns\", \"PFAM\": \"https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns\", \"RGD\": \"https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns\", \"SCOMP\": \"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns\", \"SFAM\": \"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns\"}, \"namespaces_uncached\": [], \"path\": \"c:\\\\users\\\\syedf\\\\heme\\\\curation\\\\heme_knowledge\\\\heme_19276082.bel\", \"pybel_version\": \"0.13.2\"}, \"links\": [{\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \". In the presence of reactive oxygen species (ROS), Hb is oxidized to methemoglobin (MetHb; Balla et al., 1993), characterized by the change in the oxidative state of the Fe present in the heme molecule from ferrous (Fe+2) to ferric (Fe+3).\", \"key\": \"99a8a34feb1f0a6ceee997cbd255b74dbb1a4793fd5c2f12710d1364c9630ed6ce85b7e5fc5a33b73f4dca7d9c09af245e21f63395a085d0a2a088f8a70b9790\", \"line\": 131, \"relation\": \"positiveCorrelation\", \"source\": 100, \"target\": 22}, {\"key\": \"765e8cc70e7807811db4c681aa64b003aa1d71ae719135fa57424d868cc0467aba87234adf7801c22d5367135108559bb3c6d15c5566a0da58a0d9a822e56829\", \"relation\": \"hasReactant\", \"source\": 100, \"target\": 54}, {\"annotations\": {\"Cell\": {\"bone marrow cell\": true}, \"MeSHAnatomy\": {\"Duodenum\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Using isolated duodenal loops to measure the transepithelial iron transport, we found that CEP mice presented a higher rate of iron absorption than the WT mice, although the differences between the area under the curves did not reach statistical significance (Figure 3D).\", \"key\": \"b8e544832181178c007c7d894028f70f01580f441edc815230776f07767f3cd3e4abfb1f8046c03b1a4882bdc2b68fd3b526b30b37d8838e23b3b76bc7271332\", \"line\": 196, \"relation\": \"positiveCorrelation\", \"source\": 85, \"target\": 5}, {\"annotations\": {\"Cell\": {\"bone marrow cell\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Serum iron was also increased in CEP mice, but this did not lead to elevated Tf saturation because Tf was also significantly increased, which is reminiscent of iron deficiency anemia and facilitates iron delivery to a larger number of erythroblasts (Table 1 and Figure 3G).\", \"key\": \"2e41996a9c8c453981535da1b91af25c026b1732fa2b59b7d387858101db21ddb07bca276bd119462a612340c32dbf5e92f601f13cf243c914afdd3e95c9973e\", \"line\": 213, \"relation\": \"positiveCorrelation\", \"source\": 85, \"target\": 5}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Iron was also detected in the macrophages of the red pulp of CEP mice, while almost no iron deposit was observed in the spleen of Hjv–/– mice (Figure 4B), confirming that Hb and “free” heme are the likely source of macrophage iron accumulation.\", \"key\": \"5ffaff0238af8b0b5e1c97a7bb90d168aa8c3621fedda0c1100a59398804c64d5138eb8042acf07b449ab6dca813e5f6d4e553791d923dbffcd28de24bd62870\", \"line\": 228, \"relation\": \"positiveCorrelation\", \"source\": 85, \"target\": 5}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney Cortex\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"As expected, Perl’s staining of CEP kidneys showed significant accumulation of iron in the renal cortical part, particularly in the proximal tubules (Figure 6A).\", \"key\": \"0eb3e4a6c706e130242bad07a6ed1a0eb0dae44a21e768469453a3d2937d099ac2839dea7f9dff2f85175f5fdc41b6d6d82c9b0f7aa195b063c11a258512097d\", \"line\": 285, \"relation\": \"positiveCorrelation\", \"source\": 85, \"target\": 5}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Moreover, HO-1 was highly expressed in the liver of CEP compared to WT mice (Figure 4E), confirming that residual heme uptake is rapidly degraded in the liver.\", \"key\": \"32c94f77a4e5eef1c6b378494b3af82697f0b895b3d8e7d02810540437189ba80c015e9d364bdf6437e8c2a8b11f3bfb3348813998973e246bc97ebd668a680c\", \"line\": 260, \"relation\": \"positiveCorrelation\", \"source\": 85, \"target\": 66}, {\"annotations\": {\"Cell\": {\"inner renal cortex cell\": true}, \"MeSHAnatomy\": {\"Kidney Cortex\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Interestingly, the mRNA expression levels of HO-1 and ferroportin, which are both induced transcriptionally by free heme, were enhanced significantly in the cortex, but not in the medulla, of CEP mice, resulting in large increases in their protein abundance (Figure 6).\", \"key\": \"fc86e4b10b83d741e15b5a58c2edd79196b836ce6e4e53a66c4af2266a94480c75b9bd7bba0bdb7e41cd133374cbc0450e8c17754fabf9927f9c747ae7cd04e2\", \"line\": 316, \"relation\": \"positiveCorrelation\", \"source\": 85, \"target\": 66}, {\"annotations\": {\"Cell\": {\"bone marrow cell\": true}, \"MeSHAnatomy\": {\"Duodenum\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"In addition, we observed an increase of ferroportin protein expression in duodenal enterocytes (Figure 3E and F).\", \"key\": \"39ccdeedb5c596292ee04ccb76aa60b09230d6f1729258efdc4e6c8a99337b6c3553aec4eb4bd20c039e2e82dd1cb97c6f0abf7d606304133e1709140a4f5433\", \"line\": 203, \"relation\": \"positiveCorrelation\", \"source\": 85, \"target\": 73}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"In addition, despite an increase in ferritin expression, ferroportin expression was also induced in the liver of CEP mice (Figure 4E), suggesting an increase of iron release in the circulation to satisfy the high iron demand.\", \"key\": \"ea89d048ba270ee868e5ba8cae9bbbc35a53ad9a9bdd5fdedea1cc46913de38c2edc93e7cd884703660b51bbee1edcb1b7bc3c6d290e5ac42b6bf1b70bb00914\", \"line\": 269, \"relation\": \"positiveCorrelation\", \"source\": 85, \"target\": 73}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Congenital erythropoietic porphyria mice showed increased serum bilirubin and LDH levels (Table 1), with almost undetectable levels of Hp and Hpx (Figure 1A and B, respectively), which was strongly indicative of hemolytic anemia.\", \"key\": \"6f51a4dee93282da0ac3807f2fcdcab5eaefe5bb5de442f99743d592dfa6552423793b089a927836610fcb2c5a2b9082fc93642245dc198c1d5555ec30b0160c\", \"line\": 118, \"relation\": \"negativeCorrelation\", \"source\": 85, \"target\": 67}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Atherosclerosis\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"We recently found that, contrary to other forms of oxidized hemoglobin, ferrylhemoglobin acts as a potent pro-inflammatory agonist in endothelial cells, leading to the up-regulation of adhesion molecules that support the recruitment of macrophages into the vessel wall.36\", \"key\": \"a65cca3f7ba7df7a896378112bbf22aa350ae2b7f5aa0751165153af35b6a3a0aef6dd8928b1395f6c50ac39bc6d5de6f09f50df73f4d5e73ad9b6ba51a7910e\", \"line\": 383, \"relation\": \"positiveCorrelation\", \"source\": 26, \"target\": 97}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"For example, HbFe41 (20 mM), but not HbFe31 or HbFe21, induced cytoskeletal reorganization, inflammation and disrupted barrier integrity in endothelial cells after 8 hours of incubation with the proteins.\", \"key\": \"ceb46fec05a5ae2cfb688c98abf8ef300daed3ed52e0699f65af3859aba5e898a51026ce4eea3a683f4f74e0134b8b003ae3c122dbc2e0264d0f08d35d01bc8c\", \"line\": 204, \"relation\": \"positiveCorrelation\", \"source\": 26, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Similarly to heme, ferrylHb activates endothelial cells through NFκB activation (Silva et al., 2009).\", \"key\": \"2637ca7ac4a30e5a64dd6d1050fedf73852e0218ca3c494b640e4182487fa05fb6795511962dcca458d3da0c0873cef9045953891c9ee7a7564beed4bc96e02c\", \"line\": 682, \"relation\": \"increases\", \"source\": 26, \"target\": 29}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \" Moreover, ferrylHb is unable to induce cytokine secretion by endothelial cells (Silva et al., 2009), another difference to heme which induces IL-8 production (Natarajan et al., 2007). \", \"key\": \"fc8220cd1e0c1f6b23d2cba859b8f6bab6467c1e545d7a4ed22608dd97b91495e252cf0ce1fe25d0cb77d5454f52017004f59406b706e216dac680fc7be1c1f5\", \"line\": 687, \"relation\": \"causesNoChange\", \"source\": 26, \"target\": 24}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Like MetHb, ferrylHb is unstable and releases free heme to further increase oxLDL formation (Potor et al., 2013).\", \"key\": \"3f8e92555033115bda85d0fbad6fc785e626ea6a704cdbc725f5e49259e275c2eca856494933ced4c70417f7705f62dc1aaa14db26259434995b269547645904\", \"line\": 693, \"relation\": \"increases\", \"source\": 26, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Exposure to HbFe41 resulted in a drop in hyperpolarized cell percentage over untreated control, thus indicating a significant mitochondrial depolarization or compromised mitochondrial respiration.\", \"key\": \"3a88f7768bb50e49f975b27ce7ec259b9e144e67b21f569c87ef79d40900d5f18d31df4f5b1ff484a850ee6d4add033ee70066af059ef7b929020566f1ea431e\", \"line\": 186, \"relation\": \"negativeCorrelation\", \"source\": 26, \"target\": 27}, {\"annotations\": {\"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Exposure to HbFe41 caused a significant up-regulation of HO-1 within 12 hours when compared with HbFe21 and HbFe31 (Figures 4A and 4B).\", \"key\": \"227af749c92826233f703cc55aa1b71a27d4335a57573a9ae2d9bd812eded1cea1e8b8beeb9ba117371a4ecd8d873856df28460eef34c334f1e952b7175016e9\", \"line\": 167, \"relation\": \"increases\", \"source\": 26, \"target\": 66}, {\"annotations\": {\"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"We found significant enrichment of HO-1 in mitochondrial fraction after exposure to HbFe31 and HbFe41 (Figure 4C).\", \"key\": \"ef0c9f20cdcf88af23e174c94c0e271e2be8638a19806690800eaa56a7a2a431f29a247b2616eb737198563b5df70fead4d27275d4768c001f5cf6a2433a4a31\", \"line\": 175, \"relation\": \"increases\", \"source\": 26, \"target\": 66}, {\"annotations\": {\"Cell\": {\"bone marrow cell\": true}, \"MeSHAnatomy\": {\"Duodenum\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"In addition, we observed an increase of ferroportin protein expression in duodenal enterocytes (Figure 3E and F).\", \"key\": \"d80116123d80b4a29a5c40e32baf44ca5e1ed166440ac0785002c15f8893ebb324095680b115d69676df1d72945bf34ead50ad80b21014abb4fb26adaddb140a\", \"line\": 203, \"relation\": \"positiveCorrelation\", \"source\": 73, \"target\": 85}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"In addition, despite an increase in ferritin expression, ferroportin expression was also induced in the liver of CEP mice (Figure 4E), suggesting an increase of iron release in the circulation to satisfy the high iron demand.\", \"key\": \"20789cc2d6bc95de610daca91c97807983de68fcf2931222fa653bb441044237894f6112aa8bbfca9a9b15ee2b37cb3628170a7b3758b3e5198d3f3e303caf38\", \"line\": 269, \"relation\": \"positiveCorrelation\", \"source\": 73, \"target\": 85}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"High ferroportin levels were measured in macrophages upon heme overload and erythrophagocytosis (12, 13, 31, 32, 37) and in hemolytic murine models of b-thalassemia and phenylhydrazineinduced hemolytic anemia (11, 22, 34).\", \"key\": \"cf6ca901716f69de598afeed1e2523bf135e7ee1d0865bf24fa8029d5f452cea9df568e12856ef999a77dcd955fd66f49f0a87d60f3c8ce5e39503face40ae74\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 73, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"These data suggested that during severe hemolysis, heme mediated ferroportin induction and low hepcidin in HbS mice (11) served to elevate systemic iron availability, required to sustain high erythropoietic demands in these mice.\", \"key\": \"289c5270ab60df184b104ee96347eb40cefc7cd2bd51f27ebe3618e0fde36e4b948748a89f6152201decae982951dab0c688ee90b3987052c5d7e17b9ff1ee63\", \"line\": 113, \"relation\": \"positiveCorrelation\", \"source\": 73, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"Our in vivo observations could be recapitulated in isolated macrophages, which upon stimulation with heme (25 lM; 16 h) demonstrated increased ferroportin mRNA and protein expression (Fig. 4A, B) and a significant decrease in the intracellular iron pool (2.2-fold; p < 0.01) (Fig. 4C).\", \"key\": \"9d3de5cc83fcf434ad3066aac6fc983a898c0170c8f5fe7f16253d36e6a1dcd9e34f1c33767bf362f00833f95ba0a0c5b09f1567ea4dd33d8747992dbb8a0dbe\", \"line\": 124, \"relation\": \"positiveCorrelation\", \"source\": 73, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"So far, our results established that in the conditions of acute and chronic heme overload, macrophages acquired high ferroportin expression and an efficient iron export.\", \"key\": \"88dfbb58923df7adbf2c50ad9f96280b7a554b80d00d6d6d95d5dff90f9874d4fd744e0897f69e513a3a404d8c4f6957d002784c647a049025fb940d66535712\", \"line\": 144, \"relation\": \"positiveCorrelation\", \"source\": 73, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"Under heme overload conditions, macrophages acquire an iron phenotype characterized by low intracellular iron and high ferroportin expression.\", \"key\": \"35913f167d878d42cf6e94d7884a80a051564559578998cf6d7a445126f7d068d20a1e78077955ea90fee15eadad23fefd2c8b2fbeaa51abec66b16ed4c9950d\", \"line\": 245, \"relation\": \"positiveCorrelation\", \"source\": 73, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"Our in vivo observations could be recapitulated in isolated macrophages, which upon stimulation with heme (25 lM; 16 h) demonstrated increased ferroportin mRNA and protein expression (Fig. 4A, B) and a significant decrease in the intracellular iron pool (2.2-fold; p < 0.01) (Fig. 4C).\", \"key\": \"d0ab38c3592ffa9c216d9f2b96735feab227c40f1fda0cf26fcea8ec8b09bc9ff101d6cf0a3ba457dae30fb5c5d72a074c0e3d28cb18c1899cd868f0cbb20e69\", \"line\": 123, \"relation\": \"positiveCorrelation\", \"source\": 73, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"These data suggested that during severe hemolysis, heme mediated ferroportin induction and low hepcidin in HbS mice (11) served to elevate systemic iron availability, required to sustain high erythropoietic demands in these mice.\", \"key\": \"83322dfe6fd5c5e56d2af4249fe53262d9cecf74e7bec6f1b277429ab85dc8024efe34c3c1f16cfb057491955b012e3a83b036aca8652226742bbe1d2ed01b6d\", \"line\": 114, \"relation\": \"positiveCorrelation\", \"source\": 73, \"target\": 5}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"We showed that simulation of macrophages with LPS resulted in significant reduction in ferroportin mRNA and protein expression and enhanced intracellular iron deposition throughout all time points tested (Fig. 5A–D).\", \"key\": \"d1b74933b8d47ea98d13ad1e077cd755df9106fff542717c44bfaf20aec20928b32e2da0f3a48d1fa2e54ef6719160918e3dfcee1fcf401e3bac6760c4b12fa4\", \"line\": 154, \"relation\": \"negativeCorrelation\", \"source\": 73, \"target\": 11}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"This dramatically contrasts the iron phenotype that develops in response to LPS, hallmarked by high intracellular iron levels and low ferroportin expression (10, 20, 48).\", \"key\": \"5a78711b718b6fc0d1c85b7ef9ac2c9a0126907b931898134360e9eb447be3901405eed82289c20f2dad0f183050ffaeebe65b867a1e42dee4ee5ef2d6f2cab2\", \"line\": 253, \"relation\": \"negativeCorrelation\", \"source\": 73, \"target\": 11}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"We showed that simulation of macrophages with LPS resulted in significant reduction in ferroportin mRNA and protein expression and enhanced intracellular iron deposition throughout all time points tested (Fig. 5A–D).\", \"key\": \"ca471388526745b0f8fd0d3dae473348e9ae52368fb42d28c16846e63b7e45759a02d4f34fc6c81349dac4b8235fb4565786abf6ea3a993605f43f595addd4c2\", \"line\": 153, \"relation\": \"negativeCorrelation\", \"source\": 73, \"target\": 11}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"The ability of cells to generate MPs in vivo is an important regulatory mechanism of physiologic reactions, a means for intercellular communications and a pathogenic component in many diseases that impact hemostasis and thrombosis [50, 51].\", \"key\": \"c65dca65673fc25bef7e43220d947f03efea5f9e2971f0a1ee190bce0e5144b30eff9cc749e70a92e3c2aa936a25f322e1524192bd167530a47e2bb2697d0461\", \"line\": 277, \"relation\": \"positiveCorrelation\", \"source\": 18, \"target\": 42}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"The ability of cells to generate MPs in vivo is an important regulatory mechanism of physiologic reactions, a means for intercellular communications and a pathogenic component in many diseases that impact hemostasis and thrombosis [50, 51].\", \"key\": \"99b1044ed90a71abf56a8da78595efbc62d15a6f3097b42f0641731e413c01eb9c3405f820c2251a315e35a70d401895dfa8442a25b7b68819a8d8ae1850d552\", \"line\": 278, \"relation\": \"positiveCorrelation\", \"source\": 18, \"target\": 99}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"The circulating MPs can internalize free heme and transfer it to vascular endothelium, promoting vaso-occlusion, or amplify systemic inflammation via thrombin mediated activation of the complement system [57].\", \"key\": \"8cff53235c795740484cd36a4e14112307f98f7b70921b535c64ace928615a6ad53a195abb77fdc37bda7cd501f12326a270e97c05e9db5a362eff7e834434f3\", \"line\": 298, \"relation\": \"increases\", \"source\": 18, \"target\": 77}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"The circulating MPs can internalize free heme and transfer it to vascular endothelium, promoting vaso-occlusion, or amplify systemic inflammation via thrombin mediated activation of the complement system [57].\", \"key\": \"0fd797e469231ffb911210308fd7055ff936b52f05ca4cdabc0856723492064be3666df490784d4a891f8908fc888826517c5023c2cb2e9091185d9980be8c45\", \"line\": 299, \"relation\": \"increases\", \"source\": 18, \"target\": 28}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Endothelium\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Surface accumulation of MAC may be at least partially responsible for the activated platelet phenotype seen in patients with primary Cys89Tyr CD59 mutation, as manifested both by increased CD62P expression and monocyte-platelet aggregates.\", \"key\": \"1b8c43a5650864e91d0d3dc1f7fef84b0ca7d98f30f342523c93eacc7a6eae5b0f50ce07cc50416334f3b4c0f3b127492920fd202cab379fb9999fc23a155334\", \"line\": 371, \"relation\": \"positiveCorrelation\", \"source\": 18, \"target\": 40}, {\"key\": \"364df447d512edc6268d744a4e86f0983b96864a51fa6ef0eb5c7960cb5c2c4d2bea100a5012a5a7ffe4aaced45af45562b7271af1cd180da227a2ca87b83b93\", \"relation\": \"hasComponent\", \"source\": 46, \"target\": 10}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"MeSHAnatomy\": {\"Human Umbilical Vein Endothelial Cells\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"In contrast, less ATP depletion was observed during exposure to heme-albumin, and no effect could be detected when either cell type was exposed to metHb or oxyHb at concentrations of up to 500 lmol\\u0001L\\u00031, even in the absence of serum.\", \"key\": \"38612e0f7e53ba13feb77073a66dac13e37c992adda09ae0bb31b12edad94392a0e6b974a7aae41b67abd342aff77f56c92f6eb39f0b246f33f8f7c9e0a904f5\", \"line\": 130, \"relation\": \"positiveCorrelation\", \"source\": 46, \"target\": 1}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"This experiment demonstrated that under serum-free conditions, 4 hours of exposure to NaOH-dissolved heme induced complete deterioration of mitochondrial respiration at concentrations as low as 10 lmol\\u0001L\\u00031, while exposure to albumin-associated heme in the presence of 2% FCS stimulated respiratory capacity to levels above baseline.\", \"key\": \"bc4f86ce318d338a7c01c4e62d5ad103aeafc6f78690ce2d2ddb105b2b9adb96b6a83d3f9113b5f7d93df9678c6346a1758931df4ec878feadd947c103310aca\", \"line\": 142, \"relation\": \"positiveCorrelation\", \"source\": 46, \"target\": 27}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"However, similar to Hb, heme-albumin did not induce an inflammatory response in macrophages or endothelial cells in the presence of low concentrations of serum.\", \"key\": \"5508a27feaf46b9f826e5f56f5507646c2012528eae446c0ad8931d99585cb1f55b2a763169e72aede636e9a5a64765b6677fd9070f920f69bd715dfaa99fe81\", \"line\": 217, \"relation\": \"negativeCorrelation\", \"source\": 46, \"target\": 31}, {\"annotations\": {\"MeSHDisease\": {\"Hematoma\": true}, \"Species\": {\"Bos taurus\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Gao Z\", \"Li H\", \"Wang P\", \"Wu J\"], \"date\": \"2019-04-01\", \"first\": \"Wang P\", \"last\": \"Li H\", \"name\": \"Molecular and cellular biochemistry\", \"pages\": \"57-66\", \"reference\": \"30324533\", \"title\": \"Tyrosine residues of bovine serum albumin play an important role in protecting SH-SY5Y cells against heme/H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;/NO&lt;sub&gt;2&lt;/sub&gt;&lt;sup&gt;-&lt;/sup&gt;-induced damage.\", \"type\": \"PubMed\", \"volume\": \"454\"}, \"evidence\": \"Monzani et al. [10] also concluded that the heme-SA complex promotes H2O2 activation processes that bear the characteristics of enzymatic reactions and may have biological relevance.\", \"key\": \"6a70038b905332bf61184e6eadee80e98cd912c96a2a61cb77182cfa8ec96b237add616c5b029fc8604516f5517bc09e18fc8cb53d9363743ea73ce750292a46\", \"line\": 252, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"increases\", \"source\": 46, \"target\": 4}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"In endothelial cells, we found that, in the absence of serum, heme-albumin triggered a dose-dependent HMOX1 protein expression signal in an exposure range of 0–175 lmol\\u0001L\\u00031.\", \"key\": \"1f8a67bd77c90ca1ee6a2765587dc69adbbbf9373c235413f14ae2763d7d012f458fa6c727552e3238134bcc78cc5e09681f4b92e24c4bf1e67d4e75cba47f69\", \"line\": 150, \"relation\": \"positiveCorrelation\", \"source\": 46, \"target\": 55}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"heme-albumin is also a robust inducer of dose-dependent HMOX1 expression in BMDMs (Figure 2D).\", \"key\": \"6f114de67a062058f09dfc81948a1da22e7356920fa090d09b9ea1d6415a70a726d366cf0b7e1ebaf4345d76b2f32f31be8f3c1ab5da07c70f035ebbabd00176\", \"line\": 155, \"relation\": \"positiveCorrelation\", \"source\": 46, \"target\": 55}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"heme-albumin, in contrast, induced HMOX1 in a dose-dependent manner.\", \"key\": \"2ef712ca1402b23c604fda4cac8e96c1e0370667c144a0f871f263dd2ec8d795ec928b5730fe5db2a62dff6a054decce0d9d8c69546edeaadac9099a1b90dc85\", \"line\": 160, \"relation\": \"positiveCorrelation\", \"source\": 46, \"target\": 55}, {\"key\": \"aebe79f65fb86448bb2c66ab3deef00e56bc5690fb0a5718ae87702287d840190b4a3aaf303e87bbb4a45e82ae300dda04a1e5409615d2e96a88d03ff86c4dda\", \"relation\": \"hasComponent\", \"source\": 50, \"target\": 17}, {\"annotations\": {\"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"These results demonstrate that transfusion with SRBCs and simultaneous infusion of exogenous hemopexin results in decreased levels of circulating cell-free heme.\", \"key\": \"43a2d76a42051e4606eb22155ee5f92f974be5cb4ebb5d296bd6235e4138e070c516cb79677b9e012a1f33807b9b267a5184fe29c5b1042662e7607a0917dea5\", \"line\": 197, \"relation\": \"negativeCorrelation\", \"source\": 50, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney Cortex\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Tissue iron staining revealed greater cortical iron accumulation in the kidneys of mice resuscitated with SRBCs, SRBCs combined with albumin and SRBCs combined with hemopexin than in the kidneys of mice transfused with FRBCs (Figure 6A and B).\", \"key\": \"3d1c0baf204fb69c35f71ff1c06e8b092d2f39c75a6f45fd8f7f6534d689fff003f82f66de132716a843dd6e6c7b202dacd0d2d8871aa438b0fd1e0c7745d2f1\", \"line\": 287, \"relation\": \"positiveCorrelation\", \"source\": 50, \"target\": 5}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Mice that were resuscitated with SRBCs and albumin or SRBCs and hemopexin showed a marked increase in HO-1 expression when compared to mice resuscitated with FRBCs.\", \"key\": \"9b27ba2b3a500ca11be39be369ba8603cbb7c1ebb93eb574c57949ceb5ce9884cc1895835191345c5974f3520fbb7db6db2548a0e666c279ea77ec68d9353318\", \"line\": 339, \"relation\": \"positiveCorrelation\", \"source\": 50, \"target\": 66}, {\"key\": \"0f8e85ffebc00de9fff5615cfabba5e4d2b2e8b8ae22e7fcaec7ff568f2649093149abc5dcc003d59a867c370ef7eee23abd73cca9a3d060e08fcdbe8305b8ee\", \"relation\": \"hasComponent\", \"source\": 50, \"target\": 67}, {\"annotations\": {\"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Infusion of hemopexin together with SRBCs resulted in a 6.4-fold (95% CI [5.2 – 7.6]) increase in plasma hemopexin levels at four hours after transfusion (Figure 3D).\", \"key\": \"3664e451f4cbf48e0ab776c0ea1c43f1ba1d8aa017fb41af11cb639fad6417405e2f3a90ba759e448478c83dc99f1b8892f6eee06dae01c4fc168294d556e39e\", \"line\": 186, \"relation\": \"positiveCorrelation\", \"source\": 50, \"target\": 67}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \". Interestingly, NLRP3 knockdown and mROS inhibitors reduce brain edema and improve neurological functions (Ma et al., 2014).\", \"key\": \"4bf0551bd67c1671f9725795fe3a661e7bb927a50e06ea0447b9a00c8fafa0ab8ee560b4e2a829604de30b701902e750df0c67f61140f625240979952e6eef79\", \"line\": 649, \"relation\": \"positiveCorrelation\", \"source\": 62, \"target\": 81}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Indeed, TLRs and NLRP3 have been associated with atherosclerosis development.\", \"key\": \"47285796a7af33a3c8dffffd40667bc6f659df3988d5d2f3f9240fccfd2bdc9db73f69e8e6a26c080e45d964a753bc0a418a5591839bbd0eb16d9af3dea15d24\", \"line\": 657, \"relation\": \"increases\", \"source\": 62, \"target\": 92}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Danio rerio\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Chambers I\", \"Hamza I\", \"Krause M\", \"Phillips J\", \"Yun S\", \"Zhang J\"], \"date\": \"2018-09-01\", \"first\": \"Zhang J\", \"last\": \"Hamza I\", \"name\": \"PLoS genetics\", \"pages\": \"e1007665\", \"reference\": \"30248094\", \"title\": \"Hrg1 promotes heme-iron recycling during hemolysis in the zebrafish kidney.\", \"type\": \"PubMed\", \"volume\": \"14\"}, \"evidence\": \"It has been reported that an increase in extracellular heme activates NLRP3 expression, triggering inflammasome activation [28].\", \"key\": \"9cfe317a49a9f4909a69240dab5bb941fb41115d7baccb650a03aafd41c879ca97837c8825bb95d2cc3201a234863271d85a770f3cc93ce86067b4c73d1b743b\", \"line\": 142, \"relation\": \"positiveCorrelation\", \"source\": 62, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"SnPP and CO had similar inhibitory effects on NF-kB activation in the liver (data not shown).\", \"key\": \"a177a9abad1a2d7ac6b253045dd52c05479adac62c4d73da65204e9d1cb1b044b631c66783e2594dc4e29c0b628d0a3d5f3e9d941257d2b367a5bd225a66edc8\", \"line\": 196, \"relation\": \"negativeCorrelation\", \"source\": 70, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 2}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Compared to Hb alone or Hb + albumin infused animals, sickle mice co-infused with Hb + Hp, Hb + Hpx, or Hb + Hp + Hpx had markedly diminished hepatic NF-κB activation 4h after infusion as evidenced by nuclear NF- κB phospho-p65 levels (Fig 2A).\", \"key\": \"abf2692b855a499d33273ab92a54b8e7f95438350e8d8b050fbb8d8b29c347cd84d470d3bc02a22317889742fe3b3f0f8d22d049a41f26e12fd523f61d45c1cf\", \"line\": 151, \"relation\": \"negativeCorrelation\", \"source\": 70, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 67}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Cells deficient on FtH are more susceptible to oxidative damage, while increased amounts of FtH protects cells from death induced by challenges such as Fe, tumor necrosis factor (TNF), heme, heme plus TNF, or oxidized low-density lipoprotein (LDL; Juckett et al., 1995; Pham et al., 2004; Gozzelino et al., 2012).\", \"key\": \"55dac23a4ac30f828aec78f7516b4370bda539d94e182924adfc7d66432f34b25d23d36151791d403897e43d7681de0d04a5d2813456d1bce85de2abbcd3efb1\", \"line\": 170, \"relation\": \"decreases\", \"source\": 53, \"target\": 39}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Cells deficient on FtH are more susceptible to oxidative damage, while increased amounts of FtH protects cells from death induced by challenges such as Fe, tumor necrosis factor (TNF), heme, heme plus TNF, or oxidized low-density lipoprotein (LDL; Juckett et al., 1995; Pham et al., 2004; Gozzelino et al., 2012).\", \"key\": \"9b05707d351dadcfabc4fae05fa6e7c7ddc152fbcc24ac380b9805cdadd19ee578fcaff9d056a703cf4504363a8c34202c190d95abca31c62d818042363b7262\", \"line\": 172, \"relation\": \"decreases\", \"source\": 53, \"target\": 5}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Cells deficient on FtH are more susceptible to oxidative damage, while increased amounts of FtH protects cells from death induced by challenges such as Fe, tumor necrosis factor (TNF), heme, heme plus TNF, or oxidized low-density lipoprotein (LDL; Juckett et al., 1995; Pham et al., 2004; Gozzelino et al., 2012).\", \"key\": \"ef0a92d96914a79304d6964e30acb476f802e12726659287a71e839c06fba3dc9497e464f30a0914194633581b75be6c82128740aa51aea70345b589e1651071\", \"line\": 173, \"relation\": \"decreases\", \"source\": 53, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Cells deficient on FtH are more susceptible to oxidative damage, while increased amounts of FtH protects cells from death induced by challenges such as Fe, tumor necrosis factor (TNF), heme, heme plus TNF, or oxidized low-density lipoprotein (LDL; Juckett et al., 1995; Pham et al., 2004; Gozzelino et al., 2012).\", \"key\": \"cae4d002750432e59a3e2810629d4a4a603639650ec6b0075036843509407af7cdbb8634b15ddfa807aea344d6a47f8e93d622813b551c46e8ef9d06a88f3704\", \"line\": 171, \"relation\": \"decreases\", \"source\": 53, \"target\": 64}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Akerström B\", \"Axelsson J\", \"Casslén V\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Holmqvist M\", \"Johansson ME\", \"Larsson I\", \"Ley D\", \"Marsal K\", \"Mörgelin M\", \"Rippe B\", \"Rutardottir S\", \"Shohani B\", \"Wester-Rosenlöf L\"], \"date\": \"2014-01-01\", \"first\": \"Wester-Rosenlöf L\", \"last\": \"Hansson SR\", \"name\": \"PloS one\", \"pages\": \"e86353\", \"reference\": \"24489717\", \"title\": \"A1M/α1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"The expression of A1M is up-regulated by elevated levels of free Hb, heme and ROS [23].\", \"key\": \"cf2506e1f66429520bf2dcf103410f3f3938c48d0e1e298976edb68b52d8189e2b4a4657fa08928e5e8c21010af43365a1ee733d7c8a94f6083668b0c353d2e0\", \"line\": 92, \"relation\": \"positiveCorrelation\", \"source\": 51, \"target\": 10}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Placenta\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Furthermore, the plasmaand extravascular reductase and heme- and radical scavenger α1-microglobulin (A1M) binds and degrades free heme and can reduce metHb [28–30].\", \"key\": \"44887c72f9623a58c1911bbb752fbe300dba3d67b25dff2249755e0fda9291e5c0472da9d30a0b41f006f9cd8ed47798922b9690eb6cd6cea8e74607fc4e0608\", \"line\": 126, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"increases\", \"source\": 51, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Excess extracellular heme is weakly bound to albumin [22], /1-microglobulin (which can also degrade heme) [23] and, most likely, to other plasma proteins and lipoproteins; there is a dynamic nature to such interactions.\", \"key\": \"0ce64aa8096657103c2195366be43acba1d7d7a6959b42253046bed7d6929ea52ee0b355e6d92562a03e1c9d8be4ac8fecd1cf77c6523e3cef54f792a7c8e687\", \"line\": 124, \"relation\": \"decreases\", \"source\": 51, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Synovial Fluid\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"Expression and synthesis of A1M has been shown to be upregulated in cells after exposure to heme and ROS (Olsson et al., 2007, 2011).\", \"key\": \"e4ed9656d849aa6c5275c1cb5088d56bae18e57ffc12eef669a2109d27400f108c6b7b1209b789ff8422b90787c93b0abea7179009b333420ae280bab8657f19\", \"line\": 258, \"relation\": \"positiveCorrelation\", \"source\": 51, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Synovial Fluid\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"This is consistent with our findings here that both heme and Hb were associated with increased levels of synovial fluid A1M.\", \"key\": \"e79217835575d098fc315e272f1fe421fa4117b2ef85902a0fdc7c405b447888b00164c9656392e78e233fa2ec846f43dc0e310b4c6d9d5e317d8400cd420836\", \"line\": 266, \"relation\": \"positiveCorrelation\", \"source\": 51, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Akerström B\", \"Axelsson J\", \"Casslén V\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Holmqvist M\", \"Johansson ME\", \"Larsson I\", \"Ley D\", \"Marsal K\", \"Mörgelin M\", \"Rippe B\", \"Rutardottir S\", \"Shohani B\", \"Wester-Rosenlöf L\"], \"date\": \"2014-01-01\", \"first\": \"Wester-Rosenlöf L\", \"last\": \"Hansson SR\", \"name\": \"PloS one\", \"pages\": \"e86353\", \"reference\": \"24489717\", \"title\": \"A1M/α1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"The expression of A1M is up-regulated by elevated levels of free Hb, heme and ROS [23].\", \"key\": \"9b7a095d5f632870d9f6107c1a79b9088c038c96a963e2ed9fd551504e1180f5cda0be1fc4f748125fd46ad75b99c26f419d0adabaf8c3e7b7e8170d4f9d26ed\", \"line\": 93, \"relation\": \"positiveCorrelation\", \"source\": 51, \"target\": 22}, {\"annotations\": {\"MeSHAnatomy\": {\"Synovial Fluid\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"Expression and synthesis of A1M has been shown to be upregulated in cells after exposure to heme and ROS (Olsson et al., 2007, 2011).\", \"key\": \"e9e68d2b6a0808b4b0b97d0dae18b2cd8cb992ff3babcbc9e5a14dc5b6ee9eebdd5148cc722f4022c88b41794b2195ff9241c5830986fb978ddd10ba3e5225da\", \"line\": 259, \"relation\": \"positiveCorrelation\", \"source\": 51, \"target\": 22}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Akerström B\", \"Axelsson J\", \"Casslén V\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Holmqvist M\", \"Johansson ME\", \"Larsson I\", \"Ley D\", \"Marsal K\", \"Mörgelin M\", \"Rippe B\", \"Rutardottir S\", \"Shohani B\", \"Wester-Rosenlöf L\"], \"date\": \"2014-01-01\", \"first\": \"Wester-Rosenlöf L\", \"last\": \"Hansson SR\", \"name\": \"PloS one\", \"pages\": \"e86353\", \"reference\": \"24489717\", \"title\": \"A1M/α1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"The placenta histology revealed an increased erythrophagocytosis in the starved placebo treated animals compared to controls. A1M-treatment appeared to attenuate phagocytosis (Figure 5).\", \"key\": \"03aeba14b29b1ff1a519772fef101e6ca97d3d9fd014eb6eb30c40ed3ca30e02f2f526905e48bff3df271e36aee1d80e422da14f679b639823d3a109f4a03d2a\", \"line\": 109, \"relation\": \"decreases\", \"source\": 51, \"target\": 43}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Kidney Tubules, Proximal\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Akerström B\", \"Axelsson J\", \"Casslén V\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Holmqvist M\", \"Johansson ME\", \"Larsson I\", \"Ley D\", \"Marsal K\", \"Mörgelin M\", \"Rippe B\", \"Rutardottir S\", \"Shohani B\", \"Wester-Rosenlöf L\"], \"date\": \"2014-01-01\", \"first\": \"Wester-Rosenlöf L\", \"last\": \"Hansson SR\", \"name\": \"PloS one\", \"pages\": \"e86353\", \"reference\": \"24489717\", \"title\": \"A1M/α1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"However, A1M treatment resulted in a transient increase in the total number of platelets 48 hours after the first injection and peripheral white blood cells, monocytes and lymphocytes 24 hours after the first injection.\", \"key\": \"ad41b2e649d6fbb96029fdc6ffa0f55facdb5e440f6a19c36d47b5007fc6c7e4447ceb411911696a689082bad99e23a4eef8d5115d81aae6a3ae1f6dab0bc86c\", \"line\": 139, \"relation\": \"positiveCorrelation\", \"source\": 51, \"target\": 25}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Analysis of plasma levels of the heme- and radical scavenger A1M showed a statistically significant increase of plasma A1M concentration in women with PE (p-value 0.035) as compared to controls (Table 3).\", \"key\": \"39c2774f78184fd1fb5aa493479c1fd96800cd0807cfb80893d4b65d1bb808ea65e97761bdfa7f3ea863588ab38474d7993dce4b6e50ebf38cc01cb9bc908879\", \"line\": 168, \"relation\": \"positiveCorrelation\", \"source\": 51, \"target\": 86}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"In line with previously published studies [13,14] the extravascular heme- and radical scavenger A1M was significantly increased in plasma of women with PE.\", \"key\": \"4826090d085329ba8f2368392fcee02b5f9fdb9e6b18a26bdecc1ad4ac6fab2df4e015802659f60714633823d72bcf18194f88d276b9c95b1fd899c0b0159490\", \"line\": 192, \"relation\": \"positiveCorrelation\", \"source\": 51, \"target\": 86}, {\"annotations\": {\"MeSHAnatomy\": {\"Knee\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"Another protein that in the last decade has been shown to play a central role as a protective protein against oxidative stress is a1-microglobulin (A1M) (Åkerström and Gram, 2014).\", \"key\": \"a16ae915cb8bcbe21ddffe4c6e156d13fd5d902936ef7376a1dea02bbe715ba84543a3be4f0ca287ad20ce8928e788e012b2f5c155bb33e1a30712e1e916d43c\", \"line\": 169, \"relation\": \"decreases\", \"source\": 51, \"target\": 39}, {\"annotations\": {\"MeSHAnatomy\": {\"Synovial Fluid\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"However, with A1M increased in both synovial fluid and serum in AIA, the present study further suggests that, in addition to heme and ROS, A1M may be regulated by inflammatory cytokines.\", \"key\": \"0cd4af6293cea5ae8cea9965799f646ffe13e672d441501cf8fa6d73d4ed352c82960b7e49d00e234872c4942fdf77de73ce75f6df0f3c5caf442047b3625934\", \"line\": 275, \"relation\": \"positiveCorrelation\", \"source\": 51, \"target\": 24}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Kidney Tubules, Proximal\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Akerström B\", \"Axelsson J\", \"Casslén V\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Holmqvist M\", \"Johansson ME\", \"Larsson I\", \"Ley D\", \"Marsal K\", \"Mörgelin M\", \"Rippe B\", \"Rutardottir S\", \"Shohani B\", \"Wester-Rosenlöf L\"], \"date\": \"2014-01-01\", \"first\": \"Wester-Rosenlöf L\", \"last\": \"Hansson SR\", \"name\": \"PloS one\", \"pages\": \"e86353\", \"reference\": \"24489717\", \"title\": \"A1M/α1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"Treatment with A1M led to a small, non-significant, transient increase in plasma interleukin 6 24 hours after the first injection.\", \"key\": \"b3402aca190c27d657bf5a5f928d8ca5cf1908ccd0173b44d624f25f1c1b8f17db17f09bc8af2fabdc72991b4ff13af3dbd2537424148dfcff76c5ef88e977f1\", \"line\": 146, \"relation\": \"increases\", \"source\": 51, \"target\": 59}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Akerström B\", \"Axelsson J\", \"Casslén V\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Holmqvist M\", \"Johansson ME\", \"Larsson I\", \"Ley D\", \"Marsal K\", \"Mörgelin M\", \"Rippe B\", \"Rutardottir S\", \"Shohani B\", \"Wester-Rosenlöf L\"], \"date\": \"2014-01-01\", \"first\": \"Wester-Rosenlöf L\", \"last\": \"Hansson SR\", \"name\": \"PloS one\", \"pages\": \"e86353\", \"reference\": \"24489717\", \"title\": \"A1M/α1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"The expression of A1M is up-regulated by elevated levels of free Hb, heme and ROS [23].\", \"key\": \"21b902d0cfb76793ecd95caa8249d1b08ab0f06d6da4bb19caba17329788ffe5ba5e93fe7408c6e23d7a163ebcb380674af75af848cb26b9811ddb1ce7840ec5\", \"line\": 91, \"relation\": \"positiveCorrelation\", \"source\": 51, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Synovial Fluid\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"This is consistent with our findings here that both heme and Hb were associated with increased levels of synovial fluid A1M.\", \"key\": \"3406aaa6b99113e557e59313650f05cc12706bf5c57c7444c75463e0884590b47a1810cf5d08fa73cdd60755ff2c9a0d00182bb267f5c14fd1ca6c09d9324d73\", \"line\": 267, \"relation\": \"positiveCorrelation\", \"source\": 51, \"target\": 54}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"As shown in Figure 3, the level of heme degradation is highly correlated with the level of metHb in RBCs (R = 0.6233, p < 0.0177) supporting the hypothesis that the heme degradation product formed in PRDX2 knockout mice is associated with the un-scavenged H2O2 generated during Hb autoxidation.\", \"key\": \"558ac9a4a6c48e095466952d6f849d80a0a4afbad4bb6266fd7ea3c104ab7bfd3457621108bd7766d774bb104a995236c84321c82140f0c726ec77a290c37a20\", \"line\": 149, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"positiveCorrelation\", \"source\": 4, \"target\": 10}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Once intercalated into cellular plasma membranes heme amplifies cellular susceptibility to oxidative-mediated injury by oxidants such as H2O2 or those derived from activated inflammatory cells (Balla et al., 1991a,b, 1993).\", \"key\": \"ac13992ee57158ed417213c0c69f5d55b64bd10d545dddb8f487cb967b5d337423ede594536881fa3bfda597009896f7b4a5968a3432e42ec21ae7429287a25d\", \"line\": 191, \"relation\": \"increases\", \"source\": 4, \"target\": 39}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"5 min\": true}}, \"citation\": {\"authors\": [\"Barnes S\", \"Harper VM\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\", \"Sun CW\", \"Townes T\", \"Wilson L\"], \"date\": \"2015-02-01\", \"first\": \"Harper VM\", \"last\": \"Patel RP\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"294-307\", \"reference\": \"25264713\", \"title\": \"Peroxiredoxin-2 recycling is inhibited during erythrocyte storage.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Finally, slower Prx-2 reduction correlated with increased H2O2 (10 lM)-induced hemolysis of day 35 RBC compared with day 7 RBC (Fig. 1D).\", \"key\": \"32fe40a1ecc5fae3c8c7eb93b6a4f86a289b38bd0deb795cbac47a69f72cb61cd9f9a7654701086cd1b4afc5da9cb9633ed1815b7f8042ca5c5454dff221af8c\", \"line\": 127, \"relation\": \"positiveCorrelation\", \"source\": 4, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The appreciable increase in heme degradation for RBCs from PRDX2 knockout mice in the presence of azide indicates that PRDX2 plays a major role in scavenging H2O2 in the absence of catalase, even with GPx present.\", \"key\": \"6c9faf5dd30caca319f71934ef73a4244b0451b9ec0cb96d249984a828f4c50718a5fb4543c345a7ed9f685c9364ada2081fe7ebe76b1c0dca741a01cfd684b3\", \"line\": 179, \"relation\": \"negativeCorrelation\", \"source\": 4, \"target\": 72}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"GPx removes both H2O2 and organic hydroperoxides [8,31] whereas PRDX2 removes H2O2 [2], organic hydroperoxides, lipid hydroperoxides, [32,33] peroxynitrite [34] and protein hydroperoxides [35].\", \"key\": \"d444a339335b01749cb0eba2f4059e53b0be3a08669d85af75ab1b64649fde0c26844f38a33298e1958d9454a5f0dde77d05e97da8a3c7e50f07e12a806c8da2\", \"line\": 191, \"relation\": \"negativeCorrelation\", \"source\": 4, \"target\": 72}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The in vivo effects that we have observed for PRDX2 knockout mice (Figures 1–4) imply that PRDX2 plays an important role in neutralizing the H2O2 generated in vivo (Figure 6).\", \"key\": \"f0fcc6080fd085e564f2792d27441d35b683e22b64e32f38f83b69dfe10ddfa5513671f68050d3156dc168ed7b2828af36d9e68a4063dafd013de884e74cab04\", \"line\": 206, \"relation\": \"negativeCorrelation\", \"source\": 4, \"target\": 72}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Barnes S\", \"Harper VM\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\", \"Sun CW\", \"Townes T\", \"Wilson L\"], \"date\": \"2015-02-01\", \"first\": \"Harper VM\", \"last\": \"Patel RP\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"294-307\", \"reference\": \"25264713\", \"title\": \"Peroxiredoxin-2 recycling is inhibited during erythrocyte storage.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Peroxiredoxin-2 (Prx-2) has emerged as the critical antioxidant protecting RBCs from H2O2 produced endogenously (by Hb autoxidation and subsequent superoxide dismutation) and exogenously (e.g., from activated neutrophils) at low (physiologic) concentrations (11, 32, 38, 40, 43, 45) and, therefore, may limit oxidative injury to other cells/tissues in the vasculature (6, 57).\", \"key\": \"4e9f535bbb1622e3082684086cb19428fbaaca58ee5ef8624309829b7e1b0fbaf6b2f4a7a56339c99ae0f9ca7d68a8943cd58584c36301155844c0b468345d47\", \"line\": 101, \"relation\": \"negativeCorrelation\", \"source\": 4, \"target\": 72}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Spleen\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Likewise, NAC was able to prevent iron-induced M1 polarization in M0, M1, and M2 BMDMs (supplemental Figure 13), indicating that the alteration of macrophage plasticity in response to iron is mostly explained by its pro-oxidant properties.\", \"key\": \"6c4c2d20d417c2ba19eee24f725bb7c64a28514e6ebf97070bd3075023a1ba1f4ab6fe86524c4b50a5490481318e7043bca8d02b23d13cec3706f32fea823634\", \"line\": 233, \"relation\": \"negativeCorrelation\", \"source\": 0, \"target\": 14}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Spleen\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Similarly, NAC prevented increased expression of MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and mildly compensated for the decrease of CD206 and IL-10 following heme treatment (Figure 4D; supplemental Figure 5).\", \"key\": \"9442f9a1997e8cd33d6e91e37b75d6d0387c1e7fbb54efce5c54d190c5621d2c143082f4b6989bd3e74d4d3e2b92f65c7370fea9e5facdace7a488efa3e3863d\", \"line\": 221, \"relation\": \"decreases\", \"source\": 0, \"target\": 59}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Spleen\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Similarly, NAC prevented increased expression of MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and mildly compensated for the decrease of CD206 and IL-10 following heme treatment (Figure 4D; supplemental Figure 5).\", \"key\": \"5946a89779767e3c89591b38aca3a0125e3530b23bf68a38eefa3f58ccd085adc71deed4f2a75731fa605d0d0afee20af6dc815a881b138bde93c19e62db62e9\", \"line\": 220, \"relation\": \"decreases\", \"source\": 0, \"target\": 64}, {\"annotations\": {\"MeSHAnatomy\": {\"Knee\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"Lately, much evidence has emerged to support a central role for participation of local inflammatory pathways in the disease processes (Scanzello, 2017), particularly so after knee injury (Goldring and Otero, 2011).\", \"key\": \"d67b8b3b53388d09de2f5b67a94c2621ff6f2dfaa3ba4415d23884dc7d0f687ec178779a29f653260206599b82ebd81abf4ab75acf381bc6fa916d0a022c1112\", \"line\": 115, \"relation\": \"positiveCorrelation\", \"source\": 83, \"target\": 31}, {\"annotations\": {\"MeSHAnatomy\": {\"Synovial Fluid\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"Altogether, our best interpretation of these data is that increased levels of cell-free Hb and heme in synovial fluid early after injury triggered an increase in the synovial fluid A1M concentration that appeared to be protective of oxidative damage.\", \"key\": \"889c09c236dcbb5bb1233b6b7e70537970e0e00bdc814170966d28a5718eef5e22d467aaa473ccc8191ebcec8b4c4ed693e3758ca9ddacbca7fc511970d82cc7\", \"line\": 227, \"relation\": \"increases\", \"source\": 83, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Synovial Fluid\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"Altogether, our best interpretation of these data is that increased levels of cell-free Hb and heme in synovial fluid early after injury triggered an increase in the synovial fluid A1M concentration that appeared to be protective of oxidative damage.\", \"key\": \"b19be92badb5169b3d114672868c39a41a42fe8ea66e541a3cecf7ccca286fd058383df95c40339a5c9a61249112fc240dca6991a0ce26786110d07ceaa38dd7\", \"line\": 226, \"relation\": \"increases\", \"source\": 83, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Synovial Fluid\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"Altogether, our best interpretation of these data is that increased levels of cell-free Hb and heme in synovial fluid early after injury triggered an increase in the synovial fluid A1M concentration that appeared to be protective of oxidative damage.\", \"key\": \"14f994ae3a54d26b8255ee9f6994cbccb01495dfadcc8046cdbec34c0ab5bde90bdf2442e70d16c0a2baa55b76f9c4093eb386c1bad49faaeeca844998998388\", \"line\": 228, \"relation\": \"increases\", \"source\": 83, \"target\": 51}, {\"annotations\": {\"MeSHAnatomy\": {\"Ependyma\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Du H\", \"Gao C\", \"Hua Y\", \"Keep RF\", \"Strahle J\", \"Xi G\"], \"date\": \"2014-06-01\", \"first\": \"Gao C\", \"last\": \"Xi G\", \"name\": \"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism\", \"pages\": \"1070-5\", \"reference\": \"24667910\", \"title\": \"Role of red blood cell lysis and iron in hydrocephalus after intraventricular hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"34\"}, \"evidence\": \"Twenty-four hours after injection, T2 MRI showed a significant bilateral ventricular enlargement in the iron-injected group (17.9±5.7mm3) compared with salineinjected rats (9.2±5.7mm3, Po0.01, Figure 4).\", \"key\": \"0c315962a4cfdb481ec38b1a29f564c8eeafb4776bce7db11d4fed91582d6c7ec9fd7ae1a10f05c96380620b5454717823d361c024fb65694bd184a2ddddda0c\", \"line\": 145, \"relation\": \"positiveCorrelation\", \"source\": 96, \"target\": 5}, {\"annotations\": {\"MeSHAnatomy\": {\"Ependyma\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Du H\", \"Gao C\", \"Hua Y\", \"Keep RF\", \"Strahle J\", \"Xi G\"], \"date\": \"2014-06-01\", \"first\": \"Gao C\", \"last\": \"Xi G\", \"name\": \"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism\", \"pages\": \"1070-5\", \"reference\": \"24667910\", \"title\": \"Role of red blood cell lysis and iron in hydrocephalus after intraventricular hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"34\"}, \"evidence\": \"The major findings of this study are (1) intraventricular injection of lysed RBCs but not packed RBCs resulted in hydrocephalus; (2) lysed RBCs upregulated brain HO-1 and ferritin levels; (3) intraventricular injection of iron also caused hydrocephalus; and (4) iron chelation with deferoxamine reduced lysed RBC-induced hydrocephalus.\", \"key\": \"102b3dd43ace217ddf1506f275ce5700e82020d8131c8d3f08948e3a47f3a530a1fd24c28628544fdb99441fd5444a26e9f6cc981bd34d33e5551ee7a510f947\", \"line\": 173, \"relation\": \"positiveCorrelation\", \"source\": 96, \"target\": 5}, {\"annotations\": {\"MeSHAnatomy\": {\"Ependyma\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Du H\", \"Gao C\", \"Hua Y\", \"Keep RF\", \"Strahle J\", \"Xi G\"], \"date\": \"2014-06-01\", \"first\": \"Gao C\", \"last\": \"Xi G\", \"name\": \"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism\", \"pages\": \"1070-5\", \"reference\": \"24667910\", \"title\": \"Role of red blood cell lysis and iron in hydrocephalus after intraventricular hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"34\"}, \"evidence\": \"Coinjection of deferoxamine with lysed RBC reduced ventricular enlargement (47.8±17.8 vs. 59.9±15.7mm3 in saline coinjection group, Po0.05, Figure 6).\", \"key\": \"e309734843ece337fca2c71ab0ca40a29a5d88d61817053063bd1bda463f00c96cb9c59c5b537573bc721ed8c6496336f3637d5b75b17122dd43f090ff34b42f\", \"line\": 151, \"relation\": \"negativeCorrelation\", \"source\": 96, \"target\": 3}, {\"annotations\": {\"MeSHAnatomy\": {\"Ependyma\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Du H\", \"Gao C\", \"Hua Y\", \"Keep RF\", \"Strahle J\", \"Xi G\"], \"date\": \"2014-06-01\", \"first\": \"Gao C\", \"last\": \"Xi G\", \"name\": \"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism\", \"pages\": \"1070-5\", \"reference\": \"24667910\", \"title\": \"Role of red blood cell lysis and iron in hydrocephalus after intraventricular hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"34\"}, \"evidence\": \"The major findings of this study are (1) intraventricular injection of lysed RBCs but not packed RBCs resulted in hydrocephalus; (2) lysed RBCs upregulated brain HO-1 and ferritin levels; (3) intraventricular injection of iron also caused hydrocephalus; and (4) iron chelation with deferoxamine reduced lysed RBC-induced hydrocephalus.\", \"key\": \"30d1a6fc6e937e20271f4ded5c6c5135fbd1cb09b9befdcd523c2e6156b7a95777500da751b42570a296d646e7f26765e3ab4145f971f667552a02793ab1e935\", \"line\": 174, \"relation\": \"negativeCorrelation\", \"source\": 96, \"target\": 3}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"14 days\": true}}, \"citation\": {\"authors\": [\"Brandon AP\", \"Creighton J\", \"Dull RO\", \"Evans CA\", \"Honavar J\", \"Hu PJ\", \"Kerby JD\", \"Marques MB\", \"Morgan C\", \"Oh JY\", \"Patel RP\", \"Pittet JF\", \"Richter JR\", \"Stephens SW\", \"Wagener BM\"], \"date\": \"2018-03-01\", \"first\": \"Wagener BM\", \"last\": \"Patel RP\", \"name\": \"PLoS medicine\", \"pages\": \"e1002522\", \"reference\": \"29522519\", \"title\": \"Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study.\", \"type\": \"PubMed\", \"volume\": \"15\"}, \"evidence\": \"Our findings using a mouse model of trauma and hemorrhagic shock with stored blood transfusion and subsequent PAK instillation demonstrate that transfusion with older stored RBCs increases the severity of bacterial pneumonia.\", \"key\": \"d52708c16abe109f29c710a5e99e8cf2549e9d6a104a21ebda83925f6e74eecdc5e0319caa9da9abd6916fd0e3c62eeb53bbfde487aa5b8fda1693a7e81d40f4\", \"line\": 169, \"relation\": \"positiveCorrelation\", \"source\": 98, \"target\": 15}, {\"annotations\": {\"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"14 days\": true}}, \"citation\": {\"authors\": [\"Brandon AP\", \"Creighton J\", \"Dull RO\", \"Evans CA\", \"Honavar J\", \"Hu PJ\", \"Kerby JD\", \"Marques MB\", \"Morgan C\", \"Oh JY\", \"Patel RP\", \"Pittet JF\", \"Richter JR\", \"Stephens SW\", \"Wagener BM\"], \"date\": \"2018-03-01\", \"first\": \"Wagener BM\", \"last\": \"Patel RP\", \"name\": \"PLoS medicine\", \"pages\": \"e1002522\", \"reference\": \"29522519\", \"title\": \"Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study.\", \"type\": \"PubMed\", \"volume\": \"15\"}, \"evidence\": \"Hemopexin improved post-pneumonia survival in mice that underwent massive resuscitation with stored RBCs (Fig 3A).\", \"key\": \"d292e5c3d9805e653f5b883f1aab146e1d4030de23463a4b2532676b301d5f38e7deb26816ebb231124ff8d8d6c0f99ff961dd116f91f04dc88720848946dd63\", \"line\": 123, \"relation\": \"negativeCorrelation\", \"source\": 98, \"target\": 67}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"IL-1b participates in a robust inflammatory response.\", \"key\": \"3d3f0d9917e2d4f382a66fa57d772aaf524d97601b4f35cb51eb1876a51c11318434cbca7b05e8296d781d33442098019ee2b8ca05e15e257d78f9879beb456b\", \"line\": 116, \"relation\": \"positiveCorrelation\", \"source\": 58, \"target\": 31}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"TNF, IL-6, and IL-1β are pleiotropic cytokines that regulate cell death, increase vascular endothelial permeability, recruit immune cells to inflamed tissues and induce the production of acute-phase proteins.\", \"key\": \"9c1d8aa3f816a960714bf0b0bf1046763d48e63bf11539ace6c68f26b25a1526120414a26f5b96d2c0f5cd412447654592b8bc4a2d3aeb5eeda8856e6f183639\", \"line\": 291, \"relation\": \"increases\", \"source\": 58, \"target\": 97}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \" Although KC and IL-1β functions were not investigated during heme-induced inflammatory effects, TNF and LTB4 were described as essential inflammatory mediators during inflammatory events induced by heme.\", \"key\": \"cf9c8f4382be11126e1724f2bf0fd3d023df352dddfc60835f78d288a3eac018422142f3450060fc9b80f0758ea04cc1a5975eeca7d26a9f62531e26462d561b\", \"line\": 323, \"relation\": \"increases\", \"source\": 58, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"This pro-inflammatory cytokine milieu is crucial in mediating the pro-coagulant effects of vascular endothelial cells and promotes localized inflammation and thrombosis (Qari et al, 2012).\", \"key\": \"b2af84835220fee3b71c8646d95ee333dcbf690c0cdb44aadbc114911012f1dfc0996d52eb7e2d702d0bc0743aaf62a5f1187d6722f2d966eda174cd43442bec\", \"line\": 683, \"relation\": \"increases\", \"source\": 58, \"target\": 97}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Moreover, IL-1β and TNF modifies the hypothalamus threshold of the body temperature causing fever.\", \"key\": \"408216421708271bd04f530bbe7e061ba9ecc342a4853e8efa6bff2f4e24a648676b22617184bb0726f8b3b395117b6c787f0f99cd8aa471c22734a7e3b5574a\", \"line\": 299, \"relation\": \"positiveCorrelation\", \"source\": 58, \"target\": 93}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"This pro-inflammatory cytokine milieu is crucial in mediating the pro-coagulant effects of vascular endothelial cells and promotes localized inflammation and thrombosis (Qari et al, 2012).\", \"key\": \"50f50e9841cb4ba9322b74cc44c5a35a8e15125c638a66c8f010f49f227ca209a1a202646a93e65c7168352164f286eea6ce56ae9641984ec000ed705f8a0ea5\", \"line\": 684, \"relation\": \"increases\", \"source\": 58, \"target\": 99}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"For example, monocytes from SCD patients show an enhanced state of activation, with increased expression of interleukin (IL)-15 and production of TNFα and IL-1β.\", \"key\": \"49c205b96e695beca50ee21432c4935e76d1eb4f173bebc48ff2d5b0767a9e585bd4e88f0584d23f18104f467c6543d1d946c03a1926a7dd17dbb8bda6aa6332\", \"line\": 113, \"relation\": \"positiveCorrelation\", \"source\": 58, \"target\": 25}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"28 days\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"This ATP depletion was prevented by the addition of the heme scavenger, hemopexin (Figure 5b).\", \"key\": \"49a51b290b9fc4f40ea728edc055045473d9221d26ab1088c02e6ff914fae0cdac5c87e0ccca486b3e0ca17fb36cd977369f4c16d5405ac30f6b8e23d555d2af\", \"line\": 201, \"relation\": \"positiveCorrelation\", \"source\": 8, \"target\": 57}, {\"annotations\": {\"MeSHDisease\": {\"Hematoma\": true}, \"Species\": {\"Bos taurus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Gao Z\", \"Li H\", \"Wang P\", \"Wu J\"], \"date\": \"2019-04-01\", \"first\": \"Wang P\", \"last\": \"Li H\", \"name\": \"Molecular and cellular biochemistry\", \"pages\": \"57-66\", \"reference\": \"30324533\", \"title\": \"Tyrosine residues of bovine serum albumin play an important role in protecting SH-SY5Y cells against heme/H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;/NO&lt;sub&gt;2&lt;/sub&gt;&lt;sup&gt;-&lt;/sup&gt;-induced damage.\", \"type\": \"PubMed\", \"volume\": \"454\"}, \"evidence\": \"Malondialdehyde (MDA) represents evidence of systemic oxidative stress and inflammation [31], and is commonly used to estimate the level of lipid peroxidation.\", \"key\": \"292f0f7f6b2cd9611146e33f041755c75a26a167c68ef0cfbca1864c4865271df9466caaee7bc8071e9e8ad70f6346cd96374f42542cd6e2a586d35f419daf09\", \"line\": 188, \"relation\": \"positiveCorrelation\", \"source\": 12, \"target\": 39}, {\"annotations\": {\"MeSHDisease\": {\"Hematoma\": true}, \"Species\": {\"Bos taurus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Gao Z\", \"Li H\", \"Wang P\", \"Wu J\"], \"date\": \"2019-04-01\", \"first\": \"Wang P\", \"last\": \"Li H\", \"name\": \"Molecular and cellular biochemistry\", \"pages\": \"57-66\", \"reference\": \"30324533\", \"title\": \"Tyrosine residues of bovine serum albumin play an important role in protecting SH-SY5Y cells against heme/H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;/NO&lt;sub&gt;2&lt;/sub&gt;&lt;sup&gt;-&lt;/sup&gt;-induced damage.\", \"type\": \"PubMed\", \"volume\": \"454\"}, \"evidence\": \"Malondialdehyde (MDA) represents evidence of systemic oxidative stress and inflammation [31], and is commonly used to estimate the level of lipid peroxidation.\", \"key\": \"1143b13fccf66d511d65353573cd6b49b827b74d8f1157023985bf85b7198dbddc7c2504eab5640c9ac3389f454aa155718815bfe6e1bca4afb7aab5fd6f199f\", \"line\": 189, \"relation\": \"positiveCorrelation\", \"source\": 12, \"target\": 97}, {\"annotations\": {\"MeSHDisease\": {\"Hematoma\": true}, \"Species\": {\"Bos taurus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Gao Z\", \"Li H\", \"Wang P\", \"Wu J\"], \"date\": \"2019-04-01\", \"first\": \"Wang P\", \"last\": \"Li H\", \"name\": \"Molecular and cellular biochemistry\", \"pages\": \"57-66\", \"reference\": \"30324533\", \"title\": \"Tyrosine residues of bovine serum albumin play an important role in protecting SH-SY5Y cells against heme/H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;/NO&lt;sub&gt;2&lt;/sub&gt;&lt;sup&gt;-&lt;/sup&gt;-induced damage.\", \"type\": \"PubMed\", \"volume\": \"454\"}, \"evidence\": \"Malondialdehyde (MDA) represents evidence of systemic oxidative stress and inflammation [31], and is commonly used to estimate the level of lipid peroxidation.\", \"key\": \"a4c37bd975ec3994735313037fabc0698919f2a54ed43ec4f9cf9380f1c3931d52a8ae8c22a5f8a75b593c04ca9442d8960cb1b0e2e8de17a4959067e37c3de8\", \"line\": 190, \"relation\": \"positiveCorrelation\", \"source\": 12, \"target\": 38}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"Moreover they have demonstrated that released Hb plays an important role in exacerbating RBC hemolysis, establishing a damaging hemolysis/ oxidative cycle that drives further red cell damage, vascular injury, and thrombosis.\", \"key\": \"8f7cf5ce3f9fd3afb3aa65554bb9864e94124068aeff45f54ee94748a083cefdafd610392dc6c4bb1b788ba433b6c0a7d822d390053a30947027b4f06efc1cbd\", \"line\": 222, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 91}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"Moreover they have demonstrated that released Hb plays an important role in exacerbating RBC hemolysis, establishing a damaging hemolysis/ oxidative cycle that drives further red cell damage, vascular injury, and thrombosis.\", \"key\": \"05754b0b60dca377cfe310270557e4aa14b0f6b326a4aac51b97bd279c85382b26c788ec122211fe368ca0b84ceb6b8009622dcee7a25db328964634b68f2202\", \"line\": 223, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 99}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Furthermore, experiments of nature that lead to increased levels of chronic hemolysis, such as sickle cell anemia and paroxysmal nocturnal hemoglobinuria, provide evidence that low levels of hemolysis may be harmful, and contribute to inflammation, thrombosis, vasculopathy, and impaired host defenses against infection.1,11\", \"key\": \"c8f860a5d02b0f0e760bca92e44fe8daacc755c1237ba1c043be400537398b6a06c7921323bfe918b4e00c00a9d1658dd61c1e5fc70e3ae5d7d42a3fdca77804\", \"line\": 130, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 99}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Free heme is generated by intra- and extra-vascular hemolysis or extensive cell damage [14, 15].\", \"key\": \"12876318cf1f753d1cef859a4a670795e943ac3a238f2923166e12d294dc8b0989c812a2a2652da02f4eee4b0db2b2177386b38669a359aca530015759ae622b\", \"line\": 121, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"McCulloch JC\", \"Nielsen VG\", \"Redford DT\", \"Thompson JL\"], \"date\": \"2014-09-01\", \"first\": \"Redford DT\", \"last\": \"Nielsen VG\", \"name\": \"Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis\", \"pages\": \"621-4\", \"reference\": \"24553061\", \"title\": \"Left atrial myxoma presenting as pulmonary embolism: potential role of heme oxygenase-1.\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"Lysis of red blood cells with consequent increases in free heme most likely caused the increase in HO-1 activity responsible for increased COHb concentrations, which is similar to that observed with circulatory devices [6].\", \"key\": \"5fa7dc795fb4b24ef9a36fa009a2cba16be41a8d7b727aff02c30d9fbadc09c50b5ad5181d4867051613b3022ce8b83965143bf61dd4770ca78b47d8458bd225\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Haemoglobin and haem levels increase in plasma and urine when haptoglobin and haemopexin scavenging mechanisms are saturated during acute or chronic haemolysis.\", \"key\": \"46acadb55287f3f454ef4d1ca446a363df7790550e46b4ab480ebb781f829a5dad9cfbcca955f6c5d6706bb27fe4bac0d8706ab0329a23c85a9cefb84f20d0e0\", \"line\": 190, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 10}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"Concentration\": {\"40 μM\": true}, \"MeSHAnatomy\": {\"Kidney Cortex\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"The above-discussed findings provide strong in vivo evidence that high concentrations of ferric Hb(Fe3+) and free heme can accumulate in the renal cortex during hemolysis.\", \"key\": \"836281dded07b14dfd7f6883ecb23f46bb5cdfa36731e93493f1d37e95ca5097689e7d31c7386721640de50ff342a83b806735596ad4ccf28c3b93ca7d9d24dd\", \"line\": 293, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"fa04fe63380d8ff4abeb1a7c96f3cb116f73e7193530f9721a16710ab66bcde1397c60150318f473f61ddb7d9ee6e225efc733d8e211543c430ee852b284a1fb\", \"line\": 92, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 10}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"In infectious diseases, such as malaria and sepsis, high amounts of cell-free hemoglobin and heme were found [8], suggesting that hemolysis during sepsis and systemic inflammation is of pathophysiological relevance.\", \"key\": \"2ffcf9c8df95d3f2c00ad6f56c5d784d4fed12a3606fb5d1b141323dbf2ce7190549e26add189ac2f2a3031fac560e47e6e6ceb10a499ae13f739cd95b5015ce\", \"line\": 286, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 10}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Rhabdomyolysis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \" SCD and β-thalassemia are genetic diseases associated to erythrocytes that are prone to lysis due to defective Hb production (Heinle and Read, 1948; Pauling et al., 1949; Ingram, 1957; discussed later). \", \"key\": \"852e1f94b9203eb0c605d4a1717207760839e2f33e34cd8ab579dd824f2bbe5951f220c0f13136ab1400296c13ad0cbb2daccc350b478387e4c1fdce59d17b06\", \"line\": 402, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 80}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Hemolysis can happen due to ischemia/reperfusion, SCD or β-thalassemia.\", \"key\": \"414a610d67d7b637a10883e8b1805e5e8c9ba518cc6bd8865e3c03890fb217e3dd726731a1fda09b88533051f8e8aa4c3d584e08d4f0e0f7eea5e60a0db41443\", \"line\": 526, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 80}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"SCD is a haemolytic disorder caused by a HBB (b-globin gene) mutation leading to polymerization of haemoglobin S, sickling, and haemolysis.\", \"key\": \"8a401c13757e72abf59020d400420b35806f0bd440323f04cb4db008147d5fd852352fb52332e60c27d27a329bc58b41b4fc16b919bdd77f6c20a49ee27552d1\", \"line\": 260, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 80}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"5 min\": true}}, \"citation\": {\"authors\": [\"Barnes S\", \"Harper VM\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\", \"Sun CW\", \"Townes T\", \"Wilson L\"], \"date\": \"2015-02-01\", \"first\": \"Harper VM\", \"last\": \"Patel RP\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"294-307\", \"reference\": \"25264713\", \"title\": \"Peroxiredoxin-2 recycling is inhibited during erythrocyte storage.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Finally, slower Prx-2 reduction correlated with increased H2O2 (10 lM)-induced hemolysis of day 35 RBC compared with day 7 RBC (Fig. 1D).\", \"key\": \"3ec1f4cb9fa8c7b72afc201c05b08886e17d680a7d7359c8fd85253d68c62cd3d2c75d5dff23c61a22a82f52f7222867eec9da84a9aa4752a9a6fcb4f113da1b\", \"line\": 127, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 4}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"This common X-linked inherited disorder, characterized by severe intravascular and extravascular haemolysis, is classically triggered by fava bean ingestion or pro-oxidant medications. It causes haemolysis in susceptible individuals and an association with thrombosis was described in multiple case reports (Jewett, 1976; Thompson et al, 2013; Albertsen et al, 2014).\", \"key\": \"8f4b661b57b678ef1067a7cba788bf1fc80f7ec115a06ad203e1aa401e9d9290181d576396514b2256d1360b1ddc95eda6f9129a0ab4bed96535697e83ae8698\", \"line\": 333, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 13}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.\", \"key\": \"ecd92e197c5e5fca93e5cd66c9570001a2ea310197722d63171b3fec678c1a983280233c844dc2b739984a1232ee76e1a44a35e08f40e1ef1d512e4874fca057\", \"line\": 350, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 88}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.\", \"key\": \"0e63c266eddb6805abdcb9d1644b4f35c3311bc71134b29acfc99d966cdd39b54b9e739e059e54640047b029ca9bed8a861e1e8e159f4101d7ea5a841d6bd746\", \"line\": 352, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 82}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"It is crucial, hence, to further investigate the mechanisms of sepsis-induced hemolysis with the aim of deriving possible therapeutic principles. Herein, we collected the most important previously known triggers of hemolysis during sepsis, which are (1) transfusion reactions and complement activation, (2) disseminated intravascular coagulation, (3) capillary stopped-flow, (4) restriction of glucose to red blood cells, (5) changes in red blood cell membrane properties, (6) hemolytic pathogens, and (7) red blood cell apoptosis.\", \"key\": \"5765c82fe40491150e4ae1a9080cc0a12eae72a0a287bb5bcabb0f6209eb1c7c69978bbae1b0109b7f7f5e9692f6574f5c4b3709735441087dcd6775409ce72d\", \"line\": 98, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 82}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.\", \"key\": \"e3892333dae1ff6eee01aad92cfeced2df2ffd7c91470f6c3334fad87187b03fde8dfe62dcf23a74b3aa0eeabc0290efebfa4eff0c39e66614916895c86a0cd4\", \"line\": 354, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 78}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"During intravascular haemolysis, NO availability is severely limited by its reaction with oxyhaemoglobin (i.e., NO scavenging) and by breakdown of the substrate for NO synthesis, L-arginine, by arginase released from RBCs (Schnog et al, 2004).\", \"key\": \"8f0d38b3e29a85a6ad061bc723900a15f6d5155dbff4f7403b8805eccc8934a7e4e71a4f1a67816b47693d14809e56fa268c153990d74164ae710438fef08ad5\", \"line\": 428, \"relation\": \"decreases\", \"source\": 95, \"target\": 6}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, haemolysis results in NO scavenging, systemic vasoconstriction and increased blood stasis, thereby affecting one of the principle components of Virchow’s Triad.\", \"key\": \"e87d690ea27250ed9056e5559e203dd037a648a8e283112e82635bd566805ce43001a56351a9e09eee80121344e17a5f9a2da34f2ce73614d078871723416446\", \"line\": 442, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 42}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Storage is known to result in increased hemolysis which in turn results in loss of NO-signaling, oxidative stress and inflammation post-transfusion.\", \"key\": \"b488b19e98d44ccaabc7a9b6ce2a82518b399648d5c9ce147b3d15ba54ccae067f9248265e189559fa4e12abe741bb0609ff1716ff65df5c9fff9116c6341fdf\", \"line\": 162, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 15}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Interestingly, a recent study demonstrated that, in severe hemolytic disease (sickle cell anemia), at least one third of plasma heme was associated with membrane vesicle structures (microparticles) that were generated from erythrocytes during hemolysis [24].\", \"key\": \"79d9b68ce669bed8d08036c15b10918ba621ac71eef1be4de1051bed984aebf014fafdf3e82c9eb66741a8b0a0a5c4106339aca338e0a722983ae8ce5e92712c\", \"line\": 130, \"relation\": \"increases\", \"source\": 95, \"target\": 18}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Third, hemolysis results in a massive release of procoagulant RBC-derived MPs [66].\", \"key\": \"8d8965085a26cc04c1183dd37e417d66ff0079f9e44d3aaae619c5ba9fef1de173aaca849ab1490ccf8328d4be8bc62a960638d33c1255469090bf786d94baa8\", \"line\": 338, \"relation\": \"increases\", \"source\": 95, \"target\": 18}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"Erythrocyte lysis after ICH can be mediated by the complement activation and formation of the membrane attack complex (MAC), which contains complement C5b, C6, C7, C8 and C9 proteins (C5b– 9).\", \"key\": \"55122d6bf0ba4c108a44e54a2430a8b6005d74e1581e8cb9fd8d2aef9eb6782846747de64a1faa20d5eb9ecc1af2f4da6101760bb79e7ccffb0e846e13d2c64d\", \"line\": 104, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 28}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"Activation of the complement system and the formation of MAC resulted in an increased membrane permeability and erythrocyte lysis.\", \"key\": \"e1c2355920cade0cdd5971e76233492912a4ad48211469f6e7adee240cab4d4cd01b135e88663c097768c92874c5e8c7d6927eef6bc45ff7276836dc08d7aff8\", \"line\": 127, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 28}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"It is crucial, hence, to further investigate the mechanisms of sepsis-induced hemolysis with the aim of deriving possible therapeutic principles. Herein, we collected the most important previously known triggers of hemolysis during sepsis, which are (1) transfusion reactions and complement activation, (2) disseminated intravascular coagulation, (3) capillary stopped-flow, (4) restriction of glucose to red blood cells, (5) changes in red blood cell membrane properties, (6) hemolytic pathogens, and (7) red blood cell apoptosis.\", \"key\": \"ba4449bbdd7fdd67e13a4817bdfa3de214ee0d9806a5ec91f2b033f9c27c4c1c4eb7cf46787a7b6ac2b7b9be9263067913354a8722a7e358cb74b03cf779ddb0\", \"line\": 96, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 28}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"Erythrocyte lysis after ICH can be mediated by the complement activation and formation of the membrane attack complex (MAC), which contains complement C5b, C6, C7, C8 and C9 proteins (C5b– 9).\", \"key\": \"bf5a78363f67b215af4c98b818b1d9a553502e3f7153aea359ed50bf2c23b19f3dd0b55d5216772b0f1c7d9df993695fec6e54d6594cd839c188ca7ee20146ab\", \"line\": 105, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 19}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"Activation of the complement system and the formation of MAC resulted in an increased membrane permeability and erythrocyte lysis.\", \"key\": \"d9bf539a28894bafd3037cf1fd63d28e342c465125c3fb2ae029a0d3ca73b103e4c9f51bc9a9b660d0115d3370e1705623c20b3d5d48352a9d181db01728fc46\", \"line\": 129, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 19}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"Following complement cascade activation, MAC on the cell membrane forms a pore resulting in membrane permeability changes17 finally leading to RBC morphological alterations and erythrocyte lysis.\", \"key\": \"d257bc994d083f0e7be0a22980563ae5ffd4aa6ee00b19f1db25f3a3a3f2fd3ed9d049e0a35b86fda2ebf54f8acbb885734dc91587e34efb18274adb704b8ece\", \"line\": 224, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 19}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Increased MAC deposition may lead to cell lysis and hemolysis, as is usually seen in RBCs but to a lesser extent in neutrophils and platelets (please see below).\", \"key\": \"e92bf54d1e4e794698817fdcd19721bb0cd4cdb56a92e46a80d179468055ea6af29a6cf9c0cc72bc0192f3b1448d79e98d037f24d043d5380c973213a4afa1db\", \"line\": 160, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 19}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Following MAC deposition on RBCs, intravascular hemolysis that leads to increasing levels of free hemoglobin was seen.\", \"key\": \"b507f2ae9a9b60e43e896b89c53f6adcee8b4af47c5863b557781ea41a1678d3a150b9139369432bcb10bb8b7d7ca9a07667df237c7a252cd9f7c66405d9ba7a\", \"line\": 165, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 19}, {\"annotations\": {\"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"48 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"The plasma hemoglobin levels at two and four hours after SRBC-transfusion were greater than the cell-free hemoglobin levels in the supernatant of the SRBCs before transfusion (Figure 1C, Supplemental Table I), providing evidence that hemolysis occurs in vivo during and after transfusion of SRBCs.\", \"key\": \"e4f0faefc71e7cdbebd7b9e346e5db0140ffb82a1741f982827d42bad74c0cc9150181e246a3b87015d31a570ddb619dc1a4a5fcb0433d0e097c66996c5493be\", \"line\": 139, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 17}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Furthermore, experiments of nature that lead to increased levels of chronic hemolysis, such as sickle cell anemia and paroxysmal nocturnal hemoglobinuria, provide evidence that low levels of hemolysis may be harmful, and contribute to inflammation, thrombosis, vasculopathy, and impaired host defenses against infection.1,11\", \"key\": \"49257c0627d1acb9a130801c2d4080e0bee4e2ef9c6bdf46563b3b924ea8de23bfb282bca9212ecc21eeee19b3b5aa3fea7f4cb37d6cf11ec621146283e09c26\", \"line\": 128, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 97}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Thus, hemolysis can act as a kind of amplifier of the complex response to an infection or injury [8, 15] and worsen the outcome from animals and patients with systemic inflammation, sepsis, or trauma [1–4, 10].\", \"key\": \"fa00feb000b4fa9434868a772c71ec5ab6e7e026ef4966f9cfdf54b71e8a042feb63d1b9ce2e5904325fb418979875e54499180107ff1d0762dbbbee3270903c\", \"line\": 135, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 97}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Furthermore, experiments of nature that lead to increased levels of chronic hemolysis, such as sickle cell anemia and paroxysmal nocturnal hemoglobinuria, provide evidence that low levels of hemolysis may be harmful, and contribute to inflammation, thrombosis, vasculopathy, and impaired host defenses against infection.1,11\", \"key\": \"476286316e39f084b9f81eb541b5256627b51c5f5b2b5b7a297f0b423693fe644d166acdfa556c5ca8f9ee8120b870c17be5fc2f91a927e485a5a53c96b263c1\", \"line\": 129, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 90}, {\"annotations\": {\"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"The Cys89Tyr mutation in CD59 was initially described with manifestation in infancy by chronic hemolysis and relapsing peripheral demyelinating disease resembling recurrent Guillain- Barre syndrome (GBS) or chronic inflammatory demyelinating polyneuropathy (CIDP).\", \"key\": \"09bc1902dcc0539671b64520c7ecdf5b9d604e3211e65d2a73350a95d2adcaac645009b19165e8f9c2f8e9471d068cee52ce46c19a685bca89463295830238f9\", \"line\": 130, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 76}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"Moreover they have demonstrated that released Hb plays an important role in exacerbating RBC hemolysis, establishing a damaging hemolysis/ oxidative cycle that drives further red cell damage, vascular injury, and thrombosis.\", \"key\": \"0fbfe68078f996e74e9af1133c838009894cdbcfa378e8854bd08eeee7931404699339c9ceb9eb16430c2aa54fde647cf2634c83cd7e2dde1ed01320081c337d\", \"line\": 221, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 54}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Banerjee S\", \"Crumbliss AL\", \"Jia Y\", \"Kreulen RT\", \"Mollan TL\", \"Olson JS\", \"Tsai AL\", \"Wu G\"], \"date\": \"2014-04-01\", \"first\": \"Mollan TL\", \"last\": \"Alayash AI\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"265-77\", \"reference\": \"24486321\", \"title\": \"Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Hemolysis and the transfusion of banked blood or Hb-based therapeutics can result in varying quantities of circulating acellular Hb which can induce life threatening radical generating reactions in patients with a compromised vascular system [60].\", \"key\": \"080adbcb96a3c3bf2f23c2cfea827525f5801ef3757e1314b6324c18be37f3e1182de5b27c1240c508b520b1f1d0d44605fd2eec9e706950b9cf7dff57559c3f\", \"line\": 132, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 54}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Hemolysis increases the concentration of Hb which, under oxidative stress, releases free heme.\", \"key\": \"9676d09868ce5d49e6243b28a22a4db4f2fbaf0077e29f7929fe49d574e9b903e8b2ddbd85df024790503b122e7d3342cd9d98aa7d61b40af3ee6602f95a6744\", \"line\": 532, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 54}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Haemoglobin and haem levels increase in plasma and urine when haptoglobin and haemopexin scavenging mechanisms are saturated during acute or chronic haemolysis.\", \"key\": \"1bd2b1eb863f867a2ba5dda1ded0c9f59219a0a6e5e9a7625bff752af32f1ed7625a89d1468b33f04a2290c327876b4a9f99b8fc3ea8675aa6061e3365f1ab35\", \"line\": 189, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Alveolar Epithelial Cells\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Subsequent RBC lysis leads to release of acellular Hb, which, in turn, damages the alveolar epithelial cells.\", \"key\": \"08f879d4548fdaa49927bd8eb804fcdda8317311013bd8dd807b9d10a7e6752c3011bb2fb8cafa964ec62249992fd9fbd83a60f14552a4cea005e0bcc51c3e0d\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 54}, {\"annotations\": {\"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"48 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"The plasma hemoglobin levels at two and four hours after SRBC-transfusion were greater than the cell-free hemoglobin levels in the supernatant of the SRBCs before transfusion (Figure 1C, Supplemental Table I), providing evidence that hemolysis occurs in vivo during and after transfusion of SRBCs.\", \"key\": \"09b4930298cf639376873fe578002f2582fb5f3469f75895d6eddb1d2fb269735e2d56748b8f2110e9bb80ecbb4cc1864ebb094f2a4ef4d01fba964f85ea15fe\", \"line\": 140, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Red blood cell hemolysis in sickle cell disease (SCD) releases free hemoglobin.\", \"key\": \"a084d22f91de507de2cfe0365f82f235b8b54fdfc29289ba5fbf107611f9682dc26ba7b5b0fc925e1cceadb3e21d9e13ae494792b58db6aacd594ff8e9c31506\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 54}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"22db0ca0b99e932e05ffd521f00004e50944770f3eb7b2a8adc81caf00e73ceb63449ee9a09686e09d04362489fa564c9c90181be8f50abfaca296ee1ecc76f9\", \"line\": 91, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 54}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Following MAC deposition on RBCs, intravascular hemolysis that leads to increasing levels of free hemoglobin was seen.\", \"key\": \"04549e39c60c02c2063e3be9ff16aa7794e2319cec93c7141c85bd08f08ce66907b5dea66e114fb078860f5ce71a066e129cd70c99b59189a9402f4ea67181c6\", \"line\": 166, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 54}, {\"annotations\": {\"Cell\": {\"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Excessive intravascular hemolysis saturates scavenger mechanisms, resulting in free hemoglobin in plasma that irreversibly reacts with nitric oxide (NO) to form nitrate and methemoglobin.\", \"key\": \"d29f1f2bde45d37565173f26c80f8e15ce0649b6ca08dadf7c65996932888052aa571b089120062b306c340c7c88c6756b5673ec2591fbfb05c0e5f34c23fd61\", \"line\": 279, \"relation\": \"increases\", \"source\": 95, \"target\": 54}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"In infectious diseases, such as malaria and sepsis, high amounts of cell-free hemoglobin and heme were found [8], suggesting that hemolysis during sepsis and systemic inflammation is of pathophysiological relevance.\", \"key\": \"e3c4215196bb4e98e6facc57098f28d25b9cae45abcfe085d330f5f90a6f8b976f332b8fb1fc0c45f693ddf8214c2c1f0107b27459da739a7765c90ab4910c27\", \"line\": 284, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 54}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Microvessels\": true}, \"MeSHDisease\": {\"Disseminated Intravascular Coagulation\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Finally, a bi-directional crosstalk between hemolysis and coagulation was postulated with induction of tissue factor by cell-free hemoglobin as potentially central mechanism for hemolysis to trigger coagulation [87].\", \"key\": \"49e4c22c6f31e716f17836216ca7365970854f5c0814f21be7083ba0f7ad14fe801765f7e139d5825c051bcbddcf9dda6716d769268cf02743d5b1e18a3ac9d9\", \"line\": 505, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Knee\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"In addition to inflammation, cell-free hemoglobin (Hb) released via hemolysis is a potent inducer of oxidative stress.\", \"key\": \"7512ea5bb9336e950162573bf7d91a30beaed4830d361dc399eb52146a5b3f6283eba9b2854e2c7779ac929ea2ce673f56c0b2d9179b35efca123d2aa8a1ef48\", \"line\": 131, \"relation\": \"positiveCorrelation\", \"source\": 95, \"target\": 54}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Puglia M\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2015-12-01\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"931-43\", \"reference\": \"26475040\", \"title\": \"Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity.\", \"type\": \"PubMed\", \"volume\": \"89\"}, \"evidence\": \"However, in patients with hemolysis Hp depletes early in the course of the disease while levels of Hx remain within the physiologic range for prolonged periods of sustained hemolytic disease [12].\", \"key\": \"04d2419765c7f72499c22c0a483db6fdd6b355d4fed2b8a727d8923b73120bf5dd5681e218450ad4d3eb381297d623c33e1922ce1a44502e60fca979d05d7ac5\", \"line\": 127, \"relation\": \"negativeCorrelation\", \"source\": 95, \"target\": 56}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"In cases of extensive and chronic hemolysis, levels of haptoglobin and hemopexin in plasma decrease markedly [20,21].\", \"key\": \"70c8364d95f182ee4a7f7cc3b9ec8ba8e7dfddcc1e68e63655ac11ceadff32baa1f7f1bb101ef59a7c7eeaf0b66df3c3dc6d6352ec73d9204452d151d11c0276\", \"line\": 115, \"relation\": \"negativeCorrelation\", \"source\": 95, \"target\": 56}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Plasma haptoglobin and hemopexin levels are often depleted in SCD patients and mice due to chronic intravascular hemolysis [21±24].\", \"key\": \"f55e0fb89d833e11bf2efc727e556cd4652983ef75f9736024b6099e899b5d36225be861c632cd3ed6d4a32b581d5f06e05dbc80060408bb15cf16ea5140f348\", \"line\": 117, \"relation\": \"negativeCorrelation\", \"source\": 95, \"target\": 56}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"In cases of extensive and chronic hemolysis, levels of haptoglobin and hemopexin in plasma decrease markedly [20,21].\", \"key\": \"db7ba2c247de741d30d07304f481b0504bcf8e4be1a851b9628d74130243dd6a9930e53934223c1a017708e863319c0a9d12454da1a8c37fd27f077dd247b8b9\", \"line\": 116, \"relation\": \"negativeCorrelation\", \"source\": 95, \"target\": 57}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Plasma haptoglobin and hemopexin levels are often depleted in SCD patients and mice due to chronic intravascular hemolysis [21±24].\", \"key\": \"8ba992bd6d420322d738129bb43a1038f122c4f44f2331abce8c22ae9eca47de6d3c9152c23bcdb4cc0a36cb151e38fb3cb769509811c22351878b41efa481a4\", \"line\": 118, \"relation\": \"negativeCorrelation\", \"source\": 95, \"target\": 57}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"5 min\": true}}, \"citation\": {\"authors\": [\"Barnes S\", \"Harper VM\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\", \"Sun CW\", \"Townes T\", \"Wilson L\"], \"date\": \"2015-02-01\", \"first\": \"Harper VM\", \"last\": \"Patel RP\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"294-307\", \"reference\": \"25264713\", \"title\": \"Peroxiredoxin-2 recycling is inhibited during erythrocyte storage.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Finally, slower Prx-2 reduction correlated with increased H2O2 (10 lM)-induced hemolysis of day 35 RBC compared with day 7 RBC (Fig. 1D).\", \"key\": \"16a834f6663083399bb8e50eb02ad7680e437168fc6dfac547a56cd86efe9ac36c1a1ff82860b20af2c735c3f23855bb280ec199f5c7a0f960859f17a6f07121\", \"line\": 128, \"relation\": \"negativeCorrelation\", \"source\": 95, \"target\": 72}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Second, immune hemolysis is accompanied by production of TNF- which induces tissue factor expression in endothelial cells and also decreases the endothelial expression of thrombomodulin, a potent modulator of thrombin activity [62].\", \"key\": \"451c69caaba70e98fe7654049e38ff14c53c5a803a898cd94232f1ac28d7a1e0dbef2e063332b4dbafe6f1a164ba1e05664e564ae06cfc0d285337fdca6cf1c8\", \"line\": 332, \"relation\": \"increases\", \"source\": 95, \"target\": 64}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results suggest that heme induced activation of NLRP3-Caspase-1-IL-1b axis is involved in kidney inflammation in mice UUO model and that heme serves as a dangerous factor participates in this process.\", \"key\": \"a6b9d4e290c30ee2ca2ff276dadc6f9e7015f7af7a894a0177f42eec93e9b871af76c28c807f99c9180236e6020b70aad21be95d158994dd5291433482908cb5\", \"line\": 247, \"relation\": \"positiveCorrelation\", \"source\": 69, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"The results showed that enforced HO-1 could efficiently decline the heme level in the lysates of ligated kidneys, and inhibit kidney inflammation characterized by down-regulation of NLRP3-Caspase- 1-IL-1b axis.\", \"key\": \"d9671dfcf5d02cc335b7cfd93c4a83d307c74410df619debbe98f7ff83112bf615ec099d72cf6a362bba25577ac34642e70de7ba56427da9317375a5c3177858\", \"line\": 260, \"relation\": \"negativeCorrelation\", \"source\": 69, \"target\": 66}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"As expected, NLRP3+/+ macrophages were efficiently stimulated to secrete IL-1b by heme, and displayed dose-dependent (up to 40 lM) manner.\", \"key\": \"5a4386416783605f81fe40a4876641a4de96f209f46998f16274b109b7985376a2cfa3b2163c298432268788513cfc8c52a533fc12250838e36e92a8a482bc7d\", \"line\": 196, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"positiveCorrelation\", \"source\": 69, \"target\": 71}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results demonstrate that free heme induces IL-1b through activating NLRP3 inflammasome via ASC and suggest that free heme plays an essential role in inflammation response as a dangerous signal.\", \"key\": \"16b12d8d5b53380270f129f1eb6c689430c2d849e51aa55a1f8c946659cf4ce6ba4b044a2175c982ba99671cf09a5e92769ccca0e687faeaff5f35ab8ab2a874\", \"line\": 204, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"positiveCorrelation\", \"source\": 69, \"target\": 71}, {\"key\": \"ddb1728cb7f8d60a3fc928bc31829ecd8381db8b47608875c0ab0f3be010eb20e7a67777c0b3385ad4e81d9c482522181f7fd2933f3b417e5ead8f5bb87255af\", \"relation\": \"hasComponent\", \"source\": 45, \"target\": 2}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"McCulloch JC\", \"Nielsen VG\", \"Redford DT\", \"Thompson JL\"], \"date\": \"2014-09-01\", \"first\": \"Redford DT\", \"last\": \"Nielsen VG\", \"name\": \"Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis\", \"pages\": \"621-4\", \"reference\": \"24553061\", \"title\": \"Left atrial myxoma presenting as pulmonary embolism: potential role of heme oxygenase-1.\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"Lysis of red blood cells with consequent increases in free heme most likely caused the increase in HO-1 activity responsible for increased COHb concentrations, which is similar to that observed with circulatory devices [6].\", \"key\": \"b5e8131c2ba3c87c1c9f9e0ab808aa8e2471b3851cf7d8ca0aac1bd32953f117c87d9cfc7370ae7b2f74c2471d400804a70e12e5e09178fd46e84e629540a115\", \"line\": 97, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"positiveCorrelation\", \"source\": 45, \"target\": 55}, {\"key\": \"dd61ba09d4cf75b063174204b76807826980c1e0e7663a31cd459aa1eace0833f9a1c5af7dc4822ed91eb9763577915713b8def8f830bb09a6d9df1974510e38\", \"relation\": \"hasComponent\", \"source\": 45, \"target\": 54}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"ADP induces platelet activation and may also contribute to transfusion-related vascular thrombosis.\", \"key\": \"60130851511819dd0c1f483d6f8088bc554fcf3c0212ac23db946f0394129acbd8caed8a7d97fd927f360763a3423b1d24ed77e1e6af7b6bc9cd90daa695fc8e\", \"line\": 607, \"relation\": \"positiveCorrelation\", \"source\": 16, \"target\": 40}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"ADP released from haemolysed RBCs induces CD40LG release from platelets and lymphocytes, thereby contributing to the pro-inflammatory and pro-thrombotic environment (Helms et al, 2013).\", \"key\": \"dbb625c9dff5a43a0c267bee4db2bea94cd6c69b5e870900352f902e44219c3333d159d32e6dbe9c6d0c348ccdbad82a7b5eda696a1a442c98905e7a469d8f0e\", \"line\": 616, \"relation\": \"positiveCorrelation\", \"source\": 16, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"ADP released from haemolysed RBCs induces CD40LG release from platelets and lymphocytes, thereby contributing to the pro-inflammatory and pro-thrombotic environment (Helms et al, 2013).\", \"key\": \"accaf7fcb74bede336e9639ec6c8cb20cadeb1738562ff265949026e29380c90b9a1bbf40002d3c870c977ec4620b404a16113f70d3dd927cf15002a1fa4bcb7\", \"line\": 617, \"relation\": \"positiveCorrelation\", \"source\": 16, \"target\": 99}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.\", \"key\": \"bff90fdbc43091d68f1e86008ef3f494a303e20e69d455a2007f8387497239ff56330b66292e8e1c0dee005924d2c12fd7fb9146e22122b3a3efa7bc01502f5e\", \"line\": 354, \"relation\": \"positiveCorrelation\", \"source\": 78, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.\", \"key\": \"ad180451e42547df800e0f58e50014a29b353a86e2b147bbcfb841f50b248f584d10fd9329c4cbd46805c252ea34b8916a1b613f86ae8a9f33b331afcc0b2b27\", \"line\": 355, \"relation\": \"positiveCorrelation\", \"source\": 78, \"target\": 99}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"The triad consists of hypercoagulability, blood stasis and endothelial injury/dysfunction, which are useful concepts for understanding thrombosis.\", \"key\": \"42e24ae00ee5f80c66397ceb872d45672965c871a800caac20f3cff058681f728f574acebc9abc4e02e5be833607e90b871b446ce794da1eda55046af4e79fb4\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 42, \"target\": 99}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, haemolysis results in NO scavenging, systemic vasoconstriction and increased blood stasis, thereby affecting one of the principle components of Virchow’s Triad.\", \"key\": \"3471da53ce105180dd6f44b17ab539b90d1a681bca24501e0b3e6ec58d5b29fff3e9c3f0038a592ef20541df106d07fcfc7546b762ccfd7ac76c861fd97521fc\", \"line\": 442, \"relation\": \"positiveCorrelation\", \"source\": 42, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"The ability of cells to generate MPs in vivo is an important regulatory mechanism of physiologic reactions, a means for intercellular communications and a pathogenic component in many diseases that impact hemostasis and thrombosis [50, 51].\", \"key\": \"0b0a14809dd8a12f200e845074db95b4a9f04722fb27b9ca20acb25830ebf477e02cf43133be57e9deefe914e9d141041bf14c2d0cede345332c19530a4c31c1\", \"line\": 277, \"relation\": \"positiveCorrelation\", \"source\": 42, \"target\": 18}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"The consequences of heme toxicity can be appreciated in hemolytic diseases such as β-thalassemia, sickle-cell disease (SCD), ischemia-reperfusion (IR), and malaria (Katori et al., 2002; Pamplona et al., 2007;Vinchi et al., 2013).\", \"key\": \"9e9e780031526b32894122b9e51df48445ae4c22256100ec923bbde247191c6f7e605cddcc0ab7bb89e0323b607ada4be0e20fdaecc3348556cf6c7a3868d2cc\", \"line\": 114, \"relation\": \"positiveCorrelation\", \"source\": 87, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"The released heme can activate the innate immune pattern recognition receptor toll-like receptor 4 (TLR4) on inflammatory cells, platelets and endothelium, promoting a pro-inflammatory and pro-coagulant phenotype, ultimately leading to vaso-occlusion, ischemia-reperfusion physiology, tissue injury, and pain in murine models of SCD [5, 7±10].\", \"key\": \"f1c422434c5009648d51644250a33a5aea0f700e917757866a7b610641f493c15b24a2d071481701c7cd420067eeab59b984e9ff81a6a0e3603d28e59d4c84e7\", \"line\": 109, \"relation\": \"positiveCorrelation\", \"source\": 87, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Excess production of reactive oxygen species (ROS) has been implicated in progression of chronic heart failure as well as in other cardiovascular disorders including ischemia-reperfusion injury and cardiovascular complications of hemolytic diseases [2-7].\", \"key\": \"3432063a3fbec7330984bcbce73c2d35bd862cf5bf57b8a5bd44d108c845715965f95b6a938ca54504487a230f32799003ca368ce34463bf235d81093c481814\", \"line\": 94, \"relation\": \"positiveCorrelation\", \"source\": 87, \"target\": 22}, {\"annotations\": {\"MeSHAnatomy\": {\"Ependyma\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Du H\", \"Gao C\", \"Hua Y\", \"Keep RF\", \"Strahle J\", \"Xi G\"], \"date\": \"2014-06-01\", \"first\": \"Gao C\", \"last\": \"Xi G\", \"name\": \"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism\", \"pages\": \"1070-5\", \"reference\": \"24667910\", \"title\": \"Role of red blood cell lysis and iron in hydrocephalus after intraventricular hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"34\"}, \"evidence\": \"There was a tendency that lysed RBC-induced brain edema was less in deferoxamine-treated group (brain water content in the ipsilateral hemisphere: 79.8±0.6% vs. 80.5±0.7% in the saline coinjection group, n¼6, P40.05).\", \"key\": \"619e01e43eac00df8e31a5b4e7b1000274e0a753657813a292a267e5f964558c1942eeb0a7a8c2d6993c8f7ff59e2bc0ab3d483efdcea414dfafe2d3bf4d09fc\", \"line\": 159, \"relation\": \"negativeCorrelation\", \"source\": 81, \"target\": 3}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"In fact, Tlr4-/- or anti-TLR4 treatment suppresses heme-induced neuroinflammation, edema, and neurologic deficit. \", \"key\": \"a82a53f05112641dfdaa394aab5d8ddf00757068131b6aed18a4ceb0fa3e7db5f12af8af943ae259d848ef616f503a1d08cb04bcc28ec73413a919a1da85bdad\", \"line\": 644, \"relation\": \"positiveCorrelation\", \"source\": 81, \"target\": 63}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \". Interestingly, NLRP3 knockdown and mROS inhibitors reduce brain edema and improve neurological functions (Ma et al., 2014).\", \"key\": \"da65c190b3f23bca52a7b0835d0298efc60a6581402983a205d4f25300cfb5ebd7d04fdf7a024983d6c24c333c01874e9b48a4ea8edae5a76d59987fa19e095f\", \"line\": 649, \"relation\": \"positiveCorrelation\", \"source\": 81, \"target\": 62}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Activation, aging, and apoptosis of various cells, including RBCs, are accompanied by formation of microscopic extracellular membranous structures named microvesicles or microparticles (MPs).\", \"key\": \"318b63288df23d958e72418e82f5766c7fb92edeaf414113f29f3433a473f2bee5c4eaed01fd7353796d278ef77034693e06c71540d1406bdc762d43f5fe8e72\", \"line\": 271, \"relation\": \"increases\", \"source\": 41, \"target\": 18}, {\"annotations\": {\"MeSHDisease\": {\"Hematoma\": true}, \"Species\": {\"Bos taurus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Gao Z\", \"Li H\", \"Wang P\", \"Wu J\"], \"date\": \"2019-04-01\", \"first\": \"Wang P\", \"last\": \"Li H\", \"name\": \"Molecular and cellular biochemistry\", \"pages\": \"57-66\", \"reference\": \"30324533\", \"title\": \"Tyrosine residues of bovine serum albumin play an important role in protecting SH-SY5Y cells against heme/H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;/NO&lt;sub&gt;2&lt;/sub&gt;&lt;sup&gt;-&lt;/sup&gt;-induced damage.\", \"type\": \"PubMed\", \"volume\": \"454\"}, \"evidence\": \"Apoptosis has been found to be a major rout for the elimination of cells after a variety of stresses including ROS and RNS [30].\", \"key\": \"8bee09c41f03e225bb21491962212b8a946da2aa7d8cb2a89ffd3c29c006707905e64be76e1ab916608009b93b3bd52724fa4bfe4cd53b042ec7012e3f141ed8\", \"line\": 149, \"relation\": \"positiveCorrelation\", \"source\": 41, \"target\": 22}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"In conclusion, an Hx-based therapy shows beneficial effects, in that it counteracts heme-induced proinflammatory activation of macrophages and attenuates some of its pathophysiologic consequences, such as chronic inflammation, hepatic fibrosis, and apoptosis (Figure 7E).\", \"key\": \"f0ddb4ebc89ba74548012e1cded19ec0a581c3b60f6fd7814444189746bccbf21dd0bc0b278d7c6206ce46bbab3bc7548f68c5ea2e7cf68c9eae2acc66093d91\", \"line\": 327, \"relation\": \"negativeCorrelation\", \"source\": 41, \"target\": 67}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"Moreover they have demonstrated that released Hb plays an important role in exacerbating RBC hemolysis, establishing a damaging hemolysis/ oxidative cycle that drives further red cell damage, vascular injury, and thrombosis.\", \"key\": \"cef75b47038e741c173d140c48487e11749e9323620350a511549af3bd5b1cc8d34cd1511df7669d920856739ebbd77f4d96caf83c748e72d26c7f4d635284a8\", \"line\": 221, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 95}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Banerjee S\", \"Crumbliss AL\", \"Jia Y\", \"Kreulen RT\", \"Mollan TL\", \"Olson JS\", \"Tsai AL\", \"Wu G\"], \"date\": \"2014-04-01\", \"first\": \"Mollan TL\", \"last\": \"Alayash AI\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"265-77\", \"reference\": \"24486321\", \"title\": \"Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Hemolysis and the transfusion of banked blood or Hb-based therapeutics can result in varying quantities of circulating acellular Hb which can induce life threatening radical generating reactions in patients with a compromised vascular system [60].\", \"key\": \"fe19e77e5eb11ca9ff1cd6f17fa7979cca57a6f490caec69c95e7049416b21521aa346471a033502abd79b74b607767cd02503a6d95aa94f5d3b8e932c6c8ac9\", \"line\": 132, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 95}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Hemolysis increases the concentration of Hb which, under oxidative stress, releases free heme.\", \"key\": \"8d43f6039c11fd30331114151302009a7d8e5475b194a2b039de2cd5dd04a6095c7ebc857cd556d15dc86b3a8bb14725175d28b19e6033d57aeb1c83a5708cd0\", \"line\": 532, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 95}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Haemoglobin and haem levels increase in plasma and urine when haptoglobin and haemopexin scavenging mechanisms are saturated during acute or chronic haemolysis.\", \"key\": \"e385e26469bb15deb4767eeee811bee4824911c44c82cf40311641a9315b784fb357badc32ec2106190f461099f98a854a283a9e22c0d7e2c1d8af1fad33c043\", \"line\": 189, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 95}, {\"annotations\": {\"MeSHAnatomy\": {\"Alveolar Epithelial Cells\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Subsequent RBC lysis leads to release of acellular Hb, which, in turn, damages the alveolar epithelial cells.\", \"key\": \"808d13166116057eb36388c36728e4f26ae827f2293f3141a8d39e248a88fcd5baba47669ca1d377a4e7973470ac823b5f701caad935db47f2ed09d058418186\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 95}, {\"annotations\": {\"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"48 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"The plasma hemoglobin levels at two and four hours after SRBC-transfusion were greater than the cell-free hemoglobin levels in the supernatant of the SRBCs before transfusion (Figure 1C, Supplemental Table I), providing evidence that hemolysis occurs in vivo during and after transfusion of SRBCs.\", \"key\": \"9d8dbdbd9e746f3fed1be7f03139d1dbdf17cbdbbfb39f495e951fc6ce80ba0e60b1469f79916686b713704b83ed420fc07aaba056107f68838c7e7cdeacb822\", \"line\": 140, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 95}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Red blood cell hemolysis in sickle cell disease (SCD) releases free hemoglobin.\", \"key\": \"8f9d8d710f62cc67d9d5eeb62062f28ecc236ac64751dae0e4657f9853f4b126f9369ae41875c9376f7d7222991feb85b5f38878e495b272dce440fdc985bc18\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 95}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"a8c3e8c1847f0bb9ffb044e655b994105d33c69b92cad9c68590a9b2858a15b9604284db222e09b096ca4014b33ca9b306ceac25898c97b0887f90866aadc746\", \"line\": 91, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Following MAC deposition on RBCs, intravascular hemolysis that leads to increasing levels of free hemoglobin was seen.\", \"key\": \"49ff77de9d30660441fad64d946e9ed7677e9082087b8a2bb9403133a01ddd07a8dd7a26afabb79e65ff33cc00bb5a876584273e117f0b7979a483186e908322\", \"line\": 166, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 95}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"In infectious diseases, such as malaria and sepsis, high amounts of cell-free hemoglobin and heme were found [8], suggesting that hemolysis during sepsis and systemic inflammation is of pathophysiological relevance.\", \"key\": \"4f627a41f1f12be7f2d8870e1a2d4fb4ce4450dc19f9c7b37980fecc1e92d3bbd73f33063449063aedcbfc5a297ade671be02b7bf8acfe77202e1e2155aca8b2\", \"line\": 284, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Microvessels\": true}, \"MeSHDisease\": {\"Disseminated Intravascular Coagulation\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Finally, a bi-directional crosstalk between hemolysis and coagulation was postulated with induction of tissue factor by cell-free hemoglobin as potentially central mechanism for hemolysis to trigger coagulation [87].\", \"key\": \"65348857b78c856ea863ff4280c6fea017e7b67ac2c8a3e60fb0debac1544f81e3ed6e2a05fac56b5a0b1abe9661d54b2b61b7fbbba65b0e875cd2f2463a87f8\", \"line\": 505, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 95}, {\"annotations\": {\"MeSHAnatomy\": {\"Knee\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"In addition to inflammation, cell-free hemoglobin (Hb) released via hemolysis is a potent inducer of oxidative stress.\", \"key\": \"1961c010b327e0db8f9678551a04b6760ec8395a9183bfa2a8b69f98a06ea289c9b1f0223121e45f4a6a83ad2cce46e8dc12b71eefb72a13fce9afe8a5d748d9\", \"line\": 131, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 95}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Banerjee S\", \"Crumbliss AL\", \"Jia Y\", \"Kreulen RT\", \"Mollan TL\", \"Olson JS\", \"Tsai AL\", \"Wu G\"], \"date\": \"2014-04-01\", \"first\": \"Mollan TL\", \"last\": \"Alayash AI\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"265-77\", \"reference\": \"24486321\", \"title\": \"Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Hemolysis and the transfusion of banked blood or Hb-based therapeutics can result in varying quantities of circulating acellular Hb which can induce life threatening radical generating reactions in patients with a compromised vascular system [60].\", \"key\": \"aca66d9abea27698cc88a137354c537435ac6cea8d476857d793f27eb35dc8309b42b6874f4f70405cd2b3f9c9d49cba42cfe96d436e99f09940a0a5799556fb\", \"line\": 133, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 91}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Puglia M\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2015-12-01\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"931-43\", \"reference\": \"26475040\", \"title\": \"Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity.\", \"type\": \"PubMed\", \"volume\": \"89\"}, \"evidence\": \"Free hemoglobin (Hb) triggered vascular damage occurs in many hemolytic diseases, such as sickle cell disease, with an unmet need for specific therapeutic interventions.\", \"key\": \"76f1b1741e6eccefefb0ed38dbd6f26b62442296c39f0e70a4eb273f6a61d4a707bcd581a72f1baeeda5f5560f8419bca2060807dc45160b0a9c92ae0f0d231f\", \"line\": 94, \"relation\": \"increases\", \"source\": 54, \"target\": 91}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Puglia M\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2015-12-01\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"931-43\", \"reference\": \"26475040\", \"title\": \"Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity.\", \"type\": \"PubMed\", \"volume\": \"89\"}, \"evidence\": \"Depending on the scale, rate, and site of hemolysis, the primary adverse effects triggered by free Hb are vascular dysfunction, oxidative tissue damage, and altered inflammatory response [1], \", \"key\": \"b491de88e53163ba6ebd82a6103e7ca82e800fa442d1c6cf10fbafd954ebdf50f727ec5e3d01da0f0ef6c9678d9f1a48896dc8c7691a16dcc68139e2fae66b07\", \"line\": 118, \"relation\": \"increases\", \"source\": 54, \"target\": 91}, {\"annotations\": {\"MeSHAnatomy\": {\"Arteries\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Barodka VM\", \"Berkowitz DE\", \"Frank SM\", \"Goyal A\", \"Johnson DJ\", \"Lipsitz JA\", \"Nagababu E\", \"Scott AV\"], \"date\": \"2016-08-01\", \"first\": \"Nagababu E\", \"last\": \"Frank SM\", \"name\": \"Anesthesia and analgesia\", \"pages\": \"274-82\", \"reference\": \"27308950\", \"title\": \"The Impact of Surgery and Stored Red Blood Cell Transfusions on Nitric Oxide Homeostasis.\", \"type\": \"PubMed\", \"volume\": \"123\"}, \"evidence\": \"Several studies in animals have supported the idea that infusion of free Hb, stored RBC supernatant (preservation solution + plasma), and Hb-containing microvesicles causes vasoconstriction, vascular dysfunction, and vascular injury.12,16–18\", \"key\": \"57316efd58face226f821fe6ef9f3e44cc996f6807e4bdf6df6332ffc916e8354d289dcd325e16411cbcfc8e465df5dd99052b77a1abe27b8652be207187178d\", \"line\": 116, \"relation\": \"increases\", \"source\": 54, \"target\": 91}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Banerjee S\", \"Crumbliss AL\", \"Jia Y\", \"Kreulen RT\", \"Mollan TL\", \"Olson JS\", \"Tsai AL\", \"Wu G\"], \"date\": \"2014-04-01\", \"first\": \"Mollan TL\", \"last\": \"Alayash AI\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"265-77\", \"reference\": \"24486321\", \"title\": \"Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"In that study, heme was shown to specifically bind to endothelial Toll-like receptors (TLR4) and trigger a cascade of inflammatory responses, which could be attributed to oxidation and degradation of cell-free Hb [73].\", \"key\": \"754dd8c3236704bdbf2b00b2d5cfdf9250b59c6d1dcdc249528a2826877df4d38531c56d420e92c4fa5a6476a5dd26aa2a2ede942a82d867aa0db0f6fdb84819\", \"line\": 181, \"relation\": \"increases\", \"source\": 54, \"subject\": {\"modifier\": \"Degradation\"}, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Hemolysis increases the concentration of Hb which, under oxidative stress, releases free heme.\", \"key\": \"a6c0a6c709beb063d602174a6fadc90a4b037adfb85899ab43500ea7dad7b8730960039ea65c78e31fa47eea1dc94d59d15a2db324e53cb7934e80cdbc13cfa1\", \"line\": 533, \"relation\": \"increases\", \"source\": 54, \"target\": 10}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Exposure to Hb and its oxidized products increases heme overload on the AT1 cells. Heme overload induces the expression of HO-1 and iron-sequestering proteins, such as ferritin.\", \"key\": \"a0828ff03509cd12e585c838a2842c7c5253945fcf96d4189c8c63c85531816c15c77c9efb01e1f26b6d2a72faf26d828bbc6f48c2e1b4be7d2fa49a2be6f51f\", \"line\": 240, \"relation\": \"increases\", \"source\": 54, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Toxicity of free hemoglobin is also caused by the release of cell-free heme, which produces lipid peroxidation and mitochondrial damage and increases the production of reactive oxygen species.\", \"key\": \"40bed8e815b8d4a8d5c21c949c344413c71337c54459e1199a37cba18e3a49006271159535fb39d2a6a92687541aabc5d36a144f9816e7042988536d032b7295\", \"line\": 102, \"relation\": \"increases\", \"source\": 54, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Extracellular hemoglobin and its degradation products, free heme and iron, are highly toxic due to oxidative stress induction and decrease in nitric oxide availability.\", \"key\": \"8093f381fcae471f465803a4f8e3ef2513c498e7a3be43662ae0dd3604fcfe9c0ce50372ece5081f916b32d20d838254db4f28da95ea2ef866f66243f88f3780\", \"line\": 101, \"relation\": \"increases\", \"source\": 54, \"target\": 10}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"For instance, earlier studies have demonstrated that neutrophil elastase degrades the hemoglobin liberating free hemin that induces ROS production.\", \"key\": \"ca14d1b8c4c3689f0f72022f765096ac8430267a07373840ced167531a69ad3cf6eda73ceda755fdd5d15c07cf515383be5e635f6037bbd1551f8ca19eb6bc61\", \"line\": 257, \"relation\": \"increases\", \"source\": 54, \"subject\": {\"modifier\": \"Degradation\"}, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Because of its large molecular size, this complex is maintained in the intravascular space, preventing the association of otherwise free Hb with nitric oxide (NO; Reiter et al., 2002) and inhibiting the release of free heme (Melamed-Frank et al., 2001).\", \"key\": \"a9f6d3028c1b6c209b0cb965d8f84857387c931cecc0300d2a7e89b4ae38e53bff056efc38b518c9af1565a7c3d1ad27065ad09a60cd154ef166a8ce0a21633f\", \"line\": 123, \"relation\": \"negativeCorrelation\", \"source\": 54, \"target\": 23}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).\", \"key\": \"eecbb935ae35fad86dace730d0c9c78c351f28ed351a984feb0f81b25243679d3b516a16a90c86dc3823a11eb3ce11a3280e67aacc1e76d267daacdeb23cdb66\", \"line\": 173, \"relation\": \"increases\", \"source\": 54, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Free plasma haemoglobin and haem also scavenge NO and have multiple pro-inflammatory and pro-oxidant properties that mediate many of the adverse effects of haemolysis.\", \"key\": \"491fe3b7630e5ca83052c8b25e30faff0d91f7d871271db70e0ca1ecdb61948937af1c7169096b08209655d6b89a062251fddc7c7624f08b804e84e9160609a1\", \"line\": 198, \"relation\": \"increases\", \"source\": 54, \"target\": 97}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Puglia M\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2015-12-01\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"931-43\", \"reference\": \"26475040\", \"title\": \"Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity.\", \"type\": \"PubMed\", \"volume\": \"89\"}, \"evidence\": \"Depending on the scale, rate, and site of hemolysis, the primary adverse effects triggered by free Hb are vascular dysfunction, oxidative tissue damage, and altered inflammatory response [1], \", \"key\": \"43c96921a56255494a281e7af6fb1a061a1562a1a1a3a9a12d1baa9b5388fa954fd01bc2abce654e8151ec4bfd544cd89dd7906c5e8588c1e817ec0c8dee6569\", \"line\": 120, \"relation\": \"increases\", \"source\": 54, \"target\": 97}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Extracellular hemoglobin and heme are pro-oxidative, proinflammatory, and cytotoxic [10–12], and can contribute to the pathology of hemolytic diseases.\", \"key\": \"57d6e33a0f042a8ff3d07a9a0eb18c72eea67cf1562b821b441021bdf7281644c10ad8dfc216084f26bf403407b5f676e792352f0984dc2f8bdf6710b734d88e\", \"line\": 100, \"relation\": \"increases\", \"source\": 54, \"target\": 97}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Plasma hemoglobin scavenges nitric oxide and causes vasoconstriction, platelet aggregation and inflammation9,22–24.\", \"key\": \"04316d6d1a6820d1c50a8c79da6313037c28b7a128657d1a601be319fceb8ac7fd186a81755a0d0e25ff6f845661c72034fa007e3f5ae291ac7c75ef596d098c\", \"line\": 96, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 97}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"088b606848ff77a7a94358a490dacbb1f5fbb09a7e687365efcfda9610821dfadf8f96a0eb46f9ed18a4aded5e122279ea503273806ea7c2e31f39af68388381\", \"line\": 104, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 97}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"Preoperative\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Our findings in the complex setting of critically ill pediatric cardiac surgery patients demonstrate that higher levels of free Hb and lower levels of haptoglobin are associated with serious postoperative clinical complications (infection, thrombosis, death), immunomodulation, and inflammation.\", \"key\": \"2cf2fd869a77fea975ed4687df4e107714e4cd174905f91a5974d997320bd294fc6e1cbaccd0cbf25658dd1938140f554441635dda0b0d61878569a473f13b1c\", \"line\": 198, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 97}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"153013c845684349d22187503e256ea0652db89822da30546383ff546d8505c411010c968cbe4f174cfc1932a9223ec3965a5c93d652a18d9fef2369efc7f82a\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 97}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"In infectious diseases, such as malaria and sepsis, high amounts of cell-free hemoglobin and heme were found [8], suggesting that hemolysis during sepsis and systemic inflammation is of pathophysiological relevance.\", \"key\": \"68078d9d7d3ffac6ddc06118fe0e0428674fbb1b5137c51ed3575346bca47b8602fec37988eb6f76f77be128c24c6d4c8f21438fb00feab81013edc78cc8a4dd\", \"line\": 285, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).\", \"key\": \"f96c6ea5313723f134f9aa96da3f461ffd2ee5b7eecfe0af452e78a9d75d2ba5308ce9aef5a7b0d8a614a7e48b7d7dece1f5d5046247e330dd64e875310ad015\", \"line\": 174, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"decreases\", \"source\": 54, \"target\": 9}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Free plasma haemoglobin and haem also scavenge NO and have multiple pro-inflammatory and pro-oxidant properties that mediate many of the adverse effects of haemolysis.\", \"key\": \"562a52d1984423c6284e49d58b3c1793d5753416bd2728e0e1091b2a651af96d20e3b0de98a3916f8d23315f5504852bbead92bc4877aaecf23c52672e8130ba\", \"line\": 200, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"decreases\", \"source\": 54, \"target\": 9}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Free plasma haemoglobin and haem also scavenge NO and have multiple pro-inflammatory and pro-oxidant properties that mediate many of the adverse effects of haemolysis.\", \"key\": \"4a2da28a1458c254349508dfd983fcb574c28ca89e2588ca86b179ee9d4b6bef620ceb3d44c9855bc8159685f53119b8718233f900b280ff40bb7e75c3348aaf\", \"line\": 196, \"relation\": \"decreases\", \"source\": 54, \"target\": 6}, {\"annotations\": {\"MeSHAnatomy\": {\"Endothelium, Vascular\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Barodka VM\", \"Berkowitz DE\", \"Frank SM\", \"Goyal A\", \"Johnson DJ\", \"Lipsitz JA\", \"Nagababu E\", \"Scott AV\"], \"date\": \"2016-08-01\", \"first\": \"Nagababu E\", \"last\": \"Frank SM\", \"name\": \"Anesthesia and analgesia\", \"pages\": \"274-82\", \"reference\": \"27308950\", \"title\": \"The Impact of Surgery and Stored Red Blood Cell Transfusions on Nitric Oxide Homeostasis.\", \"type\": \"PubMed\", \"volume\": \"123\"}, \"evidence\": \"In addition to cell-free Hb, membrane structural modification, externalization of phosphatidylserine,21 decreased cell membrane deformability,22,23 and increased endothelial adherence24 could alter vascular NO homeostasis.\", \"key\": \"0a625223b0d8c621ec2a9ce812c16f31a3d36b6563d2d45e0dd76b58122d608174030563ab77910cbdc91b7ca92e4e3319019c3e0a8291ffa98702640a15405d\", \"line\": 131, \"relation\": \"decreases\", \"source\": 54, \"target\": 6}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Plasma hemoglobin scavenges nitric oxide and causes vasoconstriction, platelet aggregation and inflammation9,22–24.\", \"key\": \"752413190406cf7d1be4d56dd6ec973f89512abc179e3ed0bc297133d6c0d90216dcd47fd9d38be3a92036f118b91586fc2c82526b8bf9ed7a2a8de5604c3ece\", \"line\": 93, \"relation\": \"negativeCorrelation\", \"source\": 54, \"target\": 6}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Extracellular hemoglobin and its degradation products, free heme and iron, are highly toxic due to oxidative stress induction and decrease in nitric oxide availability.\", \"key\": \"a21d0b33130ed2facb752952bcc29d8825b63a963b1fc0f172163b1d38899e48cc138a9c2db3ed63d13ab2b3508728eb488db8c92725a5aa4d8de8ea8c52e156\", \"line\": 104, \"relation\": \"decreases\", \"source\": 54, \"target\": 6}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Extracellular Hb exhibits a highly toxic nature by scavenging Nitric Oxide (NO) that reduces its bioavailability [1].\", \"key\": \"8d9fbec043d9a56a0b239d4c45c48965e44820b7c0fa8b80d5da429fc87dac012db957e1c0db1fb7589ce900b8543b3a060c09bf904914612176df28059beb8d\", \"line\": 115, \"relation\": \"decreases\", \"source\": 54, \"target\": 6}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Buys ES\", \"Graw JA\", \"Rezoagli E\", \"Warren HS\", \"Yu B\", \"Zapol WM\"], \"date\": \"2017-06-01\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"American journal of physiology. Heart and circulatory physiology\", \"pages\": \"H1120-H1127\", \"reference\": \"28314763\", \"title\": \"Endothelial dysfunction inhibits the ability of haptoglobin to prevent hemoglobin-induced hypertension.\", \"type\": \"PubMed\", \"volume\": \"312\"}, \"evidence\": \"Some of the adverse effects caused by cell-free hemoglobin are a result of depletion of nitric oxide (NO), which may lead to vasoconstriction, inflammation, and platelet activation (10, 24).\", \"key\": \"ea315510af48a7f31dae1f5ad584369131258a2e6a7df75f67ecb0c0dd23e3a5d593ffebd86ba9e9785cb3cc2d2f576b873fce1cc6098f743e3ecafa6a038c34\", \"line\": 93, \"relation\": \"decreases\", \"source\": 54, \"target\": 6}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Another mechanism for platelet activation by RBC lysate is extracellular hemoglobin, which enhances platelet activation by lowering NO bioavailability [ 29].\", \"key\": \"63899d21bb284e396a1f531a9830f3ed7c1ffcfc5c2f1c082d2599540b26457412ddf790b4376cf9e02ec1353bcf845f200e3631aa84cb6d3b451dcbd288dc92\", \"line\": 202, \"relation\": \"decreases\", \"source\": 54, \"target\": 6}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Extracellular hemoglobin sequesters NO and thus promotes activation of endothelial cells and adhesion/aggregation of platelets [64].\", \"key\": \"2a867b637019eaccbbce896d26de9db095969b81b75fee7ef9cdd7bff782183dbbe77be32693f72ab15a531de9f76bb24b43627a315300b34de0c56244f15d02\", \"line\": 317, \"relation\": \"decreases\", \"source\": 54, \"target\": 6}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"The first process links the nitric oxide (NO) reactivity of oxyHb to a cascade of cell-free Hb extravasation, hemolysis-associated NO-depletion, and vasoconstriction.21–23\", \"key\": \"ab005f89b319b3676d71487625b5f648b87f4f42206cb66f0b9b4241a9592a15c3b7decbbb12817b85c18d9fa16641ccd58cc63258d3198877101ef759af0153\", \"line\": 184, \"relation\": \"decreases\", \"source\": 54, \"target\": 6}, {\"annotations\": {\"MeSHAnatomy\": {\"Arteries\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"One of the mechanisms by which cell-free hemoglobin exerts its detrimental effects is its ability to effectively scavenge nitric oxide (NO), which in turn leads to perfusion disorders and an increased arterial and pulmonary arterial pressure [39, 40].\", \"key\": \"04261e866ca0f1eeced4121959b6a1ed7a1d8af05c90c5a82e41d3f76ffc04740057e61db4179fcbcf8803bc43c162e96f642a67296c5ced50de842e71e07919\", \"line\": 237, \"relation\": \"decreases\", \"source\": 54, \"target\": 6}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Puglia M\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2015-12-01\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"931-43\", \"reference\": \"26475040\", \"title\": \"Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity.\", \"type\": \"PubMed\", \"volume\": \"89\"}, \"evidence\": \"Depending on the scale, rate, and site of hemolysis, the primary adverse effects triggered by free Hb are vascular dysfunction, oxidative tissue damage, and altered inflammatory response [1], \", \"key\": \"d6b69129b1576642b012efab4623cd5050845bad2c8df2cfdfe1de19fa9aed3c2cb8c67faaea65b0b1622057eedc54b67e6931a1fa0ff68625c07c509ee09428\", \"line\": 119, \"relation\": \"increases\", \"source\": 54, \"target\": 39}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Extracellular hemoglobin and its degradation products, free heme and iron, are highly toxic due to oxidative stress induction and decrease in nitric oxide availability.\", \"key\": \"88ffc8cd45c980e5e0dba0bf340dcc23184ae9109d614b926a07089ae63226c93a5020bb47acda217264bc5f219e81cfaf5f9fa59344a2479d36887672a6bb99\", \"line\": 103, \"relation\": \"increases\", \"source\": 54, \"target\": 39}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"775218834e933121d8c3edf95574e5de3930d7881c2c9562b2649d36a800edc27c3eb0117a864869e4123c18ccff65263f997571381348bf42779cc0402aa0ab\", \"line\": 93, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 39}, {\"annotations\": {\"MeSHAnatomy\": {\"Knee\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"In addition to inflammation, cell-free hemoglobin (Hb) released via hemolysis is a potent inducer of oxidative stress.\", \"key\": \"94ad8a9ef151c70683b1c9c98e70b50ca0a938a9f5a68ace69ae326654196f6c44bab64b1d70acb83772a66efc5f94707c125cc386d727a5e95228ea79e420a4\", \"line\": 132, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 39}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Sickle cell disease (SCD) and malaria are paradigmatic hemolytic disorders, in which alteration in the structure of red blood cells (RBCs) leads to the release of Hb and heme into the circulation.\", \"key\": \"6dcd770c2faa86079bb84cfd7265ef41412f76069c56b5c7c504e46c167d9c8dda7148370f5f39ac41012f9f851be106f77aead05eb977b2e1d5bc5f4176a2c5\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 37}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"This is the case in a mouse model of SCD, which is hallmarked by hemolysis, increased circulating Hb/heme, and low levels of Hp and Hx and shows elevated hepatic macrophage iron levels and M1 polarization.\", \"key\": \"58b9ab026b64007ac1345c984ab781e035e24333dfbc95f33e30092a1407a12f7c17a9dd5967dc30c99e632963777a6a6620577a86edadd12637df4901bb88b9\", \"line\": 337, \"relation\": \"increases\", \"source\": 54, \"target\": 14}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"28 days\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Old blood transfusion resulted in systemic free Hb total exposure (AUC0–∞) of 4600 μmol heme-h/l, which was primarily cleared by the kidney within 24 h.\", \"key\": \"1c066ac3973b8413790992b6e0c65b5a744b6d2b092e252d4b0adf0cf81c20c98af47acd2cf715695f4ede3d9cfc16f220d6159109e4354fa4076da2e487a1cb\", \"line\": 137, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 17}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"MeSHAnatomy\": {\"Kidney Tubules\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"28 days\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"In old blood-transfused animals, strong Hb and iron deposition was observed in the tubule lumen and epithelial cells, respectively.\", \"key\": \"cdb4027c6a9b3628339febeaa1eac9944f604ef028de8e8e2354ab4101ecf70fa381ad9f490cd7921c4ede955463a051ac28b8a6f7c50ee3a55dbae0ff00c743\", \"line\": 170, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 17}, {\"annotations\": {\"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"48 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"In mice resuscitated with SRBCs, plasma hemoglobin levels were greater than in mice resuscitated with FRBCs or in sham-treated mice at two, four, and 24 hours after transfusion (Figure 1C).\", \"key\": \"c90ea955d8fb3e3ef8d5a58c8ac804a7c9bd2daedff3284fe2b8be19431d1d4034932aed8c675a4444751b48f33f82bb5a5973074dc7b16948235f0d33964af8\", \"line\": 129, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 17}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"In cases of congenital hemoglobinopathies such as sickle cell disease, deficiencies in complement system regulators such as paroxysmal nocturnal hemoglobinuria, and many other disorders, erythrocytes can lyse and liberate large quantities of hemoglobin.\", \"key\": \"0691941edc0617c17d4bf890dedfcfd6849a05bfe7ad8f55f52e8a93bfd2446089fd991a906457b0dd5f0f609d7ebe37fd0e4666fcb2430fbb4fdf55c3d7d392\", \"line\": 93, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 79}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The level of hemoglobin declined gradually over the time after the onset of ICH with a significant reduction at day 3. The contents of hemoglobin in the clot were 26.2 ± 5.2 mg/g at 4 hours, but were reduced to 13.9 ± 0.9 mg/g at day-3 (Fig. 2B, p<0.01).\", \"key\": \"da858b68f92d60a6e127195a16787446eccf845a02fd253c8a8697dd424f22d4220ff68917dfab4ff423ded3959aa408ddd10887bf9ab851e6e31b6ea05992fd\", \"line\": 121, \"relation\": \"negativeCorrelation\", \"source\": 54, \"target\": 94}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"We found that hemoglobin contents in hematoma were significantly higher in the DFX treated group compare to the vehicle-treated group (15.9 ± 1.8 vs. 11.8 ± 0.8 mg/g, p<0.05, Fig. 5A).\", \"key\": \"64ec750f7743f389ea7a66db1b1e552470220d3e64ac41fe531f410ad2b7d77258c2504dde13a274bffbb62a5fc063e87a2cfaf7dad798973365892d268c3fa4\", \"line\": 168, \"relation\": \"negativeCorrelation\", \"source\": 54, \"target\": 94}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"We found that hemoglobin contents in hematoma were significantly higher in the DFX treated group compare to the vehicle-treated group (15.9 ± 1.8 vs. 11.8 ± 0.8 mg/g, p<0.05, Fig. 5A).\", \"key\": \"22facc307c7fd7783bca9249972cdfba9f1e7c9afe0dacc7a39f1ed06b045256aa50db0662e43c7b7a3fa43dc3aa46d65b0b43cb850d31ec1de0d04cec7346d7\", \"line\": 169, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 3}, {\"annotations\": {\"MeSHAnatomy\": {\"Arteries\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Barodka VM\", \"Berkowitz DE\", \"Frank SM\", \"Goyal A\", \"Johnson DJ\", \"Lipsitz JA\", \"Nagababu E\", \"Scott AV\"], \"date\": \"2016-08-01\", \"first\": \"Nagababu E\", \"last\": \"Frank SM\", \"name\": \"Anesthesia and analgesia\", \"pages\": \"274-82\", \"reference\": \"27308950\", \"title\": \"The Impact of Surgery and Stored Red Blood Cell Transfusions on Nitric Oxide Homeostasis.\", \"type\": \"PubMed\", \"volume\": \"123\"}, \"evidence\": \"Presence of any cell-free Hb limits NO diffusion from endothelium to smooth muscle cells for activation of guanylyl cyclase; as a consequence, mean arterial blood pressure increases.12,15\", \"key\": \"106e6641626122621c253a8123edafb36f6d3c3e2ba384f6ca38d4bb585920d005569f5bd3964641d835e392ecdf86ea2e7e300abd01bbb3c175e7ea205b3120\", \"line\": 107, \"relation\": \"increases\", \"source\": 54, \"target\": 34}, {\"annotations\": {\"MeSHDisease\": {\"Diabetes Mellitus\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Buys ES\", \"Graw JA\", \"Rezoagli E\", \"Warren HS\", \"Yu B\", \"Zapol WM\"], \"date\": \"2017-06-01\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"American journal of physiology. Heart and circulatory physiology\", \"pages\": \"H1120-H1127\", \"reference\": \"28314763\", \"title\": \"Endothelial dysfunction inhibits the ability of haptoglobin to prevent hemoglobin-induced hypertension.\", \"type\": \"PubMed\", \"volume\": \"312\"}, \"evidence\": \"SBP 315 increased 27±2 mmHg during the 40 minutes following infusion of hemoglobin in 316 db/db mice (Figure 4A).\", \"key\": \"72d90c52fcdb2b7b1bf7e79e8a488d069087d53bc9fe90a6df79ad2176e9036916b96b8b4db156ffd491c931d160be773c5158c1cecc42d3556c87a27af1b792\", \"line\": 200, \"relation\": \"increases\", \"source\": 54, \"target\": 34}, {\"annotations\": {\"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Co-administration of haptoglobin with SRBCs results in a prolonged increase in plasma hemoglobin levels for more than 48 hours after transfusion.\", \"key\": \"c6dd2d003497550478f9f820b9d2f460819db57eae5fa7760d82ecd82026abba846da3bf1862b591290b099d26bf78c026124fa2b4c9c2c77fabcbc523708d80\", \"line\": 205, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 49}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Extracellular hemoglobin and its degradation products, free heme and iron, are highly toxic due to oxidative stress induction and decrease in nitric oxide availability.\", \"key\": \"223e046ac7abe310ea185cdebceca6a9cacea367dbcc1cbc5034e420113f27497468c6a6d1a20ecbab25338a6a8a73892367545cc44197ffc4e9f1160fec66d8\", \"line\": 102, \"relation\": \"increases\", \"source\": 54, \"target\": 5}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Iron was also detected in the macrophages of the red pulp of CEP mice, while almost no iron deposit was observed in the spleen of Hjv–/– mice (Figure 4B), confirming that Hb and “free” heme are the likely source of macrophage iron accumulation.\", \"key\": \"426f3d97fc2b90697bc1c9fa0651070251cd34347b93548987d7b7acfb3d6025ba33866aaf3b14be442c822163b3b5d956a6c385ca5dbc1094596a9e304a61fc\", \"line\": 229, \"relation\": \"increases\", \"source\": 54, \"target\": 5}, {\"annotations\": {\"MeSHAnatomy\": {\"Arteries\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Another pathogenic mechanism involves the release of iron from cell-free hemoglobin with consecutive radical formation, which in turn can modify lipids, proteins, and DNA, leading to inflammation [39].\", \"key\": \"1091efba40fd4c3ea2cee44aca8ba515bbba7cbca5ad1f6ea68ab9110272df3a33f10e71bf54e16b5be5c4176b3c061786a3bd01356e79c040e3de424de10576\", \"line\": 245, \"relation\": \"increases\", \"source\": 54, \"target\": 5}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Another mechanism for platelet activation by RBC lysate is extracellular hemoglobin, which enhances platelet activation by lowering NO bioavailability [ 29].\", \"key\": \"fd4fb652dff0f6901144c7a86180834f9f4c7b148363cdf0cf1910d99d4ed7213a8b8424ca5649050ccb439dc37b29ae568e684d696c113abc2bda79f90f620a\", \"line\": 201, \"relation\": \"increases\", \"source\": 54, \"target\": 40}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"2f0d4a164a02e9d113c1107f6a559d4f8000c753a8785211999d67d0b4f69d1cbe044fa64deb60909e53d6f4e4bcaa1bbda4dd7dfc454b8d0bb62d7f8a51ba73\", \"line\": 108, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 40}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Extracellular hemoglobin sequesters NO and thus promotes activation of endothelial cells and adhesion/aggregation of platelets [64].\", \"key\": \"44fbb9b5419020e2bb609ad44eb1e39ca66325b30cfe9b9ba8d77276fd3eb96275d723f730b302e9aba469427f0b419931b0ae83f5975b87525ae9cfe7ee00e2\", \"line\": 318, \"relation\": \"increases\", \"source\": 54, \"target\": 29}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"394cb82b98b6ad19938ba5440be78c0d8e64b924eba0cec4bd90e6bcfe869db8b0fc4f946056196b40cbe6235d30c531b11b7208bd9ce6a99c0ea91f1e514d11\", \"line\": 112, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 90}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"3d512aa7e1e4f12c1d0cd628ae8012f39532b88c1887c39782f3527e6f5ad475083dbeac899e244143232b2557f6e6d9060c30937f535ce815754db2355ee0ee\", \"line\": 116, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 99}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"25-38 days\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"The median (and mean—data not shown) free Hb levels preoperatively and at all postoperative time points (immediately and 6 and 12 hr postoperatively) were higher (p50.057) in those who later developed a proven thrombosis (Fig. 3 displays the 12-hr data).\", \"key\": \"09f228106efe2a6cfeed803a3f4c35e46db70fcc27c7eb83966b83ac0e9779c389076a32cdc12dc661cb6c99da03211d7187b3c77f59132bd4829f7782df2c96\", \"line\": 164, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 99}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"Preoperative\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Our findings in the complex setting of critically ill pediatric cardiac surgery patients demonstrate that higher levels of free Hb and lower levels of haptoglobin are associated with serious postoperative clinical complications (infection, thrombosis, death), immunomodulation, and inflammation.\", \"key\": \"00d67fc7c49362bf5ec7a88117bd03f4d98fab62dd12a235d13fa4825874385ea22af74270e319971cf635df9bd899f943d2d842df71b903a3c54a25f6418625\", \"line\": 196, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 99}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"Postoperative\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Children undergoing open heart surgery experience a progressively increasing risk of postoperative infection and thrombosis, increasing need for mechanical ventilation and inotropes, increasing Day 1 through Day 2 peak blood lactate, and decreased nadir mean arterial pressure as the levels of free Hb increase and the levels of haptoglobin decrease.\", \"key\": \"3f18bc390a07cd1a5bbcfd6a0b5dc7324e6652a094b367eb219221e551311e7e1bc267efacf7052d79ea71d6e19b794baac4dc9de6155fb09977f9d18dfbcc2b\", \"line\": 217, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 99}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"40aa6f722505a7362e23910a55fa86916bbd1138ab5e56519d7f1c226cb4c46737d5b521f0cdb5c742d53462111d058e533ebcd854873b430e8a4196fe6aeb4f\", \"line\": 97, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 99}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"48 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Infusion of exogenous hemoglobin into SS-mice can markedly increase stasis compared to the amount of spontaneous stasis [5].\", \"key\": \"4c0f821a1c483550624981f9fb7112fc8d1ca0fe342fdf73f95b34d6caf98a3d9b87e26596d3868c582b316d210be01e238210fb5945561fefd9735a44a5914c\", \"line\": 133, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 77}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"28 days\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Immunofluorescence confirmed that renal Hb exposure triggered overexpression of HMOX1 and the unfolded protein response (UPR) chaperone HSP70 in tubule epithelial cells (Figure 2d).\", \"key\": \"dd9cbf9cb36644638ef1559140dfb6a1ac76f06a5d42333e15210b9f2ced12f2fb0cf6ac03062da7c4d2c33b36dd7a5a1c503eba2226a468d5a8d1804d892933\", \"line\": 147, \"relation\": \"increases\", \"source\": 54, \"target\": 55}, {\"annotations\": {\"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"We found a significant enrichment of HO-1 in the mitochondrial, but not in the cytosolic fractions after exposure to HbFe21 and HbFe31 (Figures 3A and 3B).\", \"key\": \"4035c82935569803d333cca0edb9fad5a0e8c83c733c60e644cbec83e305a98177f42ba1ff7549e1daa1666141b8bbe609d7b2a96cf3cbc00abe0d70d213dbb0\", \"line\": 140, \"relation\": \"increases\", \"source\": 54, \"target\": 66}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"However, patients who died had significantly higher plasma cell-free Hb and lower haptoglobin concentrations at all time points, preoperatively and immediately postoperatively and 6 and 12 hours postoperatively (Fig. 1 shows the 12-hr postoperative data).\", \"key\": \"e6e177f1411b93b0484a0566f39f83cba0ae2e302d3a28313b186620be23eeb1b5114ab587b14df32491fd66773f2ec0cb1b2e91de0914f2c79f411144485ac5\", \"line\": 140, \"relation\": \"negativeCorrelation\", \"source\": 54, \"target\": 56}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"Postoperative\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Children undergoing open heart surgery experience a progressively increasing risk of postoperative infection and thrombosis, increasing need for mechanical ventilation and inotropes, increasing Day 1 through Day 2 peak blood lactate, and decreased nadir mean arterial pressure as the levels of free Hb increase and the levels of haptoglobin decrease.\", \"key\": \"f4270c04da0b8f13aa48effae3971d352fecde7c0b8ca58f17e43cbecdd9f9ff2fd4385fa22e3c63d47385d5d5a5ee8bcbf7dd368e5cf06acf7cf5d29efa36a6\", \"line\": 216, \"relation\": \"negativeCorrelation\", \"source\": 54, \"target\": 56}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Akerström B\", \"Axelsson J\", \"Casslén V\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Holmqvist M\", \"Johansson ME\", \"Larsson I\", \"Ley D\", \"Marsal K\", \"Mörgelin M\", \"Rippe B\", \"Rutardottir S\", \"Shohani B\", \"Wester-Rosenlöf L\"], \"date\": \"2014-01-01\", \"first\": \"Wester-Rosenlöf L\", \"last\": \"Hansson SR\", \"name\": \"PloS one\", \"pages\": \"e86353\", \"reference\": \"24489717\", \"title\": \"A1M/α1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"The expression of A1M is up-regulated by elevated levels of free Hb, heme and ROS [23].\", \"key\": \"389d97b633a9a6699b7b67e9c13f555cb6f37de4faadbef6bc6b9eccb8cf0daed0ebc27180e5696a78d30823781299030959d5f03a399deabdf731881b5c7833\", \"line\": 91, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 51}, {\"annotations\": {\"MeSHAnatomy\": {\"Synovial Fluid\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"This is consistent with our findings here that both heme and Hb were associated with increased levels of synovial fluid A1M.\", \"key\": \"1637c6776d589b4cb4974e444697e2b3fe62a6ae6288e953c1f3bf6c4be69758cb505ed5510338795d6cb59c6a125597ce8eed94105df6ab5dfed201f0612a9e\", \"line\": 267, \"relation\": \"positiveCorrelation\", \"source\": 54, \"target\": 51}, {\"annotations\": {\"MeSHAnatomy\": {\"Alveolar Epithelial Cells\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"We also found that HbFe21 and HbFe31 activate NF-kB and mitogen-activated protein kinase pathways, as shown by phosphorylation of NF-kB p65 subunit and p44/42, respectively (Figure E3) as noted previously (31).\", \"key\": \"3fea26a08cd3efb38bf03568ac30fdb3dc96e6d8101b104856fea5c6c28b8993fdfb5f0e3c3f3023b36d117a79065fd50bdeb13fc769f48e58cfdab60e34e21e\", \"line\": 106, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"increases\", \"source\": 54, \"target\": 70}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Spleen\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Likewise, NAC was able to prevent iron-induced M1 polarization in M0, M1, and M2 BMDMs (supplemental Figure 13), indicating that the alteration of macrophage plasticity in response to iron is mostly explained by its pro-oxidant properties.\", \"key\": \"99d82a6445f52acb7720bcbdce1925afa4092e4a25b2986b4b426c96f98bc9f2d837818d190cf63afbadca5c216ee3f247f73f2b7988d8f95c87e761db02dda4\", \"line\": 232, \"relation\": \"positiveCorrelation\", \"source\": 14, \"target\": 5}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Spleen\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Likewise, NAC was able to prevent iron-induced M1 polarization in M0, M1, and M2 BMDMs (supplemental Figure 13), indicating that the alteration of macrophage plasticity in response to iron is mostly explained by its pro-oxidant properties.\", \"key\": \"9f05e9756d6d9e09ced36006cec822b4a00cfd2e2af8272490ada0728ebef97940859689aff45e924699dbc40c6221f30941502f922fedf024031c65b6219523\", \"line\": 233, \"relation\": \"negativeCorrelation\", \"source\": 14, \"target\": 0}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Treatment with Hx or DFO diminished the increase of some M1 polarization markers in BMDMs following treatment with hemolytic RBCs (supplemental Figure 14).\", \"key\": \"4819e1643a0d3ab9aa14afaaaa54d9c99ee75597c0f7537a8ac1093e3182f6948afab05798e66dca8b23b29cfeb96c5a6201d0c9b1ca0092b566da5798313171\", \"line\": 259, \"relation\": \"negativeCorrelation\", \"source\": 14, \"target\": 3}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.\", \"key\": \"16a79e663d0702ee00dde3ef9687a087602a606f50561c59093821e09e567784b39921f9c33882e4cc96a24c574a17f035f48c68b2497610adc9708ca1c32cbe\", \"line\": 353, \"relation\": \"positiveCorrelation\", \"source\": 14, \"target\": 31}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Treatment with Hx or DFO diminished the increase of some M1 polarization markers in BMDMs following treatment with hemolytic RBCs (supplemental Figure 14).\", \"key\": \"4afe89ae9762022b9513103c4de8922452e0de6d1fe6851d5e698b7b35fb2346e56700bd433007101c8659f685a82ed15d9a2750eec3bcc3a2fcba2fb8c927bb\", \"line\": 258, \"relation\": \"negativeCorrelation\", \"source\": 14, \"target\": 57}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Importantly, by scavenging free heme, Hx prevents heme-induced M1 macrophage polarization and thus avoids both TLR4 activation and ROS formation.\", \"key\": \"6b26b58e1138e5bdf4b9007a46597473cf3c59f3b6182a158cda3d328e2e66c89bebc9a67be68f2779e5544ce803b62f4029c6e313e843a1043da40bd609007d\", \"line\": 343, \"relation\": \"negativeCorrelation\", \"source\": 14, \"target\": 67}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.\", \"key\": \"247f779f6025755b29f46acc24ebcfd48ffa154a9d05aaef1df82baba55e54a8193e7dab1960fff8e6fecbd0e19b1ff654d60246dcc71396fe07df8b6e25ca89\", \"line\": 355, \"relation\": \"negativeCorrelation\", \"source\": 14, \"target\": 67}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"The abnormal phospholipid membrane asymmetry present in the RBCs of b-thalassaemia and SCD patients, with resultant phosphatidylserine exposure, appears to play a significant role in the aetiology of the observed hypercoagulable state and in the link between haemolysis and thrombosis (Ataga et al, 2007).\", \"key\": \"bfc486e901b00a7d6b319a8462b230326ffddffc545cd18419e40e60b54ae9ff6505317dc312363c91d8254cb356591bf337eb9cfd9827917da19a1af12ed3d5\", \"line\": 272, \"relation\": \"increases\", \"source\": 7, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"The abnormal phospholipid membrane asymmetry present in the RBCs of b-thalassaemia and SCD patients, with resultant phosphatidylserine exposure, appears to play a significant role in the aetiology of the observed hypercoagulable state and in the link between haemolysis and thrombosis (Ataga et al, 2007).\", \"key\": \"262fb8d60e7ee47fae0862a3840fad5d9e80535c21528b60b7fa6da3dc49ee8ceb881cbcd6f3dd5cf68491c47c3173a4d9640bfdad1031ab44ca4970fd1c08e6\", \"line\": 273, \"relation\": \"increases\", \"source\": 7, \"target\": 99}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Because of the large numbers of RBCs present in the blood, even a small fraction of RBCs with phosphatidylserine exposure can result in prothrombotic conditions.\", \"key\": \"85795278dea2ee699abf1bcce77726c894b5f7ddbc54894b736ce6e21d7afe7066678a5eafb7721714f16b29f9d0029f5ce0e8d4e99f27c0ed54889413b5ebda\", \"line\": 257, \"relation\": \"positiveCorrelation\", \"source\": 7, \"target\": 99}, {\"annotations\": {\"MeSHAnatomy\": {\"Endothelium, Vascular\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Barodka VM\", \"Berkowitz DE\", \"Frank SM\", \"Goyal A\", \"Johnson DJ\", \"Lipsitz JA\", \"Nagababu E\", \"Scott AV\"], \"date\": \"2016-08-01\", \"first\": \"Nagababu E\", \"last\": \"Frank SM\", \"name\": \"Anesthesia and analgesia\", \"pages\": \"274-82\", \"reference\": \"27308950\", \"title\": \"The Impact of Surgery and Stored Red Blood Cell Transfusions on Nitric Oxide Homeostasis.\", \"type\": \"PubMed\", \"volume\": \"123\"}, \"evidence\": \"In addition to cell-free Hb, membrane structural modification, externalization of phosphatidylserine,21 decreased cell membrane deformability,22,23 and increased endothelial adherence24 could alter vascular NO homeostasis.\", \"key\": \"e506deaf076ead39ae563e8df8be8ca5d0d9d68633119b4ebd200e98eed6075abc1d7cb37b8310f92ded9c5396dacfb5dfca315040ba63fe26e571b443e06dad\", \"line\": 132, \"relation\": \"decreases\", \"source\": 7, \"target\": 6}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Under conditions of apoptosis or RBC damage, such as high shear rates, inflammation, or oxidative stress, RBCs can lose membrane asymmetry and expose phosphatidylserine [43].\", \"key\": \"d66424103b966bc62208dc20e892de9a327799212c7ffaef05738211458281c543dbb333886568f428ba9d737d3d6b94f87bde1c1013652b6ba3a06353fb5f97\", \"line\": 245, \"relation\": \"positiveCorrelation\", \"source\": 7, \"target\": 20}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Phosphatidylserine externalization and shedding are mediated by increased cellular Ca-flux and play an important role in natural RBC senescence [44].\", \"key\": \"b9e802877e2f30805edb4c23f5746e2d37ee8411399f0287d497e79206a073b1882428fc5f8b450850e21fb36b7089cc8e34f90d4668b704734b083f7f84a641\", \"line\": 252, \"relation\": \"positiveCorrelation\", \"source\": 7, \"target\": 20}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.\", \"key\": \"67eb8d1653bd3d4752c93ecdac60811ac1e5b724a50977ce80ac54e20848b35e7d02de89e4a6864f4ac16a2d78cf400facd3af176372155d1459e46399b316f0\", \"line\": 219, \"relation\": \"increases\", \"source\": 13, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"This common X-linked inherited disorder, characterized by severe intravascular and extravascular haemolysis, is classically triggered by fava bean ingestion or pro-oxidant medications. It causes haemolysis in susceptible individuals and an association with thrombosis was described in multiple case reports (Jewett, 1976; Thompson et al, 2013; Albertsen et al, 2014).\", \"key\": \"211460ae2ec236162c5984e7a5c3c3aab1c4429c545288c59157b9eee5dcdbf0c1d3405f89edbe3967ca50f531475819b9862c40a0abe806428877f05dacbe04\", \"line\": 333, \"relation\": \"positiveCorrelation\", \"source\": 13, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"This common X-linked inherited disorder, characterized by severe intravascular and extravascular haemolysis, is classically triggered by fava bean ingestion or pro-oxidant medications. It causes haemolysis in susceptible individuals and an association with thrombosis was described in multiple case reports (Jewett, 1976; Thompson et al, 2013; Albertsen et al, 2014).\", \"key\": \"6ba96d61634c77eb359758223956b47f5abfd851bb8e498e980231e383a60ebcaba5810063113cf77d33f104bc1c4aaadfe2eedaca448b002c80370153d1ef6b\", \"line\": 334, \"relation\": \"positiveCorrelation\", \"source\": 13, \"target\": 99}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Carbon monoxide has vasodilatory, anti-proliferative, anti-inflammatory and antioxidant properties, whereas bilirubin, the product of biliverdin reductase, is an antioxidant (Baranano et al, 2002).\", \"key\": \"3446fb773c2dc5b73f7635a1f89fe6511cc05c2563ecfc6364430d41ab3223fcf0a486fe0f7abaddf4b59965dede9fe9727b63033c9edc0dc29b83f8960c6855\", \"line\": 160, \"relation\": \"positiveCorrelation\", \"source\": 9, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 2}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).\", \"key\": \"ef44b332f135e0060f6c9ad938fd904cf9cbde95d4e470bbf61a7b33c3e7f5de4f41315873ae1c68a3bbfbd5a64fd68cd647d03f12e20dc646f93738fcdbb14e\", \"line\": 178, \"relation\": \"negativeCorrelation\", \"source\": 9, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Under conditions of apoptosis or RBC damage, such as high shear rates, inflammation, or oxidative stress, RBCs can lose membrane asymmetry and expose phosphatidylserine [43].\", \"key\": \"db414303a2aa9f25b466e797994814144e5a107a9120164b3dcaa3eb0015cf7b36e0d8a45a539bfa542b78a6f57bd315418cf0ca24c6d726a8826f1044d73c8d\", \"line\": 243, \"relation\": \"positiveCorrelation\", \"source\": 20, \"target\": 39}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Under conditions of apoptosis or RBC damage, such as high shear rates, inflammation, or oxidative stress, RBCs can lose membrane asymmetry and expose phosphatidylserine [43].\", \"key\": \"6c7a337a83f63e17d9fa485837c768154c62c7de4b5ae6914fc427894520d64a78b90cc72e63bac7749c3d0889fc222bab70eb65c31fa9d76a6821e6b022d7a6\", \"line\": 244, \"relation\": \"positiveCorrelation\", \"source\": 20, \"target\": 97}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Under conditions of apoptosis or RBC damage, such as high shear rates, inflammation, or oxidative stress, RBCs can lose membrane asymmetry and expose phosphatidylserine [43].\", \"key\": \"a891e9a01e8f1e88a595a10cf7cc189ab1e3843929ca36cdc430fd23b1f2fc71c47583fed56ce55728ab56a636d9dea0ee38bbf355b62082b8509899e03dcebc\", \"line\": 245, \"relation\": \"positiveCorrelation\", \"source\": 20, \"target\": 7}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Phosphatidylserine externalization and shedding are mediated by increased cellular Ca-flux and play an important role in natural RBC senescence [44].\", \"key\": \"d3ba327978b713d8079f9ecd7162ff1d93413e33f1ac4f2907200f60a127f437edfba437458feb079c1dbcace8c74c1a9dd9914c324cae032b4adc4964b182e3\", \"line\": 252, \"relation\": \"positiveCorrelation\", \"source\": 20, \"target\": 7}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"Acute Coronary Syndrome\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"When RBCs are damaged by high shear in continuous flow ventricular assist devices, free hemoglobin induces platelet aggregation, contributing to high risk of thrombotic complications [33].\", \"key\": \"adcdb4b1b80d285faa5f2eacbfae5c3b5609721b1178ee4d1173660edde6f0f9477dc2d4abbc90e28ddda5f6bcb3c16d7e36a1f5070f483c1795e70ec5e096aa\", \"line\": 220, \"relation\": \"increases\", \"source\": 20, \"target\": 54}, {\"key\": \"9797cd11d305bcc8921fa7052e6ee487d7690cbbd1e0af11fa7933a872483beb306719834421e5ee0a5982f66a460e7a5ee62d5eec215b89210ff12eacb18858\", \"relation\": \"hasComponent\", \"source\": 47, \"target\": 10}, {\"key\": \"ce658cb4409630e3b8606aaf74883f7cf5ba56f65b887c9e8e1c5c91d01d69ad2a36548efeec655a8e871aca224bc3651c8a0c094a2ca97ba8c0afb2eefb762f\", \"relation\": \"hasComponent\", \"source\": 47, \"target\": 67}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The hematoma clearance may be via red blood cell (RBC) lysis or phagocytosis.\", \"key\": \"cf8702cd72c3471afff0dfd6568b30ab0788d2f3e023c6daabb99313be96b9fae0f264f9261282abb43624dd3e9d982f15343003d50ec19f0b188f75b8fdd769\", \"line\": 97, \"relation\": \"negativeCorrelation\", \"source\": 94, \"target\": 43}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"In this present study, MAC contents in the clot gradually increased with a marked accumulation at day-3 (53.5 ± 8.2 vs. 11.0 ± 3.9 ng/g at 4 hour, p<0.01, Fig. 2C) and stayed at high levels at day 7.\", \"key\": \"d80bc9d6bed5d0c6db4e44c9e7b1992bfe9261bf49bc8f1e525d9764c4d1afc8eff8caa99bcb56f9b32e122fbc481f4fcc8ff8422e6aa7fd574444826c2e78b6\", \"line\": 138, \"relation\": \"positiveCorrelation\", \"source\": 94, \"target\": 19}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"In combination, these finding may underlie our previous results showing that DFX slows hematoma resolution after ICH in aged rats 12.\", \"key\": \"b0fcfea96495474c93d46cb9b52ca28c8613db6202b790150952bd6358b0d3c5fb7a05390b981d6c239be960ef7d3af035345c49825242e3e8ca7a61e92a8bda\", \"line\": 283, \"relation\": \"negativeCorrelation\", \"source\": 94, \"target\": 3}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"HO-1 protein levels in the hematoma also increased at day-3 (HO-1/GAPDH: 0.65 ± 0.08 at day-3 vs. 0.04 ± 0.01 at 4 hour, p<0.01).\", \"key\": \"5173b215e9265ff6327a3c6868c04bd383b2132780f6c197905abee625dc44523be035b9dc1434350b1986d14e886fbc8c0c6d73945c7dd9138cc1f2faf2603b\", \"line\": 160, \"relation\": \"positiveCorrelation\", \"source\": 94, \"target\": 55}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The level of hemoglobin declined gradually over the time after the onset of ICH with a significant reduction at day 3. The contents of hemoglobin in the clot were 26.2 ± 5.2 mg/g at 4 hours, but were reduced to 13.9 ± 0.9 mg/g at day-3 (Fig. 2B, p<0.01).\", \"key\": \"56360de1eaba70afb67d1ab34e5ecee9a4cce16211ac9dd1837afaefda92fc2eb05d01a52f111d14afcb8c985a370d408ac8b132be7ae07126466b34f2233a0a\", \"line\": 121, \"relation\": \"negativeCorrelation\", \"source\": 94, \"target\": 54}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"We found that hemoglobin contents in hematoma were significantly higher in the DFX treated group compare to the vehicle-treated group (15.9 ± 1.8 vs. 11.8 ± 0.8 mg/g, p<0.05, Fig. 5A).\", \"key\": \"f1850a6684a945e5f5d82b77a43739d729c5dae2cc7e3186203416c5d6d6f86a2be8d8b79cd45f5e0c2aec16c9c33b8e76e81a6a21821eb111409adb1baa86b0\", \"line\": 168, \"relation\": \"negativeCorrelation\", \"source\": 94, \"target\": 54}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"CD163 and HO-1 positive cells infiltrated into the hematoma from edge to center after ICH (Figs. 4A & 4B). A significant increase of CD163 cells was found at day 3.\", \"key\": \"aee3fd0eab26e01438956f049257926d98111eed9b7499a517e205d874c28f567fd4eb3f3004a32851862d18ac43ce471c919d50be77af50f7d4f621e37579c7\", \"line\": 154, \"relation\": \"positiveCorrelation\", \"source\": 94, \"target\": 52}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Placenta\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"A statistically significant increase in the mean Hp-HbF concentration was observed for women with PE as compared to controls (p-value 0.018).\", \"key\": \"403de525ec9a162ae5336e3c434d2a678c6d8c821ee9894ee525a0ca7ad62277faa0f463043b5bc5f55a77b1e34ecb2e33dde9509ac0251e796199eef04415c1\", \"line\": 140, \"relation\": \"positiveCorrelation\", \"source\": 86, \"target\": 23}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"In line with previously published studies [13,14] the extravascular heme- and radical scavenger A1M was significantly increased in plasma of women with PE.\", \"key\": \"4a516162fa3400ac881a1314f33b142e516fa8c82e59a15c380e4f1575107d37cd87ff5516d4c75f43a1e50e848fdde1d598732ad08f5baddcb326e0b5b0ab84\", \"line\": 193, \"relation\": \"positiveCorrelation\", \"source\": 86, \"target\": 10}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Analysis of the Hp concentration in plasma showed a statistically significant decrease in Hp concentration in plasma samples of women with PE as compared to controls (pvalue< 0.0001).\", \"key\": \"c99ba677e6251dd5aaac014352603c3dae615408aa2cc46c96e6c302c835d352f485d7cf3cdb282955ea9956f16bd23f5bc1bb19bfff96ccf294bdc3b7bd9ded\", \"line\": 147, \"relation\": \"negativeCorrelation\", \"source\": 86, \"target\": 56}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Analysis of the intravascular heme-scavenger protein Hpx showed a statistically significant decrease in plasma Hpx concentration of women with PE (p-value<0.0001) as compared to the controls (Table 3).\", \"key\": \"8c1f207f3ffff5de654d4e7540c5cf960a0001f0d77ce6144248a7e77246692fece53aa816e4a450cbc600f58302df1b9b8af6155246b6121f6d2849911e5081\", \"line\": 161, \"relation\": \"negativeCorrelation\", \"source\": 86, \"target\": 57}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Analysis of plasma levels of the heme- and radical scavenger A1M showed a statistically significant increase of plasma A1M concentration in women with PE (p-value 0.035) as compared to controls (Table 3).\", \"key\": \"79c02a873d20157e17c66b1e69335954a55a4dd4c8b09f2cd11fe1448eceae61dcd8a13b41bf8ed5d7a77b86e189bb7c3bfa2aafc4180657e3c5cbc28a866b2c\", \"line\": 168, \"relation\": \"positiveCorrelation\", \"source\": 86, \"target\": 51}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"In line with previously published studies [13,14] the extravascular heme- and radical scavenger A1M was significantly increased in plasma of women with PE.\", \"key\": \"9486ad4a30b1d7cbe7f992177a898a5ff2e0861b0d2c2539e04797a5accdfe18f60ef3bc14b58dab56e90dba9cec8d191c3b5da03cb860531adcbfc879d05852\", \"line\": 192, \"relation\": \"positiveCorrelation\", \"source\": 86, \"target\": 51}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Soluble, shedded CD163, the macrophage receptor mediating elimination of the Hp-Hb complex, was analyzed in plasma [40–42]. The analysis showed a small but not statistically significant (p-value 0.37) increase in the PE group as compared to the controls (Table 3).\", \"key\": \"55e196a634f0b1f9b7d2308bd5393980de1192c48e92b8aa4376afa1b1fd5f8635214e3222d74b63f26ac1a6e69f9d2bb7713c7e8cb299a7b69a2bedd43f093a\", \"line\": 154, \"relation\": \"positiveCorrelation\", \"source\": 86, \"target\": 52}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"Erythrocyte lysis after ICH can be mediated by the complement activation and formation of the membrane attack complex (MAC), which contains complement C5b, C6, C7, C8 and C9 proteins (C5b– 9).\", \"key\": \"1ae92d6e64cf78a12495f1a1739a3acc389f42dbd3b34b99deb356ccc2b0662b43f2fa3e77844fb2ce820a9e0315bf788f16d951e5a7936d698f009ba8bb3599\", \"line\": 105, \"relation\": \"positiveCorrelation\", \"source\": 19, \"target\": 95}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"Activation of the complement system and the formation of MAC resulted in an increased membrane permeability and erythrocyte lysis.\", \"key\": \"21955708fdc3c98e2ec2783af4bc1d5a052613d06d460404f13bc11d5a0748caef822d0352641374616d73b448ce3ba4b3fe8b6aede2c94c64d151a60613e20e\", \"line\": 129, \"relation\": \"positiveCorrelation\", \"source\": 19, \"target\": 95}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"Following complement cascade activation, MAC on the cell membrane forms a pore resulting in membrane permeability changes17 finally leading to RBC morphological alterations and erythrocyte lysis.\", \"key\": \"b067738cf478ab93e24dea5005abc63e082547b1c89e3049312ab1d2328d917df908f216de82a68982642259fd2500232b3bed4268ededaac79e43e7c8182c5e\", \"line\": 224, \"relation\": \"positiveCorrelation\", \"source\": 19, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Increased MAC deposition may lead to cell lysis and hemolysis, as is usually seen in RBCs but to a lesser extent in neutrophils and platelets (please see below).\", \"key\": \"12cd000c662b3eea093931b520cefb0edc178594c61444c34d3b751428882e3c550113ccdbc01801817e899f361838a93ee4193d0eff8b1d6c8637018e60d4db\", \"line\": 160, \"relation\": \"positiveCorrelation\", \"source\": 19, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Following MAC deposition on RBCs, intravascular hemolysis that leads to increasing levels of free hemoglobin was seen.\", \"key\": \"2cb138e1a12f3428fdad02bf680bf342da419e40cb319f347eeecddf973c305416e02f421f011ef850edb8904ac850038c8bc4366c25e45f82dc760ebdab378f\", \"line\": 165, \"relation\": \"positiveCorrelation\", \"source\": 19, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Hemolysis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Ultimately, activation of the complement cascade results in formation of the terminal complement complex C5b-9, the so-called membrane attack complex, and consequently a pore formation resulting in osmotic lysis of the target [71]. In the case of red blood cells, hemolysis will result.\", \"key\": \"df0e6e8ade307018fb746ef9b82acc27ef15e9ee03bae4c52964ef01da4634952f83770d4be45b49d38c775449f1e55d9016e6bec9c43e44927e2a911eee9f17\", \"line\": 340, \"relation\": \"increases\", \"source\": 19, \"target\": 95}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"In this present study, MAC contents in the clot gradually increased with a marked accumulation at day-3 (53.5 ± 8.2 vs. 11.0 ± 3.9 ng/g at 4 hour, p<0.01, Fig. 2C) and stayed at high levels at day 7.\", \"key\": \"24ea7410a2ae6d00bada5a589f589e5c8d0e55d7e5a818272cc99842c42a6ccd5d22cf6e6fd4d5acbd70635a3900602a47695eacd714f99c9c11a0b11ca829e6\", \"line\": 138, \"relation\": \"positiveCorrelation\", \"source\": 19, \"target\": 94}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"DFX also reduced the MAC content in the clot at day-3 (33.0 ± 6.6 vs. 56.2 ± 9.2 ng/g in the vehicle-treated group, p<0.05, Fig. 5B).\", \"key\": \"55cc629e1b43f9ec422d0ffb9878664eb900b2bdd2135c2f353383be580f2f58db625d170fcd57eb7b66a42fbc4a6b6c074b251aaaa117c61913bb7848233bb3\", \"line\": 175, \"relation\": \"negativeCorrelation\", \"source\": 19, \"target\": 3}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHDisease\": {\"Stroke\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The present study found that DFX treatment reduces MAC formation in the clot.\", \"key\": \"283f8220a64a6c09ba818e2fd09ee6ddbbe1d7a286ced8fba774538a2ef80a7c2d758935c0b508d40d9e667c04faf3b672df8f7773feb3a13d28c7a2ff2c5cbc\", \"line\": 271, \"relation\": \"negativeCorrelation\", \"source\": 19, \"target\": 3}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"As shown in Fig. 1, significantly increased MAC deposition is seen on RBCs (p < 0.0003), neutrophils (p < 0.009), and platelets (p < 0.0003), but not on monocytes (p=0.5, not shown).\", \"key\": \"1fd655620a1a78bb5c088ef1519f887ca2cf0de9938534e5679d131d19b708d3a98e0e6c1d33caed6c360ebc54d56f892a2fecfaa9656242f0842dbae0576d61\", \"line\": 150, \"relation\": \"positiveCorrelation\", \"source\": 19, \"target\": 76}, {\"annotations\": {\"Cell\": {\"platelet\": true}, \"MeSHAnatomy\": {\"Endothelium\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"However, in primary Cys89Tyr CD59 deficiency and not in PNH, the endothelial cells are exposed to MACmediated injury.\", \"key\": \"b33cb6c10b49c0613f1461380b84c0277543b45734886a45ee3785101cad53d9d54e95e5e536fc1f88e45e330a2a5fa20cbef2ce045cb820ddbcbe8cb7ae830c\", \"line\": 312, \"relation\": \"positiveCorrelation\", \"source\": 19, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 76}, {\"key\": \"26d927504125b5b3d0dc27ff2cecdb8d3949e89d9478256088ecdc54faa4b621f6fe427f630d0e6d671d8b64a3c4c43fadb93a10a6c67f4aa8e01f33bd039cb7\", \"relation\": \"hasComponent\", \"source\": 49, \"target\": 17}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney Cortex\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Only transfusion of SRBCs and haptoglobin prevented SRBC-induced renal iron accumulation (Figure 6A and B).\", \"key\": \"f4823ed03897ade049a223e32134180d077554934a0acb9adf34934aa385ca2bfa001a34387607b1d3083da14268e845d68a4449ad5816e465129764ce6ff6c1\", \"line\": 294, \"relation\": \"negativeCorrelation\", \"source\": 49, \"target\": 5}, {\"annotations\": {\"MeSHAnatomy\": {\"Spleen\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"In comparison to mice transfused with SRBCs alone, the spleens of mice resuscitated with SRBCs and haptoglobin contained more iron (Figure 6D).\", \"key\": \"f5e0ecac7f179316f17824b8abc56a1fc60d11e8b4491e3c44cc46ce2cf6eb3a8800867e803e28eb2b63037013c4c89a6c1b5789985b1407699fe98d532d65f9\", \"line\": 306, \"relation\": \"positiveCorrelation\", \"source\": 49, \"target\": 5}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Resuscitation with SRBCs and haptoglobin prevented the increase in SRBC-induced renal HO-1 expression (Figure 7F).\", \"key\": \"6640a65a8e95a4174829718cdacfb6dd738741b55b4aec9860ef50bf6f55d6e02e03290b26a2e9c47510aa607cf9efdb4df66efc74ef01842ff45229d133289e\", \"line\": 345, \"relation\": \"negativeCorrelation\", \"source\": 49, \"target\": 66}, {\"annotations\": {\"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Co-administration of haptoglobin with SRBCs results in a prolonged increase in plasma hemoglobin levels for more than 48 hours after transfusion.\", \"key\": \"8ac20e47de6f3f2116b29f29c40f7be0f4f0bbe22977e544a2c62e5912e64d53961097182f9a93271835d243f63c91bd9a30e6ece80e6452714941e776802690\", \"line\": 205, \"relation\": \"positiveCorrelation\", \"source\": 49, \"target\": 54}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Plaque, Atherosclerotic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Inhibition of lipid oxidation by either haptoglobin or hemopexin reduced the cytotoxicity (Fig 4B) and HO-1 induction caused by sublethal amounts of pretreated atheromatous lesion lipids (Fig 4C and D).\", \"key\": \"ca3537de95ecb43f0db4d80c59c4348d9e65fed642cb5f59d9d1d693fe832da8fa929909f544654fc1428309b86fcdd00ff0bf3ca6a80fff0cc45fde6449399c\", \"line\": 233, \"relation\": \"positiveCorrelation\", \"source\": 35, \"target\": 38}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, by participating in Fenton chemistry, non-transferrin-bound iron (i.e., iron not bound to the physiological iron transport protein, transferrin) causes oxidative damage, cytotoxicity and enhanced endothelial expression of adhesion molecules, thereby enhancing thrombotic risk (Hershko, 2007).\", \"key\": \"b0c85c0c2ae9b56cceb707bc67deac22268b6af29ab12332cc0b67272d4ab29d718ea01e068103804025efd82c4697c7a5ee2248a4afc9f0f6a8fe5a480254c3\", \"line\": 633, \"relation\": \"positiveCorrelation\", \"source\": 35, \"target\": 5}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"MeSHAnatomy\": {\"Human Umbilical Vein Endothelial Cells\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"In contrast, less ATP depletion was observed during exposure to heme-albumin, and no effect could be detected when either cell type was exposed to metHb or oxyHb at concentrations of up to 500 lmol\\u0001L\\u00031, even in the absence of serum.\", \"key\": \"656d7b41d7914a8c73bca36842a792d6f4a3ea46e0c257c061067dc40fe2065b052e44e5e3dcabeb3775b0977724a2f1b44408485d1440dea317887d75f53af1\", \"line\": 130, \"relation\": \"positiveCorrelation\", \"source\": 1, \"target\": 46}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Plaque, Atherosclerotic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Inhibition of lipid oxidation by either haptoglobin or hemopexin reduced the cytotoxicity (Fig 4B) and HO-1 induction caused by sublethal amounts of pretreated atheromatous lesion lipids (Fig 4C and D).\", \"key\": \"e33a6a0e3f680da61509f863ef15cce82671a2a41f05584aa4e341b96b98344b36631313ae0b5db4e9acbd3981d0e34a31a1dda3445c2849f62c18e95c1b5c82\", \"line\": 234, \"relation\": \"decreases\", \"source\": 56, \"target\": 38}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Banerjee S\", \"Crumbliss AL\", \"Jia Y\", \"Kreulen RT\", \"Mollan TL\", \"Olson JS\", \"Tsai AL\", \"Wu G\"], \"date\": \"2014-04-01\", \"first\": \"Mollan TL\", \"last\": \"Alayash AI\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"265-77\", \"reference\": \"24486321\", \"title\": \"Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Probably the most important Hp-mediated abrogation of Hb toxicity is stabilization of heme within the central cavity of the Hb subunits, which almost completely prevents its dissociation and subsequent free heme-mediated oxidative reactions and inflammatory responses.\", \"key\": \"181d0775a043e38690e9450498eedf2808d8cca47725afb9750a138af6b32510f39bfb27f4e11c985188b87c238b76e4901b7815e4ab4e3469786ed485ab89b9\", \"line\": 161, \"relation\": \"decreases\", \"source\": 56, \"target\": 97}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Banerjee S\", \"Crumbliss AL\", \"Jia Y\", \"Kreulen RT\", \"Mollan TL\", \"Olson JS\", \"Tsai AL\", \"Wu G\"], \"date\": \"2014-04-01\", \"first\": \"Mollan TL\", \"last\": \"Alayash AI\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"265-77\", \"reference\": \"24486321\", \"title\": \"Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"First, addition of exogenous Hp both markedly inhibits heme loss and second, as a result of this inhibition, globin precipitation is prevented.\", \"key\": \"8ffb37aa1bbd352ece1ce66cdb9f6ff9279ae77b0af74c71313ff4a2b1510615cc746bfc955c4f3961e4c48f8014f27626536a7470f6ceb6d062b93e09c42229\", \"line\": 167, \"relation\": \"positiveCorrelation\", \"source\": 56, \"target\": 10}, {\"annotations\": {\"MeSHDisease\": {\"Pulmonary Embolism\": true}, \"Species\": {\"Homo sapiens\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Bonkovsky HL\", \"Courtney M\", \"Kline JA\", \"Steuerwald NM\", \"Watts JA\"], \"date\": \"2015-10-01\", \"first\": \"Kline JA\", \"last\": \"Bonkovsky HL\", \"name\": \"Thrombosis research\", \"pages\": \"769-74\", \"reference\": \"26337933\", \"title\": \"Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.\", \"type\": \"PubMed\", \"volume\": \"136\"}, \"evidence\": \"The median values and associated interquartile ranges for hmox-1 and haptoglobin show that patients with PE+TR+ had lower expression of these genes compared with patients who were PE+TR− or PE−\", \"key\": \"a9c4e60e8afd6ac3cbcba3f03c5f046d259615f3b2130b71d62a6e40f22f279480b480806eb11f5d58599888168fa93f9f4b3748e3ecba9f019f641e957e940a\", \"line\": 106, \"relation\": \"negativeCorrelation\", \"source\": 56, \"target\": 89}, {\"annotations\": {\"MeSHAnatomy\": {\"Placenta\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Haptoglobin (Hp) is perhaps the most well investigated Hb-clearing molecule. It binds cell-free Hb in plasma [20,21] and the resulting Hp-Hb complex is cleared from blood via binding to the macrophage receptor CD163 [22].\", \"key\": \"a4d50d7ffbddf58e9a6506b3829e8588a8a922894f60ead698358422202fe5b753b94e218c48ee28509b1e7703e7b4993e87d0764ddff0c0359094a88975fd8f\", \"line\": 106, \"relation\": \"positiveCorrelation\", \"source\": 56, \"target\": 23}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Analysis of the Hp concentration in plasma showed a statistically significant decrease in Hp concentration in plasma samples of women with PE as compared to controls (pvalue< 0.0001).\", \"key\": \"4b146140504888f4696e5b71b0485968449a8347bb3df5df66e49777c1fff9402af291969f6bfb07d9e38cddd211b27da208b570b6bc8a98688174ca45f907c5\", \"line\": 147, \"relation\": \"negativeCorrelation\", \"source\": 56, \"target\": 86}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Puglia M\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2015-12-01\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"931-43\", \"reference\": \"26475040\", \"title\": \"Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity.\", \"type\": \"PubMed\", \"volume\": \"89\"}, \"evidence\": \"However, in patients with hemolysis Hp depletes early in the course of the disease while levels of Hx remain within the physiologic range for prolonged periods of sustained hemolytic disease [12].\", \"key\": \"73b9cb9aa57f6c70018d4325e2920c7752112328bfdf5c54b96597c4733b7123b8ba67d2bf4071b68e808d4a48b857d0ab803c93c230691b9384eb5b21f65395\", \"line\": 127, \"relation\": \"negativeCorrelation\", \"source\": 56, \"target\": 95}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"In cases of extensive and chronic hemolysis, levels of haptoglobin and hemopexin in plasma decrease markedly [20,21].\", \"key\": \"9fcaa42c2164421011468063ccd90980fc88f9e99b5a68839aca33eb543b03694876adb735c44b314079578e0afc300069dee821514a85449f3d79da04412e74\", \"line\": 115, \"relation\": \"negativeCorrelation\", \"source\": 56, \"target\": 95}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Plasma haptoglobin and hemopexin levels are often depleted in SCD patients and mice due to chronic intravascular hemolysis [21±24].\", \"key\": \"2bc491dc23308623ae0a39dc04adb11c25218dcdb0f8662af5ebc23f7594d9f91326d9befc3049f3f1d4ab697264bf5d106dce74754b25d081d0d64cf50f66b8\", \"line\": 117, \"relation\": \"negativeCorrelation\", \"source\": 56, \"target\": 95}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"Preoperative\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Adult normal levels of preoperative haptoglobin were associated with a substantially and significantly lower incidence of thrombosis than lower levels of haptoglobin (Table 1; row 3).\", \"key\": \"ce02ecca8f6f06dbd2df710517d20c0d8675677b4037596add058e5239f89c707821295706e5779f524843343601da9bb9eeec165d7b52baac7b642eba99c7d7\", \"line\": 172, \"relation\": \"negativeCorrelation\", \"source\": 56, \"target\": 99}, {\"annotations\": {\"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Banerjee S\", \"Crumbliss AL\", \"Jia Y\", \"Kreulen RT\", \"Mollan TL\", \"Olson JS\", \"Tsai AL\", \"Wu G\"], \"date\": \"2014-04-01\", \"first\": \"Mollan TL\", \"last\": \"Alayash AI\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"265-77\", \"reference\": \"24486321\", \"title\": \"Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Haptoglobin (Hp) is an abundant and conserved plasma glycoprotein, which binds acellular adult hemoglobin (Hb) dimers with high affinity and facilitates their rapid clearance from circulation following hemolysis.\", \"key\": \"17baf55a8b30b101b30206a95b72d4f2d137feaf8dd702fc6ee30066431068e8b719f21d8de57eda35485264a46ad5c5e88503633bfa0d1b7d396cc160eb75a2\", \"line\": 96, \"relation\": \"decreases\", \"source\": 56, \"target\": 54}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Banerjee S\", \"Crumbliss AL\", \"Jia Y\", \"Kreulen RT\", \"Mollan TL\", \"Olson JS\", \"Tsai AL\", \"Wu G\"], \"date\": \"2014-04-01\", \"first\": \"Mollan TL\", \"last\": \"Alayash AI\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"265-77\", \"reference\": \"24486321\", \"title\": \"Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Haptoglobin (Hp) is a Hb-scavenging plasma glycoprotein which binds non-covalently to hemoglobin dimers that are generated by dissociation of acellular Hb tetramers after hemolysis [6].\", \"key\": \"0d7e07bf4130febe362ae72f2146018ea18e4022b2df250ddd533fbda2e7d1870017cd7adb695ce41b2bc1e449e57b8035512e7f3723d1115ccf7a3e9d194959\", \"line\": 116, \"relation\": \"decreases\", \"source\": 56, \"target\": 54}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Banerjee S\", \"Crumbliss AL\", \"Jia Y\", \"Kreulen RT\", \"Mollan TL\", \"Olson JS\", \"Tsai AL\", \"Wu G\"], \"date\": \"2014-04-01\", \"first\": \"Mollan TL\", \"last\": \"Alayash AI\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"265-77\", \"reference\": \"24486321\", \"title\": \"Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Hp is the first-line scavenger that binds and accelerates the clearance of Hb in the circulation, although the macrophage CD163 receptor has also been the focus of several recent investigations [66– 68].\", \"key\": \"47ae39c2a05e32e89ded7e4a9576b2b0b15bd161aad593384012a39d15716ae413ca6f0b04704fc63f5b68c3272e2babda0e5960d7b762de8f51d5c7b7bb4f68\", \"line\": 153, \"relation\": \"decreases\", \"source\": 56, \"target\": 54}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Puglia M\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2015-12-01\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"931-43\", \"reference\": \"26475040\", \"title\": \"Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity.\", \"type\": \"PubMed\", \"volume\": \"89\"}, \"evidence\": \"Based on clinical observations the Hb and heme scavenger proteins haptoglobin (Hp) and hemopexin (Hx) have been characterized as a sequential defense system with Hp as the primary protector and Hx as a backup when all Hp is depleted during more severe intravascular hemolysis.\", \"key\": \"7f3ab43e58cf48c390b77a0b30c71fb37df7a4b91a2a34d483df961fee5f8ebd55639c7f4dfca7dab17e252f2eaeff318c3849596221b51e681792db049855ae\", \"line\": 104, \"relation\": \"decreases\", \"source\": 56, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Free Hb is bound by the plasma protein haptoglobin, and the large molecular size Hb: Hp complexes are ultimately cleared by spleen and liver macrophages expressing the Hb scavenger receptor CD163.8\", \"key\": \"53e34cc1a3a875c26afed8dfa5bab15aa38cc865dcd65c96df1dc7d7c2dbaffc5bd19a0e26757223bd2eb8bcba5bd5e68bcfdeff7f3c98857a6acf7cb3061813\", \"line\": 109, \"relation\": \"decreases\", \"source\": 56, \"target\": 54}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"MeSHAnatomy\": {\"Kidney Tubules\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"28 days\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Hp treatment prevented renal Hb exposure.\", \"key\": \"6ae9242eea1969e8d957fbb08c1d6145c1584afde92361e3c131b6b82eafc1da20abd061f6c06871bedd75a12a3d61aa0491a0affd5d8637776385f46f0c8636\", \"line\": 176, \"relation\": \"decreases\", \"source\": 56, \"target\": 54}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"Concentration\": {\"20 μM\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"MeSHDisease\": {\"Hemoglobinuria\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"The prevention of renal Hb filtration by Hp may be a therapeutic strategy to block renal Hb exposure and to rescue renal function in patients with severe hemoglobinuria.\", \"key\": \"3eb76c8c9319c7a7a7d994af30eca0d273fcfe7a51763211109be10531ee22dd3f5df0bb60224c0f2bcc4196ee852c24b69d18a017a57ef12264402d22a61cfe\", \"line\": 309, \"relation\": \"decreases\", \"source\": 56, \"target\": 54}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Thus, the interactions of hemoglobin with haptoglobin, and of heme with hemopexin, ensure safe disposal of potentially dangerous molecules [6,7,15–19]\", \"key\": \"7542121157fbc9291c6e3ca754d83aaaead62bda93e3185363fb932751d6e0e167b89ff35b649c96a2697da19bce637633d4cf9f63a934f1c39b39c94a8ed0b2\", \"line\": 109, \"relation\": \"decreases\", \"source\": 56, \"target\": 54}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"However, patients who died had significantly higher plasma cell-free Hb and lower haptoglobin concentrations at all time points, preoperatively and immediately postoperatively and 6 and 12 hours postoperatively (Fig. 1 shows the 12-hr postoperative data).\", \"key\": \"de5dd68b4eb2caa607faf160dac191d55df55fbf6135ec744f054d84e14ec1c62c8825bee581141782c2b56b4819afbcd5cc80cb8ef766236dcca1433162f319\", \"line\": 140, \"relation\": \"negativeCorrelation\", \"source\": 56, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"Postoperative\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Children undergoing open heart surgery experience a progressively increasing risk of postoperative infection and thrombosis, increasing need for mechanical ventilation and inotropes, increasing Day 1 through Day 2 peak blood lactate, and decreased nadir mean arterial pressure as the levels of free Hb increase and the levels of haptoglobin decrease.\", \"key\": \"7601114b4a5498b39ad9abc5492d7167553c7e81303a52adc64b0e3054a39f8eee5ad1e2c684123ef7f567e40969cf8da45635c2d2c391d1d1a557ceda79f62f\", \"line\": 216, \"relation\": \"negativeCorrelation\", \"source\": 56, \"target\": 54}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"free hemoglobin is rapidly cleared from the circulation by several scavenging mechanisms; however, we found that the plasma-free hemoglobin was high and haptoglobin levels were low in the patients examined (Table 1).\", \"key\": \"c1ffb4b0c573b7db4f0a47d05e423f128c874552f2f4779fafd368387e43db2aa6ebbecaccf3c82a69b5ea5dc16fe45c75f0b247ecb66df68e9908b51fb87d52\", \"line\": 173, \"relation\": \"decreases\", \"source\": 56, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Arteries\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Normally, cellfree hemoglobin will dimerize and rapidly be bound by its hemoglobin scavengers haptoglobin and hemopexin [12].\", \"key\": \"d40e232bc5f6e3c6a3778d4c6760a2b998f79b4ec211971bf1156566b733741558bfcaebaef43b75713c8fe2aa4393597f75438fa059f5ffb72d9742985cf79a\", \"line\": 228, \"relation\": \"decreases\", \"source\": 56, \"target\": 54}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Karnaukhova E\"], \"date\": \"2018-11-01\", \"first\": \"Buehler PW\", \"last\": \"Karnaukhova E\", \"name\": \"Current opinion in hematology\", \"pages\": \"452-458\", \"reference\": \"30281034\", \"title\": \"When might transferrin, hemopexin or haptoglobin administration be of benefit following the transfusion of red blood cells?\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"Hp is a plasma glyco-protein that normally circulates in within a concentration range of 0.3–2mg/ml and is the putative scavenger of cell-free Hb with a high affinity (KD¼10–12M) for Hb dimers (Fig. 1 A,B and Fig. 2 C [31]).\", \"key\": \"699aa162c7b418e02cf41881a7a243af5a2cce295a7b3f24860bca1084170c3dbeeb711fc83d4d203c494ec06f854b1c41fae2242b4448ee889fe370cc68fbfe\", \"line\": 230, \"relation\": \"decreases\", \"source\": 56, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Knee\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"On the extracellular level, within the circulation, haptoglobin (Hp) and hemopexin (Hpx) are two of the most prominent scavenger proteins, with antioxidative properties through their capacity to remove cell-free Hb (by Hp) and heme (by Hpx).\", \"key\": \"7ad1b983dba4ae2cc71e6b596f8be34cc71eaef40711a047231e8d406ec7f757c52307a847c71e771f4ab220f0dded1a33018f8986727bdd13db56ad2a83cf15\", \"line\": 148, \"relation\": \"decreases\", \"source\": 56, \"target\": 54}, {\"annotations\": {\"Cell\": {\"leukocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"TLR4 activation leads to MAPKs and NFκB activation, which are necessary to TNF secretion.\", \"key\": \"f032d74d45071668e2ffff502bcfa9cd91e94fa5a5f09c7df61e828a844f61435633575e76591c895f3813a56e56325f1a89b4c7ad29ef645b1155720c0a1742\", \"line\": 446, \"relation\": \"increases\", \"source\": 63, \"target\": 21}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"In fact, Tlr4-/- or anti-TLR4 treatment suppresses heme-induced neuroinflammation, edema, and neurologic deficit. \", \"key\": \"b5b2706aa4d00581a129f80519f45814502f6d611d9b9e362e722dae22ecadf26af5b13aa8d4a072ca4c2a89281b787a4cf3c3d02211711458532c2dd96bd9ad\", \"line\": 644, \"relation\": \"positiveCorrelation\", \"source\": 63, \"target\": 81}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Indeed, TLRs and NLRP3 have been associated with atherosclerosis development.\", \"key\": \"1790deeeac49ee6a0d7627a0a8f06826aec0a2596ca636b186d62197019674bd93afec6c73b8d94fe29272d9316e58a9a0a4ffb19511ce5efe79da0124dae30d\", \"line\": 658, \"relation\": \"increases\", \"source\": 63, \"target\": 92}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"Concentration\": {\"40 μM\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Other studies demonstrated that heme can trigger the activation of Toll-like receptor 4 and inflammasomes, thus leading to inflammatory reactions.5,35–37\", \"key\": \"0b9f0d14c422d4c671afa19901090e9873489f0bbad0b1beb6b1a0fcc9bb9c5dd1c384daaa49ec679e448b8b92f5ef4b98bc8ff3c100eb8500879554023c8615\", \"line\": 274, \"relation\": \"positiveCorrelation\", \"source\": 63, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Cell-free heme selectively triggers pro-inflammatory receptors such as TLR-4 and BACH-1, and activates proteasomes25.\", \"key\": \"7dc4bb236241744a2573bc28a1996a2aa2d6c1d5c4e2f6f898e1676dbeb82177a580991a5513691f0601a3603133288809eabbce7b0d8173fe4eaf9116479dd6\", \"line\": 109, \"relation\": \"positiveCorrelation\", \"source\": 63, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"The released heme can activate the innate immune pattern recognition receptor toll-like receptor 4 (TLR4) on inflammatory cells, platelets and endothelium, promoting a pro-inflammatory and pro-coagulant phenotype, ultimately leading to vaso-occlusion, ischemia-reperfusion physiology, tissue injury, and pain in murine models of SCD [5, 7±10].\", \"key\": \"e4fb6938c390d9b31d5d8a6bcd34c4f185cc46a72d59a224e3eaa8d37684a359f640a14e82c0eb8b3e6df4ca8a7166c417079c89d9f21f3563a4e88a111c9316\", \"line\": 107, \"relation\": \"positiveCorrelation\", \"source\": 63, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 10}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"Concentration\": {\"40 μM\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Other studies demonstrated that heme can trigger the activation of Toll-like receptor 4 and inflammasomes, thus leading to inflammatory reactions.5,35–37\", \"key\": \"651bd5c45140515809b21fbb7ee576acf956555429a9846ce697651ede40607258c4cde426c9be72ded24cfa03aee050cc1596f3f65ed0ceed64307c823fddd2\", \"line\": 275, \"relation\": \"positiveCorrelation\", \"source\": 63, \"target\": 31}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"The released heme can activate the innate immune pattern recognition receptor toll-like receptor 4 (TLR4) on inflammatory cells, platelets and endothelium, promoting a pro-inflammatory and pro-coagulant phenotype, ultimately leading to vaso-occlusion, ischemia-reperfusion physiology, tissue injury, and pain in murine models of SCD [5, 7±10].\", \"key\": \"701f3ab849f031bd922e51e62e0aec4cbd5a74601e528861970339558d70f24a1b3b7bf06b5d7274dcb055f12cddd5500d3b2c8e353e14d32b0e068d2d600975\", \"line\": 108, \"relation\": \"positiveCorrelation\", \"source\": 63, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 31}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Haem also induces tumour necrosis factor (TNF) secretion in monocyte/macrophages through TLR4 and the adaptor molecule, MYD88 (Figueiredo et al, 2007).\", \"key\": \"ae05160c8a70bfa3b2f34515f330f57722efb4cd4c18019fc80bd807010b854b1af2f0f4ed7022f90f4c6df37ea3b696b92ce0983645b84d5e367d130bcb1c59\", \"line\": 532, \"relation\": \"increases\", \"source\": 63, \"target\": 64}, {\"annotations\": {\"Cell\": {\"leukocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"The TLR4 activates two distinct pathways: MyD88 and TRIF. In macrophages, heme induces a biased MyD88 activation and the secretion of the pro-inflammatory cytokines TNF and KC.\", \"key\": \"3168d14694238b5ba69df315f7439973d9f126ae209e8524bdb5dcbb50f90947a8da20dc7a8b88818367cb04634ed01edad39e42c9d7e9c88a8c9c9d45277037\", \"line\": 437, \"relation\": \"increases\", \"source\": 63, \"target\": 60}, {\"annotations\": {\"Cell\": {\"leukocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"TLR4 activation leads to MAPKs and NFκB activation, which are necessary to TNF secretion.\", \"key\": \"639837b97cc2ffbb5c8fb99bacfd0bec3d28e57018da2602752a0a972ec6d1bed2f054d0c86ed8d8906718bc965f5d5c535095e010c7eb73e4c2728538cc58c0\", \"line\": 447, \"relation\": \"increases\", \"source\": 63, \"target\": 61}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"The haptoglobin–haemoglobin complex is recognized by the haemoglobin scavenger receptor, CD163, on the surface of monocytes/macrophages, which mediates haptoglobin–haemoglobin endocytosis and degradation (Kristiansen et al, 2001).\", \"key\": \"37481e067cd88760745c75bace4b9ec39e24727dd55642ad9ecdb2db58c5d88c43e659891225d10884a405b87cdf1bb26f37ac1e8565f59e42d78f38ccc03e0b\", \"line\": 117, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"increases\", \"source\": 52, \"target\": 23}, {\"annotations\": {\"MeSHAnatomy\": {\"Placenta\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Haptoglobin (Hp) is perhaps the most well investigated Hb-clearing molecule. It binds cell-free Hb in plasma [20,21] and the resulting Hp-Hb complex is cleared from blood via binding to the macrophage receptor CD163 [22].\", \"key\": \"14516506f53339b0a6811415e84310819e359572a9faf5ba8634a75c0eb417ca6554be3562cd282f5161a0156c52c5dbd7f741a5db7e7fd5b81cef6b731d2e95\", \"line\": 107, \"relation\": \"decreases\", \"source\": 52, \"target\": 23}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Buys ES\", \"Graw JA\", \"Rezoagli E\", \"Warren HS\", \"Yu B\", \"Zapol WM\"], \"date\": \"2017-06-01\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"American journal of physiology. Heart and circulatory physiology\", \"pages\": \"H1120-H1127\", \"reference\": \"28314763\", \"title\": \"Endothelial dysfunction inhibits the ability of haptoglobin to prevent hemoglobin-induced hypertension.\", \"type\": \"PubMed\", \"volume\": \"312\"}, \"evidence\": \"Haptoglobin binds to hemoglobin dimers and forms a high-molecular weight haptoglobin-hemoglobin complex, which is cleared from the circulation after binding to the CD163 receptor on hepatic and splenic macrophages (12).\", \"key\": \"cca97690f2869c615df6345e809bc2d44900ebe9a67dc4273320c90e6b18e296b8d111e68f7fbcb876c057183e86b9c517cf756158f125d5be6723f9d4fcb6d1\", \"line\": 100, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"increases\", \"source\": 52, \"target\": 23}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Soluble, shedded CD163, the macrophage receptor mediating elimination of the Hp-Hb complex, was analyzed in plasma [40–42]. The analysis showed a small but not statistically significant (p-value 0.37) increase in the PE group as compared to the controls (Table 3).\", \"key\": \"ca531ae445d2f8d27f31841423c84fb30aa34518b537cfbf8b5d0e90803fd5bd6feec19e87a207c8ce6ff4c906450dcd1ed295938c895eb9726d8108d9bc4308\", \"line\": 154, \"relation\": \"positiveCorrelation\", \"source\": 52, \"target\": 86}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"CD163 and HO-1 positive cells infiltrated into the hematoma from edge to center after ICH (Figs. 4A & 4B). A significant increase of CD163 cells was found at day 3.\", \"key\": \"f4d9bcd547fba843665d0fb86bb27144390f4a1403982286b92724437153a73db07bbb5414700b48f58b53493cfdae9c058b7555e73982d25865d70eddba5081\", \"line\": 154, \"relation\": \"positiveCorrelation\", \"source\": 52, \"target\": 94}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"DFX treatment also caused a significant reduction in infiltrating CD163-positive and HO-1 positive cell in the hematoma at day 3 (Figs. 6A and B) and day 7 (Suppl Figures II & III).\", \"key\": \"565a23c816790da0a0488556610d8064267a232e649136bcc22522d44ce0be5debc1357f1db139d4083529e26b09c9e88b2aef92ff5ef1449c7e03368417581d\", \"line\": 199, \"relation\": \"negativeCorrelation\", \"source\": 52, \"target\": 3}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"CD163 mediated hemoglobin/hematoma clearance is involved in the induction of HO-1, a rate-limiting enzyme for heme degradation 26.\", \"key\": \"0fdeeec100af419c0433e027f2bc09fb00323d89cd42d43aec733ea71103ac78d38a666400ff6af2d90051435cb0240edbc7b32b6b21160080fb4bc0824f80d6\", \"line\": 259, \"relation\": \"increases\", \"source\": 52, \"target\": 55}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Heme-induced necroptosis is reversed by deferoxamine, a Fe chelator.\", \"key\": \"3662a0b3ce19f7b538ae0926d6980333f88d512b220e19753f22539a1dfc638e505adde4b35f471c5f214935fda38fa764d42f56a45b4ab58c81ca8380669f56\", \"line\": 583, \"relation\": \"negativeCorrelation\", \"source\": 32, \"target\": 3}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Atherosclerosis\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Expression of HO-1 provides protection against atherosclerosis in several experimental models17,18 and HO-1 deficiency in humans has been associated with the appearance of vasculature fatty streaks and atheromatous plaques at age of six.19\", \"key\": \"9d2df34db6ac2a2e0fe7f4e4cfa796b2bd14f76c6a635590085634664b34fa27ed3586e7f8b9777dfe6496eca2a169a84ca1db5dfcbc01602927cddc894f9315\", \"line\": 113, \"relation\": \"negativeCorrelation\", \"source\": 55, \"target\": 92}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Interestingly, a 6-year-old patient with HO-1 deficiency experienced a severe atherosclerotic pathology (Yachie et al., 1999). \", \"key\": \"2c2e3170b6c27d75d4b8c78632ee796f8d9f2d452f1d9a8eb7ebea4adac388e1e5e515504a79aa05d81e0b92dc7566ab9fa751bd1eda548343c4f4dc824ed233\", \"line\": 670, \"relation\": \"decreases\", \"source\": 55, \"target\": 92}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Atherosclerosis\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Expression of HO-1 provides protection against atherosclerosis in several experimental models17,18 and HO-1 deficiency in humans has been associated with the appearance of vasculature fatty streaks and atheromatous plaques at age of six.19\", \"key\": \"10958a6b8c6114222f9f9deb80d0bbc67bd12e541a7a052126849288956a6c6d183379163edb336afa63af45daaef24e8f7c4feaa954857e6b4d3a4604c8ed35\", \"line\": 114, \"relation\": \"negativeCorrelation\", \"source\": 55, \"target\": 84}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Free heme is a dangerous molecule which can be recognized and degenerated by stress-responsive enzyme oxygenase- 1 (HO-1) [16] which plays an essential role in host defense against heme.\", \"key\": \"7e162a6effcfa6bf1c408e99e0dba4e27568c70edeee7ceb0e9fcc775292b26cfe887e911881b15fcf87c365c96de0c9980b965f6ba5b5cf60edec02c253c281\", \"line\": 128, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"positiveCorrelation\", \"source\": 55, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"McCulloch JC\", \"Nielsen VG\", \"Redford DT\", \"Thompson JL\"], \"date\": \"2014-09-01\", \"first\": \"Redford DT\", \"last\": \"Nielsen VG\", \"name\": \"Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis\", \"pages\": \"621-4\", \"reference\": \"24553061\", \"title\": \"Left atrial myxoma presenting as pulmonary embolism: potential role of heme oxygenase-1.\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"Lysis of red blood cells with consequent increases in free heme most likely caused the increase in HO-1 activity responsible for increased COHb concentrations, which is similar to that observed with circulatory devices [6].\", \"key\": \"19b72761bd220921f411a09d2177891b9be19c4bed4a314cb3435a92b1ea37bafbee1347057cafd491febd9c805e0ea0e214a71f2e7b2fe186d9b0daffd2e468\", \"line\": 96, \"relation\": \"positiveCorrelation\", \"source\": 55, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Importantly, heme b interaction with heme oxygenase (HO; Lad et al., 2003), the enzyme responsible for heme intracellular catabolism, and hemopexin (Hx; Paoli et al., 1999), a plasmatic heme scavenger, is essential for the regulation of free heme availability and Fe recycling (Kovtunovych et al., 2010; Tolosano et al., 2010).\", \"key\": \"507b9f32149423f5bce3d67b7932260f61a46322b7e7639fd757a09f848d6c3e4f3397beb55fa4cf47df100c0a9fc43395136b4630d3910080aaf830a05a36dd\", \"line\": 94, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"positiveCorrelation\", \"source\": 55, \"target\": 10}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Placenta\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"In the extravascular compartment, cellular heme oxygenase (HO) is the most essential heme degrading protein, converting heme to free iron, biliverdin and CO [26,27].\", \"key\": \"ca3e02ac8c2f02e14259a5297f297db3b0792ef1bd915a2186e1cb32ae91508fac780a3b7434223e4819b4ced7406ea68a6d07386035ee9620a02ae63038a00c\", \"line\": 119, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"increases\", \"source\": 55, \"target\": 10}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Despite its damaging effects, heme induces the expression of HO-1, which degrades heme to anti-inflammatory, cytoprotective, and antioxidant products [25].\", \"key\": \"38b1c604ede22352c9a039ca811bd2b6a878f2868a5a9024f6ba504dc2c11df3e06a9c3313e7a143875ffa136e71d1074ab35dd9986d0beb85765631f0510acc\", \"line\": 353, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"increases\", \"source\": 55, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"CD163 mediated hemoglobin/hematoma clearance is involved in the induction of HO-1, a rate-limiting enzyme for heme degradation 26.\", \"key\": \"33880219fa5ad49ebc726c65c831de983d8c3a88373e49017ac583ecb8bfb5f61c7af3d94ada33c258d369f691c51680b69b41910716eeb338b2b02576315549\", \"line\": 260, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"positiveCorrelation\", \"source\": 55, \"target\": 10}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"As predicted, HMOX1 expression levels (means 6 SD) in hemin-treated cells were much higher (7.25 6 5.02, n = 12; P , 0.001) than in nontreated controls (0.14 6 0.18, n = 9) or A1AT-treated cells (0.09 6 0.1, n = 9).\", \"key\": \"fa2fedaf90d4758001bb7fd97c2fc9b78a43352340230e5a6e0ceec1a5cd866b94be4621a8e746e9181764bf2627d8371c2dfdf2dc524acd999f109efb54a5d6\", \"line\": 173, \"relation\": \"positiveCorrelation\", \"source\": 55, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Cytoplasm\": true}, \"Species\": {\"Danio rerio\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Chambers I\", \"Hamza I\", \"Krause M\", \"Phillips J\", \"Yun S\", \"Zhang J\"], \"date\": \"2018-09-01\", \"first\": \"Zhang J\", \"last\": \"Hamza I\", \"name\": \"PLoS genetics\", \"pages\": \"e1007665\", \"reference\": \"30248094\", \"title\": \"Hrg1 promotes heme-iron recycling during hemolysis in the zebrafish kidney.\", \"type\": \"PubMed\", \"volume\": \"14\"}, \"evidence\": \"Upon degradation of RBCs in the erythrophagosome, heme is imported into the cytoplasm for degradation by the heme-degrading enzyme heme oxygenase-1 (HMOX1) [7].\", \"key\": \"9a786b921fd82d30117e151386bc01947ba0a85114ca81ad8957727a6a4f23cd74d9de6502df94969f3920e45b8476950d62632485ad81cbeb446cbe97621c42\", \"line\": 103, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"increases\", \"source\": 55, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Knee\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"A major intracellular antioxidant is heme oxygenase-1 (HO-1) which, through its heme-degrading activity, plays a critical role in the protection of cells.\", \"key\": \"91fb48238c17df3341bccd51aef32fb8b49ebea4cc519aeb096e7db49c74efeb8d1e01bfe3d25ea57a4dc1c70b451045dd2950ed1e3b5150505118dbe13751f8\", \"line\": 155, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"increases\", \"source\": 55, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"McCulloch JC\", \"Nielsen VG\", \"Redford DT\", \"Thompson JL\"], \"date\": \"2014-09-01\", \"first\": \"Redford DT\", \"last\": \"Nielsen VG\", \"name\": \"Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis\", \"pages\": \"621-4\", \"reference\": \"24553061\", \"title\": \"Left atrial myxoma presenting as pulmonary embolism: potential role of heme oxygenase-1.\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"Lysis of red blood cells with consequent increases in free heme most likely caused the increase in HO-1 activity responsible for increased COHb concentrations, which is similar to that observed with circulatory devices [6].\", \"key\": \"87b669e3739780b5dd85de97581a86ff916e3a0b92e7d0b8356cb38002266d0ee612c9c8ac0df9afb739645446ae07a3d532435ba21e86616ef30a018c448493\", \"line\": 97, \"relation\": \"positiveCorrelation\", \"source\": 55, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 45}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Once inside the cells, heme is catabolized by HO enzymes, generating equimolar amounts of biliverdin, carbon monoxide (CO), and Fe (Tenhunen et al., 1968). \", \"key\": \"db3aeb3213312a615e98815f4e4b14375bedbe5673526d19cd074909b6535a5a4583a788acf4565285508843a4024d64380e667076fc1a337636f4119a27850a\", \"line\": 146, \"relation\": \"positiveCorrelation\", \"source\": 55, \"target\": 30}, {\"annotations\": {\"Cell\": {\"leukocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Moreover, HO-1 has a protective effect during heme-induced necroptosis.\", \"key\": \"8b4d4f268e121e18df3c9d2e89fe969d875292de9e8ef9a4a7f544f723f25f599fc2fa74c98fe8be6ccc46cca56913f819597b7f1a12d1c553913c1df34cc7ba\", \"line\": 489, \"relation\": \"decreases\", \"source\": 55, \"target\": 32}, {\"annotations\": {\"MeSHDisease\": {\"Pulmonary Embolism\": true}, \"Species\": {\"Homo sapiens\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Bonkovsky HL\", \"Courtney M\", \"Kline JA\", \"Steuerwald NM\", \"Watts JA\"], \"date\": \"2015-10-01\", \"first\": \"Kline JA\", \"last\": \"Bonkovsky HL\", \"name\": \"Thrombosis research\", \"pages\": \"769-74\", \"reference\": \"26337933\", \"title\": \"Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.\", \"type\": \"PubMed\", \"volume\": \"136\"}, \"evidence\": \"The median values and associated interquartile ranges for hmox-1 and haptoglobin show that patients with PE+TR+ had lower expression of these genes compared with patients who were PE+TR− or PE−\", \"key\": \"28121019d3aadc52fa96a3a7f9efa64593398a036f0bb24c6d5cd1feccd53a5f3acedf2d8db9f4da38d569a37ff45f08fd3cf63892f2cf217285dc98e76bf738\", \"line\": 105, \"relation\": \"negativeCorrelation\", \"source\": 55, \"target\": 89}, {\"annotations\": {\"Cell\": {\"leukocyte\": true}, \"MeSHDisease\": {\"Pulmonary Embolism\": true}, \"Species\": {\"Homo sapiens\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Bonkovsky HL\", \"Courtney M\", \"Kline JA\", \"Steuerwald NM\", \"Watts JA\"], \"date\": \"2015-10-01\", \"first\": \"Kline JA\", \"last\": \"Bonkovsky HL\", \"name\": \"Thrombosis research\", \"pages\": \"769-74\", \"reference\": \"26337933\", \"title\": \"Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.\", \"type\": \"PubMed\", \"volume\": \"136\"}, \"evidence\": \"The inverse correlation between hmox-1 expression in circulating leukocytes and the TR jet velocity in patients with acute PE was significant (r2=0.45, p <0.001), but this significance was absent in patients without PE (r2=0.01, P=0.52).\", \"key\": \"c6f8edd349ef9da8a78bc278b5c15c27e66d0363cd2463802a9a421e4662421ce35a34d9c5a53b318bb4b87859817c3a756253740dfbccec8c6a9571f7cd70ab\", \"line\": 132, \"relation\": \"negativeCorrelation\", \"source\": 55, \"target\": 89}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"HO-1 protein levels in the hematoma also increased at day-3 (HO-1/GAPDH: 0.65 ± 0.08 at day-3 vs. 0.04 ± 0.01 at 4 hour, p<0.01).\", \"key\": \"b8e2b942cfc367390d0851862cf1efe0c2ab10812c29a579be27cf6e74210e43f0f19a9dbf760799ff008aab5329ffdba53d535d9f6484dfec09bc307a9da861\", \"line\": 160, \"relation\": \"positiveCorrelation\", \"source\": 55, \"target\": 94}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"DFX treatment also caused a significant reduction in infiltrating CD163-positive and HO-1 positive cell in the hematoma at day 3 (Figs. 6A and B) and day 7 (Suppl Figures II & III).\", \"key\": \"07a88303c3569798fdcaca9854ada4fe944dcb7f5514c1eedd3bd75510e274d6e98af15853ed69463530c196a981b14feb5d5fc9e349194b694cb9f4fb851f91\", \"line\": 200, \"relation\": \"negativeCorrelation\", \"source\": 55, \"target\": 3}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"Western blot analysis showed that the protein expression of HO-1 was decreased in the hematoma in the DFX treated group at day 3( HO-1/GAPDH: 0.32 ± 0.04 vs. 0.98 ± 0.07 in the vehicle-treated group, p<0.05, Fig. 6B) and day 7 (p<0.05, Suppl Figure III).\", \"key\": \"445da72e0355cfdcee910181fa5a2ec5f79f1f83428cfe8324a5f3245b4aeaf2b0bb64dc78821f1344f9e2c374d95e4b751eed614e8dfb80dc1b9001618bb5c0\", \"line\": 209, \"relation\": \"negativeCorrelation\", \"source\": 55, \"target\": 3}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"In endothelial cells, we found that, in the absence of serum, heme-albumin triggered a dose-dependent HMOX1 protein expression signal in an exposure range of 0–175 lmol\\u0001L\\u00031.\", \"key\": \"da44984c08b1d3d9974bd379b93ec38c88e8219299a0b2fd06ea3d056ce855362e30385c29efaba9b4e4cf8347963b65039d8c84090d72bcfb4bd9cc0556d22f\", \"line\": 150, \"relation\": \"positiveCorrelation\", \"source\": 55, \"target\": 46}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"heme-albumin is also a robust inducer of dose-dependent HMOX1 expression in BMDMs (Figure 2D).\", \"key\": \"dd13e20191272fbad0f9349f40634c4593f684aebab0de0f57e46a54e500ba9652cdd34c4d69bcb2247c750fb0a6647a24ff4100e801af556e48882497ef5c2e\", \"line\": 155, \"relation\": \"positiveCorrelation\", \"source\": 55, \"target\": 46}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"heme-albumin, in contrast, induced HMOX1 in a dose-dependent manner.\", \"key\": \"1ad26f8ca5fcbff5962aefa50d9821934059c971ffcf9ed121832375d0aa9654e992b0b0c11627dfed85cd65a337bff2582e5ccd9338190565f6c63a174580f4\", \"line\": 160, \"relation\": \"positiveCorrelation\", \"source\": 55, \"target\": 46}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.\", \"key\": \"1961fb032e678dc50fa73a9a2628580c1cb062604a140c7fcb387954b9c4b7546b3b0809d6298de03d89823d206228b22942da66bff292b5dde83594bf50aa4d\", \"line\": 352, \"relation\": \"positiveCorrelation\", \"source\": 82, \"target\": 95}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"It is crucial, hence, to further investigate the mechanisms of sepsis-induced hemolysis with the aim of deriving possible therapeutic principles. Herein, we collected the most important previously known triggers of hemolysis during sepsis, which are (1) transfusion reactions and complement activation, (2) disseminated intravascular coagulation, (3) capillary stopped-flow, (4) restriction of glucose to red blood cells, (5) changes in red blood cell membrane properties, (6) hemolytic pathogens, and (7) red blood cell apoptosis.\", \"key\": \"8a2db5d3708bd16fcd4af4c9d94c0d65c351c165bdf898d7c09b0107dce878287c0bfabde2a1317fead7515d51e015e25583cc2d6cdac076f3121991f8f138ec\", \"line\": 98, \"relation\": \"positiveCorrelation\", \"source\": 82, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.\", \"key\": \"3bd8561000e4ac9164571647cb1c832e2d32389805a3f34d3be9de17e58726957516e3110c460041ecff6aa6e0efe388f93b89cfeb78da5cbc796595208a1fd7\", \"line\": 353, \"relation\": \"positiveCorrelation\", \"source\": 82, \"target\": 99}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Microvessels\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"DIC is characterized by a systemic intravascular coagulation, formation of microvascular thrombi, insufficiently compensated consumption of platelets and coagulation factors, and eventually bleeding tendency [84].\", \"key\": \"5b7f155e4232814e7d9b34e4c6263a239404c80f885f53f0de57d645e32fac22ab87df502e6dd7c732aa2eeeb1c736798bda36fec85e3e0332904a08ca542cb8\", \"line\": 416, \"relation\": \"positiveCorrelation\", \"source\": 82, \"target\": 99}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Banerjee S\", \"Crumbliss AL\", \"Jia Y\", \"Kreulen RT\", \"Mollan TL\", \"Olson JS\", \"Tsai AL\", \"Wu G\"], \"date\": \"2014-04-01\", \"first\": \"Mollan TL\", \"last\": \"Alayash AI\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"265-77\", \"reference\": \"24486321\", \"title\": \"Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These findings are consistent with a recent study which showed that both Hp and hemopexin (heme scavenger) were equally effective in preventing vasoocclusion in a sickle cell mouse model infused with Hb [73].\", \"key\": \"94ba73c8b06c43e8c09a23fe94fa7c1a7e4a9b2e92ec0271cdd4e06da478d09a029e564a5eb25c2bbe9f84d59883dc0f9a711c4d4ab110cd9416aa7e54eb14b7\", \"line\": 175, \"relation\": \"decreases\", \"source\": 67, \"target\": 77}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"48 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Thus a single infusion of Hp or Hpx inhibited stasis for 48h.\", \"key\": \"fdeb11e16b9b08241d32d38ee29eac6c8badb82b65b134d2c0ee368c4a49d5fcde4f7a43f482f0da0180825a9eebbce9c246f359f2a311b869e249d5d45ec5a6\", \"line\": 128, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 77}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"60 min\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Sickle mice co-infused with Hb + Hp, Hb + Hpx or Hb + Hp + Hpx had less stasis 1h after infusion than mice infused with Hb + albumin or Hb (Fig 1B).\", \"key\": \"40b108c2c381d9b9ade52decad0dac8f0075a59998b773d4d63124d27ce3d8e00d4ae5dfb61b72d2b39906619816eb9ee9376cfdc27ab3a8d90d016e5cbb92f0\", \"line\": 141, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 77}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Hp and Hpx significantly inhibited stasis in response H/R or LPS (Fig 5).\", \"key\": \"ea695f3b27688177e688f1059cbafe736cf7e6e0f8e7ff2349a944bddeea665c6c2325ad5c1e07056fda9795fec5bd74c7b6140201173712376d65358290c5aa\", \"line\": 204, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 77}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Banerjee S\", \"Crumbliss AL\", \"Jia Y\", \"Kreulen RT\", \"Mollan TL\", \"Olson JS\", \"Tsai AL\", \"Wu G\"], \"date\": \"2014-04-01\", \"first\": \"Mollan TL\", \"last\": \"Alayash AI\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"265-77\", \"reference\": \"24486321\", \"title\": \"Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Hp bound metHb and prevented heme loss and hemopexin captures any free heme released from metHb during its denaturation.\", \"key\": \"f7b8e5d27e9d7de0309588959493eb3d2ca14080b7cecace621bb41c3a4e8716b4928f1694822a8fc890701ac9dfc18a58b30f10402a0f24b404b24dacae0f1e\", \"line\": 189, \"relation\": \"decreases\", \"source\": 67, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"The increase in hemopexin was associated with decreased plasma heme levels (Figure 3I).\", \"key\": \"ac40dff58750ee8ca3ca5daac0b1953062eb078e6067d8ebdd6be02cc36c2289919079ba0e73f9bbedd38271b58e5ec825713530299ba76770e9e651527469cd\", \"line\": 191, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 10}, {\"annotations\": {\"Cell\": {\"regular cardiac myocyte\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Hx-heme-treated CMs were protected from heme accumulation, compared to cells treated with albumin-heme or heme alone (Figure 1A), indicating that Hx prevents heme entry in cardiac cells.\", \"key\": \"ba99db14a20c33ee2f881bec66e95d299590bd14f4ad1010c0592a5c6e3f5ff26e39dc307364693202f94177ddbc0d47be1027a7660411c15bec4976e0bfb9c1\", \"line\": 123, \"relation\": \"decreases\", \"source\": 67, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Taken together, these data suggest that Hx administration decreases heme-driven proinflammatory activation of macrophages.\", \"key\": \"556ec183010940be326ac20254bb23549ed9369520f1acfca0fffb1bc2a7035bafa8ec883137cdaaf2a317ad40927c1edf01e0e3a576b7bfdef3d1d1fccb94f9\", \"line\": 317, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 31}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"In conclusion, an Hx-based therapy shows beneficial effects, in that it counteracts heme-induced proinflammatory activation of macrophages and attenuates some of its pathophysiologic consequences, such as chronic inflammation, hepatic fibrosis, and apoptosis (Figure 7E).\", \"key\": \"7c005cdec3dbe47e9047c87e49da6e8dcc7d8048eca9b908c652924078b12eb39e6fb084e1f1d0081ff1b8a0b29963740ae87eea7d7bf1725f3cdb8fe241e376\", \"line\": 323, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 31}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.\", \"key\": \"955d25aa3aede3b13e8af8c042c436578992349179ff04bfac7c4d34b52114a306240818323dd97acdaebb364182a2abea4a9ab2e58b7c8b7a573bcd846218a4\", \"line\": 356, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 31}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"In conclusion, an Hx-based therapy shows beneficial effects, in that it counteracts heme-induced proinflammatory activation of macrophages and attenuates some of its pathophysiologic consequences, such as chronic inflammation, hepatic fibrosis, and apoptosis (Figure 7E).\", \"key\": \"75a6a65c4c906c5bfdcad53997797c86cb931c302e4b94cd1f80d9983bbc3d12c46ef6077315e86a35c46cc83f3f8aa8815d664bf9d85de48f1441cc7b513fcd\", \"line\": 324, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"In conclusion, an Hx-based therapy shows beneficial effects, in that it counteracts heme-induced proinflammatory activation of macrophages and attenuates some of its pathophysiologic consequences, such as chronic inflammation, hepatic fibrosis, and apoptosis (Figure 7E).\", \"key\": \"a89fc0407486e5d27e61be4ec4debabdbbe5cfcc56631cd22620b8a4a1a60e209e084bc1afbbb2417e1fe5946c09e3fb4f1aa7aad436c3bfc8d68d8ad89b1208\", \"line\": 327, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 41}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Importantly, by scavenging free heme, Hx prevents heme-induced M1 macrophage polarization and thus avoids both TLR4 activation and ROS formation.\", \"key\": \"aeee9b77dde398e32216d69d7f6361ddbbb252800a73a1502bf29fb285905d4d4de0075a0d0b755144b8dc385fc35782e82cd4cd87a1135225999fbc398b3b9d\", \"line\": 343, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 14}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.\", \"key\": \"6719d140628dd09cd6d7f28e5673e32e5b9ec6479689f345dc4ae16283e70b48aeaecc27fbf1132ef6fdf4bc3eb4e2882fbd143784f6227635b545eaf46e4534\", \"line\": 355, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 14}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Importantly, by scavenging free heme, Hx prevents heme-induced M1 macrophage polarization and thus avoids both TLR4 activation and ROS formation.\", \"key\": \"71bcdc72276dd4452dffd037e244909c68d9d52f2b861868d3d73b28cef463c92054502f15b86dc45d79161c52fe40611a64d5a3c0d97295dee9b6a154b6a97e\", \"line\": 345, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 22}, {\"annotations\": {\"Cell\": {\"regular cardiac myocyte\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Being heme a well-known pro-oxidant agent [17], we then evaluated ROS levels in CMs exposed to heme alone or bound to either Hx or albumin. In the presence of Hx-heme complexes, CMs were protected from ROS formation, if compared to CMs treated with either albumin-heme complexes or heme alone (Figure 1D).\", \"key\": \"d09445e244299891cda2e79a16b2226e2e0b0725beb148421bb86bc198cdc799347837fc24ff82e38869da86e9c3d7cde711fce5dbf4d83ba324bca811b925b7\", \"line\": 147, \"relation\": \"decreases\", \"source\": 67, \"target\": 22}, {\"annotations\": {\"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"48 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"In animals resuscitated with SRBCs, plasma hemopexin levels significantly decreased from 147.1±11.4 mg/dl at baseline to 86.7±12.2 and 76.3±5. 4 mg/dl at two and four hours after resuscitation, respectively (p<0.05 for both, Figure 2A).\", \"key\": \"6f6c8181e4bdd4c93d7579842b1cd67508fd5ab6c7ec299dd5b703817b2c67943eca7c9e26586483fdf22be4ebc422c1b5e2c2f440e1721c06d82c7349d7a94f\", \"line\": 148, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 17}, {\"annotations\": {\"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Infusion of hemopexin together with SRBCs resulted in a 6.4-fold (95% CI [5.2 – 7.6]) increase in plasma hemopexin levels at four hours after transfusion (Figure 3D).\", \"key\": \"3d327703c78e2b4768375661b935e845dfe7b98808cbb42e95b25e9c3049ff8eb29b3d31e27322ba627a0622d93ea75419fe18f761f525a277b13d226f92e2cc\", \"line\": 186, \"relation\": \"positiveCorrelation\", \"source\": 67, \"target\": 50}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Congenital erythropoietic porphyria mice showed increased serum bilirubin and LDH levels (Table 1), with almost undetectable levels of Hp and Hpx (Figure 1A and B, respectively), which was strongly indicative of hemolytic anemia.\", \"key\": \"3793c9671158734c401cabe542cdcadc612a4318a8e3637b34423222f9a9a9c25ed2b1933ae58229aad4585cae3a9e35def92d55839fdcb009208ee0c1983d77\", \"line\": 118, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 85}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Arteries\": true}, \"MeSHDisease\": {\"Diabetes Mellitus\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Buys ES\", \"Graw JA\", \"Rezoagli E\", \"Warren HS\", \"Yu B\", \"Zapol WM\"], \"date\": \"2017-06-01\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"American journal of physiology. Heart and circulatory physiology\", \"pages\": \"H1120-H1127\", \"reference\": \"28314763\", \"title\": \"Endothelial dysfunction inhibits the ability of haptoglobin to prevent hemoglobin-induced hypertension.\", \"type\": \"PubMed\", \"volume\": \"312\"}, \"evidence\": \"In mouse models associated with 392 chronic hemolysis and heme overload, such as in mice with a sickle hemoglobin 393 (HbS) gene knock-in or mouse models of β-thalassemia, repeated treatment with 394 hemopexin was shown to reduce chronically elevated blood pressure (21).\", \"key\": \"6861f9f98a9e74acf6c1ad70d4463cdcf1997c8d96324742ca37bff2cf5d7139af6b74b125700088f10c689d04c84c952271c53eb868726678c5fcccd28b4f7f\", \"line\": 256, \"relation\": \"decreases\", \"source\": 67, \"target\": 34}, {\"annotations\": {\"Cell\": {\"regular cardiac myocyte\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Staining of CMs with a fluorescent probe for specific detection of mitochondrial superoxide (Mito-sox) confirmed lower oxidative stress in cells exposed to Hx-heme than in those exposed to albumin-heme or heme alone (Figure 1E).\", \"key\": \"1c56741cce68933089948eef8e77993fd0ef4576f15bd2581ad33410e900bfb9d4f78640a4f92ee0c049bea32cb2761a235e18fec0c202cb33bf7cf5c98a0236\", \"line\": 153, \"relation\": \"decreases\", \"source\": 67, \"target\": 39}, {\"annotations\": {\"Cell\": {\"regular cardiac myocyte\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Both ROS and lipid peroxidation were increased in the heart of Hx-/- mice compared to that of wild-type animals (Figure 2C, D).\", \"key\": \"529160f132de4e63185099a606eb3721e04ffc4d9b3bf1dfac457fbfe3a6063a2b5a5c45054285c277936ce48bfa61dfb7b2db2c4680c225090b5ddd5a8464ad\", \"line\": 195, \"relation\": \"decreases\", \"source\": 67, \"target\": 39}, {\"annotations\": {\"Cell\": {\"regular cardiac myocyte\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Both ROS and lipid peroxidation were increased in the heart of Hx-/- mice compared to that of wild-type animals (Figure 2C, D).\", \"key\": \"e628c0ae87a44c084d2ab61f8957226c493974cef2a8baa3b371df124735b034e22dd5f72c245a3512ed0c1fc91b1497c0c2638c7447321cdf77f1f1eaa7f863\", \"line\": 196, \"relation\": \"decreases\", \"source\": 67, \"target\": 38}, {\"annotations\": {\"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"14 days\": true}}, \"citation\": {\"authors\": [\"Brandon AP\", \"Creighton J\", \"Dull RO\", \"Evans CA\", \"Honavar J\", \"Hu PJ\", \"Kerby JD\", \"Marques MB\", \"Morgan C\", \"Oh JY\", \"Patel RP\", \"Pittet JF\", \"Richter JR\", \"Stephens SW\", \"Wagener BM\"], \"date\": \"2018-03-01\", \"first\": \"Wagener BM\", \"last\": \"Patel RP\", \"name\": \"PLoS medicine\", \"pages\": \"e1002522\", \"reference\": \"29522519\", \"title\": \"Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study.\", \"type\": \"PubMed\", \"volume\": \"15\"}, \"evidence\": \"Hemopexin improved post-pneumonia survival in mice that underwent massive resuscitation with stored RBCs (Fig 3A).\", \"key\": \"7c9575d7d0ad9e7770ef02100ece5a17b869d611de037bc079ffb712d8f45f39a098d646f882ce35cba79bedf408c294c509068d790e26d2dc566c5dad205db0\", \"line\": 123, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 98}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"The beneficial effects of Hp and Hpx were lost by inhibition of HO with SnPP, but could be restored by CO administration.\", \"key\": \"8428950b72ea2ed35b55ac709841b438218b3c60675a0a150bbd4f6809dbdc945ea1ad28a71b1a6ec41a87ae352d0eb6a6dac8a92dc814fc5c552bea85b07c3e\", \"line\": 214, \"relation\": \"positiveCorrelation\", \"source\": 67, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 2}, {\"annotations\": {\"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"We found that Hpx effectively attenuated HO-1 induction by all redox forms of Hb.\", \"key\": \"de77cc6da97c00021ea260aecc74e10b3f94aad3f6101de775d1da52fd5a18fefa866f3d285c2eee02d5528d5c09c401299e8ad3c914e384746f73d7e1732190\", \"line\": 192, \"relation\": \"decreases\", \"source\": 67, \"target\": 66}, {\"annotations\": {\"Cell\": {\"regular cardiac myocyte\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Consistently, HO-1 mRNA and protein levels were higher in hearts from Hx-/- mice than in controls (Figure 2B). Immunohistochemistry for HO-1 on heart sections indicated higher HO-1 expression in cardiomyocytes from Hx-/- mice than in wild-type animals (Figure 2B).\", \"key\": \"9342551539d7ec6ffda9673566fef293d45c4cae6c5bc14b5adc8b4f539779efc9fd620a6a3ba40aca6a2674935462039d1bcf779aecabf41604d5e186aac2c2\", \"line\": 181, \"relation\": \"decreases\", \"source\": 67, \"target\": 66}, {\"annotations\": {\"Cell\": {\"regular cardiac myocyte\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Consistently, HO-1 mRNA and protein levels were higher in hearts from Hx-/- mice than in controls (Figure 2B). Immunohistochemistry for HO-1 on heart sections indicated higher HO-1 expression in cardiomyocytes from Hx-/- mice than in wild-type animals (Figure 2B).\", \"key\": \"dd6635603a42f412b9edfa5c1d8dbd667b9479a3fc37387d7810e4567fa4e5d19100e388da690d55a245051b104e54587e657b5da6bd0e400910eb74e21b256a\", \"line\": 180, \"relation\": \"decreases\", \"source\": 67, \"target\": 66}, {\"annotations\": {\"Cell\": {\"regular cardiac myocyte\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Moreover, in CMs the heme-mediated induction of the iron exporter Ferroportin (Fpn) was abrogated by Hx treatment while the down-regulation of the iron importer Transferrin receptor 1 (TfR1) was significantly reduced by Hx (see Figure 3 in [37]) further indicating that Hx limits heme-iron accumulation within the cell.\", \"key\": \"8b8e93994791acca5eaaf6772e926638d7f81d44b97642fa3b6dfa155cda82f8bca45deafedc9637b5264f275fc73ce7894ccacd07db4d9b352cf3ddfb8e2cdd\", \"line\": 132, \"relation\": \"decreases\", \"source\": 67, \"target\": 73}, {\"annotations\": {\"Cell\": {\"regular cardiac myocyte\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Moreover, the mRNA levels of Fpn and Flvcr1a were increased in Hx-/- mice, whereas those of the iron importers Divalent Metal Transporter 1 (Dmt1) and Tfr1 were decreased (see Figure 4 in [37]).\", \"key\": \"d96f0e8fa67198654294611a623c542e677f83540bce3660c9a5ec5bad6f26fb2601a22f59c0a4c9a50455fd0b8850179f819233fc9510443a1c0009e276d559\", \"line\": 187, \"relation\": \"decreases\", \"source\": 67, \"target\": 73}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Immunofluorescence staining of VCAM-1 and ICAM-1 was decreased in the dorsal skin of SS-mice 4h after infusion of Hb+Hp and Hb+Hpx compared to SS-mice infused with vehicle or Hb (Fig 2B and 2C).\", \"key\": \"47d6139db60b14991bd29c068e77f30d367ba8ac738f604a9dd07fcab0fa7e9f5cbf4c024af080ce9c792674de3b0aef577b23b66630655998a4209f361c883c\", \"line\": 161, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 68}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Immunofluorescence staining of VCAM-1 and ICAM-1 was decreased in the dorsal skin of SS-mice 4h after infusion of Hb+Hp and Hb+Hpx compared to SS-mice infused with vehicle or Hb (Fig 2B and 2C).\", \"key\": \"1abb1777d3dbaed8e8804137300936deb57c8c60ad7e8737413bb9eb31f6e05c51929ec5ecd1fba283a1cc431a7496072b0f46c59eb3d86ed65954846c66f71c\", \"line\": 159, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 74}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Compared to Hb alone or Hb + albumin infused animals, sickle mice co-infused with Hb + Hp, Hb + Hpx, or Hb + Hp + Hpx had markedly diminished hepatic NF-κB activation 4h after infusion as evidenced by nuclear NF- κB phospho-p65 levels (Fig 2A).\", \"key\": \"b6ec1cfe5a06cacb2c40e33bd0aba33e1ea5b816837d38fb79d8b7554bd598ae56c69120568df573c5944dea795ffe991300a1853216098b0cdc3e9184e0b52e\", \"line\": 151, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"negativeCorrelation\", \"source\": 67, \"target\": 70}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"TNF, IL-6, and IL-1β are pleiotropic cytokines that regulate cell death, increase vascular endothelial permeability, recruit immune cells to inflamed tissues and induce the production of acute-phase proteins.\", \"key\": \"c7598fecc9f905247fc534ea415dd4bf20aa814808a2ebe0d996b9cb13888fa1db6677f0916feaa23e9cefe4eb2bcc788aea37091c7313bfc56bfa518138df9b\", \"line\": 288, \"relation\": \"increases\", \"source\": 59, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.\", \"key\": \"8462c4df3602d08a8ac14031aee5797449aa4be20df173955051f23941a8765c32cee34e018bade19e1a0dc8255818db48571fbb44b604243a37015f0b9054c2\", \"line\": 216, \"relation\": \"increases\", \"source\": 79, \"target\": 95}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"In PNH, uncontrolled complement activity leads to systemic complications, principally through intravascular haemolysis and platelet activation.\", \"key\": \"cf81d70950d7baf11db4736cf64fbb394fa85c5628811d12e0258c48cb10deff1e1ceafd6b2fe1b87c48d9294698f172710c030d0bfe9f91ecdab97d8eabc298\", \"line\": 246, \"relation\": \"increases\", \"source\": 79, \"target\": 95}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thrombosis is the prognostic factor with the greatest effect on survival in paroxysmal nocturnal hemoglobinuria (PNH) patients [1, 2].\", \"key\": \"cf5d37248cfb4d65eef3b6e0951f5aa13a13d01cf4ff015e9c478e1896f33cd4808536a3a5142a30462678c8c0e4a4aafca9d235afa9a983c54b3df71bb2f990\", \"line\": 101, \"relation\": \"positiveCorrelation\", \"source\": 79, \"target\": 99}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Coronary Vessels\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"In summary, thrombosis is an extremely important prognostic factor both in PNH and in primary Cys89Tyr nonfunctioning CD59.\", \"key\": \"bbcf165f9cf20ffc6f94c97e25941f47524553a8e77300e22f9bfdfc7fde855192e23f7fea98f5b4b18d5991cc44b4fadfd51b94a4c4eaa8e12a22c9414866c6\", \"line\": 411, \"relation\": \"positiveCorrelation\", \"source\": 79, \"target\": 99}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"In PNH, uncontrolled complement activity leads to systemic complications, principally through intravascular haemolysis and platelet activation.\", \"key\": \"15f3e8f95432d80f18e954787d79a059693c4078cfcff457b724d85edb570e0cb0a19b51c99dfa901b279a909a806855eece599204ee7e5381dfe76eeb5f39c8\", \"line\": 245, \"relation\": \"increases\", \"source\": 79, \"target\": 28}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"In PNH, uncontrolled complement activity leads to systemic complications, principally through intravascular haemolysis and platelet activation.\", \"key\": \"3b5ea355df8f3edb59358e8caf9a3b38405fdcb5c509984d367ea7ca6ab4246b73dffeda73b60207551c31ceb10474633c4f254b7c3ddbb43731a1d4105e1620\", \"line\": 247, \"relation\": \"increases\", \"source\": 79, \"target\": 40}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"We have assessed the presence of MPs in four patients with primary Cys89Tyr mutation in CD59 and two PNH patients, as well as in four healthy donors.\", \"key\": \"3806093c4316f4dd518ce63158f0e8613738a9236cbed96a7762547520481478a5f46bb6270338b0c7632aa9786b24dffedecf86f841f48f473870d2c8930f10\", \"line\": 189, \"relation\": \"increases\", \"source\": 79, \"target\": 18}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"In summary, patients with primary Cys89Tyr mutation in CD59 showed about 9–10-fold increase in the number of MPs compared to controls and slightly but significantly increased numbers when com pared to PNH patients. The origin of MPs was primarily RBCs and to a much lesser extent platelets and neutrophils.\", \"key\": \"f2ec13e7423951dc4c625ea06443932dcb4a14d8d5257d70075c1e074e37968bba42b5157eb18519ad8b4f12850b0b648f7d866fa249f8882080500a44d267fd\", \"line\": 199, \"relation\": \"increases\", \"source\": 79, \"target\": 18}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, in severe haemolytic diseases, such as paroxysmal nocturnal haemoglobinuria (PNH) and sickle cell disease (SCD), serum haptoglobin is typically undetectable and plasma haemoglobin is elevated (Tabbara, 1992).\", \"key\": \"324aa7f3eee8b319e184c18b962188848b028a1b1c64186251e3d9dc6a6c9104f4244f2610ed7519be53e7bbeb46b02483f2f58f31bdee7d17e1fc469182fc60\", \"line\": 130, \"relation\": \"increases\", \"source\": 79, \"target\": 54}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"In cases of congenital hemoglobinopathies such as sickle cell disease, deficiencies in complement system regulators such as paroxysmal nocturnal hemoglobinuria, and many other disorders, erythrocytes can lyse and liberate large quantities of hemoglobin.\", \"key\": \"1e13c4010d1b3071ffac05ba997c1dcb7ecb0289975e365c909eb3f4fbe6bd79d1d457da7c40240ac820ebea8c2f75d7aa3c7315bbc5fbb1a18f36a68a120f01\", \"line\": 93, \"relation\": \"positiveCorrelation\", \"source\": 79, \"target\": 54}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, in severe haemolytic diseases, such as paroxysmal nocturnal haemoglobinuria (PNH) and sickle cell disease (SCD), serum haptoglobin is typically undetectable and plasma haemoglobin is elevated (Tabbara, 1992).\", \"key\": \"86560625942009af52ffe887143ea123b69a923057bb154de0e6ca9c983cc1be29407ced33f3ad0649cfa17491dbd0e82ed95b2ce9f768386d51507daf19f8c8\", \"line\": 129, \"relation\": \"decreases\", \"source\": 79, \"target\": 56}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Free heme has been proved possess pro-inflammatory activities, such as leukocyte activation, migration and infiltration, adhesion molecules activation, and cytokines and acute phase proteins induction [17, 18].\", \"key\": \"671d04c4865d150102e91c128c63f6d7536bee3897b6d7b1c3a81af03d0ce31da2aec9a0e8896ae527eeba299862880dfc4e3879c3de2465541df5c74a6e651e\", \"line\": 137, \"relation\": \"positiveCorrelation\", \"source\": 24, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Furthermore, cytokine secretion depends on the coordinated iron in the porphyrin ring (Figueiredo et al, 2007), and nuclear factor-jB (NF-jB), MAPKs activation and ROS are essential for the increase in cytokine production induced by haem (Fernandez et al, 2010).\", \"key\": \"d88e18f3c0246190a91728591843e541c3bd478e690fde520b6ec8105c24e5456da2005f0992ca23311d8b341dd0541babbc80c47e51d19ade6861a3ec518e4d\", \"line\": 544, \"relation\": \"positiveCorrelation\", \"source\": 24, \"target\": 22}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Finally, the cytokines produced through these pathways can then affect endothelial activation, leucocyte recruitment, and ultimately thrombotic risk.\", \"key\": \"796bb5533c5b081d83e90c7b0488c7e2e10209002fdf27fce90d7694d47b5e06e3e4b3c4d50e9a8fd270c209661d6840f462bfaa0c4964fc383fede75f340939\", \"line\": 552, \"relation\": \"increases\", \"source\": 24, \"target\": 99}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Platelets may be activated during haemolysis by several different mechanisms involving decreased NO levels, increased pro-inflammatory cytokines and mediators, and ROS.\", \"key\": \"4853fdd8a214a66d77689a73be60122185107ed91e96d2c0d64f126edf322ed5993e8d777c8b968e4306fa6beb361514ec6b310618989b2338e6198e25a6f77f\", \"line\": 558, \"relation\": \"increases\", \"source\": 24, \"target\": 40}, {\"annotations\": {\"MeSHAnatomy\": {\"Synovial Fluid\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"However, with A1M increased in both synovial fluid and serum in AIA, the present study further suggests that, in addition to heme and ROS, A1M may be regulated by inflammatory cytokines.\", \"key\": \"58a31f5ad7d432ab069c8728a70b996f3a339523d47ece43195e9383a47b23173be3023704480923558a0f7b836e6ee4caf22d275b38f09d29463e975b7a60d1\", \"line\": 275, \"relation\": \"positiveCorrelation\", \"source\": 24, \"target\": 51}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"The main mediator of these adverse effects is thought to be free haem via its effects on NO scavenging, pro-inflammatory cytokine responses, and reactive oxygen species (ROS) generation.\", \"key\": \"c036ed1ea8637a6e2f75378e07e09cb71126e9482c2944327bdfd0ecd7a7b9f7ed0a8bf5ed03931c3d66b56d81807a974373b52d461af0209c46a8a27d8e4d87\", \"line\": 403, \"relation\": \"negativeCorrelation\", \"source\": 6, \"target\": 10}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Therefore, decreased NO bioavailability affects vascular tone, platelet and endothelial function and coagulation, thus increasing thrombotic risk.\", \"key\": \"6bbd2a7766012339aff91f0d770a0624d721348918b1d01cafb347168ac90ee17171f2bbdee06ec115d6c6a96150255a4c21e9b60590b31f5add7d6e8b15636a\", \"line\": 470, \"relation\": \"decreases\", \"source\": 6, \"target\": 99}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Platelets may be activated during haemolysis by several different mechanisms involving decreased NO levels, increased pro-inflammatory cytokines and mediators, and ROS.\", \"key\": \"197db0c51b04566c0b60f16135329550d665832cb72e8589b244b218c58252c646c045ffae0a2832494515a4fe83c514234639584f965d13048fd2425cbe8dca\", \"line\": 559, \"relation\": \"decreases\", \"source\": 6, \"target\": 40}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Another mechanism for platelet activation by RBC lysate is extracellular hemoglobin, which enhances platelet activation by lowering NO bioavailability [ 29].\", \"key\": \"9bde7101e7526842240625dd77a716624594afbc76b4fce1110ad3995fa63a1797ffeeaec57446223f38949cdfe8fa23cac65fdac3549fbd24abfcf96e4a475b\", \"line\": 203, \"relation\": \"decreases\", \"source\": 6, \"target\": 40}, {\"annotations\": {\"Cell\": {\"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Both processes decrease the availability of NO, which normally maintains smooth muscle cell relaxation, inhibits platelet activation and aggregation, and has anti-inflammatory effects on the endothelium.\", \"key\": \"c78ad8ba92d81cbaa7b905dd556b4d563269e9e405301dc3b46dd01f0ca765cfd66057729fa719ae15364cc6583d5af7e159f87723bfabfbf635b8cf533f4e84\", \"line\": 295, \"relation\": \"decreases\", \"source\": 6, \"target\": 40}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Because nitric oxide is known to prevent activation of endothelial cells and platelets, this nitric oxide deficiency promotes cellular activation.\", \"key\": \"9b234f9a1dd48bdd6bdfb70b36a3e6856ae292ea89d7347c85f19ceba4b5404045779afaa1f58954709811f54fee075db0b4f22da1721bba14cba3cc32bc9ae9\", \"line\": 140, \"relation\": \"decreases\", \"source\": 6, \"target\": 29}, {\"annotations\": {\"Cell\": {\"platelet\": true}, \"MeSHAnatomy\": {\"Endothelium\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Both processes decrease the availability of NO, which normally maintains smooth muscle cell relaxation, inhibits platelet activation and aggregation, and has anti-inflammatory effects on the endothelium.\", \"key\": \"7d2c319ccfe564cc0acb2a69990ac28db7d5513046afb0b62c6d906b7edbb65ab13f2cb758a9b09c5a71398d76abb8c49691bb9c4c91545e01f7c01f73137e68\", \"line\": 298, \"relation\": \"decreases\", \"source\": 6, \"target\": 97}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Plasma hemoglobin scavenges nitric oxide and causes vasoconstriction, platelet aggregation and inflammation9,22–24.\", \"key\": \"5ba8abfda5db5b9b89e06a5147129e3076e3d9d3688c1901828ae3e787e381219b8aadc9c3db713edb18d536045734d3794b9fa69d40a2706c459915b6100c13\", \"line\": 93, \"relation\": \"negativeCorrelation\", \"source\": 6, \"target\": 54}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"The consequences of heme toxicity can be appreciated in hemolytic diseases such as β-thalassemia, sickle-cell disease (SCD), ischemia-reperfusion (IR), and malaria (Katori et al., 2002; Pamplona et al., 2007;Vinchi et al., 2013).\", \"key\": \"18a6fffff4b97c13449e9c03528eaf85a982dc855688961eba643f9b6dfae231a67b40eba8a80ec2db7421dbe19315210ce04185241121f945afcc1cb4949242\", \"line\": 113, \"relation\": \"positiveCorrelation\", \"source\": 80, \"target\": 10}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Rhabdomyolysis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \" SCD and β-thalassemia are genetic diseases associated to erythrocytes that are prone to lysis due to defective Hb production (Heinle and Read, 1948; Pauling et al., 1949; Ingram, 1957; discussed later). \", \"key\": \"bd359611b717f81860adbb0322bb8d9973d02853651246f0280fe5a7403cd1d753e99dc22923b3990d35afa5623c1c27c42e26108fb7bc7489e1875ca222b7f7\", \"line\": 402, \"relation\": \"positiveCorrelation\", \"source\": 80, \"target\": 95}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Hemolysis can happen due to ischemia/reperfusion, SCD or β-thalassemia.\", \"key\": \"0094a39007a745e44842d9cec82faf1968160f75356068f5e7bf729ebde8447e4dacae2a9de902ffc35bc39c099ff073b2381404eec45823902857f704d53b4c\", \"line\": 526, \"relation\": \"positiveCorrelation\", \"source\": 80, \"target\": 95}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.\", \"key\": \"b95b8076c88d9d78f4a56f15f9c105eb786617e1555143b84bad761e462a95db3508c70f0dcaa3149aa3490f792c97ee194a09810284940ef09a76ca9445bc52\", \"line\": 217, \"relation\": \"increases\", \"source\": 80, \"target\": 95}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"SCD is a haemolytic disorder caused by a HBB (b-globin gene) mutation leading to polymerization of haemoglobin S, sickling, and haemolysis.\", \"key\": \"3220a9746d70d4194267966c05208cac8060922766f7c09e085fb34bb8d62bc3493d83780b4a1f992b96d830909c95d4c68067d240d9e6932eb846d1d301854e\", \"line\": 260, \"relation\": \"positiveCorrelation\", \"source\": 80, \"target\": 95}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Puglia M\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2015-12-01\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"931-43\", \"reference\": \"26475040\", \"title\": \"Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity.\", \"type\": \"PubMed\", \"volume\": \"89\"}, \"evidence\": \"Systemic hemolysis occurs during certain genetic and acquired anemia, such as in sickle cell disease and malaria. \", \"key\": \"c0c3a218caa9db6f46ee7907877f8979e0e1a8dba1008ed65680d8fe4090807fdd62f5b1c62d1f6afc56ab8e13230af797fde2d8d018bcebc3376bdba8dad583\", \"line\": 109, \"relation\": \"increases\", \"source\": 80, \"target\": 95}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, in severe haemolytic diseases, such as paroxysmal nocturnal haemoglobinuria (PNH) and sickle cell disease (SCD), serum haptoglobin is typically undetectable and plasma haemoglobin is elevated (Tabbara, 1992).\", \"key\": \"ec2605efd007395783e3e196856ef2670e5f58c661176da6444837a984830124ddee8042b83aa8b3861bda441bdad1f8868c0882e62cc4795274319990cad782\", \"line\": 132, \"relation\": \"increases\", \"source\": 80, \"target\": 54}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, in severe haemolytic diseases, such as paroxysmal nocturnal haemoglobinuria (PNH) and sickle cell disease (SCD), serum haptoglobin is typically undetectable and plasma haemoglobin is elevated (Tabbara, 1992).\", \"key\": \"7e6b92217d8939b1b4c396c33db9464d5a232b18a6f9b46c68584a0ef73d19e331777a208c03a9c8410ea726b9d3faf15b00b6e70d72d750507650d90ba42704\", \"line\": 131, \"relation\": \"decreases\", \"source\": 80, \"target\": 56}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Studies of sickle cell anemia patients have reported decreased levels of Hpx following hemolysis [68].\", \"key\": \"80c2480b4576c67e2268096805f9543d321af6313a3a19a1ed573ee017690407d5524d1b45c559c88f96ab019b8e3380b7df194d42e7f25f0f0170690c54dd51\", \"line\": 203, \"relation\": \"negativeCorrelation\", \"source\": 80, \"target\": 57}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Plaque, Atherosclerotic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Inhibition of lipid oxidation by either haptoglobin or hemopexin reduced the cytotoxicity (Fig 4B) and HO-1 induction caused by sublethal amounts of pretreated atheromatous lesion lipids (Fig 4C and D).\", \"key\": \"6b061dca657490cfea19072c763e28e094b47d8dd2291452424d5f4b6b0cd98a4016c8f8cb80025c72d5c840692f11c22c45e489500b92a085cb2b4a9d18ec8d\", \"line\": 233, \"relation\": \"positiveCorrelation\", \"source\": 38, \"target\": 35}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Plaque, Atherosclerotic\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Previously we have shown that heme can enter the lipid moiety of LDL and induce iron-dependent lipid peroxidation.8\", \"key\": \"c9781294b12f8f15cef9c4d4ba4824cd70248f0b40783de2d1d288d132ee97a211ef6c3122a49cb2256420fe0a5d10b52f735fdea6e5bc23e050b82afdc5d4fd\", \"line\": 280, \"relation\": \"positiveCorrelation\", \"source\": 38, \"target\": 10}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Plaque, Atherosclerotic\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Here we demonstrate that lipids isolated from human atheromatous lesions – which are already in an oxidized state – can be further oxidized in the presence of heme, whereas this effect is not observed using lipids isolated from normal vasculature.\", \"key\": \"a23b3172ac52ef552f08b2da5257cbd66f5ef4932eb47e12708e9a71f134702cda93f24094557d92dbd8ef801d135585124be8a3aac43fec64fe93c9455335cc\", \"line\": 286, \"relation\": \"positiveCorrelation\", \"source\": 38, \"target\": 10}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Atherosclerosis\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Thus, it appears that these extracts oxidize ferrohemoglobin to ferrihemoglobin, thereby leading to heme instability and heme-mediated initiation of lipid peroxidation.\", \"key\": \"5e04ddfc3287e82d0ab8d6b688c6b247983b4c6d1fabf9cd16867fa703a1f1053c2179e31923545c0fffa1690e1172a00628a4b9342c715824609c9dc618fc19\", \"line\": 335, \"relation\": \"positiveCorrelation\", \"source\": 38, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Besides its physiological importance, heme has a potent oxidative capacity oxidizing lipids (Tappel, 1953, 1955; Vincent et al., 1988) and proteins (Aft and Mueller, 1984; Vincent, 1989), and damaging DNA (Aft and Mueller, 1983).\", \"key\": \"3b99175806583d6a56b1fc213a6f80e525501a96219a65dd3d26850817d729adb2f7c810ad7e085f6c25574db7d209c599284d7154fd85c2b7074a7b1db3ad3a\", \"line\": 102, \"relation\": \"positiveCorrelation\", \"source\": 38, \"target\": 10}, {\"annotations\": {\"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Free heme is a potent trigger of lipid peroxidation and a promoter of inflammation.4–6\", \"key\": \"69a75bcc28e8bee5624357f6ece947d2f0dfcad6af0251b78fb9098d3806aa32cbb8951729768d18ffd43d5cce06f1122a03aa86a00bbe72a81314f5faf6d33a\", \"line\": 94, \"relation\": \"positiveCorrelation\", \"source\": 38, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Toxicity of free hemoglobin is also caused by the release of cell-free heme, which produces lipid peroxidation and mitochondrial damage and increases the production of reactive oxygen species.\", \"key\": \"221f8a240cb37a8c3da9245d51b1062d8cf7bce4ba2ba8b1fcbeedd4c46a4fef2a2e0cfa5c2b8383b4d3600eebf9b19100879efa5028dc298d296a7d25fe3d05\", \"line\": 103, \"relation\": \"positiveCorrelation\", \"source\": 38, \"target\": 10}, {\"annotations\": {\"MeSHDisease\": {\"Hematoma\": true}, \"Species\": {\"Bos taurus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Gao Z\", \"Li H\", \"Wang P\", \"Wu J\"], \"date\": \"2019-04-01\", \"first\": \"Wang P\", \"last\": \"Li H\", \"name\": \"Molecular and cellular biochemistry\", \"pages\": \"57-66\", \"reference\": \"30324533\", \"title\": \"Tyrosine residues of bovine serum albumin play an important role in protecting SH-SY5Y cells against heme/H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;/NO&lt;sub&gt;2&lt;/sub&gt;&lt;sup&gt;-&lt;/sup&gt;-induced damage.\", \"type\": \"PubMed\", \"volume\": \"454\"}, \"evidence\": \"Malondialdehyde (MDA) represents evidence of systemic oxidative stress and inflammation [31], and is commonly used to estimate the level of lipid peroxidation.\", \"key\": \"ff77ca9c8fd2e7c6978a32defd879c30c817ea28fd359a820ece705cdfbd04812b5a82837ac0ee08885746839f2cbb1746d7b0e008571af303dc969cf680db70\", \"line\": 190, \"relation\": \"positiveCorrelation\", \"source\": 38, \"target\": 12}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Western blotting results showed that the p10 active form of caspase-1 was detected in macrophages incubated with heme for 12 h.\", \"key\": \"bc6af294cd2cf31290ee839ddfefad1cfe15a4d2fffe032bce5f147d2ab7778c411f14b9d302235c8e65eefdc22962e0e9d833d7630219e204ade8e9eab06abf\", \"line\": 174, \"relation\": \"positiveCorrelation\", \"source\": 65, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results suggest that heme induces maturation and secretion of IL-1b in macrophages through activating caspase-1 (Fig. 2a).\", \"key\": \"0f954e03d5466c91ebce1f77b903c1f603c12f93d75a1a5ae6b29982a4345ae4615dc9a04e749ded6e5fcbefdadde4ebbd4b49d92cf52c97cf35abd09e3cedac\", \"line\": 181, \"relation\": \"positiveCorrelation\", \"source\": 65, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results suggest that heme induced activation of NLRP3-Caspase-1-IL-1b axis is involved in kidney inflammation in mice UUO model and that heme serves as a dangerous factor participates in this process.\", \"key\": \"4d06b4cde4f2cc95ad0139fab1c6f24ef9ccd1313afa9a0b5d539191ab0482066e15dff63554cf617beeef9652babd2bbcdacd49e1fc5c0cf657700b67332556\", \"line\": 246, \"relation\": \"positiveCorrelation\", \"source\": 65, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"The results showed that enforced HO-1 could efficiently decline the heme level in the lysates of ligated kidneys, and inhibit kidney inflammation characterized by down-regulation of NLRP3-Caspase- 1-IL-1b axis.\", \"key\": \"9a19e041e081bc63714fe5c24adce1654ce1a4f7a55bdb605841e27445975e267728740284290fe189af40960d35bfdf9b7a217caf37f4b5bd6c3cd8ee5cbf1a\", \"line\": 259, \"relation\": \"negativeCorrelation\", \"source\": 65, \"target\": 66}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results suggest that heme induces maturation and secretion of IL-1b in macrophages through activating caspase-1 (Fig. 2a).\", \"key\": \"fff7ee8e955a547438901250bb05e0d1abbe3534d9eecec5cdee48b00792f5f703fc8d821ed7cbd89516a69c8f07c4f71471f6df8afdc90c6a10a51ba6a1b6e9\", \"line\": 182, \"relation\": \"increases\", \"source\": 65, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 69}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"734c45d2ec696f19a0c60bfb38fddb8b3fd164113dd4993c12830efec8c24fb9d56e0a90bc0c173366d9c88ef54f7d7623b4e29193838f9829762b445f01c746\", \"line\": 113, \"relation\": \"positiveCorrelation\", \"source\": 90, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"06503bf77ef9cab252c363d34ec2dae6a24d8195c7c9a606bd9c0c12fdceb8348dd0e99f89766f2e9635b294e0822e28357fa63a412d42c744bfc41c0cbbffbd\", \"line\": 114, \"relation\": \"positiveCorrelation\", \"source\": 90, \"target\": 5}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Furthermore, experiments of nature that lead to increased levels of chronic hemolysis, such as sickle cell anemia and paroxysmal nocturnal hemoglobinuria, provide evidence that low levels of hemolysis may be harmful, and contribute to inflammation, thrombosis, vasculopathy, and impaired host defenses against infection.1,11\", \"key\": \"d1bff7493789d4cc52b1e0c8e32d79ca2f5c8a0ac1533b435c93e47fecc601463103907c67b1ec05ba0249839c8beaaf77b130d2942aedc9434bbc474e63ef47\", \"line\": 129, \"relation\": \"positiveCorrelation\", \"source\": 90, \"target\": 95}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"94cb18fbbd93844c3c89af76e5f36097d4fbe44cbf57d483029736c81a81cfc673018e4166a67d4e7910af6c1187a5dd3506a3b9a21d8d9e769da2b9f2a9068e\", \"line\": 112, \"relation\": \"positiveCorrelation\", \"source\": 90, \"target\": 54}, {\"annotations\": {\"Cell\": {\"smooth muscle cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Moreover, heme-derived ROS induce the proliferation of smooth muscle cells, that participate in vasculopathy associated with atherosclerosis and hypertension [15].\", \"key\": \"38d5f9ed77f7d4b0687e71aa96e5b6cbba6aa7948f97de47fcb7ef69dd563fa0ec02064805f0fcecdf689e0d01cf5cdac14559c6675ddf79593bb41f61defcde\", \"line\": 113, \"relation\": \"positiveCorrelation\", \"source\": 92, \"target\": 22}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Atherosclerosis\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Expression of HO-1 provides protection against atherosclerosis in several experimental models17,18 and HO-1 deficiency in humans has been associated with the appearance of vasculature fatty streaks and atheromatous plaques at age of six.19\", \"key\": \"58a2da74bd78b1d885cd81d95af5d8eabe1457a85d4d32139a46fb1e25aa6d91e5c001bd925e9df3866ca13d68ec6aa59d78e52768e32359d3b82033de68a50a\", \"line\": 113, \"relation\": \"negativeCorrelation\", \"source\": 92, \"target\": 55}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.\", \"key\": \"982164302e335f9de6920b2b299b98c2505a18bbbdfe9200d51a886a05cd4397837836c376f659bc174a237b9022be60f2e52bf325fdb3091f883d6a38489f43\", \"line\": 224, \"relation\": \"increases\", \"source\": 88, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.\", \"key\": \"dbddecafc4801306edb40021fe66cc11532c6b4c05d9ef643eaac7ad7a176319b72778941407bf60c7b0b46acdac073780b41b23916d033ad9dae40ec574b05d\", \"line\": 350, \"relation\": \"positiveCorrelation\", \"source\": 88, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.\", \"key\": \"b9102a74fc1a5e9e0c7aac4c19ffa39b6fa1c79ca7ca68dd3caaf0fef9487df9de5e355fc103e236d19b207ae512aa3362ee35ae91f7c0ae96cc35addcc217d2\", \"line\": 351, \"relation\": \"positiveCorrelation\", \"source\": 88, \"target\": 99}, {\"annotations\": {\"MeSHDisease\": {\"Pulmonary Embolism\": true}, \"Species\": {\"Homo sapiens\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Bonkovsky HL\", \"Courtney M\", \"Kline JA\", \"Steuerwald NM\", \"Watts JA\"], \"date\": \"2015-10-01\", \"first\": \"Kline JA\", \"last\": \"Bonkovsky HL\", \"name\": \"Thrombosis research\", \"pages\": \"769-74\", \"reference\": \"26337933\", \"title\": \"Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.\", \"type\": \"PubMed\", \"volume\": \"136\"}, \"evidence\": \"The median values and associated interquartile ranges for hmox-1 and haptoglobin show that patients with PE+TR+ had lower expression of these genes compared with patients who were PE+TR− or PE−\", \"key\": \"fbb6d2326f9774f60f2781ee32bae73521ed02f2d860c274e2ff36ef913eaccafbb2250655fd34d6dafd475ecc969cab69a9d3f707d6eeeebd9c4af49a489e79\", \"line\": 105, \"relation\": \"negativeCorrelation\", \"source\": 89, \"target\": 55}, {\"annotations\": {\"Cell\": {\"leukocyte\": true}, \"MeSHDisease\": {\"Pulmonary Embolism\": true}, \"Species\": {\"Homo sapiens\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Bonkovsky HL\", \"Courtney M\", \"Kline JA\", \"Steuerwald NM\", \"Watts JA\"], \"date\": \"2015-10-01\", \"first\": \"Kline JA\", \"last\": \"Bonkovsky HL\", \"name\": \"Thrombosis research\", \"pages\": \"769-74\", \"reference\": \"26337933\", \"title\": \"Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.\", \"type\": \"PubMed\", \"volume\": \"136\"}, \"evidence\": \"The inverse correlation between hmox-1 expression in circulating leukocytes and the TR jet velocity in patients with acute PE was significant (r2=0.45, p <0.001), but this significance was absent in patients without PE (r2=0.01, P=0.52).\", \"key\": \"421b4b7ce896a687a0d96afa5cc906b32945ebcf72c5c793065acf8b016504b2499304d65fe5ff3197cf1ece06106882f2816144cbf84f666f91c8837929674e\", \"line\": 132, \"relation\": \"negativeCorrelation\", \"source\": 89, \"target\": 55}, {\"annotations\": {\"MeSHDisease\": {\"Pulmonary Embolism\": true}, \"Species\": {\"Homo sapiens\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Bonkovsky HL\", \"Courtney M\", \"Kline JA\", \"Steuerwald NM\", \"Watts JA\"], \"date\": \"2015-10-01\", \"first\": \"Kline JA\", \"last\": \"Bonkovsky HL\", \"name\": \"Thrombosis research\", \"pages\": \"769-74\", \"reference\": \"26337933\", \"title\": \"Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.\", \"type\": \"PubMed\", \"volume\": \"136\"}, \"evidence\": \"The median values and associated interquartile ranges for hmox-1 and haptoglobin show that patients with PE+TR+ had lower expression of these genes compared with patients who were PE+TR− or PE−\", \"key\": \"5318df339cee4bc91248521e0ab21f88ce32f8c50db26f5ddba7536ca5ddf99eadfa34ad32f68c72bb1a96ec0f8f7d78ef3f30c03c1fdbf50ba5d63a26186cee\", \"line\": 106, \"relation\": \"negativeCorrelation\", \"source\": 89, \"target\": 56}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"In addition, reduced NO bioavailability induces platelet activation and aggregation, leading to thrombosis in a mouse model of intravascular haemolysis (Hu et al, 2010).\", \"key\": \"cad91f8bc70cfdbb283da7e5c1f995d273ad6f57b8c67733352559eea415d51f64ad8b1dfceb127133ec0c09eaa878922c87c1b87dd04a3708d13e3f9993e29b\", \"line\": 583, \"relation\": \"positiveCorrelation\", \"source\": 40, \"target\": 99}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"ADP induces platelet activation and may also contribute to transfusion-related vascular thrombosis.\", \"key\": \"0f3501c4efb8f0285e4a12815093870204fcb2187fa8e82502354318c52b599a75b8e9b9a43379432b429ee3f3d4d80cc188a8f8ec78795a28f62b4cdd182abe\", \"line\": 607, \"relation\": \"positiveCorrelation\", \"source\": 40, \"target\": 16}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"4100337d4ad28c94f04ffe3558bf822e94c8af109c079c082e23492ef79624da005b290a5cc308ea3c3c17247632b2f1498beca635d99df58f916c97837cd83b\", \"line\": 109, \"relation\": \"positiveCorrelation\", \"source\": 40, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"b6161dfddc39261459fb74bee5ac4e0ec50aaec58819658794ffdbb72bb95df207938dafb3de10d7bbb9bdc3579e241b0f8973a635d86d12365c2d55885969e4\", \"line\": 110, \"relation\": \"positiveCorrelation\", \"source\": 40, \"target\": 5}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Endothelium\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Surface accumulation of MAC may be at least partially responsible for the activated platelet phenotype seen in patients with primary Cys89Tyr CD59 mutation, as manifested both by increased CD62P expression and monocyte-platelet aggregates.\", \"key\": \"778bb626e4ab508e4132195a19f4cfe7eff0c2a0894b624c3462ccc6f7521fb7e465ed2b98e1d78902b5c5bd1a5c453b839958b01a109de7b66099461e2eeeb7\", \"line\": 371, \"relation\": \"positiveCorrelation\", \"source\": 40, \"target\": 18}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"d6e3cc9dcc0045cdf83e7426afc0900738ef493a155982bc3217d0b1934429db26995219d9df81633c780676e1b453965b2252f457f706817162b70d5aee7f8a\", \"line\": 108, \"relation\": \"positiveCorrelation\", \"source\": 40, \"target\": 54}, {\"key\": \"8bf01f84d30503aa190e69e8c0acd06f27438b50060eb04205cc3aae8d7fb0d94930cff5eeec2440be6bb13c1a2ca067874544521a3e00286059cfa826455acd\", \"relation\": \"hasComponent\", \"source\": 44, \"target\": 2}, {\"key\": \"520a8138a0f1ac9c89e5bc15f333959106b282f435358a0ef9f1122f5d2580d821517b61fa64b6d2a9a8836fb605c5765305c5a12dd2c7c17a9106ab21239add\", \"relation\": \"hasComponent\", \"source\": 44, \"target\": 5}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"Clinical studies have confirmed endothelial dysfunction and vasculopathy in a patient with HO-1 deficiency, and similarly, mice lacking HO-1 have increased vascular injury and thrombotic complications (43, 44).\", \"key\": \"ab86d2c561579589ee066996e015070724eb359031f802da37673352edbb50a9824ed9009ed200ada2cbfd93e58da09d86b034c5865f7f5f40579e1ba2205876\", \"line\": 260, \"relation\": \"negativeCorrelation\", \"source\": 66, \"target\": 91}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"Clinical studies have confirmed endothelial dysfunction and vasculopathy in a patient with HO-1 deficiency, and similarly, mice lacking HO-1 have increased vascular injury and thrombotic complications (43, 44).\", \"key\": \"c5441b30601744c74daa9068530eb6cc151e826a08dea6ef99b10e1f5da57ed4f2c653162f6fbd2efdc85fd7c64485aa2455cd36cadd326ae6c9efc07e010560\", \"line\": 261, \"relation\": \"negativeCorrelation\", \"source\": 66, \"target\": 99}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"The results showed that enforced HO-1 could efficiently decline the heme level in the lysates of ligated kidneys, and inhibit kidney inflammation characterized by down-regulation of NLRP3-Caspase- 1-IL-1b axis.\", \"key\": \"03c2bedae88342cfa04c42f2063d616576b90b4845d9ed763e8a04d11b7661f7c6b12966230ab90d6bcdb282a3c0afa54fa68dae3281cc48b62ad63b6f91400c\", \"line\": 256, \"relation\": \"negativeCorrelation\", \"source\": 66, \"target\": 10}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Mice lacking HO-1 (Hmox1−/−) are highly susceptible to pathologic conditions associated with increased serum heme concentration.\", \"key\": \"5629c85b6dcd9c9a7130ccc452630019cbee027816f554ba912575bd5184f30dc7982b0d6a7d285ccd3009baac46bd09d2ec0a6c57e98bb7014a003ac5b83995\", \"line\": 375, \"relation\": \"decreases\", \"source\": 66, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Engelsberger W\", \"Karnaukhova E\", \"Lönn M\", \"Opitz L\", \"Puglia M\", \"Schaer CA\", \"Schaer DJ\", \"Schauer S\", \"Spahn DR\", \"Stocker R\", \"Vallelian F\"], \"date\": \"2015-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Cell death and differentiation\", \"pages\": \"597-611\", \"reference\": \"25301065\", \"title\": \"Proteasome inhibition and oxidative reactions disrupt cellular homeostasis during heme stress.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"The Hmox1 (− /− ) MEF cells expressed no functional Hmox1 mRNA (Figure 1a) and as a result accumulated more cell-associated heme during extracellular exposure compared with wild-type cells (Figure 1b).\", \"key\": \"18fa260528ce5cad4fc5e0dcc40b5fa827f0c9f48545c7b5ed8078383f0bb18d03c979f8b95a98d3ee1f4f6fe6d24213d6eb6d0653bdd4233216b7474db2b78c\", \"line\": 95, \"relation\": \"negativeCorrelation\", \"source\": 66, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"Macrophages are crucial for the removal of excess heme resulting from hemolysis via the uptake and degradation of heme by HO-1 (ref. 23), encoded by Hmox1.\", \"key\": \"b2df7e6072fd26f4a8f8c44032619ab0880df753c8ebcfc904df3d20410d8479abeb8a665fe3c43e78817c2a02741df51c8d501d29a2d8c54d23664a6fe86f64\", \"line\": 96, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"increases\", \"source\": 66, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"The results showed that enforced HO-1 could efficiently decline the heme level in the lysates of ligated kidneys, and inhibit kidney inflammation characterized by down-regulation of NLRP3-Caspase- 1-IL-1b axis.\", \"key\": \"76ef11ee784230bd343639da5e6cf41e3262ca3cd40055cf0cd10323c32c11bbb3237243fd94e7c7f6d44ecad36a65189d78d8541a7efd80d0c2d7cdbf693ba0\", \"line\": 257, \"relation\": \"decreases\", \"source\": 66, \"target\": 97}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"A recent study indicated that expression of HO-1 targeted to mitochondria attenuated oxidative stress (43).\", \"key\": \"c2a2c9ccada0a6001407a9d6eccf86d9dd29b1e22d9d284d04663a82472a8c8d380a90e008b2e7f35a1cfe2baa2838d6155d503629a176018a50e48880ab635e\", \"line\": 211, \"relation\": \"decreases\", \"source\": 66, \"target\": 39}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Moreover, mitochondrial translocation of HO-1 can also lead to localized CO production as a result of heme degradation, thus inhibiting electron flow though mitochondrial electron transport chain complex IV (44).\", \"key\": \"2fa54b90d0f687263c36c8bc53d3a78f8b61193aa82c69167bf8bf2b877ddc45746573f5730ab5e470471ca780691dc2a080caa011757dc648755029e2c89a41\", \"line\": 231, \"relation\": \"increases\", \"source\": 66, \"target\": 2}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Mice that were resuscitated with SRBCs and albumin or SRBCs and hemopexin showed a marked increase in HO-1 expression when compared to mice resuscitated with FRBCs.\", \"key\": \"037d5c16d52c1c36f10d6ddf26722a7d28f4f743271da0e8581484ad31da669f6e4188b5327cb08b129925d3ff88a6d0ae57faff722f3ea9c1943e39d663ba48\", \"line\": 339, \"relation\": \"positiveCorrelation\", \"source\": 66, \"target\": 50}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Mice that were resuscitated with SRBCs and albumin or SRBCs and hemopexin showed a marked increase in HO-1 expression when compared to mice resuscitated with FRBCs.\", \"key\": \"99c3a779a7568e70312d12953b54bc9b66d172eaa202d813b99aa06653d2c01321161a8eec866ed51c1c28cda62723dee0ffe95e5d1a12e6977b2631a517640c\", \"line\": 340, \"relation\": \"positiveCorrelation\", \"source\": 66, \"target\": 48}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Resuscitation with SRBCs and haptoglobin prevented the increase in SRBC-induced renal HO-1 expression (Figure 7F).\", \"key\": \"f0e7d32e6e065c0ee9f05c6cdfe2be4e70c075f870062cb2b4d3c45bcbc06d96baecb476a1fed530a476651f2c310a4b435905084d78a96efca059dc36d96dbc\", \"line\": 345, \"relation\": \"negativeCorrelation\", \"source\": 66, \"target\": 49}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Moreover, HO-1 was highly expressed in the liver of CEP compared to WT mice (Figure 4E), confirming that residual heme uptake is rapidly degraded in the liver.\", \"key\": \"09efd9d6e7728089c00739af3bc0b32291f4f3a5089f40a1dee7b115eec99479cace063d32cdd7442ff478f6da8c729c12405471e73c11e71f7424b8acf352ac\", \"line\": 260, \"relation\": \"positiveCorrelation\", \"source\": 66, \"target\": 85}, {\"annotations\": {\"Cell\": {\"inner renal cortex cell\": true}, \"MeSHAnatomy\": {\"Kidney Cortex\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Interestingly, the mRNA expression levels of HO-1 and ferroportin, which are both induced transcriptionally by free heme, were enhanced significantly in the cortex, but not in the medulla, of CEP mice, resulting in large increases in their protein abundance (Figure 6).\", \"key\": \"826cd3ab7ed34338ac39df970341b1a8c8698290e55d78316c96d89d8ba471709c3ec0ec3cccfea9fb7b198de12df4de304ab22ea48929562fbcddb2d5dee645\", \"line\": 316, \"relation\": \"positiveCorrelation\", \"source\": 66, \"target\": 85}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"We have previously shown that induction of HO-1 expression or liver-directed HO-1 gene therapy inhibits stasis in sickle mice exposed to H/R [38, 45].\", \"key\": \"4300b645895e56db50e1c6d66ed169f7ce241f4f4559d22cf6b9d3bbed352b874e1d6ff1ee62919de4e1431b59d1d5783f31014341a8944fe286079a70dbf9db\", \"line\": 185, \"relation\": \"negativeCorrelation\", \"source\": 66, \"target\": 77}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"The results showed that enforced HO-1 could efficiently decline the heme level in the lysates of ligated kidneys, and inhibit kidney inflammation characterized by down-regulation of NLRP3-Caspase- 1-IL-1b axis.\", \"key\": \"10bba03227648406edf7b29bbb2f9cb700e8945ddfeb99b137bb9d9c527c14e480591f3d2b63a545d3c2c5ac8b8aa3b79636ee0b1ffa6c039753f0ac6b350646\", \"line\": 260, \"relation\": \"negativeCorrelation\", \"source\": 66, \"target\": 69}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"The results showed that enforced HO-1 could efficiently decline the heme level in the lysates of ligated kidneys, and inhibit kidney inflammation characterized by down-regulation of NLRP3-Caspase- 1-IL-1b axis.\", \"key\": \"f42be7deeeb2cb57e61e1b66e6a9c7350f82cd1032f8ac44ea9e44346dc358f370789a399d6f6f8c144a37ead1bb82c6c13a1279118281208a01b9ee327751d2\", \"line\": 259, \"relation\": \"negativeCorrelation\", \"source\": 66, \"target\": 65}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"The results showed that enforced HO-1 could efficiently decline the heme level in the lysates of ligated kidneys, and inhibit kidney inflammation characterized by down-regulation of NLRP3-Caspase- 1-IL-1b axis.\", \"key\": \"fcb4ffb617eb3aa5be4ece005a8de9f847c0c831ca01ec516bfe4d1b7e9280dc49f8c960708fb77e5acf74a001772adffae533ba4daeca37341339736fe06b6c\", \"line\": 258, \"relation\": \"negativeCorrelation\", \"source\": 66, \"target\": 71}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Haem also induces tumour necrosis factor (TNF) secretion in monocyte/macrophages through TLR4 and the adaptor molecule, MYD88 (Figueiredo et al, 2007).\", \"key\": \"f129e1007a6b0be44fec45f9bcdc1d7cfdc8841f08718c6ef3c1539451637ec0da4b82a10c1ba1c5548f16f7628e9ea0904f4c78708209d7c562908ec82f81f7\", \"line\": 533, \"relation\": \"increases\", \"source\": 60, \"target\": 64}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Correlation analysis using Pearson’s correlation coefficient showed statistically significant inverse correlation between Hpx and blood pressure, both systolic (r = -0.511, pvalue< 0.00001, n = 145) and diastolic (r = -0,520, p-value<0.00001, n = 145)(Fig 3).\", \"key\": \"050ed46af67bfa74d73423ef5780984fd734b8f35b4a8a22afc25ac5c07c4777969a8470c086369919b40048dca63fe6d2fd2ecf5242a34d9b759ada321c365a\", \"line\": 183, \"relation\": \"negativeCorrelation\", \"source\": 34, \"target\": 57}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Plaque, Atherosclerotic\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Previously we have shown that heme can enter the lipid moiety of LDL and induce iron-dependent lipid peroxidation.8\", \"key\": \"cd63cad44a6641d80bac2d76e64d0bdec5c1d1fcbd0fb81ba4bdf7c16383c942c4eebeaf8fc637298246554d9feb3b6955497aff82ed1e3b65b9a0a8ddb20b01\", \"line\": 280, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 38}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Plaque, Atherosclerotic\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Here we demonstrate that lipids isolated from human atheromatous lesions – which are already in an oxidized state – can be further oxidized in the presence of heme, whereas this effect is not observed using lipids isolated from normal vasculature.\", \"key\": \"8b90a80da198f4ac3e696a93178910d91cd55eea38c33f47462aee8ed316d1b6a4a4e71cb46732a69ee9fca228639d30d827435aea8ab252d24c57fa6cdaa166\", \"line\": 286, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 38}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Atherosclerosis\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Thus, it appears that these extracts oxidize ferrohemoglobin to ferrihemoglobin, thereby leading to heme instability and heme-mediated initiation of lipid peroxidation.\", \"key\": \"703ce106d583d415a18308746ce86d7db0e87c7e14c53554392fc62d797f05d0541df4302c8fc9fb6d6ac6ccab0a2ad6b181dc4858a616f9bcf08fc79732332d\", \"line\": 335, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 38}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Besides its physiological importance, heme has a potent oxidative capacity oxidizing lipids (Tappel, 1953, 1955; Vincent et al., 1988) and proteins (Aft and Mueller, 1984; Vincent, 1989), and damaging DNA (Aft and Mueller, 1983).\", \"key\": \"70fc14fb3ea63ebd857cddf7ced852a02b67798dbbd0a7ff26cb836f43287b53213224e6c709b8965310c55cf59d5a3f2163c1b887f0d27afda15c5b6117699d\", \"line\": 102, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 38}, {\"annotations\": {\"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Engelsberger W\", \"Karnaukhova E\", \"Lönn M\", \"Opitz L\", \"Puglia M\", \"Schaer CA\", \"Schaer DJ\", \"Schauer S\", \"Spahn DR\", \"Stocker R\", \"Vallelian F\"], \"date\": \"2015-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Cell death and differentiation\", \"pages\": \"597-611\", \"reference\": \"25301065\", \"title\": \"Proteasome inhibition and oxidative reactions disrupt cellular homeostasis during heme stress.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"In contrast, at an equal antioxidant concentration, Trolox completely blocked heme-triggered lipid peroxidation (measured as production of thiobarbituric acid reactive substances (TBARS)) in soybean lecithin micelles (Figure 7g).\", \"key\": \"e29b76922778dd39f9e9e8e7f0fe42c8f71dfbec9385f67b96da8e9d4b149f80c100507f11191a7348895668dfff93fcc73c0ed5c1df102bb12ef24e09e985d9\", \"line\": 196, \"relation\": \"increases\", \"source\": 10, \"target\": 38}, {\"annotations\": {\"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Free heme is a potent trigger of lipid peroxidation and a promoter of inflammation.4–6\", \"key\": \"3b8440497f3309518162da0044d9e548c91bf32a732caf45a0df7de4ebe2da25941857cc29e6395caa32f59202fc83b12a30f6a9a53526d075a23eb058e07c19\", \"line\": 94, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 38}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Toxicity of free hemoglobin is also caused by the release of cell-free heme, which produces lipid peroxidation and mitochondrial damage and increases the production of reactive oxygen species.\", \"key\": \"45298db5c549648d80e34653afe0ec2fc0c18593d1407044abf466841d534bbd3fd8134fafea9a7bac4f59d5dc93b12d6c581ad26a751b255af1053bbd712f05\", \"line\": 103, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 38}, {\"annotations\": {\"Cell\": {\"regular cardiac myocyte\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Consistently, we measured increased lipid peroxidation in both cells and tissues exposed to free heme, which can be rescued by α-tocopherol, an agent able to react with lipid radicals and interrupt the oxidation reaction.\", \"key\": \"636daa2ea4eee00d7e3c9f1a4aef2e99ab82fa048f2eff37b52a7450d4d4f2d7360ff3cfd9db7f15e68feb0ccd19f4c63fb972d7a529f077f8d35064cd0165fb\", \"line\": 247, \"relation\": \"increases\", \"source\": 10, \"target\": 38}, {\"annotations\": {\"Concentration\": {\"10 mM\": true}, \"MeSHAnatomy\": {\"Muscle, Smooth, Vascular\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"60 min\": true}}, \"citation\": {\"authors\": [\"Arruda MA\", \"Assreuy J\", \"Barcellos-de-Souza P\", \"Barja-Fidalgo C\", \"Moraes JA\", \"Nascimento-Silva V\", \"Rodrigues G\", \"Silva SV\"], \"date\": \"2012-10-01\", \"first\": \"Moraes JA\", \"last\": \"Barja-Fidalgo C\", \"name\": \"Atherosclerosis\", \"pages\": \"394-400\", \"reference\": \"22954673\", \"title\": \"Heme modulates smooth muscle cell proliferation and migration via NADPH oxidase: a counter-regulatory role for heme oxygenase system.\", \"type\": \"PubMed\", \"volume\": \"224\"}, \"evidence\": \"Accordingly, Fig. 2A shows that heme (10 mM) induces a strong ROS production after 1 h of incubation with VSMC.\", \"key\": \"8a1ff6039bac8b2c19f6d69f512fcff18f9c6922c341eeff3a1c79429dbcd76927c54cd3c1c003a293fc7c1c0690f8f63900468e9053e7cb8c836353f9f3d457\", \"line\": 111, \"relation\": \"increases\", \"source\": 10, \"target\": 22}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"Concentration\": {\"10 mM\": true}, \"MeSHAnatomy\": {\"Muscle, Smooth, Vascular\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"60 min\": true}}, \"citation\": {\"authors\": [\"Arruda MA\", \"Assreuy J\", \"Barcellos-de-Souza P\", \"Barja-Fidalgo C\", \"Moraes JA\", \"Nascimento-Silva V\", \"Rodrigues G\", \"Silva SV\"], \"date\": \"2012-10-01\", \"first\": \"Moraes JA\", \"last\": \"Barja-Fidalgo C\", \"name\": \"Atherosclerosis\", \"pages\": \"394-400\", \"reference\": \"22954673\", \"title\": \"Heme modulates smooth muscle cell proliferation and migration via NADPH oxidase: a counter-regulatory role for heme oxygenase system.\", \"type\": \"PubMed\", \"volume\": \"224\"}, \"evidence\": \"Corroborating recent studies that showed heme as an inductor of ROS generation via NADPHox in neutrophils, macrophages and in VSMC [7,8,19], the pretreatment of cells with DPI (10 mM), a NADPHox inhibitor [20], prevented heme-induced ROS production in A7r5 VSMC (Fig. 2A).\", \"key\": \"6c8d72c1d47c78856e98059fca1a1850962c8287e04dc99a4951f3782d56b73df96cae16bc290f26d9b8b03936ea3bcf77f5b35ee9be953ee652d0dbcf2d66e5\", \"line\": 121, \"relation\": \"increases\", \"source\": 10, \"target\": 22}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Furthermore, heme induces ROS generation dependent on enzymatic reactions.\", \"key\": \"9e3fa5ef1aab92a6f9b91fd19041c492f459021927d78f43905e2bfe956b5c95d478a9b28e2b9d64e2bdd3f0535dbd3ba8f24d686e388bfac9114345cd9b3944\", \"line\": 196, \"relation\": \"increases\", \"source\": 10, \"target\": 22}, {\"annotations\": {\"Cell\": {\"leukocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Heme induces ROS generation independently of TLR4.\", \"key\": \"7cfbfffcfe66d9270521d95885b092d90dd043213ea43d6753874f16b3c68b6eaa9443a53ccd5482b82597168110d8ccb57678b50cbff1d6b90e5daf6a2c71c2\", \"line\": 453, \"relation\": \"increases\", \"source\": 10, \"target\": 22}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Heme activates neutrophils and endothelial cells, by ROS generation.\", \"key\": \"6ee65abaf696644785d865a37775388c7c96234fcfcc646c8cb434f101460c29a009f6b779a7d402e74d21a4e59d4b3aa3ff700a126703ca8f6f50a5b64cc4db\", \"line\": 538, \"relation\": \"increases\", \"source\": 10, \"target\": 22}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"The main mediator of these adverse effects is thought to be free haem via its effects on NO scavenging, pro-inflammatory cytokine responses, and reactive oxygen species (ROS) generation.\", \"key\": \"0dc33b79eae61c7cb234a804f73a147233bd57e11ac2e1ce87c4ee5f6c7e009903e836fe98fa76a9221904fb17d024b9f7145edfb43350ac203472afc40491d9\", \"line\": 404, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 22}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"In addition, we observed increased ROS production ( Figure 2I; supplemental Figure 2), as well as an enhanced expression of IL-6 and TNFα in cells treated with heme-albumin compared with heme-Hx (Figure 2J-K).\", \"key\": \"481a54403f785bdbd2bab7f521f817fbaad470d2cf3b217eceb9be2654d243dd741b73f2c5343cd903cb2c26b3f62d512cd9002b682f8a46c785b45b4c2ef363\", \"line\": 145, \"relation\": \"increases\", \"source\": 10, \"target\": 22}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Toxicity of free hemoglobin is also caused by the release of cell-free heme, which produces lipid peroxidation and mitochondrial damage and increases the production of reactive oxygen species.\", \"key\": \"91bb024fa819889b42fecc3ac461a30776e6572f6adad64b81390a2441e4fa23c9e513fcebe68f8e2842354c54fc4cc3588063a4a6826ee592bceae66e652b47\", \"line\": 104, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 22}, {\"annotations\": {\"Cell\": {\"monocyte\": true}, \"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"Species\": {\"Escherichia coli\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"Heme is an amphipathic molecule that can promote the generation of reactive oxygen species (ROS) via Fenton chemistry, thereby leading to membrane damage.\", \"key\": \"159a017e214a04d1b1044362ee07a5f7d622579f57bc0fcac9a4f9f5e39487a2d66f6236e21b8c0ed934feb92b82184ef5f5e5646c23467d35d41c4b2a95b849\", \"line\": 192, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 22}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Moreover, heme-derived ROS induce the proliferation of smooth muscle cells, that participate in vasculopathy associated with atherosclerosis and hypertension [15].\", \"key\": \"481549262dcbeaaef030e5a0c41183ff3ca1911082769281572da9a794c4b0a8f30777cd4b79848a0f87441017d54fceda170ff69bf8a6cbae9a79266f83782b\", \"line\": 110, \"relation\": \"increases\", \"source\": 10, \"target\": 22}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Free heme upregulates heme oxygenase activity, generates reactive oxygen species, and activates endothelial cells and macrophages directly[65].\", \"key\": \"8ab16fe2c1d431bf63fa5dd5f81cda7091b68d4a8e406dd8f890f84abd2b5bc71ae7df26f6a1b70cb5a4af67afe8b2add6e71cc098dd07f804a77dd361787364\", \"line\": 325, \"relation\": \"increases\", \"source\": 10, \"target\": 22}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"As expected, incubation of neutrophils with hemin resulted in a significant number of cells producing ROS (Fig. 8A and B).\", \"key\": \"097d71fd878dfb17ec6ef618b2f025d0c9e38e770ed8f4ed525ddbdf34b518eaa1edec5ee6a6d291345dedb82e33dff1e988389a38ce0daf4e8cb48bc4cf270f\", \"line\": 160, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 22}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"For instance, earlier studies have demonstrated that neutrophil elastase degrades the hemoglobin liberating free hemin that induces ROS production.\", \"key\": \"07caedcdfeecae9f4f31e2106d281d120ffafd68858111a8a23f06099545e2cd4955c576e3bf3512ca98b92514236b798888c04a8a057b16c8a9db301c312531\", \"line\": 258, \"relation\": \"increases\", \"source\": 10, \"target\": 22}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"We show that heme, in a concentration range found during hemolytic episodes, increases intracellular ROS production and consequentially signals for ferroportin induction and subsequent iron export from the macrophages.\", \"key\": \"924414e8f3df9f49488bbab010d04b0ad0e03a3d6744427606f35cb61b712396d2762c33b2a5db153465b1404cebea5fdbd90fa1a7671b0fe44c271f3ec380fd\", \"line\": 236, \"relation\": \"increases\", \"source\": 10, \"target\": 22}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"As shown in Figure 3, the level of heme degradation is highly correlated with the level of metHb in RBCs (R = 0.6233, p < 0.0177) supporting the hypothesis that the heme degradation product formed in PRDX2 knockout mice is associated with the un-scavenged H2O2 generated during Hb autoxidation.\", \"key\": \"df8b39442596a725db67c8ef9122a0b095645e718f543687f93b3402ec9df585cc0557c3b43727d3b53d96e39e3454ca7fe23e46f9d8a5d72084c34906b9ba1b\", \"line\": 149, \"relation\": \"positiveCorrelation\", \"source\": 10, \"subject\": {\"modifier\": \"Degradation\"}, \"target\": 4}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"As a component of hemoglobin, free heme is released when hemolysis or extensive cell damage occur which results in inflammatory response.\", \"key\": \"ca77b58f34d7c8d3957a77e5faa54454a3f2a48ea25652490ca0c8f41a5f7fbab1f48901cac158c3663840e31d5666c01bd4721643f429e1b2ff2d2772543c09\", \"line\": 94, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 31}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Hemin induces expression of the adhesion molecules on endothelial cells [7, 8] and enables firm neutrophil attachment to the endothelium and initiation of an inflammatory response [9, 10].\", \"key\": \"e2c3acbfce7cc1c9d532879ca9b38f80bef566f5f56ee14cade9307f88bf5d9fe92ee6783cc8910b1acfe0059b54f0f579e2ecbaa5969edee7be49d691fcdfba\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 31}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"These experiments confirm a number of earlier reports and support the idea that certain solutions derived from purified/crystalline heme have the potential to induce weak TLR4-mediated inflammatory responses in macrophages in the complete absence of plasma derived proteins.\", \"key\": \"de60f70d5a677354a71cf0a867120ee5ccb4f400383c9f1bd8541cca7e435ab344f4dd984f270ceb141a322f3925e699be1aa562eae6bc81f9f430fff2be6cd8\", \"line\": 176, \"relation\": \"increases\", \"source\": 10, \"target\": 31}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Free heme is generated by intra- and extra-vascular hemolysis or extensive cell damage [14, 15].\", \"key\": \"eb92bc7820577e8551c91572d70b189cc8b805f124fa72a593223e4721de215dde2c64858aec38c025a49c91b7ec804c3290cf4143e0aebb44aa7e4d99ecf1c7\", \"line\": 121, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 95}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"McCulloch JC\", \"Nielsen VG\", \"Redford DT\", \"Thompson JL\"], \"date\": \"2014-09-01\", \"first\": \"Redford DT\", \"last\": \"Nielsen VG\", \"name\": \"Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis\", \"pages\": \"621-4\", \"reference\": \"24553061\", \"title\": \"Left atrial myxoma presenting as pulmonary embolism: potential role of heme oxygenase-1.\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"Lysis of red blood cells with consequent increases in free heme most likely caused the increase in HO-1 activity responsible for increased COHb concentrations, which is similar to that observed with circulatory devices [6].\", \"key\": \"a1d9d0afd988d7a682d615244a4d3bd1bd7033d4199fbf5dea26786d6a2f7ea0c1c72a11c6c78d0b69bb2941cc61768ec3474f1b2d7146b2f6e038c6ca76e609\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 95}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Haemoglobin and haem levels increase in plasma and urine when haptoglobin and haemopexin scavenging mechanisms are saturated during acute or chronic haemolysis.\", \"key\": \"f7bddf6b7003a304e780bcd16444e4c6a7eea003d91955b6c6cedde2a0371535ba480fb3331e3cdc3b4c220fc8b712f949251de4f26c3e6653ce5b169a399778\", \"line\": 190, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 95}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"Concentration\": {\"40 μM\": true}, \"MeSHAnatomy\": {\"Kidney Cortex\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"The above-discussed findings provide strong in vivo evidence that high concentrations of ferric Hb(Fe3+) and free heme can accumulate in the renal cortex during hemolysis.\", \"key\": \"8e56f9821a0b27a53ce7290fead1176b1e1a9d39522545e3200d9de8783e0e15b45c564d0b1b57ca7b517c7b51f4516b6734142ea178e3ef59eddc00cfe03592\", \"line\": 293, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 95}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"c36fae74af5995124148e27f7462f4dde25226aed598a2e892b719ec538f8db83350c72ddf1717a07114acf483f36d1f6f07cfa1d65891c44f0dfe75ab1dd939\", \"line\": 92, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 95}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"In infectious diseases, such as malaria and sepsis, high amounts of cell-free hemoglobin and heme were found [8], suggesting that hemolysis during sepsis and systemic inflammation is of pathophysiological relevance.\", \"key\": \"21daa9352dc5a9b8ee65095d955e1809d87dba237434d341f8a22660683fc7423582b4158e4c6efaa9e42c6a831053761bed26d4b0bb70e07eeda9c7963e4d8b\", \"line\": 286, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 95}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Free heme has been proved possess pro-inflammatory activities, such as leukocyte activation, migration and infiltration, adhesion molecules activation, and cytokines and acute phase proteins induction [17, 18].\", \"key\": \"ee3bf20e5fa57f91c89efcd706d176327f62ed18f52f5f6dc8ff467dc94bd0da5071be495e44f187c5c0ba9f01ed8b4cb65a964ff274ee197bea906b060a4183\", \"line\": 137, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 24}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \" Heme amplifies cytokines induced by cell surface receptors (TLR2, TLR4, TLR5), endosome receptors (TLR3, TLR9), and cytosolic receptors (NOD1 and NOD2).\", \"key\": \"05f7d5b61f0a247e6c350e78239dd22f40e98f26eeaf88c67f080226287585cce6e45f8941d39dc72dee3b52e5c2bf21ff865878a6ae3b9dbaf8350e7dcfabae\", \"line\": 500, \"relation\": \"increases\", \"source\": 10, \"target\": 24}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results suggest that heme plays an essential role in kidney inflammation via regulating NLRP3-Caspase-1-IL-1b axis.\", \"key\": \"0d3f0d9da8805407a1b5598d54d90157cbe69ba91dcf085fef9c7a8ad092d8013b4da5ba41721b93ba3f7e19c29b70173eec666b679df5ebb9dd092063417d01\", \"line\": 267, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \" CO inhibits Hb oxidation and subsequently heme release, thus blocking heme accumulation in serum and preventing heme from exerting its inflammatory effects in the course of malaria disease (Ferreira et al., 2011).\", \"key\": \"191e52ff98c4051f00b2de97df888e385244d023c0937eff32954ee555c123509f4b56d4d9e87c6b759ea5f5a286b2f19a868ab8a602a8489625813b9cfe7f18\", \"line\": 412, \"relation\": \"increases\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"During intravascular hemolysis the serum proteins responsible for removing heme get saturated and heme can exert its inflammatory effects.\", \"key\": \"57a36208355a0bbe8738a216043ff76e8d78b68e5a4b13d7b7c28fa27126e1acc2e33c8ecc7bfcc7017253b51bbbfac629ca030fd7401d8b2d8025431aa755d7\", \"line\": 520, \"relation\": \"increases\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).\", \"key\": \"ad5b1fd5ea3d7aa36ed91670f95a8112267026ccdcc99631f60e16096d40501d4d58e445edf966882a4041b78289b36ee0f6784af37c4d6422fde2469ac9f410\", \"line\": 177, \"relation\": \"increases\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Free plasma haemoglobin and haem also scavenge NO and have multiple pro-inflammatory and pro-oxidant properties that mediate many of the adverse effects of haemolysis.\", \"key\": \"d1d056e3689edcbbcbd139e3e8f76bea8e3b1fd1afce55246234288dc492614264bd5a7adbe98fdc4923de816b4774cefbffabe81864ec759ed0d6985046b0e6\", \"line\": 199, \"relation\": \"increases\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"More recently, we have also shown that free heme is also released during storage and may mediate further inflammation28\", \"key\": \"5fe44a513894accc5f7f8597d1c68d4ba4744cf5ceade9d6cae3af24b644b9c6a69f1f37f24f64db2c30d53e00025ebd9ddc16142372761da8879415655364b8\", \"line\": 171, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Free heme is a potent trigger of lipid peroxidation and a promoter of inflammation.4–6\", \"key\": \"24dcd333b71aa724cce39ee52a878c82e1e31b4a9920f09f592a639402ed8a0115ec903a013f45aab46e6a4c3e7624c9a12fb249d591cab03e41e14a2d0f4ae1\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Extracellular hemoglobin and heme are pro-oxidative, proinflammatory, and cytotoxic [10–12], and can contribute to the pathology of hemolytic diseases.\", \"key\": \"26676cf9bda12f4a6331de98960fd133ed5ab8cc99a324fdb723989ff4cf51f67b42ba4388cd2d5d60dbcf7c90b11101d176359858420088f25c649978789dac\", \"line\": 103, \"relation\": \"increases\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Arteries\": true}, \"MeSHDisease\": {\"Diabetes Mellitus\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Buys ES\", \"Graw JA\", \"Rezoagli E\", \"Warren HS\", \"Yu B\", \"Zapol WM\"], \"date\": \"2017-06-01\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"American journal of physiology. Heart and circulatory physiology\", \"pages\": \"H1120-H1127\", \"reference\": \"28314763\", \"title\": \"Endothelial dysfunction inhibits the ability of haptoglobin to prevent hemoglobin-induced hypertension.\", \"type\": \"PubMed\", \"volume\": \"312\"}, \"evidence\": \"Increased plasma concentrations of cell-free heme, the breakdown product of 390 hemoglobin, promote activation and inflammation of endothelial cells and enhance 391 oxidative stress and vascular permeability (22).\", \"key\": \"1774ab653c42777ce8e9a484d93944eaa5dce2f383546b419b4f36f0449b7e3e743223822461a47dbb32cf713368f067dbc291f3e2d0ec0f834de83734b19415\", \"line\": 248, \"relation\": \"increases\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Free hemin is a cytotoxic molecule that mediates oxidative stress, endothelial activation, and inflammation, and it is implicated in malaria pathogenesis [40] and AKI, among others [41].\", \"key\": \"40f3a9f9817938f4ecfff3ab2c7a8b083248e7af45e4d3ce3de64cb05b10b43cc38c11f8734f71e270bf0f9f729a8cb467a1953a5ea94f7d031f9354d6472765\", \"line\": 236, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"e4ce7e7c22cce7628c8b728e7f0917ef59b1969c342d45e463046348f8a3d95dd590408490a252004efe6626bcc8995539ef476475691691504f3317252ade97\", \"line\": 105, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"712c47371ec10fa93fdb6848a45f4f5a53752344730b8f5fb433c2d4ee187cad07b32040e8d36477dffa7eb695e23c67a3fd52efc9048382b416c53233cc6e13\", \"line\": 96, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Administration of heme in healthy volunteers caused thrombophlebitis, demonstrating that it can cause vascular inflammation followed by vascular obstruction [18].\", \"key\": \"fdb662eddcf25709c43ae52be1089fc813a4140c88d3fcfda226e16704a685dd9edd732609acb715d37e53c6bb2629a47947e862b1bf462be12cc8f643246b3a\", \"line\": 264, \"relation\": \"increases\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"In infectious diseases, such as malaria and sepsis, high amounts of cell-free hemoglobin and heme were found [8], suggesting that hemolysis during sepsis and systemic inflammation is of pathophysiological relevance.\", \"key\": \"905d85dc6c4b39ea43a0dbc1d0350dbde6398c836fbb4882bc7c38d80a42c5d3d10da3589cc2a74e4a77f71e967b5d14f5cc0927a03c395fef81ab29f9ec16dd\", \"line\": 287, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Karnaukhova E\"], \"date\": \"2018-11-01\", \"first\": \"Buehler PW\", \"last\": \"Karnaukhova E\", \"name\": \"Current opinion in hematology\", \"pages\": \"452-458\", \"reference\": \"30281034\", \"title\": \"When might transferrin, hemopexin or haptoglobin administration be of benefit following the transfusion of red blood cells?\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"In mice, this response was attenuated after administration of the TLR-4 inhibitor, TAK-242, suggesting hemin potentiates pulmonary macrophage activation and inflammation through hemin-induced TLR-4 receptor binding [27].\", \"key\": \"6e4d9d44d9a74a725d028660b73639bb2687dc70aae15d9ccc635c93738857f33ab0f5540f8349d21038c288357dd5b9f7a5d3cfce06c7e6c97417aaca795444\", \"line\": 221, \"relation\": \"increases\", \"source\": 10, \"target\": 97}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"The consequences of heme toxicity can be appreciated in hemolytic diseases such as β-thalassemia, sickle-cell disease (SCD), ischemia-reperfusion (IR), and malaria (Katori et al., 2002; Pamplona et al., 2007;Vinchi et al., 2013).\", \"key\": \"35aa73cd634b318d8bbe67d51b884fbf3d6bdf7afe2e9a029a0e33c33fbeb9488a91798a32df86a4163967d231d55b4ac93377a9dfd6639327d421df21dbb5d5\", \"line\": 113, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 80}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"The consequences of heme toxicity can be appreciated in hemolytic diseases such as β-thalassemia, sickle-cell disease (SCD), ischemia-reperfusion (IR), and malaria (Katori et al., 2002; Pamplona et al., 2007;Vinchi et al., 2013).\", \"key\": \"220e249f43437606b6a9ecae35acbcebe45fc1ce3468effff8299989c9b63a904ffa4a19e085d7aded1dae1dc287708cdbbccc9a61eb9795c6598abb110bf08e\", \"line\": 114, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 87}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"The released heme can activate the innate immune pattern recognition receptor toll-like receptor 4 (TLR4) on inflammatory cells, platelets and endothelium, promoting a pro-inflammatory and pro-coagulant phenotype, ultimately leading to vaso-occlusion, ischemia-reperfusion physiology, tissue injury, and pain in murine models of SCD [5, 7±10].\", \"key\": \"0240f6b249de65d9d22252ef9890214ea69212b34988cc26c6aff84e42452b5a99cce1ccd2155a242e1b88df753429604d4826d0c4204db256d308b8ddb61b6d\", \"line\": 109, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 87}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Heme activates endothelial cells inducing the expression of the adhesion molecules ICAM-1 (intercellular adhesion molecule 1), VCAM-1 (vascular cell adhesion molecule 1), E-selectin, Pselectin, and von Willebrand factor (VWF; Wagener et al., 1997; Belcher et al., 2014) and causes neutrophil migration (GraçaSouza et al., 2002; Porto et al., 2007). \", \"key\": \"69de7c85c085934aa648f9c156aa8c9845f4fb87a3be9b898f99d35075354c14e4d2a5ab7de69df9efb2a4b4b6015b50545155c99f72618504b05df49a67beda\", \"line\": 229, \"relation\": \"increases\", \"source\": 10, \"target\": 29}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Heme is one of the factors capable of inducing stimulation and damage of endothelium, promoting the recruitment of neutrophils and sickle-cell erythro- cytes, and subsequently prompting a vaso-occlusive crisis.\", \"key\": \"d871b7e296f7be7eee2d6a407f70bfdf2067c6864dec5f67427e289df231346dd79f2c6b56ec7971b09409d8a9f7c1e6aca218c4654b4c2a449dd4308ca284e9\", \"line\": 153, \"relation\": \"increases\", \"source\": 10, \"target\": 29}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Arteries\": true}, \"MeSHDisease\": {\"Diabetes Mellitus\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Buys ES\", \"Graw JA\", \"Rezoagli E\", \"Warren HS\", \"Yu B\", \"Zapol WM\"], \"date\": \"2017-06-01\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"American journal of physiology. Heart and circulatory physiology\", \"pages\": \"H1120-H1127\", \"reference\": \"28314763\", \"title\": \"Endothelial dysfunction inhibits the ability of haptoglobin to prevent hemoglobin-induced hypertension.\", \"type\": \"PubMed\", \"volume\": \"312\"}, \"evidence\": \"Increased plasma concentrations of cell-free heme, the breakdown product of 390 hemoglobin, promote activation and inflammation of endothelial cells and enhance 391 oxidative stress and vascular permeability (22).\", \"key\": \"b285aed7e1c0453ccec11b8c276d504e7dac90e8fff6b712a2220bc4f2ae70912e54488fee6a160c4c59cc4da74473128b3c0a5f6e203848a6c82a09dfe6cb73\", \"line\": 247, \"relation\": \"increases\", \"source\": 10, \"target\": 29}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Free heme upregulates heme oxygenase activity, generates reactive oxygen species, and activates endothelial cells and macrophages directly[65].\", \"key\": \"7d3a6f16d8fb41ed08dc4eb871ac24f6093ea1746495fa0bc264d15b60683db600a5e05f566c11893f547e0209ad8cd88f96376af2e2102bf05f47095b444025\", \"line\": 324, \"relation\": \"increases\", \"source\": 10, \"target\": 29}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Free hemin is a cytotoxic molecule that mediates oxidative stress, endothelial activation, and inflammation, and it is implicated in malaria pathogenesis [40] and AKI, among others [41].\", \"key\": \"98688488bb830a250a9ae1ee390c644600a48d5ab1655364f6390fd31b63cb5f1fed2c31afb3b5d06c8d13fe08e13429b47ebb0a0058ea5e7134a01925934e1d\", \"line\": 235, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 29}, {\"annotations\": {\"Cell\": {\"leukocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Moreover, HO-1 has a protective effect during heme-induced necroptosis.\", \"key\": \"7b9bb29af9f3320ffe4a71aacbcdfac8ef28570a6349bc9be596ba6309a683a7ed760f350f970ae677521106849a5a6599a5ec9b471fd0972613a6f82729c6a9\", \"line\": 488, \"relation\": \"increases\", \"source\": 10, \"target\": 32}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Therefore, it is clear that heme triggers ROS-induced sensitization of macrophages to TNFR-mediated cell death through RIP1 and RIP3 activation to promote necroptosis (Figure 2).\", \"key\": \"218a686321a2bd135e75fb9a6f195a46d824d2f59fb8b03961eaea0fe5edce57d9905fcf4993843459db28042116083f3a705b032d6eec3d3d2734a5e582527d\", \"line\": 579, \"relation\": \"increases\", \"source\": 10, \"target\": 32}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Moreover, heme induces apoptosis in human brain vascular endothelial cells (HBVEC) by STAT3 (signal transducer and activator of transcription 3)-dependent activation of matrix metallopeptidase 3 (MMP3; Liu et al., 2013).\", \"key\": \"e56efec07ee56a69a17b424b4d0a62cec2a7b0d5a6d19ec5ee87584026da92dc4640519cd5261babbdc82bb45ea08858d48c5bea3dc106c2642fb5d05dd696a6\", \"line\": 605, \"relation\": \"increases\", \"source\": 10, \"target\": 41}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).\", \"key\": \"ad883dce5c610b10d584a58e019d544ac8589abe0f83fd00a7af292f2f052744b3de6222974ccdc42c32c4892326cde93222f16c105a5036592c6b694833a99d\", \"line\": 178, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"negativeCorrelation\", \"source\": 10, \"target\": 9}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Free plasma haemoglobin and haem also scavenge NO and have multiple pro-inflammatory and pro-oxidant properties that mediate many of the adverse effects of haemolysis.\", \"key\": \"0b184d613a6e3b43197421755e934da4610de1918e8666a0cc0935074aaa9e7568c53226c6ac807546fac9d572cc9d044c037f01b0a9fe13625314b26cee53b5\", \"line\": 201, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"decreases\", \"source\": 10, \"target\": 9}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Free plasma haemoglobin and haem also scavenge NO and have multiple pro-inflammatory and pro-oxidant properties that mediate many of the adverse effects of haemolysis.\", \"key\": \"34db52d6ff42cb7c5c5a2dfd9249d398c800d6d4fe685eb604e958783b680515556fc19396a2f37b33fc74f7241dfb3ab3dc20a2f2f3e2ad4208159835b014b5\", \"line\": 197, \"relation\": \"decreases\", \"source\": 10, \"target\": 6}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"The main mediator of these adverse effects is thought to be free haem via its effects on NO scavenging, pro-inflammatory cytokine responses, and reactive oxygen species (ROS) generation.\", \"key\": \"49a224d0914d6f433625458e59ee8553082c608169d7f83a43d892c14d8e255a013f115554715d52df5d5be3bad5adcaee0cbf64064307929f66ffc2e7b47951\", \"line\": 403, \"relation\": \"negativeCorrelation\", \"source\": 10, \"target\": 6}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Extracellular hemoglobin and its degradation products, free heme and iron, are highly toxic due to oxidative stress induction and decrease in nitric oxide availability.\", \"key\": \"c0b1c69a2e581a480afdf8290c1b8684fb09f98ebd0191745c4afe1f8da4b9a8c30b26bcc0d59dd01f3b689ae72b6b31624576ac4382956d6856b4ac9eac311e\", \"line\": 107, \"relation\": \"decreases\", \"source\": 10, \"target\": 6}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Hb and its degradation products – free heme and iron - perpetuate oxidative stress, and together with decreased NO availability promote many SCD complications.\", \"key\": \"ed17b5b0610bdd18510de34015a4e1f5bad8f6d8703817bd975ad7ecb65c510b1cfe7c0db981e15e4896edfcd76f11b0caf0454b0384ebea2d7471181bd3b2d2\", \"line\": 124, \"relation\": \"decreases\", \"source\": 10, \"target\": 6}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Heme promotes endothelial dysfunction by inducing the expression of adhesion molecules and reducing nitric oxide (NO) availability, which causes vasoconstriction [9-14].\", \"key\": \"766980cec9d693c319c716854821ac5af782d801699be29cfd5e2be7fc342d81916ee0b2149428229b21151690b9700dff0d0a5ca3966647e3ba0bedb508e51a\", \"line\": 103, \"relation\": \"decreases\", \"source\": 10, \"target\": 6}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"The large amounts of haem released upon haemolysis can overwhelm the capacity of haem scavengers and enzyme systems (i.e., HMOX1), thus causing oxidative stress (Jeney et al, 2002).\", \"key\": \"14e214ae4b3fcbee50ebc1f8c43cdc403dd25a176615b2d54123ac9ab40ac56f58f3cf4d43be4f0eef59a909ccff4f22a6d56bbcb883c7d59e52ac559db18009\", \"line\": 477, \"relation\": \"increases\", \"source\": 10, \"target\": 39}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Reduced glutathione (GSH) was also depleted after 4 h of heme exposure, indicating that heme induces oxidative stress in exposed cells (Figure 5c).\", \"key\": \"525d5e4bcb6a50c4851599d55325017b6734d314e24e1fc79405cba13211b355307de1d5ec3cd867a3e5197e497d686451f7e73f4fff72544672a92ae6280f25\", \"line\": 210, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 39}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"These data suggest that the estimated free heme concentrations that occur in the renal tubular system during severe intravascular hemolysis are in the range of heme concentrations that could trigger oxidative stress and cell damage to the renal epithelium.\", \"key\": \"8ce4ae3155544742eced695fc4f255c5e256cf3a20af74b8f0bd067139e8d7bec899cdb5a07d36c40feca9e18853938f37d2fa1f62e36adc71e69c1f68539c5d\", \"line\": 221, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 39}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Most studies concerning the pathophysiological roles of heme have focused on the protective effect of the heme-degrading enzyme, heme oxygenase 1 (HO-1) [25] (Box 2), and on the effect of this danger-associated molecule on cells, leading to oxidative stress, TLR4 signaling [26,27], and NLRP3 inflammasome activation [28] (Box 4).\", \"key\": \"37d623dbdc7e1d9e23533b8fd3f3aa26c999f557cc972c7bce0f0b91f3f3fe60ff4ab9926988d196ddf630d967f490beb7563d78adbc6dfcbe91820c2c4a5503\", \"line\": 138, \"relation\": \"increases\", \"source\": 10, \"target\": 39}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Extracellular hemoglobin and its degradation products, free heme and iron, are highly toxic due to oxidative stress induction and decrease in nitric oxide availability.\", \"key\": \"cd489e55e5969500ef1e2add98fe6d9631627cce530b7d6dcb770af865adb35829e8dff19d2fd06f27a4a1208b8dfc4f77c77302951eff5160c583aee11d59b2\", \"line\": 105, \"relation\": \"increases\", \"source\": 10, \"target\": 39}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Hb and its degradation products – free heme and iron - perpetuate oxidative stress, and together with decreased NO availability promote many SCD complications.\", \"key\": \"ee0e24aab060796a45bf571b0d7365bc52f8f4118a837b5f1477cc3404e83d162d7c952449d8effdef7513e79592f7738dad4ff28318dbff834480253f7d5f0e\", \"line\": 122, \"relation\": \"increases\", \"source\": 10, \"target\": 39}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Arteries\": true}, \"MeSHDisease\": {\"Diabetes Mellitus\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Buys ES\", \"Graw JA\", \"Rezoagli E\", \"Warren HS\", \"Yu B\", \"Zapol WM\"], \"date\": \"2017-06-01\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"American journal of physiology. Heart and circulatory physiology\", \"pages\": \"H1120-H1127\", \"reference\": \"28314763\", \"title\": \"Endothelial dysfunction inhibits the ability of haptoglobin to prevent hemoglobin-induced hypertension.\", \"type\": \"PubMed\", \"volume\": \"312\"}, \"evidence\": \"Increased plasma concentrations of cell-free heme, the breakdown product of 390 hemoglobin, promote activation and inflammation of endothelial cells and enhance 391 oxidative stress and vascular permeability (22).\", \"key\": \"ed6ab70fa56225385094e623422f4124299bb291ba034ffda2a6155bbba9273ac74b50e1ea80c5b226a79fb134a9046f3fb447dc2eebe66c887fcb9d42414f1a\", \"line\": 249, \"relation\": \"increases\", \"source\": 10, \"target\": 39}, {\"annotations\": {\"Cell\": {\"regular cardiac myocyte\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"In agreement with data on pro-oxidant effects of heme in neonatal mouse CMs (Figure 1D-F), oxidative stress was significantly increased in adult rat CMs exposed to free heme (see Figure 1 in [37]).\", \"key\": \"a32d4a227639a0f0f687b17520c79035180e899c986c344e81d95d8855b39b0bf485725492cb70b0df26b6da111fe7d59bc696de00ed0f8465e7acb44c49f1d0\", \"line\": 219, \"relation\": \"increases\", \"source\": 10, \"target\": 39}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Free hemin is a cytotoxic molecule that mediates oxidative stress, endothelial activation, and inflammation, and it is implicated in malaria pathogenesis [40] and AKI, among others [41].\", \"key\": \"7bc41be8641f72ac5be7502cdc17d7e01332734b68cd597e555db3b7212f83607c79de8bc846ad95b863fb71eeeee3df32bba221912a60c7c5653f580cc53b50\", \"line\": 234, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 39}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"951d9bc6c67ed90d981d822bf61e9e0584779f2381f3f9f921e09abcc06f3efc189a171b345f23137daf08890c4e527f03bfb8967f4615373566486aae1566af\", \"line\": 94, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 39}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Cell-free hemoglobin and its prosthetic group heme can contribute to organ dysfunction and death [1–4, 9–12]; the pathological mechanisms include nitric oxide consumption, vasoconstriction, oxidative injury to lipid membranes, activation of the transcription factor NF-κB, endothelial injury as well as iron-driven oxidative inhibition of glucose metabolism[10–14].\", \"key\": \"bdcac18b20c7bfea0caa8d444afe533de11dbdab691abfd0eda3cf89af1e63bb7a9a9d5eba39cc899015e1a2c53ebc7f28d9be45b68948d4fc585bbc8f13748a\", \"line\": 126, \"relation\": \"increases\", \"source\": 10, \"target\": 39}, {\"annotations\": {\"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Figures 2A-F show changes in oxyhemoglobin, methemoglobin and free heme in both the intraerythrocytic and supernatant fractions in both d7 and d35 RBC. Significant storage-dependent increases for all species in the cell-free fraction were observed, with no storage-dependent differences observed in the erythrocyte.\", \"key\": \"4ff32471d5e76d25a195555f5144cd86a80625e99622fcc861a765e0dbc4e9448119c32e0a9d8259118e2a5728bb7bda45d55d8aaffbac8f5970db7729c4f15a\", \"line\": 118, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 15}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"More recently, we have also shown that free heme is also released during storage and may mediate further inflammation28\", \"key\": \"04cc71728f4a3701a3e18cf8f081e94dfbc92d27919356349436491771a487f646cc356fc4e1a6dac520308c3dc54b540943abb31678cd5edeebfab056a62e81\", \"line\": 170, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 15}, {\"annotations\": {\"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"14 days\": true}}, \"citation\": {\"authors\": [\"Brandon AP\", \"Creighton J\", \"Dull RO\", \"Evans CA\", \"Honavar J\", \"Hu PJ\", \"Kerby JD\", \"Marques MB\", \"Morgan C\", \"Oh JY\", \"Patel RP\", \"Pittet JF\", \"Richter JR\", \"Stephens SW\", \"Wagener BM\"], \"date\": \"2018-03-01\", \"first\": \"Wagener BM\", \"last\": \"Patel RP\", \"name\": \"PLoS medicine\", \"pages\": \"e1002522\", \"reference\": \"29522519\", \"title\": \"Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study.\", \"type\": \"PubMed\", \"volume\": \"15\"}, \"evidence\": \"Consistent with our previous studies [25,36], free oxyHb, metHb, and heme levels were increased after 14 d of RBC storage, being 930 ± 125 μM, 40.3 ± 8.8 μM, and 168 ± 44.7 μM, respectively (mean ± SEM, n = 7).\", \"key\": \"00f1e36250681941d40c1cc5e445ce70964a9cab6415dc0e3d14c292e38bd2ba558a41a72510f7e49ecbf9ec0a0a66279123ebfbc5b1bdd37e382c68abb361d1\", \"line\": 106, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 15}, {\"annotations\": {\"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"14 days\": true}}, \"citation\": {\"authors\": [\"Brandon AP\", \"Creighton J\", \"Dull RO\", \"Evans CA\", \"Honavar J\", \"Hu PJ\", \"Kerby JD\", \"Marques MB\", \"Morgan C\", \"Oh JY\", \"Patel RP\", \"Pittet JF\", \"Richter JR\", \"Stephens SW\", \"Wagener BM\"], \"date\": \"2018-03-01\", \"first\": \"Wagener BM\", \"last\": \"Patel RP\", \"name\": \"PLoS medicine\", \"pages\": \"e1002522\", \"reference\": \"29522519\", \"title\": \"Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study.\", \"type\": \"PubMed\", \"volume\": \"15\"}, \"evidence\": \"Fig 2 shows that free hemoglobin and free heme were higher 4 h after resuscitation with stored RBCs compared to fresh RBCs (n = 3±7 as indicated); NTBI level was also higher, but this difference did not reach statistical significance (p = 0.07).\", \"key\": \"a36a858cb997ecb525609b0ff51c7fd56e478e06d61ccc0c10a1d94264f56bc99090b3498c554009832ba61cc4ba6e0c9d08265855f413cfb32ebd83d07cb5e2\", \"line\": 115, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 15}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Placenta\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"In the extravascular compartment, cellular heme oxygenase (HO) is the most essential heme degrading protein, converting heme to free iron, biliverdin and CO [26,27].\", \"key\": \"c14cae5bda4ed39105b57c3792aaf080f21de3ecb8c03096b52239a839def67370554a982722f190fddc629a123be7c1cf8fe0d3a9f9efe0e53bb6d86c63e2d6\", \"line\": 120, \"relation\": \"increases\", \"source\": 10, \"subject\": {\"modifier\": \"Degradation\"}, \"target\": 44}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"In line with previously published studies [13,14] the extravascular heme- and radical scavenger A1M was significantly increased in plasma of women with PE.\", \"key\": \"f02ec5581e49804c1204e75d22fe1a16600f62cd0adb5711b5ca492e111cb79373d58a36b3c0210e0a34c0cf6b033716c1442fc1dbf361d6cd697c3758c62077\", \"line\": 193, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 86}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Sickle cell disease (SCD) and malaria are paradigmatic hemolytic disorders, in which alteration in the structure of red blood cells (RBCs) leads to the release of Hb and heme into the circulation.\", \"key\": \"2571627d8d8f36af9975183d53377e786d1131d3bd3a0ba0764bf2abd211d6a4f59902ff2df0c79478e59aea3cbc25a169ad393e0db0e38749141bf5183b52d7\", \"line\": 96, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 37}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Within cells, heme is catabolized by the activity of heme oxygenases (inducible HO-1 and constitutive HO-2) into iron, carbon monoxide, and biliverdin.\", \"key\": \"19f40cdec50ad026402c9c524654bc83404e4612917294c5b2c8c57d4155a410b176a99145022b991c73ad4c22eaa5c5bbc381115bf2c640578c3696ae916f5b\", \"line\": 102, \"relation\": \"positiveCorrelation\", \"source\": 10, \"subject\": {\"modifier\": \"Degradation\"}, \"target\": 5}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Iron was also detected in the macrophages of the red pulp of CEP mice, while almost no iron deposit was observed in the spleen of Hjv–/– mice (Figure 4B), confirming that Hb and “free” heme are the likely source of macrophage iron accumulation.\", \"key\": \"e3ccfd666c869e2ff028697c22e03f16404dfa9c9a1d2e64042f0072ab3354433e4341d14359e24adc470b1f2a8db013d861559f1cb317a0928cf25f085b6e91\", \"line\": 230, \"relation\": \"increases\", \"source\": 10, \"target\": 5}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"Under heme overload conditions, macrophages acquire an iron phenotype characterized by low intracellular iron and high ferroportin expression.\", \"key\": \"b7f0f21a384d378fa0120c88f1700c451131e37e3aa7ed17512366267841815ba6624052792a8406f375f74445a7a5b3ab9edd0b472642f4b2e6445a8059cb12\", \"line\": 244, \"relation\": \"negativeCorrelation\", \"source\": 10, \"target\": 5}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"In subsequent reactions, metHb or metHb-derived heme participates in redox chain reactions that lead to the accumulation of modified lipids and proteins, as well as to heme degradation and to the release of free iron.19,25\", \"key\": \"ad73d87cbd8bc87f5c1ba65f8919b001c77f022e78de2914c89c8b916bd21f6858a508970abd2e8178d4d8f909b92683447a5c03a2a4a18a4e12a4d8b5966235\", \"line\": 202, \"relation\": \"increases\", \"source\": 10, \"subject\": {\"modifier\": \"Degradation\"}, \"target\": 5}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Within cells, heme is catabolized by the activity of heme oxygenases (inducible HO-1 and constitutive HO-2) into iron, carbon monoxide, and biliverdin.\", \"key\": \"d394d54b0588fcf526a3548b3e748523faaf8c2afbaddf732bd48f81480c85a6ad5d4aa6ee4b31f140b69907aec6800bd9db749350af5ea22da7a00bb4d544bd\", \"line\": 103, \"relation\": \"positiveCorrelation\", \"source\": 10, \"subject\": {\"modifier\": \"Degradation\"}, \"target\": 2}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"This is the case in a mouse model of SCD, which is hallmarked by hemolysis, increased circulating Hb/heme, and low levels of Hp and Hx and shows elevated hepatic macrophage iron levels and M1 polarization.\", \"key\": \"a5284c7349a37254403b6a72a48de618f17cf403c8f9e217fbaf5fc12a25d0558480a6bb406c1d583cb9a27432be9fb260a43220da96bf146b90f9446b1b74d5\", \"line\": 336, \"relation\": \"increases\", \"source\": 10, \"target\": 14}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Importantly, by scavenging free heme, Hx prevents heme-induced M1 macrophage polarization and thus avoids both TLR4 activation and ROS formation.\", \"key\": \"280b3e4286c3620016b34e19b6c73bafb109848488f8f06776e7e7bca38990ed9d51739f4f9b67ae86a4e906d6fcb969fa0081fc25c221afef90dc404ded9e1d\", \"line\": 342, \"relation\": \"increases\", \"source\": 10, \"target\": 14}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.\", \"key\": \"eb38f1ddbe5921b33e3d3c5e21632ed5f1d1d59c92451f6ff0ef3abad9f1fc15b90caa9d0484b0392785b66f3166b154a6c9731bc523e7bf43e17bec2718a68c\", \"line\": 352, \"relation\": \"increases\", \"source\": 10, \"target\": 14}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"28 days\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Accordingly, heme exposures of more than 10 μM caused the significant and progressive depletion of cellular ATP, which was measured after an 8-h exposure period.\", \"key\": \"837f832fd375ff5ce7d11b4b0df3e676604795d46a6507dce4d2b0e0dc5055069cd63f9e56e0c8bf9e10f85a403dc35a95f1a795c63d4f196945f0641a26d4a7\", \"line\": 195, \"relation\": \"decreases\", \"source\": 10, \"target\": 8}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"For example, one of the severe complications of sickle-cell disease is vaso-occlusion, an outcome that can be triggered in mice upon heme administration [27,32].\", \"key\": \"c12fb3ba16f4ab75d282f4f10d0a243f95ddfb0969cd02c9a0cdeca8a3f8058b234471ad913c7a850d567de35833723952f07fc374b413e56b72aea01d4db551\", \"line\": 147, \"relation\": \"increases\", \"source\": 10, \"target\": 77}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Heme is one of the factors capable of inducing stimulation and damage of endothelium, promoting the recruitment of neutrophils and sickle-cell erythro- cytes, and subsequently prompting a vaso-occlusive crisis.\", \"key\": \"1969202b1f6671b04267f358f0865034fe1b615f02f33cc9597056a22670d47b74e716e05e856d10e3e04e8fe341a96d618302e35fb42b52885004587efea5f8\", \"line\": 155, \"relation\": \"increases\", \"source\": 10, \"target\": 77}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Heme may be implicated and contribute to the development of (i) bp(MESH:\", \"key\": \"8a8bf8b5e2d4d26da0b0cf365546ceb2e5e11050e8b82ec985d51613620feb10f1221614fb6e26a7c75deb89fb1dd6e6dfc794b22de865c9653f7ba618e71228\", \"line\": 340, \"relation\": \"increases\", \"source\": 10, \"target\": 77}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"The released heme can activate the innate immune pattern recognition receptor toll-like receptor 4 (TLR4) on inflammatory cells, platelets and endothelium, promoting a pro-inflammatory and pro-coagulant phenotype, ultimately leading to vaso-occlusion, ischemia-reperfusion physiology, tissue injury, and pain in murine models of SCD [5, 7±10].\", \"key\": \"061705fb10ba819fd1f986bf1deda836c5aba37630abc7b41dfd1c6d9fe68236b9f29272d95b95b21d0d27b6b3b5d398b33857a1823a3e51975e8d358daafa95\", \"line\": 111, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 77}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Administration of heme in healthy volunteers caused thrombophlebitis, demonstrating that it can cause vascular inflammation followed by vascular obstruction [18].\", \"key\": \"3ecf75b9c06be05790d7872c05e5bf5f095a4c28c8314bb8596efce66d0d95c480c61211d22db6689b17ff6725a42626c91558f4ffd10eae92d3636a00809aff\", \"line\": 265, \"relation\": \"increases\", \"source\": 10, \"target\": 77}, {\"annotations\": {\"MeSHAnatomy\": {\"Arteries\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Heme/TLR-4 signaling, moreover, was found to activate NF-κB and trigger vaso-occlusion [42].\", \"key\": \"c8b6745ab3c400d462a04504c5f995cb40f27b9676c15f99bef378b3c524de395f941416c60996e241f7c4d3c53c759fcdbcee4c27430cafa74d42965dd40c56\", \"line\": 259, \"relation\": \"increases\", \"source\": 10, \"target\": 77}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Hemolytic diseases are often accompanied by dysregulation and overactivation of the complement system [72–74], which may be induced by free extracellular heme [33,75–77] (Figure 3B).\", \"key\": \"ee7bc49ffcb4b0cc490ad7c75ec456dd0ae740dab9722a2271c64a4a91b1c4f2984dd2d1d21a472be24501534b1e09e2d7af3d51d5405693495b0e3011cc5bba\", \"line\": 227, \"relation\": \"increases\", \"source\": 10, \"target\": 28}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"C3a and C5a anaphylatoxins, as well as the soluble membrane attack complex (sC5b9), are generated by incubation of heme with human serum or blood in vitro, via the alternative complement pathway [33,77] (Box 5).\", \"key\": \"d8831db48cf3b15ec72c04fa00d3d881d1918d5a5d7dda88fb410f988dec9365f02334847a6b19ba6dc660423ba9aed239238152436673cde287e520e375d90e\", \"line\": 236, \"relation\": \"increases\", \"source\": 10, \"target\": 19}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Atypical Hemolytic Uremic Syndrome\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Heme may be implicated and contribute to the development of (i) bp(MESH:\", \"key\": \"a399dafef603dea737ff5785ced689f796837b8c03969bf77cad767e283d7db51b7f2ecf308ac96552e45ba66e18395b654ac83852763eb9ad35f42df3f5a75f\", \"line\": 337, \"relation\": \"increases\", \"source\": 10, \"target\": 88}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Heme may be implicated and contribute to the development of (i) bp(MESH:\", \"key\": \"d1b91760801fcfa32035fb1a269ab590ee7cef2d45d747fbf332d2c24b7c7230e715e4d97dc32495d5dd9b5700192957a6a5282322311590ccfd73349ff17de2\", \"line\": 341, \"relation\": \"increases\", \"source\": 10, \"target\": 91}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Heme may be implicated and contribute to the development of (i) bp(MESH:\", \"key\": \"9a9affc49e24a73228686039a82b716ca0c5650b85682caac94ce5209efd9f594854abb37b333d864ca0ee6a18c919a4ad0d52df3abb0766cd0aeb2cd27b08c1\", \"line\": 344, \"relation\": \"increases\", \"source\": 10, \"target\": 92}, {\"annotations\": {\"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"These results demonstrate that transfusion with SRBCs and simultaneous infusion of exogenous hemopexin results in decreased levels of circulating cell-free heme.\", \"key\": \"b89f9a901113bb3038ecbcf1fdf08fd1399602e08c0f2e87b3f4b79f8dee276f0088095bbeb55b35b879c6de5b1436d72a352e8e25da3246e3f052d38cb17814\", \"line\": 197, \"relation\": \"negativeCorrelation\", \"source\": 10, \"target\": 50}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"Following i.p. E. coli infection, we observed a significant increase in plasma heme levels in LysM-Cre+/−Hmox1fl/fl mice (Fig. 1e and Supplementary Fig. 1c), which was accompanied by increased bacterial numbers in blood and liver (Fig. 1f and Supplementary Fig. 1d) and impaired survival (Fig. 1g) when compared with LysM-Cre−/−Hmox1fl/fl controls.\", \"key\": \"a067df0bffdb620be07d3c772891f33d50228b187433b8a8bdb0e69730f0c5432277363e1adc39763be3db3e1c08bb55f1d66867bf830bd4e4c9fbc2e5075f1c\", \"line\": 108, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 33}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"Thus, enhanced levels of plasma heme, induced by either exogenous heme administration or a lack of HO-1 expression in macrophages, resulted in an increased susceptibility to E. coli sepsis.\", \"key\": \"081c7e1d4da98b6c5d0c614d170b4ca21b3165fb78b963402635ee605e93b71d8c3130ff2d28f72ed7853345a4bcc87b9cb3b5460e7666b88e2d3f1d3c979ef2\", \"line\": 116, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 33}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"Plasma heme amounts were comparable in mice pretreated with Fe3+ or PBS (Fig. 2d), and despite the similarly increased availability of iron in both heme- and Fe3+-treated mice (Fig. 2e), only heme-treated mice presented a significantly higher bacterial burden in the blood and liver compared with PBS- or Fe3+-treated mice (Fig. 2f).\", \"key\": \"4d7b1925403e33ce163b016ea9764e6cd896357828d5ba43f3a4206d49168bcc987ca51c2c0acbf60fef3500ae9877dc87f3fa32fad1cbd43e07f11a920cc39d\", \"line\": 133, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 33}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"These results indicate that increased heme concentrations directly lead to increased bacterial counts during sepsis and that bacterial iron requirements are met via heme-independent mechanisms.\", \"key\": \"732ee32642cc30c7ef3a8382b64ba025576c2b327c250c9866c3d87f24c380d4882c19ed64c9ced9ff4d94c7652aa130a17b72c2578dcdaa15e54ecfb28cfe1b\", \"line\": 141, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 33}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"We focused on macrophage effector functions and found that heme pretreatment (15 min, 3–30 μM unless otherwise indicated) led to a strong, dose-dependent reduction of phagocytosis of E. coli by RAW264.7 macrophages compared with DMSO-treated controls (Fig. 3a,b and Supplementary Fig. 2a).\", \"key\": \"c3b2768157019c4157c330fd12ee3ec441dcf8b8471642cbba2df7435e09124558885aa6b23e3c4c26f2b1f7c02dcd93ae099518a4f3877d83c6d0267b304662\", \"line\": 150, \"relation\": \"negativeCorrelation\", \"source\": 10, \"target\": 43}, {\"annotations\": {\"Cell\": {\"monocyte\": true}, \"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"Species\": {\"Escherichia coli\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"Induction of hemolysis with phenylhydrazine or addition of heme to whole blood at concentrations mimicking the physiological range of plasma heme in hemolytic patients (5–50 μM)6 led to a dose-dependent impairment of E. coli phagocytosis by neutrophils and monocytes, as compared with DMSO controls (Fig. 3g and Supplementary Fig. 2n,o), indicating that our mouse model was reflective of human hemolytic conditions.\", \"key\": \"ed41f2e964c151b123a22e62fd52aa49a5c864b065dfee119c7ba65e472603aa922d35097c6cfec72e652aa73e6973dde7bc43bee655276711ba05484d21e6ce\", \"line\": 172, \"relation\": \"negativeCorrelation\", \"source\": 10, \"target\": 43}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"In a time-line experiment, we showed that heme loading of macrophages decreased the expression of heme–hemopexin complex receptor and transferrin receptor 1 (TfR1) (Fig. 4D), while ferritin levels remained largely unchanged except for an increase in ferritin levels at 16 h post-treatment (Fig. 4D).\", \"key\": \"0d74e2982355422e3d6ee756e8b0b85ace8cfb4c7dc2965844ace5ebbea9c00cd842707de19567966aa5b0dc87c296ca8fbc865cf0dab983b37cbf05c6ab9c5b\", \"line\": 134, \"relation\": \"decreases\", \"source\": 10, \"target\": 47}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"56da27ea23dc544a8435c340f345c131b1355cd63bf7f2376df5490df1ed5401c7ddbb03e9892620b9346e5af8747a7308b50604d73edcf1cc5244bdb3247967\", \"line\": 109, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 40}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"f945c680525050c60f10ce4ffdf4f591ccabeadf7fd423dfad7fac58b542b57e6605889dd2d32d57af57b49b309a8afa8d3edac44c11b0cea18282607796f52a\", \"line\": 113, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 90}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"789ca36598b54ef679ab37260e5904ee7c070dcdbfbdbcb6b1261c2fe00db1473262688f7f4d2aa09e85e202147fd3e93793868b26a112ce6bff75f21836a8d0\", \"line\": 117, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 99}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"0461d990f4d7cb21c7bef646e4d213332e0a82fc7e5618919d09d283b3c28d11cd6633fc774152b728cc97e3acb82dd6471230dbd8f184655aea712c564f1ec1\", \"line\": 98, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 99}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"MeSHAnatomy\": {\"Human Umbilical Vein Endothelial Cells\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"In serum-free conditions, NaOH-dissolved heme (final pH 7.8) reduced cellular ATP in both cell types in a dose-dependent manner after 8 hours of exposure (Figure 2A)\", \"key\": \"b9c844ca4645cf338b87e891666cf9ca1df857b9f9524e4babb87acf0c8759a7a939907152be193be01e3c9d21ed38c799793df3cc8d5a823bc9236a848f0bde\", \"line\": 122, \"relation\": \"decreases\", \"source\": 10, \"target\": 1}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"This experiment demonstrated that under serum-free conditions, 4 hours of exposure to NaOH-dissolved heme induced complete deterioration of mitochondrial respiration at concentrations as low as 10 lmol\\u0001L\\u00031, while exposure to albumin-associated heme in the presence of 2% FCS stimulated respiratory capacity to levels above baseline.\", \"key\": \"a5a4f747ec134c152099a068c54ca9531d6da511cb0014ef1e26e91b045f918441b78d444efcbca18df7e3c3db26c30bab4e0f4a78302c7fb37ea53c2df5c7e3\", \"line\": 141, \"relation\": \"decreases\", \"source\": 10, \"target\": 27}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Consistently, CD11b cells (granulocytes and monocytes) and iron-rich cells (macrophages) isolated from heme-treated Hx-null mice show a higher heme content and increased mRNA and protein expression of HO-1, Lferritin, and Fpn (Figure 1B-G) and elevated mRNA levels of the proinflammatory cytokine IL-6 ( Figure 1H).\", \"key\": \"d5ee0dd053f64e0ee047b4cf669930d4c6aff8568b89e6567a75b17724b2f1274d6590d3b8523b63d42cc7cb7718a61204d070b4533bf32f5bcc25fa04935fa8\", \"line\": 135, \"relation\": \"increases\", \"source\": 10, \"target\": 55}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Free heme is a dangerous molecule which can be recognized and degenerated by stress-responsive enzyme oxygenase- 1 (HO-1) [16] which plays an essential role in host defense against heme.\", \"key\": \"a3ed094e6d6fa2478f6df5afcbc8fa99d02dcfe52d2935cf7357cc9e748dc8bef04ee500f656afe8718ad239dff6596522bbc444d73749ba77167cf0d17c1676\", \"line\": 128, \"relation\": \"positiveCorrelation\", \"source\": 10, \"subject\": {\"modifier\": \"Degradation\"}, \"target\": 55}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"McCulloch JC\", \"Nielsen VG\", \"Redford DT\", \"Thompson JL\"], \"date\": \"2014-09-01\", \"first\": \"Redford DT\", \"last\": \"Nielsen VG\", \"name\": \"Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis\", \"pages\": \"621-4\", \"reference\": \"24553061\", \"title\": \"Left atrial myxoma presenting as pulmonary embolism: potential role of heme oxygenase-1.\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"Lysis of red blood cells with consequent increases in free heme most likely caused the increase in HO-1 activity responsible for increased COHb concentrations, which is similar to that observed with circulatory devices [6].\", \"key\": \"7b826f33acc167f78e20af6b26646183626b654b7f8939294d61205c367c8c021aa879d2141ca3fb9b0ab1ca4f424ff0e31849a8b0a09303160b115824dae083\", \"line\": 96, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 55}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Importantly, heme b interaction with heme oxygenase (HO; Lad et al., 2003), the enzyme responsible for heme intracellular catabolism, and hemopexin (Hx; Paoli et al., 1999), a plasmatic heme scavenger, is essential for the regulation of free heme availability and Fe recycling (Kovtunovych et al., 2010; Tolosano et al., 2010).\", \"key\": \"2e9fae7461be4f10ab56f619852bb8f6872482b7621c2037e476066b42ed4ec18094cbf0b7ae01beb8c496988c1221eeff57509a5d34327e8619b55b1e4a5591\", \"line\": 94, \"relation\": \"positiveCorrelation\", \"source\": 10, \"subject\": {\"modifier\": \"Degradation\"}, \"target\": 55}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Consistently, CD11b cells (granulocytes and monocytes) and iron-rich cells (macrophages) isolated from heme-treated Hx-null mice show a higher heme content and increased mRNA and protein expression of HO-1, Lferritin, and Fpn (Figure 1B-G) and elevated mRNA levels of the proinflammatory cytokine IL-6 ( Figure 1H).\", \"key\": \"eac48ff57132abc207e7e9047469867324bdc8b35a79d0457623d888df8a84ca9315c97813426cb21faa6248b3a34cb28b8b0605aabed744badf76de7a84e6e0\", \"line\": 136, \"relation\": \"increases\", \"source\": 10, \"target\": 55}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"Concentration\": {\"10 μM\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"In agreement with the electrical cell–substrate impedance sensing data described above, the proteome changes triggered by 10 μM heme were indicative of an adaptive response with prominent induction of HMOX1 and ferritin light (FTL) and heavy (FTH1) chains (Figure 5d,left panel).\", \"key\": \"e040313002689877a29173e91c4387f70f9103f9de16d0760b3e449ec6a6641ead8282e4c8bbbb681a929b5c85496d122ffb7db394d8f641c718596ab69702bb\", \"line\": 230, \"relation\": \"increases\", \"source\": 10, \"target\": 55}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Despite its damaging effects, heme induces the expression of HO-1, which degrades heme to anti-inflammatory, cytoprotective, and antioxidant products [25].\", \"key\": \"028d4091c29e5287ae1266e88ec8aa2dc55523a5b6643f5e261c126c2740d28ec0311b83115dbe3fd671e178f0eb7bd7712825074a48749bdf77c952e44ce93c\", \"line\": 352, \"relation\": \"increases\", \"source\": 10, \"target\": 55}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"A recent Phase IIB clinical trial showed that preconditioning using hemin upregulated HO-1 in renal transplantation, launching further studies on clinical outcome [97].\", \"key\": \"80d07663d7d63a8383cc2fc4d0cc90477984b15f20181d0299bf8a38257ab1122fe2669fba0d52decd51bc1f3617d6f7ba47d6881e35f4501eb5301d44dfb1ca\", \"line\": 358, \"relation\": \"increases\", \"source\": 10, \"target\": 55}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"CD163 mediated hemoglobin/hematoma clearance is involved in the induction of HO-1, a rate-limiting enzyme for heme degradation 26.\", \"key\": \"a1dbc35c037445e98cc2bb539dc265d5dea28d5567ce1f150f29883b78dd1bc98f4cb864c6a284b536e6a80450dd05c0d97113062fc6c2ae9f167fc047b93860\", \"line\": 260, \"relation\": \"positiveCorrelation\", \"source\": 10, \"subject\": {\"modifier\": \"Degradation\"}, \"target\": 55}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"As predicted, HMOX1 expression levels (means 6 SD) in hemin-treated cells were much higher (7.25 6 5.02, n = 12; P , 0.001) than in nontreated controls (0.14 6 0.18, n = 9) or A1AT-treated cells (0.09 6 0.1, n = 9).\", \"key\": \"292ff94f5c6c80392dd284e8441e7a0cd9b334abc7af13b80cfd7dc31f68d6efc4e907b678fcde83f2b46a2075b5f7647607dd45479b0e4955f7d3751d791724\", \"line\": 173, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 55}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Moreover, heme amplifies MyD88- (TNF and IL-6) and TRIF-dependent (IP-10) cytokines.\", \"key\": \"2b361432e190aa9f027de209585ca2ab4a35381ab791ff63ce8b0175efab525c4d5144e37c4144157998111eaddfc676f76c465a86d7da4e4c04b1dbbf569836\", \"line\": 513, \"relation\": \"increases\", \"source\": 10, \"target\": 59}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"In addition, we observed increased ROS production ( Figure 2I; supplemental Figure 2), as well as an enhanced expression of IL-6 and TNFα in cells treated with heme-albumin compared with heme-Hx (Figure 2J-K).\", \"key\": \"b7a9a2cd5598e57bf4f138922c65ea13740d122f3001a3c58d634373ba0c8a3ddee59680d65cb634d7989f02bab6e9d902324913c19769bf8d4ffbd916eb55d8\", \"line\": 146, \"relation\": \"increases\", \"source\": 10, \"target\": 59}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Likewise, heme and FeNTA treatment causes the induction of the M1 markers MHCII, CD86, CD14, TNFα, IL-6, and IL1β and a decrease in the M2 markers CD206, IL-10, and Arginase-1 (the last with FeNTA only) in M0 BMDMs (Figure 3A; supplemental Figures 5, 6A, and 7).\", \"key\": \"4e5f165e02e9c9b5fccf83ebefeedeb6e36887e7835ff653e5ce94f9b0264e2212b400e6709ed5b888b7563419be86571a4ceb23dc20ec31053dfb85c8deac98\", \"line\": 165, \"relation\": \"increases\", \"source\": 10, \"target\": 59}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Consistently, CD11b cells (granulocytes and monocytes) and iron-rich cells (macrophages) isolated from heme-treated Hx-null mice show a higher heme content and increased mRNA and protein expression of HO-1, Lferritin, and Fpn (Figure 1B-G) and elevated mRNA levels of the proinflammatory cytokine IL-6 ( Figure 1H).\", \"key\": \"033ae89f54c3084fb7656e6981609321512714f53bcae78453c41b9d59516a4fce66c8f291fe0dab8f6e8cdb3f44344adcb5d5a97e0839354510d7f071077ce2\", \"line\": 139, \"relation\": \"increases\", \"source\": 10, \"target\": 59}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"The results showed that enforced HO-1 could efficiently decline the heme level in the lysates of ligated kidneys, and inhibit kidney inflammation characterized by down-regulation of NLRP3-Caspase- 1-IL-1b axis.\", \"key\": \"ab28cafc4800117a873bd4ed386431064adba04c3b76ee66d552c30cb0bdcbdb1d15c3382ea1771b8fc5031c148803d11bb10863e91c0c8cd37e57b0b7467d97\", \"line\": 256, \"relation\": \"negativeCorrelation\", \"source\": 10, \"target\": 66}, {\"annotations\": {\"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Arase H\", \"Baltimore D\", \"Briseño CG\", \"Egawa T\", \"Haldar M\", \"Igarashi K\", \"Kc W\", \"Kohyama M\", \"Kretzer NM\", \"Murphy KM\", \"Murphy TL\", \"Rajasekaran NS\", \"Satpathy AT\", \"So AY\", \"Wang L\", \"Wu X\"], \"date\": \"2014-03-13\", \"first\": \"Haldar M\", \"last\": \"Murphy KM\", \"name\": \"Cell\", \"pages\": \"1223-1234\", \"reference\": \"24630724\", \"title\": \"Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages.\", \"type\": \"PubMed\", \"volume\": \"156\"}, \"evidence\": \"Heme induced the expression of Ho1 and Blvrb as well as Slc40a1, which encodes the mammalian iron exporter (Figure 5A), in agreement with previous reports (Delaby et al., 2008).\", \"key\": \"fb3cdd3e9eb81cc1175c93545852ddbb3feb5dca84d342f4ee2bc7df84fd5df1a5b013f2cd38b31d69cab4e6f05d34212f727216df7dae70f22ed07e339bf4fb\", \"line\": 104, \"relation\": \"increases\", \"source\": 10, \"target\": 66}, {\"annotations\": {\"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Engelsberger W\", \"Karnaukhova E\", \"Lönn M\", \"Opitz L\", \"Puglia M\", \"Schaer CA\", \"Schaer DJ\", \"Schauer S\", \"Spahn DR\", \"Stocker R\", \"Vallelian F\"], \"date\": \"2015-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Cell death and differentiation\", \"pages\": \"597-611\", \"reference\": \"25301065\", \"title\": \"Proteasome inhibition and oxidative reactions disrupt cellular homeostasis during heme stress.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"The Hmox1 (− /− ) MEF cells expressed no functional Hmox1 mRNA (Figure 1a) and as a result accumulated more cell-associated heme during extracellular exposure compared with wild-type cells (Figure 1b).\", \"key\": \"5859ac5b636fc33ebaa78eddfae1bb7673fbe045bf74fc07e0faca0458f52c4ee11fe31b90cb0b82dd6b34f5b3177c5b0e725edde2d3c14a73f647c3785a3f4e\", \"line\": 95, \"relation\": \"negativeCorrelation\", \"source\": 10, \"target\": 66}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Exposure to Hb and its oxidized products increases heme overload on the AT1 cells. Heme overload induces the expression of HO-1 and iron-sequestering proteins, such as ferritin.\", \"key\": \"686cd87c8cacffcf44d971fae9a6372152a8eff2a71e6bc098f20dceaedc97835f9acaf88b0381295ef010fe66e112e38668fee84b501ec3af36fb15322dd139\", \"line\": 241, \"relation\": \"increases\", \"source\": 10, \"target\": 66}, {\"annotations\": {\"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Arase H\", \"Baltimore D\", \"Briseño CG\", \"Egawa T\", \"Haldar M\", \"Igarashi K\", \"Kc W\", \"Kohyama M\", \"Kretzer NM\", \"Murphy KM\", \"Murphy TL\", \"Rajasekaran NS\", \"Satpathy AT\", \"So AY\", \"Wang L\", \"Wu X\"], \"date\": \"2014-03-13\", \"first\": \"Haldar M\", \"last\": \"Murphy KM\", \"name\": \"Cell\", \"pages\": \"1223-1234\", \"reference\": \"24630724\", \"title\": \"Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages.\", \"type\": \"PubMed\", \"volume\": \"156\"}, \"evidence\": \"Heme induced the expression of Ho1 and Blvrb as well as Slc40a1, which encodes the mammalian iron exporter (Figure 5A), in agreement with previous reports (Delaby et al., 2008).\", \"key\": \"bf5abd087389fbc1649c735c0c110e10862c90f07330d453c408a9832e08f184ae3887e19f6125fa71992800ab1ce8f970eef22cb6682bb05bd1ce3cf6bca626\", \"line\": 106, \"relation\": \"increases\", \"source\": 10, \"target\": 73}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"High ferroportin levels were measured in macrophages upon heme overload and erythrophagocytosis (12, 13, 31, 32, 37) and in hemolytic murine models of b-thalassemia and phenylhydrazineinduced hemolytic anemia (11, 22, 34).\", \"key\": \"a3eae32bc338831153f30fd5fd4e1dc4dc041f509de137b22b751c10749b696b272a38f4d15bfae5a0b31ea23a1dbe0807f3d733a7fdf3151906ad7469eff0d9\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 73}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"These data suggested that during severe hemolysis, heme mediated ferroportin induction and low hepcidin in HbS mice (11) served to elevate systemic iron availability, required to sustain high erythropoietic demands in these mice.\", \"key\": \"180527d1f29c528e47fb963b459817c2e8d0071fe6ad17de65d4918f34bbce30d8586d6ae04f6406655618bc7218a81925a0f89b168e84362eec077faa369e2b\", \"line\": 113, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 73}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"Our in vivo observations could be recapitulated in isolated macrophages, which upon stimulation with heme (25 lM; 16 h) demonstrated increased ferroportin mRNA and protein expression (Fig. 4A, B) and a significant decrease in the intracellular iron pool (2.2-fold; p < 0.01) (Fig. 4C).\", \"key\": \"78b5d8f8b8d8869fa78241f1f2c9591a500e389bd692128944c6eaef070a4ad3647a8cdeda1c90d4b7b0d85793efa7c40064266f9da19bfcd5528f73c1c9a75b\", \"line\": 124, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 73}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"So far, our results established that in the conditions of acute and chronic heme overload, macrophages acquired high ferroportin expression and an efficient iron export.\", \"key\": \"bf614df88cfe83ac44efff59fe19e7abf8f64dd4659eac26bb4a33c50a0bbe0f7f8aa14502cc866bf79a3be9a7572ab35823b3e8cfda66e04e924203de055c57\", \"line\": 144, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 73}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"Under heme overload conditions, macrophages acquire an iron phenotype characterized by low intracellular iron and high ferroportin expression.\", \"key\": \"260177cbf69129138369a359af2ed0e18763c382254242be58bbab2d09f579ce1d69881ee8e811dd18085743d19275006e583f8d1e1ec498b9a8f971be35fb8f\", \"line\": 245, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 73}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"Our in vivo observations could be recapitulated in isolated macrophages, which upon stimulation with heme (25 lM; 16 h) demonstrated increased ferroportin mRNA and protein expression (Fig. 4A, B) and a significant decrease in the intracellular iron pool (2.2-fold; p < 0.01) (Fig. 4C).\", \"key\": \"dda0d9bb8b5ee07a87b73cde755791ec40fd659b6521684e5162e59ef4cd23ed3ea8134de29da90151e64b499d724268d631dc90c9216796f082aab5e6aa1e64\", \"line\": 123, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 73}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \" Heme amplifies cytokines induced by cell surface receptors (TLR2, TLR4, TLR5), endosome receptors (TLR3, TLR9), and cytosolic receptors (NOD1 and NOD2).\", \"key\": \"0f466aed0e7c5ed6f22e0c30d187e23cbe5971a66ecc0d73f7ebe30664d547c2fecc171aaefaea9ae3c060f75647a8d4d192dee40a37935e5d49cbcba20f7b92\", \"line\": 502, \"relation\": \"increases\", \"source\": 10, \"target\": 63}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"In fact, TLR4 is involved in intracerebral hemorrhage (ICH) induced by heme (Lin et al., 2012).\", \"key\": \"d59b5e8108047f0478d38aabc9ff0836b1d5e21bb2b3731aec29094d80c61a4b49bc7709e02b6ca7cd0edf7ab33ff00dd0dc99f562db9d472794a4a417b07bd6\", \"line\": 598, \"relation\": \"increases\", \"source\": 10, \"target\": 63}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"Concentration\": {\"40 μM\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Other studies demonstrated that heme can trigger the activation of Toll-like receptor 4 and inflammasomes, thus leading to inflammatory reactions.5,35–37\", \"key\": \"c28a1b6c1112c0e01a4ceee5adc4d8624badf1b64f52a8bd50aa27a8af5ec3557c9521fb4d58705387b92497e3e17e997f26ca2d9f8ceb17bf765e355a32f50f\", \"line\": 274, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 63}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Most studies concerning the pathophysiological roles of heme have focused on the protective effect of the heme-degrading enzyme, heme oxygenase 1 (HO-1) [25] (Box 2), and on the effect of this danger-associated molecule on cells, leading to oxidative stress, TLR4 signaling [26,27], and NLRP3 inflammasome activation [28] (Box 4).\", \"key\": \"31e5bd8be2cfc67df5790bcca74750f44a5384a27d2e9e849aa7703625cc52fc18cb7eeb25c18a3fb3340b88ad1dadbe1b32b0b353699c38d21e6aa4be0658cc\", \"line\": 140, \"relation\": \"increases\", \"source\": 10, \"target\": 63}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Cell-free heme selectively triggers pro-inflammatory receptors such as TLR-4 and BACH-1, and activates proteasomes25.\", \"key\": \"d64dac60b11d7b07d9731dab3207402423d26775b494be4450b40955de810ed908458f84b2829fd97814145e86dfee76d30526fe18d09b507a31d92829879512\", \"line\": 109, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 63}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"Purified heme was found to be an activator of TLR4 8,11,27 in some studies and of the inflammasome 9 in others, and these activities were considered to be the molecular mechanism behind the coexistence of inflammation and hemolysis.\", \"key\": \"e0b4a596bc48868a678142fd9ddb03323fb7f77f000baad149a28ec8a758cb4b082d1355b89c5789b51532e24decc3bccdf8353e27b45d5ed22b6eb9e64b24b7\", \"line\": 209, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"increases\", \"source\": 10, \"target\": 63}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"The released heme can activate the innate immune pattern recognition receptor toll-like receptor 4 (TLR4) on inflammatory cells, platelets and endothelium, promoting a pro-inflammatory and pro-coagulant phenotype, ultimately leading to vaso-occlusion, ischemia-reperfusion physiology, tissue injury, and pain in murine models of SCD [5, 7±10].\", \"key\": \"abc6f1b243efbd101d5137d996f04c3657d371b970d0a2644c150f8f860e844c07dbe400e97509570be0c39d647208ce00bbe5630ca63867c1eace0e85a690d3\", \"line\": 107, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 63}, {\"annotations\": {\"MeSHAnatomy\": {\"Arteries\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Heme released from cell-free hemoglobin has been described to be an activator of TLR-4 [39, 41, 42].\", \"key\": \"73a381db1c1e8e0f971905c068fd4f0a1c4a09cd718940ef6ba7a0e34f6615454e24c37f280cfbf737014d1ebb16fe31180fb0e2c7befac1f5950e6626cfa06a\", \"line\": 251, \"relation\": \"increases\", \"source\": 10, \"target\": 63}, {\"annotations\": {\"MeSHAnatomy\": {\"Arteries\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Heme/TLR-4 signaling, moreover, was found to activate NF-κB and trigger vaso-occlusion [42].\", \"key\": \"d232e69215f6d4b8be13fddc5428a0a919d7456c86552f35994b91c7fc750dc9d9c98f0ac21a93f3fb0eb51c91d9b3c3c7b53e1a0cec861a4d60ab2bc21ce221\", \"line\": 257, \"relation\": \"increases\", \"source\": 10, \"target\": 63}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Karnaukhova E\"], \"date\": \"2018-11-01\", \"first\": \"Buehler PW\", \"last\": \"Karnaukhova E\", \"name\": \"Current opinion in hematology\", \"pages\": \"452-458\", \"reference\": \"30281034\", \"title\": \"When might transferrin, hemopexin or haptoglobin administration be of benefit following the transfusion of red blood cells?\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"In mice, this response was attenuated after administration of the TLR-4 inhibitor, TAK-242, suggesting hemin potentiates pulmonary macrophage activation and inflammation through hemin-induced TLR-4 receptor binding [27].\", \"key\": \"205901a543bdf82a55665282d8301574512479e9ead168f17225003771bc9fbabc8a5338da0681ffd8486254062f98dbe0ad5de70ce2a26ca8c30eea41bfaf36\", \"line\": 219, \"relation\": \"increases\", \"source\": 10, \"target\": 63}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Exposure of cells to hemin or hemin plus A1AT did not change TLR2/4 mRNA levels (Fig. 12).\", \"key\": \"534a10d4ea9807d5844357c1c365e28690c96c09980a6ff11c530388074df5675dc6776880f3f45c42a55c4e488d687478af11764246ac914d812d7f7ffb762d\", \"line\": 210, \"relation\": \"causesNoChange\", \"source\": 10, \"target\": 63}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"Free heme is lipophilic and intercalates into the membrane of endothelial cells increasing vascular permeability and ICAM-1, VCAM-1, and E-selectin expression (19).\", \"key\": \"366dbece9588d08e1306ec568398e78a773f30e39a4363fbe18300a9065d61b3bf21217b787a7847a2566db302bb7a46d8a10d7df4beecd0f3231b0ddf99d783\", \"line\": 238, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 68}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Heme activates endothelial cells inducing the expression of the adhesion molecules ICAM-1 (intercellular adhesion molecule 1), VCAM-1 (vascular cell adhesion molecule 1), E-selectin, Pselectin, and von Willebrand factor (VWF; Wagener et al., 1997; Belcher et al., 2014) and causes neutrophil migration (GraçaSouza et al., 2002; Porto et al., 2007). \", \"key\": \"896a1469009dbcb920617f9f69f8abef65d7909e3afa23d1da2edad462f6e34bbf614ebd3dd28c02abd1b1d4904951ddce43e7657b4c2d7a10ea0569d728fef6\", \"line\": 230, \"relation\": \"increases\", \"source\": 10, \"target\": 68}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"Free heme is lipophilic and intercalates into the membrane of endothelial cells increasing vascular permeability and ICAM-1, VCAM-1, and E-selectin expression (19).\", \"key\": \"f3520ed340663a2325fc402a512f666c7f6ddc2dcdd095342663af4c1a16317fa0cc50de510030f83350a7f178225879ce73ec109b451374e281cd9dfcbcc26f\", \"line\": 239, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 74}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Heme activates endothelial cells inducing the expression of the adhesion molecules ICAM-1 (intercellular adhesion molecule 1), VCAM-1 (vascular cell adhesion molecule 1), E-selectin, Pselectin, and von Willebrand factor (VWF; Wagener et al., 1997; Belcher et al., 2014) and causes neutrophil migration (GraçaSouza et al., 2002; Porto et al., 2007). \", \"key\": \"e43d5a9aa3461ea1a1b0749e1351bc5c38b41a6d6d1e1ef797c30f865e6dbb60d55299d187855fba320063cf1c3b9aa599bfedfb2c13097423d78ca1edd48cc5\", \"line\": 231, \"relation\": \"increases\", \"source\": 10, \"target\": 74}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Banerjee S\", \"Crumbliss AL\", \"Jia Y\", \"Kreulen RT\", \"Mollan TL\", \"Olson JS\", \"Tsai AL\", \"Wu G\"], \"date\": \"2014-04-01\", \"first\": \"Mollan TL\", \"last\": \"Alayash AI\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"265-77\", \"reference\": \"24486321\", \"title\": \"Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"First, addition of exogenous Hp both markedly inhibits heme loss and second, as a result of this inhibition, globin precipitation is prevented.\", \"key\": \"a8736354d0b5489ebd008780d1f83a10ec0e02ee2879d246350414b839b5e89fa27822c69f69aff0acc0f4fd0fdaacc012a8542bfbd0c4a2a1876bae0c5427b7\", \"line\": 167, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 56}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"Concentration\": {\"10 mM\": true}, \"MeSHAnatomy\": {\"Muscle, Smooth, Vascular\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"60 min\": true}}, \"citation\": {\"authors\": [\"Arruda MA\", \"Assreuy J\", \"Barcellos-de-Souza P\", \"Barja-Fidalgo C\", \"Moraes JA\", \"Nascimento-Silva V\", \"Rodrigues G\", \"Silva SV\"], \"date\": \"2012-10-01\", \"first\": \"Moraes JA\", \"last\": \"Barja-Fidalgo C\", \"name\": \"Atherosclerosis\", \"pages\": \"394-400\", \"reference\": \"22954673\", \"title\": \"Heme modulates smooth muscle cell proliferation and migration via NADPH oxidase: a counter-regulatory role for heme oxygenase system.\", \"type\": \"PubMed\", \"volume\": \"224\"}, \"evidence\": \"On the other hand, heme induced HO-1 expression in VSMC (Suppl. Fig. 2).\", \"key\": \"86ef1e44d4a175aa4d746f4b786bb44df333a510ccee62678f6ad21dcd58e0da110e4ba56352a28f5d8b9d66347156d636b2cf79e924d647f9e38f270ee2df9a\", \"line\": 157, \"relation\": \"increases\", \"source\": 10, \"target\": 75}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"These results indicate that heme degradation increases in RBCs of PRDX2 knockout mice in spite of the presence of catalase and GPx.\", \"key\": \"b26c4a7d208a87006695e4fe8f42806f105ec3f257e00502df5abd6fe2ed28d01b3748fc8b8bf50cb92f1bf88194dd3874e2a18eb38cbda00565ecb93aacd764\", \"line\": 106, \"relation\": \"negativeCorrelation\", \"source\": 10, \"subject\": {\"modifier\": \"Degradation\"}, \"target\": 72}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Most studies concerning the pathophysiological roles of heme have focused on the protective effect of the heme-degrading enzyme, heme oxygenase 1 (HO-1) [25] (Box 2), and on the effect of this danger-associated molecule on cells, leading to oxidative stress, TLR4 signaling [26,27], and NLRP3 inflammasome activation [28] (Box 4).\", \"key\": \"fdf4aacc9cb31e91e5276271a5aef60418d53c97d040bc16ec077d3082c0ed084a4a7891db437d0dd44a9c01140b923bf705820921a22dff01bd407043aaa1b9\", \"line\": 139, \"relation\": \"increases\", \"source\": 10, \"target\": 62}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Danio rerio\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Chambers I\", \"Hamza I\", \"Krause M\", \"Phillips J\", \"Yun S\", \"Zhang J\"], \"date\": \"2018-09-01\", \"first\": \"Zhang J\", \"last\": \"Hamza I\", \"name\": \"PLoS genetics\", \"pages\": \"e1007665\", \"reference\": \"30248094\", \"title\": \"Hrg1 promotes heme-iron recycling during hemolysis in the zebrafish kidney.\", \"type\": \"PubMed\", \"volume\": \"14\"}, \"evidence\": \"It has been reported that an increase in extracellular heme activates NLRP3 expression, triggering inflammasome activation [28].\", \"key\": \"f183000c2480c360f1f7da50688240bde0127b3e675119ed9461739cd17fb6dcc6e93fc3f352987c2b8c428d2d2cfdde00f0f01b91c30c97bde85a0fa700f9d4\", \"line\": 142, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 62}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \". Heme activates macrophages inducing the production of TNF, KC (Figueiredo et al., 2007), IL-1β (unpublished), and LTB4 (Monteiro et al., 2011).\", \"key\": \"5fab58eca22bafb11e7f37ca585bdf1a77507805dd021d444d3c8389d23f842edc0e21da3a58ba2a8d39a19eb3aa93d27c545b9b4ba568d8c74395bf32d10ee4\", \"line\": 314, \"relation\": \"increases\", \"source\": 10, \"target\": 58}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Likewise, heme and FeNTA treatment causes the induction of the M1 markers MHCII, CD86, CD14, TNFα, IL-6, and IL1β and a decrease in the M2 markers CD206, IL-10, and Arginase-1 (the last with FeNTA only) in M0 BMDMs (Figure 3A; supplemental Figures 5, 6A, and 7).\", \"key\": \"24c9b73e83f204e48f4ff4fbe19847cabde20b2f2f769d538d36eec221aed6daa9474ae353fa36f4e9b815a0f8d0004d908320350cd84f8316c6827d48087c10\", \"line\": 166, \"relation\": \"increases\", \"source\": 10, \"target\": 58}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"ELISA analysis displayed that the concentration of IL-1b in culture supernatants was significantly enhanced after stimulated by heme and PPIX.\", \"key\": \"5d98623a4c3ebe4335cb47a36939267e40ec65bb4b558bfac9acc3ac28517e095a46763d372f2784f017fff3d4ad80c6074a7f81b016f095eb880a5a83fe3c8c\", \"line\": 148, \"relation\": \"increases\", \"source\": 10, \"target\": 69}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"The effect of heme on IL-1b production initiated as early as 4 h after stimulation and displayed strict time- and dose-dependent manner (Fig. 1a– d).\", \"key\": \"2d96691380121a05ec2c03147e1306a300514b36292e0f80f18356164659c9bd601161ac92733337d864043f58b044653032a4aaa79fead536e8e8b59ba96b60\", \"line\": 157, \"relation\": \"increases\", \"source\": 10, \"target\": 69}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results demonstrate that heme could efficiently induce maturation and secretion of IL-1b in macrophages and primarily suggested that heme participates in immune response.\", \"key\": \"0c8f33e64bf57eeec299edf4a99fc018f866678be1616079eae73e7e16f987bba8539c8c31dc4dba5221c99f5122b0355b910ee8cdd64547d33ce74552c8ce38\", \"line\": 166, \"relation\": \"increases\", \"source\": 10, \"target\": 69}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Western blotting results showed that the p10 active form of caspase-1 was detected in macrophages incubated with heme for 12 h.\", \"key\": \"19699aa8e13930e404c1622004003badd1c347a04a484cdadc40f434b4eec868cfcaef0f8d98fcac6df0e76a1fab1e669ce45de2b600acd7173798e315256e1a\", \"line\": 174, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 65}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results suggest that heme induces maturation and secretion of IL-1b in macrophages through activating caspase-1 (Fig. 2a).\", \"key\": \"337b4702c1422860ab065d0a329e6af901e2540f365f1f16839594cfaeaf3c9cb748f84134662b0333fad21ec517bb4b29f30638f830df81d4198ca867b14cc2\", \"line\": 181, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 65}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results demonstrate that free heme induces IL-1b through activating NLRP3 inflammasome via ASC and suggest that free heme plays an essential role in inflammation response as a dangerous signal.\", \"key\": \"933c81fcce003bcd3288a320ef1e12636ef370e4f23ec5be9dfcb08d4bbb54c364b9ce94f87ef3cb2f421997237a8c404d78e2e718fb391f077b37163fa8a336\", \"line\": 203, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 71}, {\"annotations\": {\"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"The increase in hemopexin was associated with decreased plasma heme levels (Figure 3I).\", \"key\": \"6f5f5854aa87bcbe0cb25215812bbc3b9a0e88d7edb2e4c1eaa3ba94c28c56803101285a8c278b4fba81cefa8cafe4e6c2c2229cb04e6b9fede1aa51f886d289\", \"line\": 191, \"relation\": \"negativeCorrelation\", \"source\": 10, \"target\": 67}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Akerström B\", \"Axelsson J\", \"Casslén V\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Holmqvist M\", \"Johansson ME\", \"Larsson I\", \"Ley D\", \"Marsal K\", \"Mörgelin M\", \"Rippe B\", \"Rutardottir S\", \"Shohani B\", \"Wester-Rosenlöf L\"], \"date\": \"2014-01-01\", \"first\": \"Wester-Rosenlöf L\", \"last\": \"Hansson SR\", \"name\": \"PloS one\", \"pages\": \"e86353\", \"reference\": \"24489717\", \"title\": \"A1M/α1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"The expression of A1M is up-regulated by elevated levels of free Hb, heme and ROS [23].\", \"key\": \"531876418856b91f18825288a5052d4526dfdfa85254c4d67193b078dfb7fdbf227a68fbe3efe9e51742f2e156d3d5812ac9201d47c63aa35c4dbd714da7984f\", \"line\": 92, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 51}, {\"annotations\": {\"MeSHAnatomy\": {\"Synovial Fluid\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"Expression and synthesis of A1M has been shown to be upregulated in cells after exposure to heme and ROS (Olsson et al., 2007, 2011).\", \"key\": \"0c7bb907f10c4c6bdf8f8fd55afec08bd66870a1c6ea7e8eeb8a3e0e43d9bd99aadb1240de62c9b2a377621a5627d10ad32bcb7577278f104c8c3a024a4e8f6d\", \"line\": 258, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 51}, {\"annotations\": {\"MeSHAnatomy\": {\"Synovial Fluid\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"This is consistent with our findings here that both heme and Hb were associated with increased levels of synovial fluid A1M.\", \"key\": \"01434cfcd644f72aa5993471658b702f0728f612bbf6f29f9d11ae8186cff74ba9f957916f39ae7637b3fbf3fbab1efe373d79afaae0fd345f73bddd1ff8bc7f\", \"line\": 266, \"relation\": \"positiveCorrelation\", \"source\": 10, \"target\": 51}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"Concentration\": {\"10 μM\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"In agreement with the electrical cell–substrate impedance sensing data described above, the proteome changes triggered by 10 μM heme were indicative of an adaptive response with prominent induction of HMOX1 and ferritin light (FTL) and heavy (FTH1) chains (Figure 5d,left panel).\", \"key\": \"eefc778b404c30394b05eddeecd9e9afb5e3ea419c9f38a85ebb46db260336bae65d6c3fd409ed9d2eacaa590dd2b3d699a028c9b0ac4a717dbaad458a3bfd9f\", \"line\": 232, \"relation\": \"increases\", \"source\": 10, \"target\": 53}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \". Heme activates macrophages inducing the production of TNF, KC (Figueiredo et al., 2007), IL-1β (unpublished), and LTB4 (Monteiro et al., 2011).\", \"key\": \"4c7451b3f4407771c972d7ec7f2e16c11c54b155dadd0bd8f68a08056ff11bd560dbf1600a4b0c8087e18c98f80ec92fbf46888c2cf7421773cdfa1cbf6140dc\", \"line\": 313, \"relation\": \"increases\", \"source\": 10, \"target\": 64}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"On the other hand, TNF secretion induced by heme is essential for the activation of the programed necrotic cell death pathway, which is denominated necroptosis (Fortes et al., 2012).\", \"key\": \"879fce85a8321d9152797d1053d4467ca9829a42686bd6f8e7ec35d1806a5087da51f50c1abd6e74e756cd51c3576f088b5708edfff703baaaf77a5699786c7a\", \"line\": 337, \"relation\": \"increases\", \"source\": 10, \"target\": 64}, {\"annotations\": {\"Cell\": {\"leukocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"The TLR4 activates two distinct pathways: MyD88 and TRIF. In macrophages, heme induces a biased MyD88 activation and the secretion of the pro-inflammatory cytokines TNF and KC.\", \"key\": \"3d40f64ea86ec4758207d01b737b22467fff9df466bc7956e6377e9601a0eb292d2d6a490e864bb537129481adc731a1f65b9e1f6465cd88bdd917bec3fa1a3f\", \"line\": 440, \"relation\": \"increases\", \"source\": 10, \"target\": 64}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Moreover, heme amplifies MyD88- (TNF and IL-6) and TRIF-dependent (IP-10) cytokines.\", \"key\": \"fe5c49432dab1d2c3d68b2c7112f31e19838d41125b19516a1c27a487cf1e1474427961cdfef5e26b8fe731d207e46dd9104c58d75670a100f79cc4ab05b7261\", \"line\": 512, \"relation\": \"increases\", \"source\": 10, \"target\": 64}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Haem also induces tumour necrosis factor (TNF) secretion in monocyte/macrophages through TLR4 and the adaptor molecule, MYD88 (Figueiredo et al, 2007).\", \"key\": \"46ce6537ad74582070ec5ba418b016b8c3546d59b97794a876f9380555b73c4f71391924573aaef1923e0614fffe22480ad57b01a81f691410fba8a92aa6abfd\", \"line\": 531, \"relation\": \"increases\", \"source\": 10, \"target\": 64}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"In addition, we observed increased ROS production ( Figure 2I; supplemental Figure 2), as well as an enhanced expression of IL-6 and TNFα in cells treated with heme-albumin compared with heme-Hx (Figure 2J-K).\", \"key\": \"252577d306a047ad74c4802c17732c6e3a5781f2b73d79f1e9c719233602f9dde1320e73e3828a3939e345fd36e3f6b2db21c945002ed713122b739d83d993ec\", \"line\": 147, \"relation\": \"increases\", \"source\": 10, \"target\": 64}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Taken sequentially, it appears that the release of heme under hemolytic conditions initiates the extrinsic pathway of coagulation through the upregulation of TF on endothelial cells and leukocytes, but subsequently blocks the propagation of coagulation by inhibiting FVIII and FV, and by inhibiting the conversion of fibrinogen into fibrin and fibrin clots.\", \"key\": \"9ac083c44dc8919378ca19a2b288128ab3529d785a1fba223e4d31f7220873e9798742712ba4a61954a1bccb008a232cdf822ee0b2bbd9a13f876056642babbd\", \"line\": 211, \"relation\": \"increases\", \"source\": 10, \"target\": 64}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"Only under protein-free conditions did we observe a limited heme-induced TNF-alpha response in cultured macrophages, which was triggered via signaling of the classical TLR4–MyD88–TRIF pathway of NF-kB activation.28\", \"key\": \"832efa2272bcaad141172579afc72cdfd32ff9d37460817999e9c28ed50037687a0854dcd9a702a72c59ea0828b2b9fee4b6be4ec560bac8cc7dbbc2569f820c\", \"line\": 225, \"relation\": \"increases\", \"source\": 10, \"target\": 64}, {\"annotations\": {\"Cell\": {\"leukocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"The TLR4 activates two distinct pathways: MyD88 and TRIF. In macrophages, heme induces a biased MyD88 activation and the secretion of the pro-inflammatory cytokines TNF and KC.\", \"key\": \"cd04f35b99dd501191cc6e2ad6672219a5115167196deb155ac6e1161be95baf65a0560c141b619b726fc79fe468e104a023256ebb89d814ca1fe8e8cc07fef9\", \"line\": 439, \"relation\": \"increases\", \"source\": 10, \"target\": 60}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Cell-free hemoglobin and its prosthetic group heme can contribute to organ dysfunction and death [1–4, 9–12]; the pathological mechanisms include nitric oxide consumption, vasoconstriction, oxidative injury to lipid membranes, activation of the transcription factor NF-κB, endothelial injury as well as iron-driven oxidative inhibition of glucose metabolism[10–14].\", \"key\": \"abd2a482da2ac40543a922d6c07fc285fc6aff8ea3c675624f4ed625a9ff6760143af71e12dd0510e164e35b9877060a1aa379cb47a4f18f175ff8dd9385b155\", \"line\": 127, \"relation\": \"increases\", \"source\": 10, \"target\": 61}, {\"annotations\": {\"MeSHAnatomy\": {\"Arteries\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Heme/TLR-4 signaling, moreover, was found to activate NF-κB and trigger vaso-occlusion [42].\", \"key\": \"b1daccc18f64dae38fa645e1982e1d3220eb2214dbd1223f54607301b8a995ff37abc75ae2679748dbcaf4b42dc81d0b903911c00946407eb0373aa08cbb18d1\", \"line\": 258, \"relation\": \"increases\", \"source\": 10, \"target\": 61}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"These results indicate that heme degradation increases in RBCs of PRDX2 knockout mice in spite of the presence of catalase and GPx.\", \"key\": \"b0d9587ec2de3c8739e3f9088eb4c1e14d647523badcf1f163e2240ad567eb36cc6b62529a53495c6df84d7c555447fc8744be70dcb2c25350b22723b6e9d60b\", \"line\": 106, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"negativeCorrelation\", \"source\": 72, \"target\": 10}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"Figure 4 shows a significant decrease in the elongation index, which is a measure of deformability, for the PRDX2 knockout mice.\", \"key\": \"52e870e24bbb0c562b43cd49a82fe05908d642013284dc685a52b71f07aefd401624731fb9bc82f6d8bafcb672d44d1f16092276c2c3fee865128204d140d735\", \"line\": 161, \"relation\": \"positiveCorrelation\", \"source\": 72, \"target\": 37}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The role of PRDX2 in inhibiting impaired deformability can be attributed to both a reduction in ROS as well as a direct reaction of PRDX2 with protein hydroperoxides [52], which will inhibit the damage to cytoskeletal proteins required for impaired deformability.\", \"key\": \"bbd43a21f330e6d1c47caf261c7d32aa25d8e9adf1483b64d69adb2130d49cadd74c44aaa3550b2a42c6d93c9b33a57103b17d0a88e2a18bd0e3a623319338e5\", \"line\": 218, \"relation\": \"positiveCorrelation\", \"source\": 72, \"target\": 37}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"PRDX2 deficiency, thus, causes cells to undergo more oxidative stress during in vitro aging, even in the presence of catalase.\", \"key\": \"69d70c90b4db8aabb4337b1175cd90c707fd9315a67c6ff1e98c053710d05c7459123b5ece884e8ec09082216f7859281c17eb924a31b8e19525a0a39c414eab\", \"line\": 172, \"relation\": \"negativeCorrelation\", \"source\": 72, \"target\": 39}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"PRDX2, which is able to react with low levels of H2O2 even at reduced glutathione levels, may therefore play a role in limiting the increased formation of heme degradation products in older cells.\", \"key\": \"cea786314b652b2824272418246cce01b8fd8bf06fd32550a1e268c4d9593f20d833f6b4f25a1910cff5c5407629998be804e33d889a79de5760cc73a72eb710\", \"line\": 212, \"relation\": \"negativeCorrelation\", \"source\": 72, \"target\": 39}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Barnes S\", \"Harper VM\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\", \"Sun CW\", \"Townes T\", \"Wilson L\"], \"date\": \"2015-02-01\", \"first\": \"Harper VM\", \"last\": \"Patel RP\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"294-307\", \"reference\": \"25264713\", \"title\": \"Peroxiredoxin-2 recycling is inhibited during erythrocyte storage.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Peroxiredoxin-2 (Prx-2) has emerged as the critical antioxidant protecting RBCs from H2O2 produced endogenously (by Hb autoxidation and subsequent superoxide dismutation) and exogenously (e.g., from activated neutrophils) at low (physiologic) concentrations (11, 32, 38, 40, 43, 45) and, therefore, may limit oxidative injury to other cells/tissues in the vasculature (6, 57).\", \"key\": \"766eb10f2a49f37ff5f407c23d9de59023916f2920df01d8621c298b7b82ea677bacd88cecd28b2cb0c0b385c0a1f07fedc54897aa00983178f746cfd0ed27c8\", \"line\": 102, \"relation\": \"negativeCorrelation\", \"source\": 72, \"target\": 39}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"5 min\": true}}, \"citation\": {\"authors\": [\"Barnes S\", \"Harper VM\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\", \"Sun CW\", \"Townes T\", \"Wilson L\"], \"date\": \"2015-02-01\", \"first\": \"Harper VM\", \"last\": \"Patel RP\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"294-307\", \"reference\": \"25264713\", \"title\": \"Peroxiredoxin-2 recycling is inhibited during erythrocyte storage.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"This is consistent with increased Prx-2 oxidation and a role for this enzyme in protecting RBC membrane constituents from storage-dependent oxidative stress (49, 50).\", \"key\": \"a9f63280559b1bbfdb8ab11e2a8d83106a5a4a91a982df715c4631e78f6fadb43cfcf968284057d59f12321f0389ee5081ef151fd3afb2ec752f22d326d3abb0\", \"line\": 170, \"relation\": \"decreases\", \"source\": 72, \"target\": 39}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"5 min\": true}}, \"citation\": {\"authors\": [\"Barnes S\", \"Harper VM\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\", \"Sun CW\", \"Townes T\", \"Wilson L\"], \"date\": \"2015-02-01\", \"first\": \"Harper VM\", \"last\": \"Patel RP\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"294-307\", \"reference\": \"25264713\", \"title\": \"Peroxiredoxin-2 recycling is inhibited during erythrocyte storage.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"The potential significance of this finding is underscored by the fact that Prx-2 is considered the primary antioxidant system to negate H2O2-mediated oxidative damage in the RBC (41).\", \"key\": \"bf2e3ee132d7e711fe0a3b6edb93f42dbec399431228380e4e6d975921c49dbfd863d999d86640a0eb155404008599db022646f2cda46cc14fcaee0837144731\", \"line\": 178, \"relation\": \"decreases\", \"source\": 72, \"target\": 39}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The appreciable increase in heme degradation for RBCs from PRDX2 knockout mice in the presence of azide indicates that PRDX2 plays a major role in scavenging H2O2 in the absence of catalase, even with GPx present.\", \"key\": \"0e501f270e6cd499e5086afa056bf66d2061476270a82710632d4fb5591e6380af997befec662e5ed31510c801493f385ef20eab18d50a8fe52ea181d6aea58a\", \"line\": 179, \"relation\": \"negativeCorrelation\", \"source\": 72, \"target\": 4}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"GPx removes both H2O2 and organic hydroperoxides [8,31] whereas PRDX2 removes H2O2 [2], organic hydroperoxides, lipid hydroperoxides, [32,33] peroxynitrite [34] and protein hydroperoxides [35].\", \"key\": \"024776cc43aadefcf3e9160ff38e9b7c34101f1e0a8af9115fea75eff7bfad2c78b8f9bd8787ea268d7404a5c5818146f7213872dda8e374f87406a9d5d3ee78\", \"line\": 191, \"relation\": \"negativeCorrelation\", \"source\": 72, \"target\": 4}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The in vivo effects that we have observed for PRDX2 knockout mice (Figures 1–4) imply that PRDX2 plays an important role in neutralizing the H2O2 generated in vivo (Figure 6).\", \"key\": \"df1d5a78062f9fc13e56da39a95df0bf78221e8ff635bd4db57058e327ac4f322c98556f194f0a18d8f7bdabe1681f915b39496f661d166af7583cad29da0bf0\", \"line\": 206, \"relation\": \"negativeCorrelation\", \"source\": 72, \"target\": 4}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Barnes S\", \"Harper VM\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\", \"Sun CW\", \"Townes T\", \"Wilson L\"], \"date\": \"2015-02-01\", \"first\": \"Harper VM\", \"last\": \"Patel RP\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"294-307\", \"reference\": \"25264713\", \"title\": \"Peroxiredoxin-2 recycling is inhibited during erythrocyte storage.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Peroxiredoxin-2 (Prx-2) has emerged as the critical antioxidant protecting RBCs from H2O2 produced endogenously (by Hb autoxidation and subsequent superoxide dismutation) and exogenously (e.g., from activated neutrophils) at low (physiologic) concentrations (11, 32, 38, 40, 43, 45) and, therefore, may limit oxidative injury to other cells/tissues in the vasculature (6, 57).\", \"key\": \"7f9df922d86f909db3d4b1c672499e2dff3becd07b4ff5116a0e553584b2f9bf02586092a8aa5d80ed530ac636ab1f7f746255bf7691d5837eddf3c79469d8fb\", \"line\": 101, \"relation\": \"negativeCorrelation\", \"source\": 72, \"target\": 4}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"5 min\": true}}, \"citation\": {\"authors\": [\"Barnes S\", \"Harper VM\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\", \"Sun CW\", \"Townes T\", \"Wilson L\"], \"date\": \"2015-02-01\", \"first\": \"Harper VM\", \"last\": \"Patel RP\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"294-307\", \"reference\": \"25264713\", \"title\": \"Peroxiredoxin-2 recycling is inhibited during erythrocyte storage.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"The potential significance of this finding is underscored by the fact that Prx-2 is considered the primary antioxidant system to negate H2O2-mediated oxidative damage in the RBC (41).\", \"key\": \"94dc3663f76b5a825daaf764bc2d779b63eca788cfeed971faa94c7012a8719f06ab29788aed61df712d6d3d7824aea28114f8b765455646e52e122133e94185\", \"line\": 177, \"relation\": \"decreases\", \"source\": 72, \"target\": 4}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The role of PRDX2 in inhibiting impaired deformability can be attributed to both a reduction in ROS as well as a direct reaction of PRDX2 with protein hydroperoxides [52], which will inhibit the damage to cytoskeletal proteins required for impaired deformability.\", \"key\": \"3a0303cf48149c76e237d90d4bf7a9f26af4419ad322dc94af5b09cd500dbd793d552a6ec5fd8b4165c69d39e0003719510bdca1c18d6a9cebdf608d0e3c2b50\", \"line\": 220, \"relation\": \"negativeCorrelation\", \"source\": 72, \"target\": 22}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"5 min\": true}}, \"citation\": {\"authors\": [\"Barnes S\", \"Harper VM\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\", \"Sun CW\", \"Townes T\", \"Wilson L\"], \"date\": \"2015-02-01\", \"first\": \"Harper VM\", \"last\": \"Patel RP\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"294-307\", \"reference\": \"25264713\", \"title\": \"Peroxiredoxin-2 recycling is inhibited during erythrocyte storage.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Finally, slower Prx-2 reduction correlated with increased H2O2 (10 lM)-induced hemolysis of day 35 RBC compared with day 7 RBC (Fig. 1D).\", \"key\": \"46ea7bae2dd4b34ec7403e8654e04729abf341dddaf5cb440d4d5fb49d59764b4c8309790e3af705fd5a5483b97ce4e1a7d132cf33ecceab841ecb670d560232\", \"line\": 128, \"relation\": \"negativeCorrelation\", \"source\": 72, \"target\": 95}, {\"annotations\": {\"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Figure 2G shows storage also resulted in a significant increase in Prx-2 oxidation.\", \"key\": \"962469877c9313c3167a85a5f242b86bbf87543790b4abb4c7768f312702ac4edffbc07e15e5d9ba213aaf56f63b127f7e934088b794a0164134c1ee05a550ee\", \"line\": 123, \"relation\": \"positiveCorrelation\", \"source\": 72, \"target\": 15}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"The higher the basal (d7) level of Prx-2 oxidation, the higher the level of Prx-2 oxidation in the same RBC after 35 days of storage.\", \"key\": \"dc059fed96645ebb64cb62f3ae3a1a820283d748a3643cc36947da27b5be05fb5dd5f95b2af5fcfe8d63c1b6f816dca907494fde75b92a12f2e7e02defda8f55\", \"line\": 177, \"relation\": \"positiveCorrelation\", \"source\": 72, \"target\": 15}, {\"annotations\": {\"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"The Cys89Tyr mutation in CD59 was initially described with manifestation in infancy by chronic hemolysis and relapsing peripheral demyelinating disease resembling recurrent Guillain- Barre syndrome (GBS) or chronic inflammatory demyelinating polyneuropathy (CIDP).\", \"key\": \"93f788d6617ce7a5a4f5e6773cbc01fcca340e5d6771e1b8aaaaf11e064c61de598d17b244d6d60fc9b570d5e9ba6376428a411298aa37cb4f88ee5dd7b58a57\", \"line\": 130, \"relation\": \"positiveCorrelation\", \"source\": 76, \"target\": 95}, {\"annotations\": {\"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"More recently, we have described two infants carrying the mutation who manifested with recurrent strokes [8], establishing the concept that primary Cys89Tyr mutation in CD59 leads to a thrombophilic state.\", \"key\": \"7c7e0cd60d1d158f2b8a58c468d46de52b2bdeacbc72d1ad7389420aa89f2b2c7a89de23e002f5c8e98166d9cc8776edf45f2f0dc45ee2d972bc3b2ed4748afa\", \"line\": 140, \"relation\": \"positiveCorrelation\", \"source\": 76, \"target\": 99}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Coronary Vessels\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"In summary, thrombosis is an extremely important prognostic factor both in PNH and in primary Cys89Tyr nonfunctioning CD59.\", \"key\": \"311ba92745023954ce0d02350ba99d1d48b8deede763d282c467a8d8f012e5ce41508a84dd4f455dc566b556616b677329cca1e72c07659a69880f7acf21b10c\", \"line\": 412, \"relation\": \"positiveCorrelation\", \"source\": 76, \"target\": 99}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"As shown in Fig. 1, significantly increased MAC deposition is seen on RBCs (p < 0.0003), neutrophils (p < 0.009), and platelets (p < 0.0003), but not on monocytes (p=0.5, not shown).\", \"key\": \"bf68b6181935799a41560230a4c2b3dd0c3a5dfb12d5c29a7f2fce83b3f1a19c5c45d734886fe8a0de5f62e91536d61488193fe1a0e262ce03fc083dd7724cec\", \"line\": 150, \"relation\": \"positiveCorrelation\", \"source\": 76, \"target\": 19}, {\"annotations\": {\"Cell\": {\"monocyte\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"As shown in Fig. 1, significantly increased MAC deposition is seen on RBCs (p < 0.0003), neutrophils (p < 0.009), and platelets (p < 0.0003), but not on monocytes (p=0.5, not shown).\", \"key\": \"7907a648c23e015d2021bf19cbf2635514723c9f2ac4a655ed2586318c24e1cdb1fba1a53571754c3391ee7fd13ebd1a46972340fa13d6bd5b65dfa48becfc03\", \"line\": 153, \"relation\": \"causesNoChange\", \"source\": 76, \"target\": 19}, {\"annotations\": {\"Cell\": {\"platelet\": true}, \"MeSHAnatomy\": {\"Endothelium\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"However, in primary Cys89Tyr CD59 deficiency and not in PNH, the endothelial cells are exposed to MACmediated injury.\", \"key\": \"e06a05f483581ea5d1dfba0eb42f3f570ee046d228606129be031fa1a5455d9b7b48585317c993ea4f3d70ca251b370d9bbbb6f771c78aefac86206ecbecb1ea\", \"line\": 312, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"positiveCorrelation\", \"source\": 76, \"target\": 19}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"We have assessed the presence of MPs in four patients with primary Cys89Tyr mutation in CD59 and two PNH patients, as well as in four healthy donors.\", \"key\": \"6c235f0b18743ba4c8d97fb7e367ff8c3f738fe094da3e6577bc3710bb617e3476bdae9add5fe91065811651aad02eff95d51f1144757e1bcb298a13ed0f1ed7\", \"line\": 188, \"relation\": \"increases\", \"source\": 76, \"target\": 18}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"In summary, patients with primary Cys89Tyr mutation in CD59 showed about 9–10-fold increase in the number of MPs compared to controls and slightly but significantly increased numbers when com pared to PNH patients. The origin of MPs was primarily RBCs and to a much lesser extent platelets and neutrophils.\", \"key\": \"920291e4de63651e3332724b220ad6f40b1263a82c97e100929038282177ab1ad9a7053df4ce68538366753203aaa54b685b706eb8f7fc62a83e4476289d1828\", \"line\": 198, \"relation\": \"increases\", \"source\": 76, \"target\": 18}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true, \"neutrophil\": true, \"platelet\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"High free hemoglobin was shown in patients with primary Cys89Tyr mutation in CD59 (Table 1) and it has been suggested in several ways that free hemoglobin may serve as a major mechanism for thrombophilia.\", \"key\": \"00d2573efb72f76b3f465b7873166d093fde5e7ab2f84eb354b955741f60ebc23880ef660faf5d97459b4cd2ebc2533e95f508c0ccdf44f8ecb3215623efff4b\", \"line\": 240, \"relation\": \"increases\", \"source\": 76, \"target\": 54}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results demonstrate that free heme induces IL-1b through activating NLRP3 inflammasome via ASC and suggest that free heme plays an essential role in inflammation response as a dangerous signal.\", \"key\": \"9c0891b7005809d7dc28a695ded407856001d253ba3c3d45879ce14f70281d2385847a9899371b7e513d84ee2c128f05b5605c1ed70066735c8451a47d45c813\", \"line\": 203, \"relation\": \"positiveCorrelation\", \"source\": 71, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results suggest that heme induced activation of NLRP3-Caspase-1-IL-1b axis is involved in kidney inflammation in mice UUO model and that heme serves as a dangerous factor participates in this process.\", \"key\": \"62665eedf7f1303b761d9294ec084d61d0903f6569dde1b2cac5430ba5fd2a3c6c583590c8f20188e20633e65497cf99176fae257421fe3e99169bc61dad45fb\", \"line\": 245, \"relation\": \"positiveCorrelation\", \"source\": 71, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"The results showed that enforced HO-1 could efficiently decline the heme level in the lysates of ligated kidneys, and inhibit kidney inflammation characterized by down-regulation of NLRP3-Caspase- 1-IL-1b axis.\", \"key\": \"e0a6732ab289d2c33776957b9e642bc6ea64d87420a8644c3968e691e30718c3a8b47ad32a3b3a97866a2a11dec340fc6e0321bd2b672ace0e417ce552ecd81b\", \"line\": 258, \"relation\": \"negativeCorrelation\", \"source\": 71, \"target\": 66}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"As expected, NLRP3+/+ macrophages were efficiently stimulated to secrete IL-1b by heme, and displayed dose-dependent (up to 40 lM) manner.\", \"key\": \"6477f383a52c322f37e457380dabd6b05dcbd95d5e01e7b1b351f427214e6e6ccc0d6fbae3b7aa5e1a16370198f890ac010089280a51dafa8caabcf8b5579ab5\", \"line\": 196, \"relation\": \"positiveCorrelation\", \"source\": 71, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 69}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results demonstrate that free heme induces IL-1b through activating NLRP3 inflammasome via ASC and suggest that free heme plays an essential role in inflammation response as a dangerous signal.\", \"key\": \"0b46b341d207910d4b12ef6771f9a30e3ac862ff6cc1e85b7bd455a06356c6bc0385a670caf0a3a7399b761a5cf06b862dea7f7cf3ff09362759f6c7b3cca8aa\", \"line\": 204, \"relation\": \"positiveCorrelation\", \"source\": 71, \"subject\": {\"modifier\": \"Activity\"}, \"target\": 69}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"Free heme is lipophilic and intercalates into the membrane of endothelial cells increasing vascular permeability and ICAM-1, VCAM-1, and E-selectin expression (19).\", \"key\": \"64efc15c436e6f38faaf7a201dd9f9e686ef4b0e2e4da68b39236ef5690e7f7452291d04833a8c89d6dad49e9a2a02e276a4cc306f62136f436cb2c8170a6244\", \"line\": 239, \"relation\": \"positiveCorrelation\", \"source\": 74, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Immunofluorescence staining of VCAM-1 and ICAM-1 was decreased in the dorsal skin of SS-mice 4h after infusion of Hb+Hp and Hb+Hpx compared to SS-mice infused with vehicle or Hb (Fig 2B and 2C).\", \"key\": \"9ec4ad36a815a2cbde78271ef216e311c0a2dbc5069027fb4772708396bca77c6081fd25b4582b0908f184f107042b4a3388fdaff805931d63cc86a89c85cf52\", \"line\": 159, \"relation\": \"negativeCorrelation\", \"source\": 74, \"target\": 67}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"TNF, IL-6, and IL-1β are pleiotropic cytokines that regulate cell death, increase vascular endothelial permeability, recruit immune cells to inflamed tissues and induce the production of acute-phase proteins.\", \"key\": \"aa4315698220908d84a3421fe4e2f4d5528509b46dc69d9e9dc64e39a7eeffa40668c01dfaedaa740346a6192aa7ac46dc8d6e1fab817c1c85175f4ebe2e87c2\", \"line\": 285, \"relation\": \"increases\", \"source\": 64, \"target\": 97}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \" Although KC and IL-1β functions were not investigated during heme-induced inflammatory effects, TNF and LTB4 were described as essential inflammatory mediators during inflammatory events induced by heme.\", \"key\": \"8f55726f7f1760c577eb0f9045c189f9bc0c2a376b322640309f2b764c51f3b5cbaa8c7b233d9205e7a94f8fcd5eaf297e8e6552a68244fce59102aae64817c2\", \"line\": 322, \"relation\": \"increases\", \"source\": 64, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"This pro-inflammatory cytokine milieu is crucial in mediating the pro-coagulant effects of vascular endothelial cells and promotes localized inflammation and thrombosis (Qari et al, 2012).\", \"key\": \"91193fc3861b04b853783e4f498b6f24534c29d4a174fa43a255ce8073c5e6e1c7c33156744f3deb42e59630d0fcd532347e6186c337b6522676dcdcd8da6a19\", \"line\": 687, \"relation\": \"increases\", \"source\": 64, \"target\": 97}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Moreover, IL-1β and TNF modifies the hypothalamus threshold of the body temperature causing fever.\", \"key\": \"5ded8c17c132a147de0c2c051dbfce59d95872dcc9bc916d3c53c6e741ca4acbbd486e020eec64c3d0535d2042dd4fde09d4578296747f6688934d1a090e4b7b\", \"line\": 298, \"relation\": \"positiveCorrelation\", \"source\": 64, \"target\": 93}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"On the other hand, TNF secretion induced by heme is essential for the activation of the programed necrotic cell death pathway, which is denominated necroptosis (Fortes et al., 2012).\", \"key\": \"ea3299aa84be4df21b0293896e013178ab02ad684f8137c9b138a913889a6fe87cf27c963ce02c766fbf10ee3a6a729e34bb7b667b5c829c079b61a38fc8ca5a\", \"line\": 338, \"relation\": \"increases\", \"source\": 64, \"target\": 32}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"This pro-inflammatory cytokine milieu is crucial in mediating the pro-coagulant effects of vascular endothelial cells and promotes localized inflammation and thrombosis (Qari et al, 2012).\", \"key\": \"735d9acdcfc40afd735cd1ca335aea6ddf8ea1a2b276baa822029255cb62d159ca64c57d92c5b8d3b699ca2d01d72f1d7b4b6f0b9e5fff8d992407d8d1e73a35\", \"line\": 688, \"relation\": \"increases\", \"source\": 64, \"target\": 99}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"For example, monocytes from SCD patients show an enhanced state of activation, with increased expression of interleukin (IL)-15 and production of TNFα and IL-1β.\", \"key\": \"63ccffe22f6d5ecf2bd4f6957561cff838a488645187b1b2a05b7ff8c93554f50a454afb2fb2a7e8005c517c500dd827b0e02b38ea81fbebfb28044ba4be7ca4\", \"line\": 112, \"relation\": \"positiveCorrelation\", \"source\": 64, \"target\": 25}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.\", \"key\": \"734884a307873e75599cea4897beaf5824bf666bbfa08275096ca73d8004b18c30d32e9f1c9da150c18660227b3a5cc64b5913e6a73bc5d0d85d0a21161979e2\", \"line\": 225, \"relation\": \"increases\", \"source\": 17, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Biochemical and biomechanical changes occur in the RBCs during the storage process, ultimately leading to increased haemolysis upon transfusion (Cohen & Matot, 2013).\", \"key\": \"fbb6bdea00aeff8931e408d003a1ae0e1c49678baff166973b16a59f2cf6074b3e844073679a2f61fb0dca8153a3316827a8c7609f744dba10cc5911b3760448\", \"line\": 382, \"relation\": \"increases\", \"source\": 17, \"target\": 95}, {\"annotations\": {\"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"48 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"The plasma hemoglobin levels at two and four hours after SRBC-transfusion were greater than the cell-free hemoglobin levels in the supernatant of the SRBCs before transfusion (Figure 1C, Supplemental Table I), providing evidence that hemolysis occurs in vivo during and after transfusion of SRBCs.\", \"key\": \"71ee1236aca3520f92cd855dd228da0e7ff7d818a4b25c25753bb39b3692f9abdc4482c421db60233438897264b8424ef1379acf22db3af5fee7d1cfbb7d5b8c\", \"line\": 139, \"relation\": \"positiveCorrelation\", \"source\": 17, \"target\": 95}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"MeSHAnatomy\": {\"Kidney Tubules\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"28 days\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"In old blood-transfused animals, strong Hb and iron deposition was observed in the tubule lumen and epithelial cells, respectively.\", \"key\": \"eefb211d82d320423d3164936ee1b15e00f0040cdc5047e70093881cfeae3ac298a3cd97f0fb11ead71dd461cfe0d35d00043809153104cff4085aeaf14e8983\", \"line\": 171, \"relation\": \"positiveCorrelation\", \"source\": 17, \"target\": 5}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney Cortex\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Tissue iron staining revealed greater cortical iron accumulation in the kidneys of mice resuscitated with SRBCs, SRBCs combined with albumin and SRBCs combined with hemopexin than in the kidneys of mice transfused with FRBCs (Figure 6A and B).\", \"key\": \"ebd17756c49132a4bb7530bf62b1af2b5308ed6995eb4ec9f2ccf4ba5b506e2abb5ee9f4e63ae33ea54da602ae16817d9b576ca55941d31aba6fe6e65bb30a0b\", \"line\": 286, \"relation\": \"positiveCorrelation\", \"source\": 17, \"target\": 5}, {\"annotations\": {\"MeSHAnatomy\": {\"Spleen\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Splenic iron content was greater in mice after resuscitation with SRBCs than in FRBC-transfused mice.\", \"key\": \"c659711b970dd5a8c97735d0d55bea02f802dd96163ad265cfb83bbd272cca1dd06463c3cb388453b00734a003630d7eae1f91a829a9e77b8f50f5767079bac2\", \"line\": 300, \"relation\": \"positiveCorrelation\", \"source\": 17, \"target\": 5}, {\"annotations\": {\"MeSHAnatomy\": {\"Spleen\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Taken together, these results indicate that haptoglobin co-transfusion prevented stored blood transfusion-associated renal iron uptake and led to increased weight and greater iron- accumulation in the spleens of mice.\", \"key\": \"b29d170aa829b9520c7cc302e59fbc61b6834815b5b4a79fdac7c42468b148ccb2758d5394ae32f96213e69b9622c44e347e1d670c5f78c212d65f55efab3773\", \"line\": 323, \"relation\": \"positiveCorrelation\", \"source\": 17, \"target\": 5}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Karnaukhova E\"], \"date\": \"2018-11-01\", \"first\": \"Buehler PW\", \"last\": \"Karnaukhova E\", \"name\": \"Current opinion in hematology\", \"pages\": \"452-458\", \"reference\": \"30281034\", \"title\": \"When might transferrin, hemopexin or haptoglobin administration be of benefit following the transfusion of red blood cells?\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"There is a clear need for, and medical benefit from, blood transfusions; nonetheless, administration of red blood cells (RBCs) does result in exposure to toxicants specific to hemoglobin (Hb) and its degradation components, hemin and iron.\", \"key\": \"3b1b56ad971f323755cb114f479896f6b60269312bf2479a40bf4c27c1ba5df983e91aedd36748d74a6012dc9569af03657c97c4000c045599469ce70767b225\", \"line\": 98, \"relation\": \"increases\", \"source\": 17, \"target\": 5}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"Acute Coronary Syndrome\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"In acute coronary syndrome, RBC transfusion increases platelet reactivity [31].\", \"key\": \"8261df03dbb7d79e86d11c07d57985c43902025b0bcfd27f393016fe1cf962cc93f11aa3619877eab64340e8af3918c1cf21edbf257d881120346d140ed188a7\", \"line\": 214, \"relation\": \"increases\", \"source\": 17, \"target\": 40}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Karnaukhova E\"], \"date\": \"2018-11-01\", \"first\": \"Buehler PW\", \"last\": \"Karnaukhova E\", \"name\": \"Current opinion in hematology\", \"pages\": \"452-458\", \"reference\": \"30281034\", \"title\": \"When might transferrin, hemopexin or haptoglobin administration be of benefit following the transfusion of red blood cells?\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"There is a clear need for, and medical benefit from, blood transfusions; nonetheless, administration of red blood cells (RBCs) does result in exposure to toxicants specific to hemoglobin (Hb) and its degradation components, hemin and iron.\", \"key\": \"5506b77a2c46d8ec9fbc177d01d5240cc21d0a021b9bd74192f631be8fa4329fe78f9e383b417c4ac8e7f2f2a857bd92dd20eff7e8dc5cd64cc50400b3c8fcfa\", \"line\": 97, \"relation\": \"increases\", \"source\": 17, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"28 days\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Old blood transfusion resulted in systemic free Hb total exposure (AUC0–∞) of 4600 μmol heme-h/l, which was primarily cleared by the kidney within 24 h.\", \"key\": \"f86b02be2dceced967ac1e7d6ecd7c0e2b33be52d682eabc855c4ece7fc1a381e7e6df5ccc62737a45a6b95b9ffc41b59f2146dc19ed123a175df56c12e20ee6\", \"line\": 137, \"relation\": \"positiveCorrelation\", \"source\": 17, \"target\": 54}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"MeSHAnatomy\": {\"Kidney Tubules\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"28 days\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"In old blood-transfused animals, strong Hb and iron deposition was observed in the tubule lumen and epithelial cells, respectively.\", \"key\": \"1916c0c28a395c6c72ff273e3010670df1c731beac0d401cd438972d6a69e766c06d76ad213b9650908940a365844d9301b9f3f93c294057d712f0099c0ad763\", \"line\": 170, \"relation\": \"positiveCorrelation\", \"source\": 17, \"target\": 54}, {\"annotations\": {\"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"48 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"In mice resuscitated with SRBCs, plasma hemoglobin levels were greater than in mice resuscitated with FRBCs or in sham-treated mice at two, four, and 24 hours after transfusion (Figure 1C).\", \"key\": \"c22595e2569c4a14afc4d6ac8cd2f3394df5b069aea1f8c1d9d2689bae1fc57b260c69c561ac8d195183d1100460c783f25d7b75001c646ba0fb4cb207545283\", \"line\": 129, \"relation\": \"positiveCorrelation\", \"source\": 17, \"target\": 54}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Karnaukhova E\"], \"date\": \"2018-11-01\", \"first\": \"Buehler PW\", \"last\": \"Karnaukhova E\", \"name\": \"Current opinion in hematology\", \"pages\": \"452-458\", \"reference\": \"30281034\", \"title\": \"When might transferrin, hemopexin or haptoglobin administration be of benefit following the transfusion of red blood cells?\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"There is a clear need for, and medical benefit from, blood transfusions; nonetheless, administration of red blood cells (RBCs) does result in exposure to toxicants specific to hemoglobin (Hb) and its degradation components, hemin and iron.\", \"key\": \"d26429f61de5379654536090162baa39155c136b43c0ed73c618ebbead49ed8c9ab60d7907dff5c1f370d371c47b193389ad6b25ab721f33fa9b21b5849cb610\", \"line\": 96, \"relation\": \"increases\", \"source\": 17, \"target\": 54}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Karnaukhova E\"], \"date\": \"2018-11-01\", \"first\": \"Buehler PW\", \"last\": \"Karnaukhova E\", \"name\": \"Current opinion in hematology\", \"pages\": \"452-458\", \"reference\": \"30281034\", \"title\": \"When might transferrin, hemopexin or haptoglobin administration be of benefit following the transfusion of red blood cells?\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"In diseases of intravascular hemolysis, Hp is often not detectable and lower Hp levels are associated with transfusion.\", \"key\": \"b8f9226d7b321ec6649cd800bda77739d886ef0bab870bb206af072a2e54c1cecb1ebc2d3773b4ad1a46214f08c0905c8d97fe040c2d38dc83e2b8ace9e29fed\", \"line\": 236, \"relation\": \"decreases\", \"source\": 17, \"target\": 56}, {\"annotations\": {\"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"48 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"In animals resuscitated with SRBCs, plasma hemopexin levels significantly decreased from 147.1±11.4 mg/dl at baseline to 86.7±12.2 and 76.3±5. 4 mg/dl at two and four hours after resuscitation, respectively (p<0.05 for both, Figure 2A).\", \"key\": \"ba1f4ac4bd79419d1dae4b2d190d316960e7245328de23bab713d095692707b54c77fc8c729952920618e9d99b93aecb49a02380396f14fa8f06c4f8b94fb686\", \"line\": 148, \"relation\": \"negativeCorrelation\", \"source\": 17, \"target\": 67}, {\"annotations\": {\"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Figures 2A-F show changes in oxyhemoglobin, methemoglobin and free heme in both the intraerythrocytic and supernatant fractions in both d7 and d35 RBC. Significant storage-dependent increases for all species in the cell-free fraction were observed, with no storage-dependent differences observed in the erythrocyte.\", \"key\": \"0fca9528c044526a92e6dc43cdc3b61eced4fbea90a21a42da5614406d9fc4aa0c11d96e8a3655b19191c929406550c87c8ef7503edd2f2b4a72db3af7eb943c\", \"line\": 118, \"relation\": \"positiveCorrelation\", \"source\": 15, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"More recently, we have also shown that free heme is also released during storage and may mediate further inflammation28\", \"key\": \"cba3e50250b0e4f57a1b2fe0fe98af925f8acf80046efcb4908fc902b3e6251fc11e63c57721a78c938d3e2ff7715cf96a44b45f66c8c2e651228cacf3af8300\", \"line\": 170, \"relation\": \"positiveCorrelation\", \"source\": 15, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"14 days\": true}}, \"citation\": {\"authors\": [\"Brandon AP\", \"Creighton J\", \"Dull RO\", \"Evans CA\", \"Honavar J\", \"Hu PJ\", \"Kerby JD\", \"Marques MB\", \"Morgan C\", \"Oh JY\", \"Patel RP\", \"Pittet JF\", \"Richter JR\", \"Stephens SW\", \"Wagener BM\"], \"date\": \"2018-03-01\", \"first\": \"Wagener BM\", \"last\": \"Patel RP\", \"name\": \"PLoS medicine\", \"pages\": \"e1002522\", \"reference\": \"29522519\", \"title\": \"Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study.\", \"type\": \"PubMed\", \"volume\": \"15\"}, \"evidence\": \"Consistent with our previous studies [25,36], free oxyHb, metHb, and heme levels were increased after 14 d of RBC storage, being 930 ± 125 μM, 40.3 ± 8.8 μM, and 168 ± 44.7 μM, respectively (mean ± SEM, n = 7).\", \"key\": \"eaafe7b92db21e71eaaa6a5acfeaead8fb85428236be04b6707ba37a75cd0bccd49e693e94c56cf008512891cecb6065b1e7ba6cb7120188e57328df84c11d3a\", \"line\": 106, \"relation\": \"positiveCorrelation\", \"source\": 15, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"14 days\": true}}, \"citation\": {\"authors\": [\"Brandon AP\", \"Creighton J\", \"Dull RO\", \"Evans CA\", \"Honavar J\", \"Hu PJ\", \"Kerby JD\", \"Marques MB\", \"Morgan C\", \"Oh JY\", \"Patel RP\", \"Pittet JF\", \"Richter JR\", \"Stephens SW\", \"Wagener BM\"], \"date\": \"2018-03-01\", \"first\": \"Wagener BM\", \"last\": \"Patel RP\", \"name\": \"PLoS medicine\", \"pages\": \"e1002522\", \"reference\": \"29522519\", \"title\": \"Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study.\", \"type\": \"PubMed\", \"volume\": \"15\"}, \"evidence\": \"Fig 2 shows that free hemoglobin and free heme were higher 4 h after resuscitation with stored RBCs compared to fresh RBCs (n = 3±7 as indicated); NTBI level was also higher, but this difference did not reach statistical significance (p = 0.07).\", \"key\": \"e1e7a63958a29cf126113fb1cb4b0a91f4c724f20d0e53a22cdfe41926d52e425c11a3e0b240831013d478240d8f3be6a289b918153f7f56e980433f34cea8e2\", \"line\": 115, \"relation\": \"positiveCorrelation\", \"source\": 15, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Storage is known to result in increased hemolysis which in turn results in loss of NO-signaling, oxidative stress and inflammation post-transfusion.\", \"key\": \"ca0aa0580641b5ad147aa690bd8b61824e9fd4dc0a8bfd359f12acca1541522b9e2f38591b2ab6c99b3fa028fb9fbf3fadb76dc5e347976e4a19fec88df2bcd1\", \"line\": 162, \"relation\": \"positiveCorrelation\", \"source\": 15, \"target\": 95}, {\"annotations\": {\"MeSHAnatomy\": {\"Endothelium, Vascular\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Barodka VM\", \"Berkowitz DE\", \"Frank SM\", \"Goyal A\", \"Johnson DJ\", \"Lipsitz JA\", \"Nagababu E\", \"Scott AV\"], \"date\": \"2016-08-01\", \"first\": \"Nagababu E\", \"last\": \"Frank SM\", \"name\": \"Anesthesia and analgesia\", \"pages\": \"274-82\", \"reference\": \"27308950\", \"title\": \"The Impact of Surgery and Stored Red Blood Cell Transfusions on Nitric Oxide Homeostasis.\", \"type\": \"PubMed\", \"volume\": \"123\"}, \"evidence\": \"The stored RBCs had approximately 7 times the hemolysis of fresh blood.\", \"key\": \"a77cbf2cb5b8cc824a9f69570154f5075f246172bd27b9770723f13962d0dfc26593175eaf3acc0094f98b06f1f47cbf7e8d477f3426bb77d10d6b55e62188f0\", \"line\": 147, \"relation\": \"increases\", \"source\": 15, \"target\": 95}, {\"annotations\": {\"MeSHAnatomy\": {\"Plasma\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Barodka VM\", \"Berkowitz DE\", \"Frank SM\", \"Goyal A\", \"Johnson DJ\", \"Lipsitz JA\", \"Nagababu E\", \"Scott AV\"], \"date\": \"2016-08-01\", \"first\": \"Nagababu E\", \"last\": \"Frank SM\", \"name\": \"Anesthesia and analgesia\", \"pages\": \"274-82\", \"reference\": \"27308950\", \"title\": \"The Impact of Surgery and Stored Red Blood Cell Transfusions on Nitric Oxide Homeostasis.\", \"type\": \"PubMed\", \"volume\": \"123\"}, \"evidence\": \"Any increase in hemolysis after transfusion of stored RBCs can be attributed to lysis of RBCs during storage or after transfusion (Figure 1B).\", \"key\": \"45ccaf8b276304dd4eb819fed36c50a0222e2f5bcf1ee96238a5f6396942f23f8d40d16853c04de8611f092602ce691d33411886129a95169a5ac10f2cd8b001\", \"line\": 198, \"relation\": \"increases\", \"source\": 15, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Stored RBCs undergo a complex structural and metabolic impairment that includes leakage of hemoglobin from the cells and hemolysis, reduced energy and NO production, formation of toxic products, such as lysophospholipids and free iron, phosphatidylserine exposure and shedding MPs [59].\", \"key\": \"f9aa633ea05801061d0e1598a2bc71d312cae59d7d59d312d169c7b97fe250efb80487e0224fc04124244ef2f3334e83b4b03a8f3a2ced8ef5c5736da21c60af\", \"line\": 307, \"relation\": \"increases\", \"source\": 15, \"target\": 95}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Storage is known to result in increased hemolysis which in turn results in loss of NO-signaling, oxidative stress and inflammation post-transfusion.\", \"key\": \"a0a9ad96675171f5d471d408be66ac89d027ac34811a0edeb229d72982af47f37c859ba730b08a7154869c44d60da30da7883a46b890d9ff2453a46c8b4f0ead\", \"line\": 164, \"relation\": \"positiveCorrelation\", \"source\": 15, \"target\": 39}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Storage is known to result in increased hemolysis which in turn results in loss of NO-signaling, oxidative stress and inflammation post-transfusion.\", \"key\": \"f81ff6fe8d26e55b3b846fd61503a631cb39ae48449dd78343b6794a53bc40e40d06c5e8bba8e5fc5ced3bf190486a225c004d11478d13a13f6e1fc9cc4b46b0\", \"line\": 165, \"relation\": \"positiveCorrelation\", \"source\": 15, \"target\": 97}, {\"annotations\": {\"MeSHAnatomy\": {\"Endothelium, Vascular\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Barodka VM\", \"Berkowitz DE\", \"Frank SM\", \"Goyal A\", \"Johnson DJ\", \"Lipsitz JA\", \"Nagababu E\", \"Scott AV\"], \"date\": \"2016-08-01\", \"first\": \"Nagababu E\", \"last\": \"Frank SM\", \"name\": \"Anesthesia and analgesia\", \"pages\": \"274-82\", \"reference\": \"27308950\", \"title\": \"The Impact of Surgery and Stored Red Blood Cell Transfusions on Nitric Oxide Homeostasis.\", \"type\": \"PubMed\", \"volume\": \"123\"}, \"evidence\": \"In the current observational study in patients undergoing multilevel spinal fusion surgery, we tested the hypothesis that moderate doses of stored RBC transfusions increase intravascular cell-free Hb and decrease NO availability in surgical patients.\", \"key\": \"e48c587295b0904169eec89c962be98ad6e9eef45da77009137751f1595cbaba3f59bd28e77afaef7a8ac616c2a23facb813a1dac3b9ccaacd3c829d892d8adc\", \"line\": 142, \"relation\": \"decreases\", \"source\": 15, \"target\": 6}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Stored RBCs undergo a complex structural and metabolic impairment that includes leakage of hemoglobin from the cells and hemolysis, reduced energy and NO production, formation of toxic products, such as lysophospholipids and free iron, phosphatidylserine exposure and shedding MPs [59].\", \"key\": \"3de27bf25e8c3d3d7c814f7b63bdf522b2edd6cb751a3f5aad17b6f5586656ccc588a4edd2685e8b9980ed6607ec172036649bfd692cc5f0064bed9f781e4ddd\", \"line\": 308, \"relation\": \"decreases\", \"source\": 15, \"target\": 6}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Stored RBCs exhibit altered biophysical characteristics, including higher cell rigidity that accounts in part for impaired blood flow hemodynamics and adverse effects of RBC transfusion [26].\", \"key\": \"ec2c1138da9971f080d55b3412f10235d5638b55ccc11012e5db3a1c0bd699c500d86379d1e8327277dbed59233bb354fddbbb6c089445d56f72bd56db7c94df\", \"line\": 187, \"relation\": \"decreases\", \"source\": 15, \"target\": 37}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Karnaukhova E\"], \"date\": \"2018-11-01\", \"first\": \"Buehler PW\", \"last\": \"Karnaukhova E\", \"name\": \"Current opinion in hematology\", \"pages\": \"452-458\", \"reference\": \"30281034\", \"title\": \"When might transferrin, hemopexin or haptoglobin administration be of benefit following the transfusion of red blood cells?\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"For example, Hb and subsequently, hemin accumulate during storage of human blood as RBC membrane integrity decreases [4].\", \"key\": \"497931fc96b9494427841f42fe5dbe910112eca010a3b1f72055ee5cc98059bf691ba17eb1e857ef4a534caf818528eb930c0b4fdc1178d5c31c983d93b29ef4\", \"line\": 127, \"relation\": \"increases\", \"source\": 15, \"target\": 37}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Stored RBCs undergo a complex structural and metabolic impairment that includes leakage of hemoglobin from the cells and hemolysis, reduced energy and NO production, formation of toxic products, such as lysophospholipids and free iron, phosphatidylserine exposure and shedding MPs [59].\", \"key\": \"534e5502ba5a2d857d0df4ca8dc63c301b3fd2be0f88d4e7dd169240afe82d83204097819e7368af83a39531cd44739d241226f80d7e0f3f81df971910a08371\", \"line\": 310, \"relation\": \"increases\", \"source\": 15, \"target\": 5}, {\"annotations\": {\"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"14 days\": true}}, \"citation\": {\"authors\": [\"Brandon AP\", \"Creighton J\", \"Dull RO\", \"Evans CA\", \"Honavar J\", \"Hu PJ\", \"Kerby JD\", \"Marques MB\", \"Morgan C\", \"Oh JY\", \"Patel RP\", \"Pittet JF\", \"Richter JR\", \"Stephens SW\", \"Wagener BM\"], \"date\": \"2018-03-01\", \"first\": \"Wagener BM\", \"last\": \"Patel RP\", \"name\": \"PLoS medicine\", \"pages\": \"e1002522\", \"reference\": \"29522519\", \"title\": \"Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study.\", \"type\": \"PubMed\", \"volume\": \"15\"}, \"evidence\": \"Fig 2 shows that free hemoglobin and free heme were higher 4 h after resuscitation with stored RBCs compared to fresh RBCs (n = 3±7 as indicated); NTBI level was also higher, but this difference did not reach statistical significance (p = 0.07).\", \"key\": \"2582ff892d6be67e3696df6cfd9901609984ca21df91a81076064e2d6c26370c37de3fc3747ea535cd400098aa3f68704371b2dbd06a822fb826bd6a526f5be9\", \"line\": 117, \"relation\": \"positiveCorrelation\", \"source\": 15, \"target\": 5}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Stored RBCs undergo a complex structural and metabolic impairment that includes leakage of hemoglobin from the cells and hemolysis, reduced energy and NO production, formation of toxic products, such as lysophospholipids and free iron, phosphatidylserine exposure and shedding MPs [59].\", \"key\": \"29ec66c2f7b378fc6dafea3cacef8e55333f2b577c178e352f3e24a5cf22a3f35a9576a6735812d74b254a1bff117a4f2a005b6fcc55c8ec21b5e768b0f3bee9\", \"line\": 311, \"relation\": \"increases\", \"source\": 15, \"target\": 7}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Stored RBCs undergo a complex structural and metabolic impairment that includes leakage of hemoglobin from the cells and hemolysis, reduced energy and NO production, formation of toxic products, such as lysophospholipids and free iron, phosphatidylserine exposure and shedding MPs [59].\", \"key\": \"7420648448578536d0fdc6e24df64f2a15f97addead1ad575016b58e3c707c6e85813e3eb535fa7e603690bcf121e1cc806dfeb5418f6b53aaae49ff65040d0b\", \"line\": 312, \"relation\": \"increases\", \"source\": 15, \"target\": 18}, {\"annotations\": {\"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"20 hours\": true}}, \"citation\": {\"authors\": [\"Brandon AP\", \"Creighton J\", \"Dull RO\", \"Evans CA\", \"Honavar J\", \"Hu PJ\", \"Kerby JD\", \"Marques MB\", \"Morgan C\", \"Oh JY\", \"Patel RP\", \"Pittet JF\", \"Richter JR\", \"Stephens SW\", \"Wagener BM\"], \"date\": \"2018-03-01\", \"first\": \"Wagener BM\", \"last\": \"Patel RP\", \"name\": \"PLoS medicine\", \"pages\": \"e1002522\", \"reference\": \"29522519\", \"title\": \"Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study.\", \"type\": \"PubMed\", \"volume\": \"15\"}, \"evidence\": \"Pulmonary edema approximately doubled (Fig 1D), and lung bacterial CFUs significantly increased (Fig 1E) in mice resuscitated with stored RBCs compared to those that received fresh RBCs.\", \"key\": \"8fc3a2fb73223d43b891b08819f449a21d8c676b03353237f7b7455008f6bf01e392bf71f44da90e55a72a65e251337f6db6ce970f7ef8f587db95610c546987\", \"line\": 99, \"relation\": \"positiveCorrelation\", \"source\": 15, \"target\": 33}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"14 days\": true}}, \"citation\": {\"authors\": [\"Brandon AP\", \"Creighton J\", \"Dull RO\", \"Evans CA\", \"Honavar J\", \"Hu PJ\", \"Kerby JD\", \"Marques MB\", \"Morgan C\", \"Oh JY\", \"Patel RP\", \"Pittet JF\", \"Richter JR\", \"Stephens SW\", \"Wagener BM\"], \"date\": \"2018-03-01\", \"first\": \"Wagener BM\", \"last\": \"Patel RP\", \"name\": \"PLoS medicine\", \"pages\": \"e1002522\", \"reference\": \"29522519\", \"title\": \"Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study.\", \"type\": \"PubMed\", \"volume\": \"15\"}, \"evidence\": \"Our findings using a mouse model of trauma and hemorrhagic shock with stored blood transfusion and subsequent PAK instillation demonstrate that transfusion with older stored RBCs increases the severity of bacterial pneumonia.\", \"key\": \"39cf54f0aebc08e79b95823bd0057d1e4316cab1e9d4ef09d0f73ade84eedd2bb52cd2b14e7de9f9060fb8b0944f79974e8d4127e012c0998ba9a2dd1ff7c7c8\", \"line\": 169, \"relation\": \"positiveCorrelation\", \"source\": 15, \"target\": 98}, {\"annotations\": {\"MeSHAnatomy\": {\"Endothelium, Vascular\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Barodka VM\", \"Berkowitz DE\", \"Frank SM\", \"Goyal A\", \"Johnson DJ\", \"Lipsitz JA\", \"Nagababu E\", \"Scott AV\"], \"date\": \"2016-08-01\", \"first\": \"Nagababu E\", \"last\": \"Frank SM\", \"name\": \"Anesthesia and analgesia\", \"pages\": \"274-82\", \"reference\": \"27308950\", \"title\": \"The Impact of Surgery and Stored Red Blood Cell Transfusions on Nitric Oxide Homeostasis.\", \"type\": \"PubMed\", \"volume\": \"123\"}, \"evidence\": \"In the current observational study in patients undergoing multilevel spinal fusion surgery, we tested the hypothesis that moderate doses of stored RBC transfusions increase intravascular cell-free Hb and decrease NO availability in surgical patients.\", \"key\": \"4ff189beb02acebb7498fffb59150db1dc263d866b5a8f947209aeb8267a3e59bf6977a911c2cbc1af0d7cea29a03ee611cf3ce54a22d75c5602b86a458aae3d\", \"line\": 141, \"relation\": \"increases\", \"source\": 15, \"target\": 54}, {\"annotations\": {\"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Figure 2G shows storage also resulted in a significant increase in Prx-2 oxidation.\", \"key\": \"058ff432160673c3c61966c8f30513f9ed805675e9e462868af71467d1be0e6aa3ce818f45b48389bbb88011180ca17ea3b4fd70606413a49911b9a598fa1f4a\", \"line\": 123, \"relation\": \"positiveCorrelation\", \"source\": 15, \"target\": 72}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"The higher the basal (d7) level of Prx-2 oxidation, the higher the level of Prx-2 oxidation in the same RBC after 35 days of storage.\", \"key\": \"0a62b3999ccac9c3ec32e62ec9de0d423e71b0e6cb49748130f6953010791ade05e4e90d28e37c7e2512567a43a14e661932f4b1ce7e1210c8d4022a6d27a77f\", \"line\": 177, \"relation\": \"positiveCorrelation\", \"source\": 15, \"target\": 72}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Banerjee S\", \"Crumbliss AL\", \"Jia Y\", \"Kreulen RT\", \"Mollan TL\", \"Olson JS\", \"Tsai AL\", \"Wu G\"], \"date\": \"2014-04-01\", \"first\": \"Mollan TL\", \"last\": \"Alayash AI\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"265-77\", \"reference\": \"24486321\", \"title\": \"Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"For example, Hp 2-2 has been associated with an increased susceptibility to diabetic cardiovascular disease; uptake of Hb-Hp(1-1) complexes by CD163 receptors is reportedly faster and its binding results in increased concentrations of anti-inflammatory mediators than Hb-Hp(2-2) complexes; and the angiogenic potency of Hp 2-2 is reportedly greater than that of Hp 1-1 [18].\", \"key\": \"2ab10ea99b15079a5e0175e4171a91bfd1626ac3352fc85f275a1a509d648c2795653e9eec563ab448a850e2ea7253fc63ea417747d376c0acb38e492d2af939\", \"line\": 124, \"relation\": \"decreases\", \"source\": 23, \"target\": 97}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Placenta\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"A statistically significant increase in the mean Hp-HbF concentration was observed for women with PE as compared to controls (p-value 0.018).\", \"key\": \"593ff94ea524c2ecfa1330cd66dd46de0e4544707fb1188c2e4745e9f758534d41654caed447cc9e37d769c5fe888382fb46a1eb3cfc09745238f61d2ea6a536\", \"line\": 140, \"relation\": \"positiveCorrelation\", \"source\": 23, \"target\": 86}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Because of its large molecular size, this complex is maintained in the intravascular space, preventing the association of otherwise free Hb with nitric oxide (NO; Reiter et al., 2002) and inhibiting the release of free heme (Melamed-Frank et al., 2001).\", \"key\": \"fd590c5b2c48d0bfc911bc08094498c059675ab7a7e8ec07e3896a8c1004053624c02c29272b6285ebe93a3689e03f0fe6d8ba1c8feb5c19f00bc1187e86b6be\", \"line\": 123, \"relation\": \"negativeCorrelation\", \"source\": 23, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true, \"Macrophages\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Macrophages and liver cells capture large HP-Hb complexes clearing the plasma from free hemoglobin.\", \"key\": \"ddc39618a8b90580bc30fe1f754d0a9e0d18e00448b43b23808155494ad8370301490ef2cc93e0ab9f0f96f99e166926189678eae0e9503e39349e6b77f8a08b\", \"line\": 131, \"relation\": \"decreases\", \"source\": 23, \"target\": 54}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Formation of large amounts of haptoglobin– haemoglobin complexes rapidly depletes haptoglobin.\", \"key\": \"5646be3a4f7f4e2a04165ee90b0436650e0810bad764bb6d16bf8dc50c1f0255ff18436e4dc902c1ef9fb5cb0534f01477526ef2cbb8694d3b32ffcb18f4c53c\", \"line\": 122, \"relation\": \"decreases\", \"source\": 23, \"target\": 56}, {\"annotations\": {\"MeSHAnatomy\": {\"Placenta\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Haptoglobin (Hp) is perhaps the most well investigated Hb-clearing molecule. It binds cell-free Hb in plasma [20,21] and the resulting Hp-Hb complex is cleared from blood via binding to the macrophage receptor CD163 [22].\", \"key\": \"97a1a8dee4895c752e50a7e53637c04ea12cd83ff9563b5634d8ea841c119b1993ebe0606890119e4327d35c8e4c1624c3b487635833603052dfb89b6bd87088\", \"line\": 106, \"relation\": \"positiveCorrelation\", \"source\": 23, \"target\": 56}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Plaque, Atherosclerotic\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"This engenders the release of iron, which can promote further the oxidation of plaque lipids through redox cycling reactions. The result of these chemical reactions is the formation of deleterious oxidized ‘gruel’ which, among other things, leads to endothelial oxidative stress and ultimately to cytotoxicity.\", \"key\": \"3d4598f02bfacbe5ecfaf95456bdcdaa3a296f7b99b1c6d6b9d64ef161af96426adef0a1e6c24b22658253c940cf81442ef27442eebb498b4a96fae847894b4f\", \"line\": 275, \"relation\": \"positiveCorrelation\", \"source\": 39, \"target\": 5}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, by participating in Fenton chemistry, non-transferrin-bound iron (i.e., iron not bound to the physiological iron transport protein, transferrin) causes oxidative damage, cytotoxicity and enhanced endothelial expression of adhesion molecules, thereby enhancing thrombotic risk (Hershko, 2007).\", \"key\": \"e63672e950c8a328ccb7d9ac82661255d15ecef8245aeeb439f5a21093b0890f6de7e3ddc8b0829bbd4349ec1dab1a9d01cb0b5eb97e797db869248fb087a3fc\", \"line\": 632, \"relation\": \"positiveCorrelation\", \"source\": 39, \"target\": 5}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Extracellular hemoglobin and its degradation products, free heme and iron, are highly toxic due to oxidative stress induction and decrease in nitric oxide availability.\", \"key\": \"3ee08f61668146761fa04510808c5f030ca7f9c78063b27ec465d8ddd4c2031334e2fa37c6f017f9715d1647829b162c9e04f021e970ff9b35e9cdf64b8dd517\", \"line\": 106, \"relation\": \"positiveCorrelation\", \"source\": 39, \"target\": 5}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Hb and its degradation products – free heme and iron - perpetuate oxidative stress, and together with decreased NO availability promote many SCD complications.\", \"key\": \"9c6e9ecac4b4cf703f1dd6bbbebcb8c358888f4ecf3e04cfc6b0401d7676f4508a32a75a31f49e4c390ffde90e6cbecb9c2d8384b156a64b03e3a23e7bcc5821\", \"line\": 123, \"relation\": \"positiveCorrelation\", \"source\": 39, \"target\": 5}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"It has been shown that RBC oxidative stress that damages the membrane reduces the deformability and flexibility of cells.\", \"key\": \"47a921ae4b73253161239f7a53633791aa6514197758354ed7fa9afa2ab601532d8bb6e454f6c84792e8f20b5eda722a39e999f682d83d30c0f7344d31460b8b\", \"line\": 155, \"relation\": \"negativeCorrelation\", \"source\": 39, \"target\": 37}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Storage is known to result in increased hemolysis which in turn results in loss of NO-signaling, oxidative stress and inflammation post-transfusion.\", \"key\": \"508bad230431d5f7d71670c1c7879a1514d0a49e8193b016f4e496c027b55a38e2a49107058c804dbd070c8f45d9effc3b774522c5045ab3e5df4e024dd5d1a0\", \"line\": 164, \"relation\": \"positiveCorrelation\", \"source\": 39, \"target\": 15}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Reduced glutathione (GSH) was also depleted after 4 h of heme exposure, indicating that heme induces oxidative stress in exposed cells (Figure 5c).\", \"key\": \"56248516689e2772358b80d206d320633ec19dbd7ac2afc54cea65081fab0fc5b41ee1a24cd82c5946dc2937631754f0f91566e59da2adac61077471a53a1e8f\", \"line\": 210, \"relation\": \"positiveCorrelation\", \"source\": 39, \"target\": 10}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"These data suggest that the estimated free heme concentrations that occur in the renal tubular system during severe intravascular hemolysis are in the range of heme concentrations that could trigger oxidative stress and cell damage to the renal epithelium.\", \"key\": \"05c00132e7e01448c062ad6af9f004d15a2f25574871e833bc60d7e3e1e06badf394dae3f325c5e07b1dc0cd6c97f268bb905ae64d5263d06c3ffc54f017dd9b\", \"line\": 221, \"relation\": \"positiveCorrelation\", \"source\": 39, \"target\": 10}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Free hemin is a cytotoxic molecule that mediates oxidative stress, endothelial activation, and inflammation, and it is implicated in malaria pathogenesis [40] and AKI, among others [41].\", \"key\": \"780169fad20a873894afae4ecbe0e0495785b8d1b387d953836aded594983ddab9ccfd77b6abc2cffe8f429eef5cc132cfda9d642ed44519340413de955a9e3b\", \"line\": 234, \"relation\": \"positiveCorrelation\", \"source\": 39, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"ca29f9ef8e88cf95a7af17db904d0ae27e492553f3b1b550ac366d469219ca39bfb8b23a4adf0279a5a58ef2b9b8b436024f263125cc71a6a9348c9da33e059a\", \"line\": 94, \"relation\": \"positiveCorrelation\", \"source\": 39, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Under conditions of apoptosis or RBC damage, such as high shear rates, inflammation, or oxidative stress, RBCs can lose membrane asymmetry and expose phosphatidylserine [43].\", \"key\": \"525b1090439075ee74cd9fe16e5c6c76eab182277f99930e03786f25b3edca42af49d09a487ffa5222a273bbb093749f26a575ec4149b26aae78a153418b20a0\", \"line\": 243, \"relation\": \"positiveCorrelation\", \"source\": 39, \"target\": 20}, {\"annotations\": {\"MeSHDisease\": {\"Hematoma\": true}, \"Species\": {\"Bos taurus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Gao Z\", \"Li H\", \"Wang P\", \"Wu J\"], \"date\": \"2019-04-01\", \"first\": \"Wang P\", \"last\": \"Li H\", \"name\": \"Molecular and cellular biochemistry\", \"pages\": \"57-66\", \"reference\": \"30324533\", \"title\": \"Tyrosine residues of bovine serum albumin play an important role in protecting SH-SY5Y cells against heme/H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;/NO&lt;sub&gt;2&lt;/sub&gt;&lt;sup&gt;-&lt;/sup&gt;-induced damage.\", \"type\": \"PubMed\", \"volume\": \"454\"}, \"evidence\": \"Malondialdehyde (MDA) represents evidence of systemic oxidative stress and inflammation [31], and is commonly used to estimate the level of lipid peroxidation.\", \"key\": \"d0419ea15c0847aad4132f106cac1791b19209bdfbb7dcac2f0a18e9f4c671d0ccc41fbf3d785c8c40aa3bd9930e9d1cdb07f9230fbd61b8f1e6e5b9693316d5\", \"line\": 188, \"relation\": \"positiveCorrelation\", \"source\": 39, \"target\": 12}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"7a0edf24d5843fa55dcbf72d98c0fc47e3034fdbf9a16b4930c99711b38fb05813c854d648048f709362c72b0ae852a6bebd52515aef6fe15144244340f4c548\", \"line\": 93, \"relation\": \"positiveCorrelation\", \"source\": 39, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Knee\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"In addition to inflammation, cell-free hemoglobin (Hb) released via hemolysis is a potent inducer of oxidative stress.\", \"key\": \"f74712aecdd73964ee3ab77dca17e982c64e0296799281dc0e1276d76529a39589f90d8ad0574b283e8945dc0296f0073bda042b257d7accc12d8d3c093e1cb4\", \"line\": 132, \"relation\": \"positiveCorrelation\", \"source\": 39, \"target\": 54}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"PRDX2 deficiency, thus, causes cells to undergo more oxidative stress during in vitro aging, even in the presence of catalase.\", \"key\": \"c5c66733a4598dfce10f0aa3100760787399a2a4868faf29cbb1548c11eeca0a0010c60f01a5f9f9568a65272e233473801e59b252d40e3ee5f606d1995bc557\", \"line\": 172, \"relation\": \"negativeCorrelation\", \"source\": 39, \"target\": 72}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"PRDX2, which is able to react with low levels of H2O2 even at reduced glutathione levels, may therefore play a role in limiting the increased formation of heme degradation products in older cells.\", \"key\": \"720163dd6f8927dcfd4a324e1350fe9d1922a025a55eaae8f5627ef4c4a1a60e31d997a5e6ab4db069bd09896e06b93db78ad09e22e5b853574b4b41f71cbc62\", \"line\": 212, \"relation\": \"negativeCorrelation\", \"source\": 39, \"target\": 72}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Barnes S\", \"Harper VM\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\", \"Sun CW\", \"Townes T\", \"Wilson L\"], \"date\": \"2015-02-01\", \"first\": \"Harper VM\", \"last\": \"Patel RP\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"294-307\", \"reference\": \"25264713\", \"title\": \"Peroxiredoxin-2 recycling is inhibited during erythrocyte storage.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Peroxiredoxin-2 (Prx-2) has emerged as the critical antioxidant protecting RBCs from H2O2 produced endogenously (by Hb autoxidation and subsequent superoxide dismutation) and exogenously (e.g., from activated neutrophils) at low (physiologic) concentrations (11, 32, 38, 40, 43, 45) and, therefore, may limit oxidative injury to other cells/tissues in the vasculature (6, 57).\", \"key\": \"19cd7a50fe159be30edc37151392c08a2f4cc94f9abba09425d8baea45df0dfaea7d089d80770ea08973082f9f45380a790b375666a4a7ee2f99a652aa58a93c\", \"line\": 102, \"relation\": \"negativeCorrelation\", \"source\": 39, \"target\": 72}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Plaque, Atherosclerotic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Inhibition of lipid oxidation by either haptoglobin or hemopexin reduced the cytotoxicity (Fig 4B) and HO-1 induction caused by sublethal amounts of pretreated atheromatous lesion lipids (Fig 4C and D).\", \"key\": \"3ccf6e86a8a3d47efde1cba4b9816849cc1188bfd1bbab8babcf3edd2fa0089fbf07e458b9956c251a67f9a5dcbe938f17e51549a0aff58dd5252e7300ce8a10\", \"line\": 235, \"relation\": \"decreases\", \"source\": 57, \"target\": 38}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Importantly, heme b interaction with heme oxygenase (HO; Lad et al., 2003), the enzyme responsible for heme intracellular catabolism, and hemopexin (Hx; Paoli et al., 1999), a plasmatic heme scavenger, is essential for the regulation of free heme availability and Fe recycling (Kovtunovych et al., 2010; Tolosano et al., 2010).\", \"key\": \"1d14f4fcf65bbcd0b4ddc1268759fe5b4fb56d1cd3aed62443dcfddbe1c972e5a953752b18f68a4689229ab8db4a6a3ecf26e94a70180c8cf2650935fa2c61f8\", \"line\": 95, \"relation\": \"decreases\", \"source\": 57, \"target\": 10}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Puglia M\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2015-12-01\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"931-43\", \"reference\": \"26475040\", \"title\": \"Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity.\", \"type\": \"PubMed\", \"volume\": \"89\"}, \"evidence\": \"Based on clinical observations the Hb and heme scavenger proteins haptoglobin (Hp) and hemopexin (Hx) have been characterized as a sequential defense system with Hp as the primary protector and Hx as a backup when all Hp is depleted during more severe intravascular hemolysis.\", \"key\": \"d883383b18307ee41ffc771b657baecec0f9f61b1e781d0051ae926d5865b3cdcbfee923f11c354369fc15accb4a3c068deaa9cd8e338036aa1ffad92020dd02\", \"line\": 103, \"relation\": \"decreases\", \"source\": 57, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Recently, we demonstrated that Hx controls hepatic heme uptake and thus limits heme accumulation in extrahepatic tissues, such as the vessel wall and the heart, preventing heme-induced toxicity and tissue injury.\", \"key\": \"5f580240c76eb38b5bbce00684cf1a82c6c24d2be5ec8f623ff0f172745dc18735a76c4c01106862a47cf83eda782ee9ae17b53200a427137cb5c71bb5a2d8c3\", \"line\": 127, \"relation\": \"decreases\", \"source\": 57, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Taken together, these data demonstrate that Hx limits macrophage heme overload and prevents the prooxidant and proinflammatory effects triggered by heme in cellular assays and in vivo.\", \"key\": \"b8d852403687d91d829fe2208c74460b98115d58e9bc1f00f1a4574867d936dc5a98ca4bd2ddb0277138be251b9f06acb7fe09e87e9000dc20f6f6db67e435d3\", \"line\": 153, \"relation\": \"decreases\", \"source\": 57, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"Thus, the interactions of hemoglobin with haptoglobin, and of heme with hemopexin, ensure safe disposal of potentially dangerous molecules [6,7,15–19]\", \"key\": \"b39b0b14dd131435d2918fb5f7d93bfa2051b647286862b8383fccd9c5ab1a15f6ed2c956d45f1d9ec8499cfa5fc3185a68699bb0c020bab43cf740251efe103\", \"line\": 110, \"relation\": \"decreases\", \"source\": 57, \"target\": 10}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Heme released from cell-free hemoglobin on oxidation is bound by hemopexin and degraded by hepatocytes in the liver [12].\", \"key\": \"d496f71298c8c1ac177beda2b8041331655c1fc45fa531ffee7b4550f7ef8f90af5a79ffa71029d5647c3cf9b0e23583420618acb31f9314ec82ca8ee94ea97c\", \"line\": 276, \"relation\": \"decreases\", \"source\": 57, \"target\": 10}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Karnaukhova E\"], \"date\": \"2018-11-01\", \"first\": \"Buehler PW\", \"last\": \"Karnaukhova E\", \"name\": \"Current opinion in hematology\", \"pages\": \"452-458\", \"reference\": \"30281034\", \"title\": \"When might transferrin, hemopexin or haptoglobin administration be of benefit following the transfusion of red blood cells?\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"Of the biological components known to bind hemin, Hpx is by far the most efficient with a dissociation constant (Kd) lower than 1 x 10–13 M; as a result, after binding, the transfer of hemin from Hpx to other proteins or lipids is not possible [24].\", \"key\": \"29965a1a0da6b9980ad72200a0f741c9cfdd69a23c8b84f2fa8c8535bb8e18f0fa5fea151d78c7578454f7e23fec5591428bb9f9d5298801825d093b59300a10\", \"line\": 202, \"relation\": \"decreases\", \"source\": 57, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Knee\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"On the extracellular level, within the circulation, haptoglobin (Hp) and hemopexin (Hpx) are two of the most prominent scavenger proteins, with antioxidative properties through their capacity to remove cell-free Hb (by Hp) and heme (by Hpx).\", \"key\": \"ccb0fc4fc21369b16cab160985c3eb99b02c8ece8d68f963987ab99c9e5fe1689c55a918cc359886e24a21ec27f2df7bb506073a34f5807084cb973fc0b53aeb\", \"line\": 149, \"relation\": \"decreases\", \"source\": 57, \"target\": 10}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"In fact, hemolysis or heme injection in Hx−/− mice cause increased inflammation and severe renal damage compared to wild type (WT) mice (Tolosano et al., 1999; Vinchi et al., 2008). \", \"key\": \"6b4eb68b78a792b54af7398777ed1c2a789351ba682119668ac59d81771b09cf52a9f45646762e917de47c443b0eb8bb22c5b88d3bbaf091f62e9ccea7fc968d\", \"line\": 368, \"relation\": \"decreases\", \"source\": 57, \"target\": 97}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Analysis of the intravascular heme-scavenger protein Hpx showed a statistically significant decrease in plasma Hpx concentration of women with PE (p-value<0.0001) as compared to the controls (Table 3).\", \"key\": \"c077ac8ae953fd33d85c3569f047ed9a5c2ab7aee30fee2e6da063c1f0e237de24f73ebea1847f9038144d545c9b2b89d686b32979b56d86b392f110d8da4948\", \"line\": 161, \"relation\": \"negativeCorrelation\", \"source\": 57, \"target\": 86}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Correlation analysis using Pearson’s correlation coefficient showed statistically significant inverse correlation between Hpx and blood pressure, both systolic (r = -0.511, pvalue< 0.00001, n = 145) and diastolic (r = -0,520, p-value<0.00001, n = 145)(Fig 3).\", \"key\": \"66cbb189e8500fb7910d27d42d99393fb8e4594f07c11447b6417edb7443a337041c99907c89a3fac46f5d248f95520b2b26ff6b5f5f012408e786aa551a108c\", \"line\": 183, \"relation\": \"negativeCorrelation\", \"source\": 57, \"target\": 34}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Pre-Eclampsia\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Anderson UD\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Johansson ME\", \"Jälmby M\", \"Larsson I\", \"Åkerström B\"], \"date\": \"2015-01-01\", \"first\": \"Gram M\", \"last\": \"Åkerström B\", \"name\": \"PloS one\", \"pages\": \"e0138111\", \"reference\": \"26368565\", \"title\": \"The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.\", \"type\": \"PubMed\", \"volume\": \"10\"}, \"evidence\": \"Studies of sickle cell anemia patients have reported decreased levels of Hpx following hemolysis [68].\", \"key\": \"ec4fc0dc3ea24d4ad2a2a9860055da7a9d330d8569c1f7923cd0b9af20c37cd99cabeef8e778a83276cce0d719015656a576340f640e154a29063ba1b1a22341\", \"line\": 203, \"relation\": \"negativeCorrelation\", \"source\": 57, \"target\": 80}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Taken together, these data demonstrate that Hx limits macrophage heme overload and prevents the prooxidant and proinflammatory effects triggered by heme in cellular assays and in vivo.\", \"key\": \"d719a4b2921fed8730f3425c0a96a1c0785ffa13ad920cddbcee6068b0fe74afd25c9cc60106ae57952bb1fe547c82de89d9c0130152c7cd246daf8858fdb783\", \"line\": 154, \"relation\": \"decreases\", \"source\": 57, \"target\": 22}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Taken together, these data demonstrate that Hx limits macrophage heme overload and prevents the prooxidant and proinflammatory effects triggered by heme in cellular assays and in vivo.\", \"key\": \"58d8e84499ba434e0efbf32314cb2b401c3ea2211670fae6ed651696184366c681910335d97f1a278f89ca6c7d57e0739cf2a2a0b7d8806828dbbb1b9a64e75e\", \"line\": 155, \"relation\": \"decreases\", \"source\": 57, \"target\": 31}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Treatment with Hx or DFO diminished the increase of some M1 polarization markers in BMDMs following treatment with hemolytic RBCs (supplemental Figure 14).\", \"key\": \"1acfbef06e4c5823914a68ea73037a590006063e2c900cee4781757ae1f467cbda7d6b18c455f648d92bac657af55e5ba39c725a07372c9317f58236cb2904a2\", \"line\": 258, \"relation\": \"negativeCorrelation\", \"source\": 57, \"target\": 14}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"28 days\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"This ATP depletion was prevented by the addition of the heme scavenger, hemopexin (Figure 5b).\", \"key\": \"2dbf5dafa3054be781e6e2713617a5b9ed031b230e4546c32a2411082af0e197fe61ec6f128537e7195ca68cd44cb9998e2c54d1d359f75d3b5297a674def80b\", \"line\": 201, \"relation\": \"positiveCorrelation\", \"source\": 57, \"target\": 8}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Dimitrov JD\", \"Lacroix-Desmazes S\", \"Rayes J\", \"Roumenina LT\"], \"date\": \"2016-03-01\", \"first\": \"Roumenina LT\", \"last\": \"Dimitrov JD\", \"name\": \"Trends in molecular medicine\", \"pages\": \"200-213\", \"reference\": \"26875449\", \"title\": \"Heme: Modulator of Plasma Systems in Hemolytic Diseases.\", \"type\": \"PubMed\", \"volume\": \"22\"}, \"evidence\": \"In cases of extensive and chronic hemolysis, levels of haptoglobin and hemopexin in plasma decrease markedly [20,21].\", \"key\": \"4511723cd9b29cca0c6421097da8006d60461345f3b17bfbbd022d4159d0590f7d50385f8b44c441c5a8d92287f35bce3c571e7e26cb96efd7587cc19fac0f45\", \"line\": 116, \"relation\": \"negativeCorrelation\", \"source\": 57, \"target\": 95}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Plasma haptoglobin and hemopexin levels are often depleted in SCD patients and mice due to chronic intravascular hemolysis [21±24].\", \"key\": \"0b61b1b091c5a70b268ec033f83c62e4cea97b0fdbbd59d938c94766a274e4fb8b76cce0aa22b3a98b0a521a3cbe7f7b5116e1de8d2b5d0bdccf67854a617d79\", \"line\": 118, \"relation\": \"negativeCorrelation\", \"source\": 57, \"target\": 95}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"In addition, Hx and DFO prevented the heme- and ironmediated induction of the M1 markers MHCII, CD86, CD14, and TNFα and the decrease of some M2 markers, such as CD206, IL-10, and Arginase-1 (the last for FeNTA only) in M0 BMDMs (Figure 6A; supplemental Figure 15A).\", \"key\": \"3a32830e90a9a8d53c362ed598a584f9babe06a491c6960ba44cda6b9cd8f2e2c149b6271c98b2553deb7469c942a8056aeb463e2a721d0ec78a88a09175a939\", \"line\": 269, \"relation\": \"decreases\", \"source\": 57, \"target\": 64}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"Free heme is lipophilic and intercalates into the membrane of endothelial cells increasing vascular permeability and ICAM-1, VCAM-1, and E-selectin expression (19).\", \"key\": \"183245f97ab9af05b426e19dcda531e021bea9ecd529292895de1f146d3a201b097bc5b6dfe48c498e93c8d322b060bb5f1e4f940001ccfdb9652f2acf78efcf\", \"line\": 238, \"relation\": \"positiveCorrelation\", \"source\": 68, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Immunofluorescence staining of VCAM-1 and ICAM-1 was decreased in the dorsal skin of SS-mice 4h after infusion of Hb+Hp and Hb+Hpx compared to SS-mice infused with vehicle or Hb (Fig 2B and 2C).\", \"key\": \"4b13d13651ca79c1150144b738d4a38103ab881bc3ca4e123d26eedce2c8fe7fe07d3729334595f7bd07847f08a78cd5b8a730c85791527af9a0125cbbe51d58\", \"line\": 161, \"relation\": \"negativeCorrelation\", \"source\": 68, \"target\": 67}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHDisease\": {\"Atherosclerosis\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Earlier chemical investigations of gruel from advanced lesions revealed that it contains ceroid-like insoluble material composed mainly of hydoxyapatite, iron and calcium.\", \"key\": \"5184d5d06782daca633e7cc9b82440d92a3861ad0ef5fd4f1c122eb62e22413f9856fffec4434f55828257e5b5ae60120529ef497eed5c8f4261f4ae937eb374\", \"line\": 360, \"relation\": \"positiveCorrelation\", \"source\": 84, \"target\": 5}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Atherosclerosis\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Expression of HO-1 provides protection against atherosclerosis in several experimental models17,18 and HO-1 deficiency in humans has been associated with the appearance of vasculature fatty streaks and atheromatous plaques at age of six.19\", \"key\": \"12095a8c123baf4025d9934dfc5b9bb33d9ed55c318bef6537e106a74cf85a6776468c1af65be5c153247db074f0dc31acfb6826e3a1f9db7e6cdd2faa6eeea8\", \"line\": 114, \"relation\": \"negativeCorrelation\", \"source\": 84, \"target\": 55}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Introduction\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"By-products of heme and iron metabolism, such as heme oxygenase-dependent generation of carbon monoxide (CO), have antioxidant and anti-inflammatory protective functions against iron-induced vascular damage (33); therefore we examined the impact of CO donors on collagen exposure and thrombus formation in the ex vivo vascular injury model.\", \"key\": \"8e979c60245a3e016dc82e1c8cd83e8f6445f27c414bdbd292a96925b7ecfb59b45520c3fbf2caba2a38e4a2eae84c9ed854023a3d783db691a708bead6986b2\", \"line\": 203, \"relation\": \"negativeCorrelation\", \"source\": 91, \"target\": 2}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"Moreover they have demonstrated that released Hb plays an important role in exacerbating RBC hemolysis, establishing a damaging hemolysis/ oxidative cycle that drives further red cell damage, vascular injury, and thrombosis.\", \"key\": \"94b69ef373e3f4d9edfa86d107c6d2da2be1c1f0b5954687d984922a698857900470a55da6df61fb7d23423541c51b2252baa9bf09fb6e97c4e258952ac819fa\", \"line\": 222, \"relation\": \"positiveCorrelation\", \"source\": 91, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"Clinical studies have confirmed endothelial dysfunction and vasculopathy in a patient with HO-1 deficiency, and similarly, mice lacking HO-1 have increased vascular injury and thrombotic complications (43, 44).\", \"key\": \"f8cb6a4fe18f97e3a3c9d5f887cebc816040907d1bacffea64d8d7ffdf878cd46deafb9e7c03b86caad29a36ecf7535d3da7e17eb79b31ddce09c5856bf9fe14\", \"line\": 260, \"relation\": \"negativeCorrelation\", \"source\": 91, \"target\": 66}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Banerjee S\", \"Crumbliss AL\", \"Jia Y\", \"Kreulen RT\", \"Mollan TL\", \"Olson JS\", \"Tsai AL\", \"Wu G\"], \"date\": \"2014-04-01\", \"first\": \"Mollan TL\", \"last\": \"Alayash AI\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"265-77\", \"reference\": \"24486321\", \"title\": \"Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"Hemolysis and the transfusion of banked blood or Hb-based therapeutics can result in varying quantities of circulating acellular Hb which can induce life threatening radical generating reactions in patients with a compromised vascular system [60].\", \"key\": \"fa570e2291de5f8d322ea9adb792cf8a0c74517ff98c5076d5ac69bd95dbb1bb07b3e763b588e547236e39c2b13de80089d5327b1f74f3e0277e967966407a34\", \"line\": 133, \"relation\": \"positiveCorrelation\", \"source\": 91, \"target\": 54}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"It has been shown that RBC oxidative stress that damages the membrane reduces the deformability and flexibility of cells.\", \"key\": \"c5cfd20252874a9022f2f9c8ac61b3aff1ca3c4b39ed67d599c4ea219fd830977f2c677c3eef55e95af70190d981111d3a9453ec166cbb9a84bab33bde899e6d\", \"line\": 155, \"relation\": \"negativeCorrelation\", \"source\": 37, \"target\": 39}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The role of PRDX2 in inhibiting impaired deformability can be attributed to both a reduction in ROS as well as a direct reaction of PRDX2 with protein hydroperoxides [52], which will inhibit the damage to cytoskeletal proteins required for impaired deformability.\", \"key\": \"ca3ca07821eb11eb8ac5503770ef649469a557108519ff919ec58dd358fc59fe26158d31d294defbc9e752362244da7c80896886ba3c61f215c5dbb164068b15\", \"line\": 219, \"relation\": \"negativeCorrelation\", \"source\": 37, \"target\": 22}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Sickle cell disease (SCD) and malaria are paradigmatic hemolytic disorders, in which alteration in the structure of red blood cells (RBCs) leads to the release of Hb and heme into the circulation.\", \"key\": \"294660bf8b1ecf3cf924ad030745b908b65a82d16a4dbcbe2b27479aa5e749bb8be4fb21cdf5bce41b1c2f2e64706989f3e798d939a734c25dd40c6ece1eba10\", \"line\": 96, \"relation\": \"positiveCorrelation\", \"source\": 37, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"More rigid RBCs may be less able to squeeze through the capillaries and they also increase platelet margination described above, both of which increase the susceptibility to thrombosis [18].\", \"key\": \"902f0901a0cc091556ee735b1f64b310c1347f92fbb76c461df7f46ff9e2292c5c0236864949cd9fa333e4329582417bfd79d8ecffc972b5b55fedc627a7487f\", \"line\": 166, \"relation\": \"decreases\", \"source\": 37, \"target\": 99}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Some diseases, such as diabetes, hypertension, lower limb vein thrombosis, coronary heart disease, can secondarily alter the properties of RBCs, making them stiffer and prothrombotic [24].\", \"key\": \"b1abe64519a995493c7378de044bf51b5831138b26e0e9b10193f5bc829b0c4b8ae2e1656a1b3e6b22e45968e52db6d1a51728e25990f0ca78c7ac9bbb326d82\", \"line\": 181, \"relation\": \"negativeCorrelation\", \"source\": 37, \"target\": 99}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Sickle cell disease (SCD) and malaria are paradigmatic hemolytic disorders, in which alteration in the structure of red blood cells (RBCs) leads to the release of Hb and heme into the circulation.\", \"key\": \"df3ffa89762be101998a8a3f0f701e23cbd0b9d8e85938dc9eba522ebcc5dc7b8794819806c180d32a0965b37a76fde6886a0fca82ef49e50aa4cc7946b95db0\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 37, \"target\": 54}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"Figure 4 shows a significant decrease in the elongation index, which is a measure of deformability, for the PRDX2 knockout mice.\", \"key\": \"111d5684fa261a1be43b7006b3aca1ad252ef2b6df36a4126e9de725930c5c960fb5b90e69928315bb46a7a6ff75fddcbadc55af4659e5ede90c51670db6ad9e\", \"line\": 161, \"relation\": \"positiveCorrelation\", \"source\": 37, \"target\": 72}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The role of PRDX2 in inhibiting impaired deformability can be attributed to both a reduction in ROS as well as a direct reaction of PRDX2 with protein hydroperoxides [52], which will inhibit the damage to cytoskeletal proteins required for impaired deformability.\", \"key\": \"cfac3940fc6a2775347bc95afbc49dfa3dfc72ed47453b3cd4f4dedce87be8d7cd658ed8045b2af828cca6eeaeaa75dc25f404e3239ed73f290a4b44f2b15efe\", \"line\": 218, \"relation\": \"positiveCorrelation\", \"source\": 37, \"target\": 72}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Another consequence of the axial RBC accumulation followed by reduction in local viscosity is a decrease of the wall shear stress causing a lesser local release of nitric oxide [15].\", \"key\": \"b1d1c8bd7a1bda26f13fbcdffd60e59d5266936632b30d8b2502b0975bda4e708d311e9aa7e4b87874a393484cb208e55e1a4f92297016e3f455981cc47a0789\", \"line\": 134, \"relation\": \"decreases\", \"source\": 36, \"target\": 6}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"RBC aggregation promotes thrombosis in veins, confirming the pathogenic importance of locally altered blood rheology in the development of venous thrombosis [17].\", \"key\": \"986a66f9658d8c9b285cc55d68557faecc84b2728ead6947324469682aaeb6cf33781eae976f70d97b8abd8b76cd17e6c76683ece3852bc256654eaa3b023348\", \"line\": 158, \"relation\": \"increases\", \"source\": 36, \"target\": 99}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"An increase of fibrinogen concentration can result in greater RBC aggregation, which is associated with a higher incidence of thrombosis.\", \"key\": \"4ff237bfd6e610b6daa773aa85c462e3029b32500bb4f1262e0d9d077693c19c01aa695fd4f6794492a7153fe25eebd978fce0a92df9825dc886163e011f3561\", \"line\": 344, \"relation\": \"positiveCorrelation\", \"source\": 36, \"target\": 99}, {\"annotations\": {\"MeSHAnatomy\": {\"Ependyma\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Du H\", \"Gao C\", \"Hua Y\", \"Keep RF\", \"Strahle J\", \"Xi G\"], \"date\": \"2014-06-01\", \"first\": \"Gao C\", \"last\": \"Xi G\", \"name\": \"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism\", \"pages\": \"1070-5\", \"reference\": \"24667910\", \"title\": \"Role of red blood cell lysis and iron in hydrocephalus after intraventricular hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"34\"}, \"evidence\": \"Coinjection of deferoxamine with lysed RBC reduced ventricular enlargement (47.8±17.8 vs. 59.9±15.7mm3 in saline coinjection group, Po0.05, Figure 6).\", \"key\": \"e22b98cec7efe0e07cb43f4d490bffece7937211d5a64872ed78f27558cb15199dcf04181a448eaf048d1dee058b8b9229b0da1ab856ddc91ebf1720b35024ec\", \"line\": 151, \"relation\": \"negativeCorrelation\", \"source\": 3, \"target\": 96}, {\"annotations\": {\"MeSHAnatomy\": {\"Ependyma\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Du H\", \"Gao C\", \"Hua Y\", \"Keep RF\", \"Strahle J\", \"Xi G\"], \"date\": \"2014-06-01\", \"first\": \"Gao C\", \"last\": \"Xi G\", \"name\": \"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism\", \"pages\": \"1070-5\", \"reference\": \"24667910\", \"title\": \"Role of red blood cell lysis and iron in hydrocephalus after intraventricular hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"34\"}, \"evidence\": \"The major findings of this study are (1) intraventricular injection of lysed RBCs but not packed RBCs resulted in hydrocephalus; (2) lysed RBCs upregulated brain HO-1 and ferritin levels; (3) intraventricular injection of iron also caused hydrocephalus; and (4) iron chelation with deferoxamine reduced lysed RBC-induced hydrocephalus.\", \"key\": \"4d384c9ae4fd03c35e6a6f19d0ed242f389d7175e0d422135d02e22af8efc499a6247db3fb5b03e664b3d1fd49b20d264c6c1e97b92b4d72cb18840ef2618537\", \"line\": 174, \"relation\": \"negativeCorrelation\", \"source\": 3, \"target\": 96}, {\"annotations\": {\"MeSHAnatomy\": {\"Ependyma\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Du H\", \"Gao C\", \"Hua Y\", \"Keep RF\", \"Strahle J\", \"Xi G\"], \"date\": \"2014-06-01\", \"first\": \"Gao C\", \"last\": \"Xi G\", \"name\": \"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism\", \"pages\": \"1070-5\", \"reference\": \"24667910\", \"title\": \"Role of red blood cell lysis and iron in hydrocephalus after intraventricular hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"34\"}, \"evidence\": \"There was a tendency that lysed RBC-induced brain edema was less in deferoxamine-treated group (brain water content in the ipsilateral hemisphere: 79.8±0.6% vs. 80.5±0.7% in the saline coinjection group, n¼6, P40.05).\", \"key\": \"4e7f375348c345399d79bc43ff82d38ad6d7da9f5d038e18098a79ddb4ea0fcb8d08066ee2d4bfb0de72b4cd8717f964f754ac5c331938f2d1e407d5de75ce91\", \"line\": 159, \"relation\": \"negativeCorrelation\", \"source\": 3, \"target\": 81}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Heme-induced necroptosis is reversed by deferoxamine, a Fe chelator.\", \"key\": \"ce8cd68c230149ca53a53ead10c3edfebf4d54e8aaad162723cd450602e072544a4aa96363ade36aa0342f183aa875f6949090abc286059935ce6dd9c95e2b5e\", \"line\": 583, \"relation\": \"negativeCorrelation\", \"source\": 3, \"target\": 32}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Treatment with Hx or DFO diminished the increase of some M1 polarization markers in BMDMs following treatment with hemolytic RBCs (supplemental Figure 14).\", \"key\": \"7051f1f1a77056da0696c4399492347e749a48e97d1306c0572e6880ef91f3fd9c49e698bd870f21182def8d3f2fb17888b7ef7db5f1fb4218ff43ebab5b03d1\", \"line\": 259, \"relation\": \"negativeCorrelation\", \"source\": 3, \"target\": 14}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"DFX also reduced the MAC content in the clot at day-3 (33.0 ± 6.6 vs. 56.2 ± 9.2 ng/g in the vehicle-treated group, p<0.05, Fig. 5B).\", \"key\": \"14806d8f2a044d7dd05114158c207685fbcc8c6eec30fde8a774de9aab440e4ada54a21595f3788dea3168d0585064e02024beb269135511bc61bbf35ed107ab\", \"line\": 175, \"relation\": \"negativeCorrelation\", \"source\": 3, \"target\": 19}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHDisease\": {\"Stroke\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The present study found that DFX treatment reduces MAC formation in the clot.\", \"key\": \"f4edde5560930a942ccef8f27a4e78ec00b0c0d5571d5b3c557b8ef8044ac751be4af61d0da1e2471d2b83101c116b71ec7e05c5fb440ba5c8447e2be9bf6f19\", \"line\": 271, \"relation\": \"negativeCorrelation\", \"source\": 3, \"target\": 19}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"These results suggested that the treatment of DFX reduced the process of hemolysis after ICH, which might be due to alleviating MAC formation.\", \"key\": \"1e237cd1c51c69e64e935b4e815960e9cef0f978bd9b9a8532faa94df7fc5504e7a7d5b410933cb03af8c2ccaca1abf141afa54a88f730898ce85b025751f094\", \"line\": 182, \"relation\": \"decreases\", \"source\": 3, \"target\": 95}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"In combination, these finding may underlie our previous results showing that DFX slows hematoma resolution after ICH in aged rats 12.\", \"key\": \"ed870947dae8d2ec2e881184442e4a08921762ba62d46daf0f8cd98cf141a73dfb46b7c9ba493ceaeaa486c364df3a2fb54597847ea013a47987b5b7869537f8\", \"line\": 283, \"relation\": \"negativeCorrelation\", \"source\": 3, \"target\": 94}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"Chelation of growth-medium iron with deferoxamine (DFO, 10 μM) led to a reduction in bacterial growth, as compared with non-chelated controls (Fig. 2a).\", \"key\": \"a4ae72ee9456a8f8769d6f0281594db5e22a72bcb842519974bc05cf3664af676cbcdb20cfc47d995d2c8d5950ba756e81ce86e91c05db3860649d115d2a0a2c\", \"line\": 122, \"relation\": \"decreases\", \"source\": 3, \"target\": 33}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"DFX treatment also caused a significant reduction in infiltrating CD163-positive and HO-1 positive cell in the hematoma at day 3 (Figs. 6A and B) and day 7 (Suppl Figures II & III).\", \"key\": \"e4a6e24dc6345794a38251de5a52fb3d888b1c66246bc0cb65103b49df23232d66038187c6455bd8dffdf5f4256578c0a9c01dd488ff45550c8f9ea3e016ca2a\", \"line\": 200, \"relation\": \"negativeCorrelation\", \"source\": 3, \"target\": 55}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"Western blot analysis showed that the protein expression of HO-1 was decreased in the hematoma in the DFX treated group at day 3( HO-1/GAPDH: 0.32 ± 0.04 vs. 0.98 ± 0.07 in the vehicle-treated group, p<0.05, Fig. 6B) and day 7 (p<0.05, Suppl Figure III).\", \"key\": \"6e7369025d1597aad23ee16eaac92bf310ef5b5b8c76778d1926d4272f83a4f6ad48e49c0e0f3a64871575c0c8a9671db76b4ec06d89b45279decff495b772e4\", \"line\": 209, \"relation\": \"negativeCorrelation\", \"source\": 3, \"target\": 55}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"Expectedly, and in line with previous report (13), treatment of macrophages with DFO abolished ferroportin and ferritin induction by heme, whereas TfR1 expression was lowered upon heme and combined treatment with heme and DFO (Fig. 7D).\", \"key\": \"7c77b19518582902af1e7fb6f20ffb5c39d7946274e58220e1257add0b417eeb9964cf90e2be74336fa7c1a438c7921c09de5f73e9f543e449202922f1c0827c\", \"line\": 185, \"relation\": \"decreases\", \"source\": 3, \"target\": 73}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"We found that hemoglobin contents in hematoma were significantly higher in the DFX treated group compare to the vehicle-treated group (15.9 ± 1.8 vs. 11.8 ± 0.8 mg/g, p<0.05, Fig. 5A).\", \"key\": \"fd8c2c705640d019baf1e29fff3cfc58d143b5ebe7c84ed04fff513a896b53bcff85dec8d3973c9453f28e701d5ab96f8b20c453cc6c6ceb2dfd7f40a9ef3572\", \"line\": 169, \"relation\": \"positiveCorrelation\", \"source\": 3, \"target\": 54}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"3 days\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"DFX treatment also caused a significant reduction in infiltrating CD163-positive and HO-1 positive cell in the hematoma at day 3 (Figs. 6A and B) and day 7 (Suppl Figures II & III).\", \"key\": \"28f143351b7911481933b73ab6149f085a1542855d8bfbda6d9ad0a0eff5f53abfae43b414276550d2c6238d4c93e779a44048e65271c5b42a94f67c1b7db95c\", \"line\": 199, \"relation\": \"negativeCorrelation\", \"source\": 3, \"target\": 52}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The role of PRDX2 in inhibiting impaired deformability can be attributed to both a reduction in ROS as well as a direct reaction of PRDX2 with protein hydroperoxides [52], which will inhibit the damage to cytoskeletal proteins required for impaired deformability.\", \"key\": \"888ede07c5d0975a78c3c1520dfc24eb3a144c26d0baaa33a86b9b65ca5b7061ddb9f34e7ab6c1239f0ad1684b1e8b3ef1c7b441e46f2e72d275ba347068335c\", \"line\": 219, \"relation\": \"negativeCorrelation\", \"source\": 22, \"target\": 37}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \". In the presence of reactive oxygen species (ROS), Hb is oxidized to methemoglobin (MetHb; Balla et al., 1993), characterized by the change in the oxidative state of the Fe present in the heme molecule from ferrous (Fe+2) to ferric (Fe+3).\", \"key\": \"a405b1daad22caeec0bffddc6f642e4e0d6bada27f00efe2afbea36ab3172ffb729dcc0224ff525ea77d66634163fd208f7be6f585342a2be2f208feabc8fa3b\", \"line\": 131, \"relation\": \"positiveCorrelation\", \"source\": 22, \"target\": 100}, {\"annotations\": {\"Cell\": {\"leukocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"However, ROS is necessary to induce TNF secretion and MAPK activation.\", \"key\": \"76866e2bf247ddad569860f4bc1917f33eff868df7f621c5c36bca5eea022ca9631824e3f4a72c5a648b1c1b81eacdcae7c2ab6028d3be278c30db86822427a6\", \"line\": 459, \"relation\": \"increases\", \"source\": 22, \"target\": 21}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Furthermore, ROS induction by haem directly depends on signal transduction involving Ga inhibitory protein and phosphoinositide 3-kinase, and partially depends on phospholipase Cb, protein kinase C, the mitogen-activated protein kinases (MAPKs) and Rho kinase in neutrophils (Porto et al, 2007).\", \"key\": \"c7ddcc9d9e2ea6536d14b863f8c74743e80d3e6037f742634b81560a34597c0645137e00120518cf424fd62ada4ddc7bfa8d1c04b3546e14135e510ea37c69f6\", \"line\": 503, \"relation\": \"positiveCorrelation\", \"source\": 22, \"target\": 21}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Heme activates neutrophils and endothelial cells, by ROS generation.\", \"key\": \"9db7578962a0c2e70cd93a9d4f110e56a27899cb93cb6d0cecb6f6b84fcb55f0baff0c9d50377a17ce1b566d572c01f04f842bcfccdd816be4c71fd68f5a5d38\", \"line\": 540, \"relation\": \"increases\", \"source\": 22, \"target\": 29}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"The main mediator of these adverse effects is thought to be free haem via its effects on NO scavenging, pro-inflammatory cytokine responses, and reactive oxygen species (ROS) generation.\", \"key\": \"fbfc41df8e7e470a360fd0e77b3f893bf5147c69735ae188c671f66e739756c2d9fb4164fdc5dd9bf5d323bd4ee34383136bbfa3fab01201c715ae57e8bff047\", \"line\": 404, \"relation\": \"positiveCorrelation\", \"source\": 22, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Toxicity of free hemoglobin is also caused by the release of cell-free heme, which produces lipid peroxidation and mitochondrial damage and increases the production of reactive oxygen species.\", \"key\": \"5c5c40886ac0bfb4ae60aebe8a942453a5fefc0923071c5137e4f0f025d133c6b340e3b486d2e7ceb86cac5552dfb1d7aeed0ca52adf140dcf4bac2fb87768a3\", \"line\": 104, \"relation\": \"positiveCorrelation\", \"source\": 22, \"target\": 10}, {\"annotations\": {\"Cell\": {\"monocyte\": true}, \"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"Species\": {\"Escherichia coli\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"Heme is an amphipathic molecule that can promote the generation of reactive oxygen species (ROS) via Fenton chemistry, thereby leading to membrane damage.\", \"key\": \"78ad82ef28082bb473debb4a2afded71da3f3cfa1305223638da56c2698db1ed005994ebb61cb89b4e4d0e1a3d3a66e80ba8d99af0e60d38656de243df3592c2\", \"line\": 192, \"relation\": \"positiveCorrelation\", \"source\": 22, \"target\": 10}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"As expected, incubation of neutrophils with hemin resulted in a significant number of cells producing ROS (Fig. 8A and B).\", \"key\": \"f201dcc69b19d16d7d363e91387c9e42a5fe22ece5434b4ca43bb0416f81eecfb463ecefba08f9e1fe7a0339d37f30af4ddd7a4410020f77c6b73ef87b990efd\", \"line\": 160, \"relation\": \"positiveCorrelation\", \"source\": 22, \"target\": 10}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"These ROS then oxidize cell membrane constituents to induce cytotoxicity and promote inflammation and thrombosis.\", \"key\": \"e0ccf61ae694f6fbe8a3a6a59b5f749310b8997ba0407a5c1bda095d91183d723ced2329b57fc4f99e9cc6720ef54ac5d6346b0b9b6c825207841f018d42f1a5\", \"line\": 489, \"relation\": \"increases\", \"source\": 22, \"target\": 35}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"These ROS then oxidize cell membrane constituents to induce cytotoxicity and promote inflammation and thrombosis.\", \"key\": \"afc7aec899a1bd101f763ebaaae536aa8f6f5fd6969dbda8dbf5b85c9b62e3f8fc18f4541da86b88ba9f6b596e4fb2d7c22e349edb8e3cfbe95ae5d100b6e0cb\", \"line\": 490, \"relation\": \"increases\", \"source\": 22, \"target\": 97}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"These ROS then oxidize cell membrane constituents to induce cytotoxicity and promote inflammation and thrombosis.\", \"key\": \"a2259b4ff714dea28368bba26043b226215789cbad6d574b47f9ec1b584294aa90341f18daef04331bac4f67bebf0b932b2f9a9aab840d5c69bbb9950dfce4a7\", \"line\": 491, \"relation\": \"increases\", \"source\": 22, \"target\": 99}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Furthermore, cytokine secretion depends on the coordinated iron in the porphyrin ring (Figueiredo et al, 2007), and nuclear factor-jB (NF-jB), MAPKs activation and ROS are essential for the increase in cytokine production induced by haem (Fernandez et al, 2010).\", \"key\": \"37ff3212bd9e20477d6d25fddd34c70de7a21783c8f50f12fb6cf250c1fce30966710d51dc45f543d0f966b032c7c16f741b3bc133cde4fedb2d38ec0ff6112b\", \"line\": 544, \"relation\": \"positiveCorrelation\", \"source\": 22, \"target\": 24}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Platelets may be activated during haemolysis by several different mechanisms involving decreased NO levels, increased pro-inflammatory cytokines and mediators, and ROS.\", \"key\": \"288f8ccaba42bb99ba9161f810db8c99f23ab4d1461a6a9812cea0a54a56d24a3d733a20c663f913fc9cd10b877211b54eaf2cd219df465870fa2bd55d1270bd\", \"line\": 560, \"relation\": \"increases\", \"source\": 22, \"target\": 40}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Excess production of reactive oxygen species (ROS) has been implicated in progression of chronic heart failure as well as in other cardiovascular disorders including ischemia-reperfusion injury and cardiovascular complications of hemolytic diseases [2-7].\", \"key\": \"eabfca97ca75ce00333cb972d2e38b0de87f80b351aaa02424a727d710623a201b31c787928cc84db779d9f088ec0862ede98366b78cf49ba27a901961ab1f51\", \"line\": 94, \"relation\": \"positiveCorrelation\", \"source\": 22, \"target\": 87}, {\"annotations\": {\"Cell\": {\"smooth muscle cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Altruda F\", \"Cimino J\", \"De Franceschi L\", \"Ghigo A\", \"Hirsch E\", \"Ingoglia G\", \"Kreitmeier K\", \"Maier LS\", \"Petrillo S\", \"Rex N\", \"Sag CM\", \"Silengo L\", \"Tolosano E\", \"Vinchi F\", \"Wagner S\"], \"date\": \"2017-07-01\", \"first\": \"Ingoglia G\", \"last\": \"Tolosano E\", \"name\": \"Free radical biology &amp; medicine\", \"pages\": \"452-464\", \"reference\": \"28400318\", \"title\": \"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"108\"}, \"evidence\": \"Moreover, heme-derived ROS induce the proliferation of smooth muscle cells, that participate in vasculopathy associated with atherosclerosis and hypertension [15].\", \"key\": \"3cd6e4e6f07c0625ae11120af4fac8708231cd37379b2d7ddfea953afaa3e1b0e591e1162dbd2cfad2a3955b661d58440d2240b207d19ec6d90973e5001fd9f3\", \"line\": 113, \"relation\": \"positiveCorrelation\", \"source\": 22, \"target\": 92}, {\"annotations\": {\"MeSHDisease\": {\"Hematoma\": true}, \"Species\": {\"Bos taurus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Gao Z\", \"Li H\", \"Wang P\", \"Wu J\"], \"date\": \"2019-04-01\", \"first\": \"Wang P\", \"last\": \"Li H\", \"name\": \"Molecular and cellular biochemistry\", \"pages\": \"57-66\", \"reference\": \"30324533\", \"title\": \"Tyrosine residues of bovine serum albumin play an important role in protecting SH-SY5Y cells against heme/H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;/NO&lt;sub&gt;2&lt;/sub&gt;&lt;sup&gt;-&lt;/sup&gt;-induced damage.\", \"type\": \"PubMed\", \"volume\": \"454\"}, \"evidence\": \"Apoptosis has been found to be a major rout for the elimination of cells after a variety of stresses including ROS and RNS [30].\", \"key\": \"68dcce20b53813758305960ef2b9efeb21969e9c4acb5b2a14d6554b4417ee4534dad5e61b9c09f37767112461d4a26e2ea02f7f21d4794ed7eb32cec29d59b5\", \"line\": 149, \"relation\": \"positiveCorrelation\", \"source\": 22, \"target\": 41}, {\"annotations\": {\"MeSHAnatomy\": {\"Knee\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"As a part of the inflammatory response after injury, oxidative stress due to formation of reactive oxygen species (ROS) is involved both in direct damage of cartilage components and as integral factors in cell signaling leading to cartilage degradation (Henrotin et al., 2003).\", \"key\": \"12985f90d19574b7253cbafbfe72907a0461f35afc5c9e84e776e8b15d4472d6e3ff4718ccfa3e2bdc0b1de0f5f2ffb6a868dbf907dad4fd92ad0d93d67dc163\", \"line\": 123, \"relation\": \"positiveCorrelation\", \"source\": 22, \"target\": 31}, {\"annotations\": {\"MeSHAnatomy\": {\"Knee\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"As a part of the inflammatory response after injury, oxidative stress due to formation of reactive oxygen species (ROS) is involved both in direct damage of cartilage components and as integral factors in cell signaling leading to cartilage degradation (Henrotin et al., 2003).\", \"key\": \"9633c6109f15b91e4a5a469f1a18e5e8a7eccaa0f97c0790c5ac2937d596e13ca764d4080403b9c246f2202cab7145aa5edec08c4884f7d2435ae6871393b32b\", \"line\": 124, \"relation\": \"increases\", \"source\": 22, \"target\": 39}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"We show that heme, in a concentration range found during hemolytic episodes, increases intracellular ROS production and consequentially signals for ferroportin induction and subsequent iron export from the macrophages.\", \"key\": \"dfa2eda990ba133789c14d9584f2c55864f588e0b7ee567157e91038360fa399c412afe4420d12ff9a021c12d193490ab16310610461fb9bb25dcc1cac4bba62\", \"line\": 237, \"relation\": \"increases\", \"source\": 22, \"target\": 73}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Friedman JS\", \"Mohanty JG\", \"Nagababu E\", \"Rifkind JM\"], \"date\": \"2013-03-01\", \"first\": \"Nagababu E\", \"last\": \"Rifkind JM\", \"name\": \"Free radical research\", \"pages\": \"164-71\", \"reference\": \"23215741\", \"title\": \"Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The role of PRDX2 in inhibiting impaired deformability can be attributed to both a reduction in ROS as well as a direct reaction of PRDX2 with protein hydroperoxides [52], which will inhibit the damage to cytoskeletal proteins required for impaired deformability.\", \"key\": \"19bdf8cb5ffa15606258c07cfa64bb484d820e9858eb13689b9705c7f63fb9c7c0724418847e3629216d93e0ddfb0d851ce2fbb0bd253f6c650e9ac5e15e7427\", \"line\": 220, \"relation\": \"negativeCorrelation\", \"source\": 22, \"target\": 72}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Importantly, by scavenging free heme, Hx prevents heme-induced M1 macrophage polarization and thus avoids both TLR4 activation and ROS formation.\", \"key\": \"6014c9d4a2c99a64e2b940238701aaee03e12c9e002e85d9d3bc15fea7edaf39e656424245c9d566642e49439fcbf8b46f9d883720bcd30210f959ddda0fe7fe\", \"line\": 345, \"relation\": \"negativeCorrelation\", \"source\": 22, \"target\": 67}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Akerström B\", \"Axelsson J\", \"Casslén V\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Holmqvist M\", \"Johansson ME\", \"Larsson I\", \"Ley D\", \"Marsal K\", \"Mörgelin M\", \"Rippe B\", \"Rutardottir S\", \"Shohani B\", \"Wester-Rosenlöf L\"], \"date\": \"2014-01-01\", \"first\": \"Wester-Rosenlöf L\", \"last\": \"Hansson SR\", \"name\": \"PloS one\", \"pages\": \"e86353\", \"reference\": \"24489717\", \"title\": \"A1M/α1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"The expression of A1M is up-regulated by elevated levels of free Hb, heme and ROS [23].\", \"key\": \"5fd2e47d66b62ad9bf8ab4397cf2f1345bbab9b414d01520140f4a1e8dc9bed921e3e45f306aa2d57391c3a9bf7132bdaafc9382d4b79ebad2e1c51d65bf08b7\", \"line\": 93, \"relation\": \"positiveCorrelation\", \"source\": 22, \"target\": 51}, {\"annotations\": {\"MeSHAnatomy\": {\"Synovial Fluid\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"Expression and synthesis of A1M has been shown to be upregulated in cells after exposure to heme and ROS (Olsson et al., 2007, 2011).\", \"key\": \"2ef43ede9789406680f79254a150cb873658aade70e0263a42978405698a267fc95a18f3057c50e20a7fb2e56cf83d4aed44d0efcc884279527e87fcf31e7a92\", \"line\": 259, \"relation\": \"positiveCorrelation\", \"source\": 22, \"target\": 51}, {\"annotations\": {\"Cell\": {\"leukocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"However, ROS is necessary to induce TNF secretion and MAPK activation.\", \"key\": \"3f5355848cf77c3cab7bb32ed8ceaf0757593ae4e4ec4230dafada0cb4ff53be44b9ffcc4c0f9e33a05cd9adcc29469cd361923e68c7e91bed7db64a7ee9dba3\", \"line\": 458, \"relation\": \"increases\", \"source\": 22, \"target\": 64}, {\"annotations\": {\"MeSHAnatomy\": {\"Endothelium, Vascular\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Barodka VM\", \"Berkowitz DE\", \"Frank SM\", \"Goyal A\", \"Johnson DJ\", \"Lipsitz JA\", \"Nagababu E\", \"Scott AV\"], \"date\": \"2016-08-01\", \"first\": \"Nagababu E\", \"last\": \"Frank SM\", \"name\": \"Anesthesia and analgesia\", \"pages\": \"274-82\", \"reference\": \"27308950\", \"title\": \"The Impact of Surgery and Stored Red Blood Cell Transfusions on Nitric Oxide Homeostasis.\", \"type\": \"PubMed\", \"volume\": \"123\"}, \"evidence\": \"In addition to cell-free Hb, membrane structural modification, externalization of phosphatidylserine,21 decreased cell membrane deformability,22,23 and increased endothelial adherence24 could alter vascular NO homeostasis.\", \"key\": \"fd5d586a12318fd59f445771d34c0391f3e6543412ae25844482e2034d3006a3c1dcd9d7aac3d5841409b44d31d6ff44db4c20a3692d475ad491dc77c05f2084\", \"line\": 133, \"relation\": \"decreases\", \"source\": 29, \"target\": 6}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Free hemin is a cytotoxic molecule that mediates oxidative stress, endothelial activation, and inflammation, and it is implicated in malaria pathogenesis [40] and AKI, among others [41].\", \"key\": \"67c5bf412e3f20362f469800dd25928ae3a36fa1db978b2cbe314918951897c3e4b559a74e8ccdb0d700e329789d75fe4baef10cb99ef567fcd37d741c3a71eb\", \"line\": 235, \"relation\": \"positiveCorrelation\", \"source\": 29, \"target\": 10}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Moreover, IL-1β and TNF modifies the hypothalamus threshold of the body temperature causing fever.\", \"key\": \"313fb77a13087b7e3b27dc3526bee2de23623e9b17c2c255a6c51ec056c1ca7a69503405fa8b7c32ede99cfeeec3bd67505b732963de7c8984ca1de45bedb014\", \"line\": 299, \"relation\": \"positiveCorrelation\", \"source\": 93, \"target\": 58}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Moreover, IL-1β and TNF modifies the hypothalamus threshold of the body temperature causing fever.\", \"key\": \"b4ad7536308485e842ae2e9e48c87f16f1cddeab8d5abcf5e39bd7318c589d4b12ca99f0e46ab8f8bedbc869721ffe6d1eb4e363f4fa7f2347bada1ffbf2e2ca\", \"line\": 298, \"relation\": \"positiveCorrelation\", \"source\": 93, \"target\": 64}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"Concentration\": {\"10 mM\": true}, \"MeSHAnatomy\": {\"Muscle, Smooth, Vascular\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"60 min\": true}}, \"citation\": {\"authors\": [\"Arruda MA\", \"Assreuy J\", \"Barcellos-de-Souza P\", \"Barja-Fidalgo C\", \"Moraes JA\", \"Nascimento-Silva V\", \"Rodrigues G\", \"Silva SV\"], \"date\": \"2012-10-01\", \"first\": \"Moraes JA\", \"last\": \"Barja-Fidalgo C\", \"name\": \"Atherosclerosis\", \"pages\": \"394-400\", \"reference\": \"22954673\", \"title\": \"Heme modulates smooth muscle cell proliferation and migration via NADPH oxidase: a counter-regulatory role for heme oxygenase system.\", \"type\": \"PubMed\", \"volume\": \"224\"}, \"evidence\": \"Additionally, it was observed that inhibition of HO-1 by ZnPP induced a further increase in hemeinduced ROS production (Fig. 4C), suggesting that activation of HO system attenuates the NADPHox-dependent activation of VSMC induced by heme.\", \"key\": \"e997c3253f8ed91dfb726435e61065036d6e1d003f7486ef9737ac9326acb51c28e05a23f2d5b8ce51e4be3c8cafff830caa9fe59efb007bc92f1800a780c23f\", \"line\": 173, \"relation\": \"decreases\", \"source\": 75, \"target\": 22}, {\"key\": \"699be7c3a86950871660dd1b041bf37fd7b7ea38380ff13926984fda5b6e1a74ece3bd9ae195a653084a34699b2479883799f1c2151456f169c4db0dee7e6213\", \"relation\": \"hasComponent\", \"source\": 48, \"target\": 17}, {\"annotations\": {\"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"2 weeks\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Resuscitation with SRBCs together with albumin did not alter plasma levels of hemoglobin, hemopexin, haptoglobin, or heme as compared to resuscitation with SRBCs alone (Figure 3C–E, I, Supplemental Material and Supplemental Figure II A–B).\", \"key\": \"9e7e0465eeb1c88cd52fbabf0baec83b88089588a178b71537c16440917fd010d8f98296e6d4ed87e48b1eec86c962e4af20e4e260aaa0c89dec923c40a2631a\", \"line\": 177, \"relation\": \"causesNoChange\", \"source\": 48, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney Cortex\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Tissue iron staining revealed greater cortical iron accumulation in the kidneys of mice resuscitated with SRBCs, SRBCs combined with albumin and SRBCs combined with hemopexin than in the kidneys of mice transfused with FRBCs (Figure 6A and B).\", \"key\": \"0395d44e505fdb838703e6fc1d3e2a03deea321cb25cf68b0c305b702e8f0967a48973680225fca3aff26ad30e9416fd7856d25641f2b392870e9f8f7343bce9\", \"line\": 288, \"relation\": \"positiveCorrelation\", \"source\": 48, \"target\": 5}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Mice that were resuscitated with SRBCs and albumin or SRBCs and hemopexin showed a marked increase in HO-1 expression when compared to mice resuscitated with FRBCs.\", \"key\": \"fb819020a5a9c0bbe1c8fd0c3a1d26c0416411022a757111f607bd250e4d39f07c2419c3258b1031644a2918b9723aa7447a9a289fee161a605403f67d23eda5\", \"line\": 340, \"relation\": \"positiveCorrelation\", \"source\": 48, \"target\": 66}, {\"annotations\": {\"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"2 weeks\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Resuscitation with SRBCs together with albumin did not alter plasma levels of hemoglobin, hemopexin, haptoglobin, or heme as compared to resuscitation with SRBCs alone (Figure 3C–E, I, Supplemental Material and Supplemental Figure II A–B).\", \"key\": \"a1c0d3d5387b2e3695d8efdc765bbb4c4cb00ae09ca36576fd8fc6c96821d625b5ebd8c099807e123b0b587dc59f71e113d262b71881f35d4f91eaec5af6a812\", \"line\": 176, \"relation\": \"causesNoChange\", \"source\": 48, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"2 weeks\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Resuscitation with SRBCs together with albumin did not alter plasma levels of hemoglobin, hemopexin, haptoglobin, or heme as compared to resuscitation with SRBCs alone (Figure 3C–E, I, Supplemental Material and Supplemental Figure II A–B).\", \"key\": \"c6a60ce1c3c5ec615e387832b6f4acb7a2d17bd88086b64069d4cf03eb1c9b1c2a645feb7289734b7cbdd7514a3de905ce8c11fb26d2c62a2152e9b4b1998bc1\", \"line\": 178, \"relation\": \"causesNoChange\", \"source\": 48, \"target\": 67}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"The hematoma clearance may be via red blood cell (RBC) lysis or phagocytosis.\", \"key\": \"56dd95cef240fd761dc43facaa0d5c940de085a1fb5004dc01603911dfc4087cc5fb9b1554d100055229b42e7e0830ad3abc5f0173b2748d6c9cdb1445f9ddb6\", \"line\": 97, \"relation\": \"negativeCorrelation\", \"source\": 43, \"target\": 94}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"We focused on macrophage effector functions and found that heme pretreatment (15 min, 3–30 μM unless otherwise indicated) led to a strong, dose-dependent reduction of phagocytosis of E. coli by RAW264.7 macrophages compared with DMSO-treated controls (Fig. 3a,b and Supplementary Fig. 2a).\", \"key\": \"315e688c041224a050e3ae0ba4931dba4bf21722ba4196dab0bab09d206b12caefd05e3c2e57b56510bd97012628f00f973a22c155388be161be5ec012643898\", \"line\": 150, \"relation\": \"negativeCorrelation\", \"source\": 43, \"target\": 10}, {\"annotations\": {\"Cell\": {\"monocyte\": true}, \"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"Species\": {\"Escherichia coli\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"Induction of hemolysis with phenylhydrazine or addition of heme to whole blood at concentrations mimicking the physiological range of plasma heme in hemolytic patients (5–50 μM)6 led to a dose-dependent impairment of E. coli phagocytosis by neutrophils and monocytes, as compared with DMSO controls (Fig. 3g and Supplementary Fig. 2n,o), indicating that our mouse model was reflective of human hemolytic conditions.\", \"key\": \"b2b9530c69b08755f91a7d502e30dd4a77e8a5ff31a557281ae579e9bda55d9a08021e3ca339171312b5d21415434f576151d5de9c58b78c7937e57143669b0e\", \"line\": 172, \"relation\": \"negativeCorrelation\", \"source\": 43, \"target\": 10}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Karnaukhova E\"], \"date\": \"2018-11-01\", \"first\": \"Buehler PW\", \"last\": \"Karnaukhova E\", \"name\": \"Current opinion in hematology\", \"pages\": \"452-458\", \"reference\": \"30281034\", \"title\": \"When might transferrin, hemopexin or haptoglobin administration be of benefit following the transfusion of red blood cells?\", \"type\": \"PubMed\", \"volume\": \"25\"}, \"evidence\": \"The causes for RBC-based toxicant exposures are multifactorial; however, following acute transfusion, the most common occurs during the processes of extravascular hemolysis, which includes macrophage erythrophagocytosis followed by macrophage death [1&&], release of iron, transferrin (Tf) saturation and, finally, accumulation of labile plasma iron (LPI) [2].\", \"key\": \"4798503d1739722bb4060471a851027b71c02d778bb586d4aaa6a21ef2b1f844af08c7f970e4fc126b35b61af2288f1a7109dd7af85352c3488cf532d21fb96c\", \"line\": 112, \"relation\": \"increases\", \"source\": 43, \"target\": 5}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Furthermore, cytokine secretion depends on the coordinated iron in the porphyrin ring (Figueiredo et al, 2007), and nuclear factor-jB (NF-jB), MAPKs activation and ROS are essential for the increase in cytokine production induced by haem (Fernandez et al, 2010).\", \"key\": \"cac57e6a133814747e9edb9cbb610a387a03f809740f0b7aa981d6fbb73c6d17e6aa952d4778bb121d134778708d9f4f3e8def1ad4e64d5dc817c06386286acd\", \"line\": 542, \"relation\": \"increases\", \"source\": 61, \"target\": 24}, {\"annotations\": {\"Cell\": {\"leukocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"TLR4 activation leads to MAPKs and NFκB activation, which are necessary to TNF secretion.\", \"key\": \"e26deca76edbb8090b620e649dab3fb40dcec637f6b3ea0bdbba7eb3269b1059d60af7cb08a9539eb07386f106d764f4ad48be7a453c6ff67d546567767aab2d\", \"line\": 448, \"relation\": \"increases\", \"source\": 61, \"target\": 64}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"Moreover they have demonstrated that released Hb plays an important role in exacerbating RBC hemolysis, establishing a damaging hemolysis/ oxidative cycle that drives further red cell damage, vascular injury, and thrombosis.\", \"key\": \"29ab8fe26282f2e73e37be9e44bb79a925171df1565dd62bce4c2fbdd2ff92d9f65b87f4bc906daa90d286b85b7c5da63ecce31ff671cfb1f115bad947dc0f9f\", \"line\": 223, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 95}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Furthermore, experiments of nature that lead to increased levels of chronic hemolysis, such as sickle cell anemia and paroxysmal nocturnal hemoglobinuria, provide evidence that low levels of hemolysis may be harmful, and contribute to inflammation, thrombosis, vasculopathy, and impaired host defenses against infection.1,11\", \"key\": \"2847ba0d80f72b8d181ccf66c68c9a2390c3e81dfc327252b61bd6b208360fe9c4b9c3a360ddbb51a3182e7ab7fb0b1745223e8b25b94314323d2df0dab98ab9\", \"line\": 130, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 95}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"The triad consists of hypercoagulability, blood stasis and endothelial injury/dysfunction, which are useful concepts for understanding thrombosis.\", \"key\": \"6027db8c6610fd54b5479492870eb2474c3aa82dd9ba18371cb50ae5dfa3a60587112f70ec27f05cab1550b4dec727822cf4196cd33aec2d7cc00946583300e2\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 42}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thrombosis is the prognostic factor with the greatest effect on survival in paroxysmal nocturnal hemoglobinuria (PNH) patients [1, 2].\", \"key\": \"8cd038b87876058a25178fed2d4ab1730f1d4e0b94aa57f535a7583754b3427e3d5f5af8a356aafc051c0a1d127dd52f50c5abe4f2c4bc733dc8b4d236e30daf\", \"line\": 101, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 79}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Coronary Vessels\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"In summary, thrombosis is an extremely important prognostic factor both in PNH and in primary Cys89Tyr nonfunctioning CD59.\", \"key\": \"b2e4856ccecad9ee999a5f5b73d6571b57d06e2da59b3aa26458257b4d27c45a5d01f3f2b727e8d27a93743183da845674343c2a0d26d872767688ce478e9b88\", \"line\": 411, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 79}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"This common X-linked inherited disorder, characterized by severe intravascular and extravascular haemolysis, is classically triggered by fava bean ingestion or pro-oxidant medications. It causes haemolysis in susceptible individuals and an association with thrombosis was described in multiple case reports (Jewett, 1976; Thompson et al, 2013; Albertsen et al, 2014).\", \"key\": \"a4a75882421204099629514206be644df28612904e053e4c91add3f27febacad81e690e75567433e74c8a4563cf56ee8ef7f82825c3a120ea4b95b3f257f23b2\", \"line\": 334, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 13}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.\", \"key\": \"433436441db2844d1ba9e83799dee7e1c11f5854099def77b2889e73237293168b634016d6d99daf35af0b4e6bfb25d379bc06a64af256b2dc1390c1dea946b2\", \"line\": 351, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 88}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.\", \"key\": \"52fb7bc1390fee443c99f3a243eeec819cb78691640eb9a2166b05992e42545d549a4501170be8c51e31111e8daca9a8f9f54eef31d1fc2a8e01503f6c8e8c9f\", \"line\": 353, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 82}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Microvessels\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"DIC is characterized by a systemic intravascular coagulation, formation of microvascular thrombi, insufficiently compensated consumption of platelets and coagulation factors, and eventually bleeding tendency [84].\", \"key\": \"ce65b29006d2cc8e3a77ff15cf1c02346148cebe74bd50b028c0f8e916acb7c9b7e7317cd5b9f904baa39e594f47210de9f9a0b700ee65bdae3df42dceeb7bc4\", \"line\": 416, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 82}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.\", \"key\": \"2cf9258dbdab759bbf86653fb7d51bf740325da9f5fbbcad755b2a7b99c650c08a778a4e46bef1bdd3d53e8ca722ed70cbe2a76f937094b1e816aa5426e7bf65\", \"line\": 355, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 78}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"In addition, reduced NO bioavailability induces platelet activation and aggregation, leading to thrombosis in a mouse model of intravascular haemolysis (Hu et al, 2010).\", \"key\": \"c3ee717fa90952d50d4fcf52135566421d30c8f6c1e8c46d242919f7a486a2e96f7f10074e825a4ec82a9ce7f197edb2ff5729dec02e573c78e20a383a9b761b\", \"line\": 583, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 40}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"ADP released from haemolysed RBCs induces CD40LG release from platelets and lymphocytes, thereby contributing to the pro-inflammatory and pro-thrombotic environment (Helms et al, 2013).\", \"key\": \"b2e87f13903fca0e122709408bd5fa13ef1aa4be145dac9107ec88c1aa06e4eecc88261776a7a5e1c75f8326d73ecbc6b643e2f406fccb7959a0b7a2351ea31d\", \"line\": 617, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 16}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Some diseases, such as diabetes, hypertension, lower limb vein thrombosis, coronary heart disease, can secondarily alter the properties of RBCs, making them stiffer and prothrombotic [24].\", \"key\": \"d9df28f04451b73d5bea55d5036008b24a78ddabd9f0822519dcbc493435251939860872efac4109f2754cd21b3fba37288d65603a47fb63461db4f196df12e0\", \"line\": 181, \"relation\": \"negativeCorrelation\", \"source\": 99, \"target\": 37}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Because of the large numbers of RBCs present in the blood, even a small fraction of RBCs with phosphatidylserine exposure can result in prothrombotic conditions.\", \"key\": \"d7b43424b41ff9899eeb7d8770af16c2e9a3fb989b353fb8e4ec9ba27af95a189ba4e3e80ebd8099ca49350f2837cdd89467e413993df07e73d93ff177519222\", \"line\": 257, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 7}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"The ability of cells to generate MPs in vivo is an important regulatory mechanism of physiologic reactions, a means for intercellular communications and a pathogenic component in many diseases that impact hemostasis and thrombosis [50, 51].\", \"key\": \"d3e8fef0438f915b64c4274c74b8465a8ac03436dd6f849048dcb7f3768b79a3a6b34bb55c864485581825ad2b7a2f35a387bfa5ceda8e067d6513636b4535d6\", \"line\": 278, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 18}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"An increase of fibrinogen concentration can result in greater RBC aggregation, which is associated with a higher incidence of thrombosis.\", \"key\": \"ad1adea623745ed896daa50ea87cd1d32ae67d73eca5e7024787c6a94a03ad9bd22ca0619ea5685d51dc05d6189ed14eb6d5123e75390db19fb4708c4963359f\", \"line\": 344, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 36}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"4203211b62cd3cdbc50a161d0d516a306addbfb046f98bf540856c5506c1f83e058011e0b4b3ca42e72ad5e871b595c26fc541cec3a44caa9bad2a587925614c\", \"line\": 117, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"5311ea97250e43f099d7ca1531da18d96947b5a7ffe13abb4ac9803cca1155234b1e60a9f56e4538a7f60ddc838b16d21a1581135cf60c1c6f1691a23cc092f3\", \"line\": 98, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"35aa5122c7c3779e7b8893f6699c08aec8479eef93a5651ad4cff9030086eaa791daad8f92b21a7a56ac51af796456c3a9fe5e6167d38ba26d2950f5cbeba8c8\", \"line\": 118, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 5}, {\"annotations\": {\"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"More recently, we have described two infants carrying the mutation who manifested with recurrent strokes [8], establishing the concept that primary Cys89Tyr mutation in CD59 leads to a thrombophilic state.\", \"key\": \"65888f366b3e9cc0ff1356825a5676cdcfbf201a272a0581f7f9659e7c53cc39100a892dc120996c44d05d976c39350055b5c012d2f20c8de49c27b1937f4d72\", \"line\": 140, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 76}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Coronary Vessels\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"In summary, thrombosis is an extremely important prognostic factor both in PNH and in primary Cys89Tyr nonfunctioning CD59.\", \"key\": \"d1bc138cd9088fffd1f0b4bde7e85190e3939cc250f8f4f2b8523472863343a1be1af51440898548dddc40fe80f2847eee7376d9df4d063aa6eb78985316e397\", \"line\": 412, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 76}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"Clinical studies have confirmed endothelial dysfunction and vasculopathy in a patient with HO-1 deficiency, and similarly, mice lacking HO-1 have increased vascular injury and thrombotic complications (43, 44).\", \"key\": \"c23ad047e37e602dfe983205258598f778f6322e10c33dd1cc428a6522b792147840a7aa29a3e7a8ab71a2ba453e44ece3232e41204cbb037314abb939d0e23b\", \"line\": 261, \"relation\": \"negativeCorrelation\", \"source\": 99, \"target\": 66}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"9ba59cedeb61aa697f77ba68c1812d92e8b9cee3184cf0903e0457659608da47dac17717f0e4b6f622e06075cca3dce42e79abcbc6bc21cafb37199334651f4d\", \"line\": 116, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 54}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"25-38 days\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"The median (and mean—data not shown) free Hb levels preoperatively and at all postoperative time points (immediately and 6 and 12 hr postoperatively) were higher (p50.057) in those who later developed a proven thrombosis (Fig. 3 displays the 12-hr data).\", \"key\": \"26432ea088e96b17601fdeefeb7eca624d976bc1b8e1e9230517579c6dfa4d29984b325a0436e93bcad8cae1da700160df8c41e36c1c039b074a200ac32784d9\", \"line\": 164, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"Preoperative\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Our findings in the complex setting of critically ill pediatric cardiac surgery patients demonstrate that higher levels of free Hb and lower levels of haptoglobin are associated with serious postoperative clinical complications (infection, thrombosis, death), immunomodulation, and inflammation.\", \"key\": \"9a393f1886911e28a594a2a99c7b33df5eb41d9b6c6c537736f2df54cf82365ad55909ef8c221a360f7187c76754b1a0b1883921e1910b653dec25b05e39bda7\", \"line\": 196, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"Postoperative\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Children undergoing open heart surgery experience a progressively increasing risk of postoperative infection and thrombosis, increasing need for mechanical ventilation and inotropes, increasing Day 1 through Day 2 peak blood lactate, and decreased nadir mean arterial pressure as the levels of free Hb increase and the levels of haptoglobin decrease.\", \"key\": \"93585a2fa8677851981163e8e352060853381b46afe09bd473ca5e20a6dbb369a987942aea0792d8f6dfd29f4aebe6c8ff0b0a71be2101a93423e1f78af07936\", \"line\": 217, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 54}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"e874a2f3ea0e40407da8b121e02e51049e30f6827b1fb42b2755b9d2dadf9d61ff2f0baa752b76e6ddf67df3eac912d2f4d9afb8c49c8927aa9cd3797e5f8c70\", \"line\": 97, \"relation\": \"positiveCorrelation\", \"source\": 99, \"target\": 54}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"Preoperative\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Adult normal levels of preoperative haptoglobin were associated with a substantially and significantly lower incidence of thrombosis than lower levels of haptoglobin (Table 1; row 3).\", \"key\": \"7e3a0856adb441a7bd71a3d6bec6d93df3f4ca704f28dc40ecbc89b43c5ac58ce071a2babd1352a3f5149d08ac84d18e47cb40c1f581af875b51424ecff25a26\", \"line\": 172, \"relation\": \"negativeCorrelation\", \"source\": 99, \"target\": 56}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Atherosclerosis\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"We recently found that, contrary to other forms of oxidized hemoglobin, ferrylhemoglobin acts as a potent pro-inflammatory agonist in endothelial cells, leading to the up-regulation of adhesion molecules that support the recruitment of macrophages into the vessel wall.36\", \"key\": \"b4af46418afb24f9c3c58decd52544a6a035a53921f311c894b6eeb7e351fdd0e097d7eb59820379b80ad128dd9d49d4777b8a820688acb17d972cc3a5300aa0\", \"line\": 383, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 26}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"For example, HbFe41 (20 mM), but not HbFe31 or HbFe21, induced cytoskeletal reorganization, inflammation and disrupted barrier integrity in endothelial cells after 8 hours of incubation with the proteins.\", \"key\": \"39bc467429298a00dbbbff834cb837e006ab2d5df6e1e0d6027a4891bce06c824aa6af17328428cf7a9e9283c2cac749a381b785fc5786753f61398ccc6db8f8\", \"line\": 204, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 26}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results suggest that heme plays an essential role in kidney inflammation via regulating NLRP3-Caspase-1-IL-1b axis.\", \"key\": \"a01cfda1487a466201adf1835912279fd05d7b0f2c8cff63dd1b62674df6dcd87a652858ab787e1c4e77cfe193ff903fc79c0d0632ce98583ffb3933c1c1570c\", \"line\": 267, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"More recently, we have also shown that free heme is also released during storage and may mediate further inflammation28\", \"key\": \"817c6a0368919e4bf6060a4f5e2eaabfc60c515f5908c3d09b722f5c09b569662975d651603b65ee1ed0d5767dabf4456f25efdb40ec1144006cd9731e63a39d\", \"line\": 171, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 10}, {\"annotations\": {\"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Free heme is a potent trigger of lipid peroxidation and a promoter of inflammation.4–6\", \"key\": \"3913f6de7df5f0400f0db1d0106f63af146257c940dc9632430d949d07c59a8c124b9c4ac5144037203d9def7d66d12f13ff1972c9a4ffa764cf3b24dea827b3\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 10}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Free hemin is a cytotoxic molecule that mediates oxidative stress, endothelial activation, and inflammation, and it is implicated in malaria pathogenesis [40] and AKI, among others [41].\", \"key\": \"5e1450d69c44f26c3f040a722f8014e18b4983f3cb79fae7e89e868073ed8100344855a32a7902bcfc5b67f6d44255671e567e9f534be92c91f80c41b1c2a880\", \"line\": 236, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"b6cd0f0cbc209e817a4725912cad8ab066f957c28f75087be5bfb43869f7b41a82bd30d2668756b95fccb55097fd5819bea99207325bab7d934a73dfa81e8f86\", \"line\": 105, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"13ad8635b9c3c7fce9c83db263cafd0450dbd71aae10d2745dda1cff3308d6bc3e158078d0b9f9e2189d13d57543ca696c4036817f43f807f871a40b9ac31676\", \"line\": 96, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 10}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"In infectious diseases, such as malaria and sepsis, high amounts of cell-free hemoglobin and heme were found [8], suggesting that hemolysis during sepsis and systemic inflammation is of pathophysiological relevance.\", \"key\": \"99417e5931b2eaba05238ea30c381f1b5438d7cee57875dd2e4b2787e9b92fe02e2e2c3de3801b711e7163174000733f2c8ce263facd2b3f0e8538e9702018e6\", \"line\": 287, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"ADP released from haemolysed RBCs induces CD40LG release from platelets and lymphocytes, thereby contributing to the pro-inflammatory and pro-thrombotic environment (Helms et al, 2013).\", \"key\": \"02badac716f369403d923bdc1af3b277845565d6efd1c65ba44eff28f0aed30a8e7463f3e10944212f8eb2b4c0fe0c332b25984e0fd3c687e15f8e6f70779cdc\", \"line\": 616, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 16}, {\"annotations\": {\"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"1 week\": true}}, \"citation\": {\"authors\": [\"Harper V\", \"Marques MB\", \"Oh JY\", \"Patel RP\", \"Stapley R\"], \"date\": \"2015-12-01\", \"first\": \"Oh JY\", \"last\": \"Patel RP\", \"name\": \"Transfusion\", \"pages\": \"2967-78\", \"reference\": \"26202471\", \"title\": \"Predicting storage-dependent damage to red blood cells using nitrite oxidation kinetics, peroxiredoxin-2 oxidation, and hemoglobin and free heme measurements.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Storage is known to result in increased hemolysis which in turn results in loss of NO-signaling, oxidative stress and inflammation post-transfusion.\", \"key\": \"30409656cb59ad9099e71d0240c3b46039d08ed5747ad0ba8fff5df909ac4402399d3416b9702b34a2cdd4171d8b967823cf2546e8ad27a6f87a988e81ff27df\", \"line\": 165, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 15}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.\", \"key\": \"a53dd15252d85b5e8044f1e3ca87d4c455798b810dc6c311aa294afcbd76e5ef35853724a4da4bee880ec28eb33e260ff7dd5fa5038dcbd190fb79eea1de2719\", \"line\": 354, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 31}, {\"annotations\": {\"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true, \"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"Under conditions of apoptosis or RBC damage, such as high shear rates, inflammation, or oxidative stress, RBCs can lose membrane asymmetry and expose phosphatidylserine [43].\", \"key\": \"0e492f09f2721fd92ac0f8c4110787e4f9a9eedf33c90eb00908145c057737dce8d6de19502b5caa5744bc98fca19667473acdd1ac084aa6c3728f525b649dab\", \"line\": 244, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 20}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"1a2ab57b1766b4226880fabe382bc8c5ab2400fe004a80851ea141973f83d85840a529664f44dc9b817084fe041a13837d51c5d2f5e005c41afd8083915485d6\", \"line\": 106, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 5}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Furthermore, experiments of nature that lead to increased levels of chronic hemolysis, such as sickle cell anemia and paroxysmal nocturnal hemoglobinuria, provide evidence that low levels of hemolysis may be harmful, and contribute to inflammation, thrombosis, vasculopathy, and impaired host defenses against infection.1,11\", \"key\": \"4e8663146be8bc85a355cbdd4cbe844f38a3a5de039a141b8a0677f9bc2456fc5427823901f6ad8c28a761068fd219e5070d280e4354fdc257f10ed402bfd822\", \"line\": 128, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 95}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Thus, hemolysis can act as a kind of amplifier of the complex response to an infection or injury [8, 15] and worsen the outcome from animals and patients with systemic inflammation, sepsis, or trauma [1–4, 10].\", \"key\": \"0d37d63bcbd8edd06fae509560db74680f120d5ce8df9dec468849a54a8a134b1d8ea32cc6f083048c4bfd6d4cbe32ff3a5e72edb9a1ef6de4f78e83645dd1ca\", \"line\": 135, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 95}, {\"annotations\": {\"Cell\": {\"platelet\": true}, \"MeSHAnatomy\": {\"Endothelium\": true}, \"MeSHDisease\": {\"Hemoglobinuria, Paroxysmal\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Falach B\", \"Hindi I\", \"Karbian N\", \"Mevorach D\", \"Tabib A\", \"Zelig O\"], \"date\": \"2018-08-01\", \"first\": \"Tabib A\", \"last\": \"Mevorach D\", \"name\": \"Thrombosis research\", \"pages\": \"67-77\", \"reference\": \"29929138\", \"title\": \"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"MPs are small membrane-derived vesicles that are shed upon activation, inflammation, or cell death/damage.\", \"key\": \"31ead39762f06f4fe7bddac192b02f20d43f2cf36d468cb2831e2530958b528413935b3c05e996218759cedac7f2748efa5d7fd5b7eefc9a1e8374ca66f76f44\", \"line\": 347, \"relation\": \"increases\", \"source\": 97, \"target\": 18}, {\"annotations\": {\"MeSHDisease\": {\"Hematoma\": true}, \"Species\": {\"Bos taurus\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Gao Z\", \"Li H\", \"Wang P\", \"Wu J\"], \"date\": \"2019-04-01\", \"first\": \"Wang P\", \"last\": \"Li H\", \"name\": \"Molecular and cellular biochemistry\", \"pages\": \"57-66\", \"reference\": \"30324533\", \"title\": \"Tyrosine residues of bovine serum albumin play an important role in protecting SH-SY5Y cells against heme/H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;/NO&lt;sub&gt;2&lt;/sub&gt;&lt;sup&gt;-&lt;/sup&gt;-induced damage.\", \"type\": \"PubMed\", \"volume\": \"454\"}, \"evidence\": \"Malondialdehyde (MDA) represents evidence of systemic oxidative stress and inflammation [31], and is commonly used to estimate the level of lipid peroxidation.\", \"key\": \"ab9d4440986d201e9a708aa202740c50767dc9647b816353e5878ea2848c407f172c4597b04a7e1e9292bd9c3c4feb754a148eae06ab367008ffebd2af5d21bc\", \"line\": 189, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 12}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Plasma hemoglobin scavenges nitric oxide and causes vasoconstriction, platelet aggregation and inflammation9,22–24.\", \"key\": \"e042cca3207f91df0f37f4c090f2bfc227a8287da19503710ab1518b805e10902f591d1a4a926aee7dd0d9551c11611c34a590d2804b2bab044bee3f28bb93e1\", \"line\": 96, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 54}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"159169da28c182a25b3db158455151a7e7ea79f35022f8e5610f3eb9a440de89de5b079dcdee505948e2740193d058c444cfca232a1f76c2fb11d84e44e66664\", \"line\": 104, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"Preoperative\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"Our findings in the complex setting of critically ill pediatric cardiac surgery patients demonstrate that higher levels of free Hb and lower levels of haptoglobin are associated with serious postoperative clinical complications (infection, thrombosis, death), immunomodulation, and inflammation.\", \"key\": \"0e6ec75f973fb5bf1626b0cd9b8c4b25a5a28e289ca9d4e6b3841d0d7973eb8978fe9e0fcf0d241eb8fd72c74f4c167205b03e1d7d769b3112d26653b1e787a8\", \"line\": 198, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 54}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis.\", \"key\": \"225e8f2c8aefd8ce92b62792dcb5f748d0ea9c9457e0d367d9d851fa03cde63acb757440bc8a0975d6fecc1c1abc2e975644fa88d7a2b31a95d165d18cd5a3f2\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 54}, {\"annotations\": {\"Cell\": {\"hepatocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"In infectious diseases, such as malaria and sepsis, high amounts of cell-free hemoglobin and heme were found [8], suggesting that hemolysis during sepsis and systemic inflammation is of pathophysiological relevance.\", \"key\": \"01b704e72ca601650b75b2beb771cec10e970b5d68d959c2e787d00cac48972bacf2c509c694dd5d21be3a07fdf287f160b59bda2852055ec38a1340920f4451\", \"line\": 285, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 54}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results suggest that heme induced activation of NLRP3-Caspase-1-IL-1b axis is involved in kidney inflammation in mice UUO model and that heme serves as a dangerous factor participates in this process.\", \"key\": \"08451dcf1bad6eb3906221582c36c1d150fb1b543efefed89deadeb66e1d02ffbe05c3ef5a1370fe2dcb9fd768e1499ea458861a99d35b606d7aa27dea1c57b4\", \"line\": 247, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 69}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results suggest that heme induced activation of NLRP3-Caspase-1-IL-1b axis is involved in kidney inflammation in mice UUO model and that heme serves as a dangerous factor participates in this process.\", \"key\": \"23cb03e969efd4d31164ef57263fd2f9eeeb5b229dfb7a4f510d80e1fca35a0398624b50ad93afda55500edda3e234cca17714f5d0c92f317df36b62530c14ed\", \"line\": 246, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 65}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"12 hours\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"These results suggest that heme induced activation of NLRP3-Caspase-1-IL-1b axis is involved in kidney inflammation in mice UUO model and that heme serves as a dangerous factor participates in this process.\", \"key\": \"60817a9a4b361309b72c05f46d0551a1533a1a5c49d07fa573a5373b95f83759f2d5e6c857451769f079f5e7d37a3c073fb3bde1739b48921f065ccc68763866\", \"line\": 245, \"relation\": \"positiveCorrelation\", \"source\": 97, \"target\": 71}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"In conclusion, an Hx-based therapy shows beneficial effects, in that it counteracts heme-induced proinflammatory activation of macrophages and attenuates some of its pathophysiologic consequences, such as chronic inflammation, hepatic fibrosis, and apoptosis (Figure 7E).\", \"key\": \"b412981fa05537c19afa44bb808f49ae2048575c9ce9d05dc0d8a0a33b43b9010c56a88b970dc718c45f7c859f9e8048f106d90fef1c795d5fe91c1de81e55c3\", \"line\": 324, \"relation\": \"negativeCorrelation\", \"source\": 97, \"target\": 67}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"For example, monocytes from SCD patients show an enhanced state of activation, with increased expression of interleukin (IL)-15 and production of TNFα and IL-1β.\", \"key\": \"02a5eb7afb5e1225ee9be38adbd0152c6b7f509ada8ffc443a0cd10d4a03b0c0c985aebaf60f4d41c41b8f953dab828eceaad1428fc059ebc6e536dadb5f4df0\", \"line\": 113, \"relation\": \"positiveCorrelation\", \"source\": 25, \"target\": 58}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Kidney Tubules, Proximal\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Akerström B\", \"Axelsson J\", \"Casslén V\", \"Edström-Hägerwall A\", \"Gram M\", \"Hansson SR\", \"Holmqvist M\", \"Johansson ME\", \"Larsson I\", \"Ley D\", \"Marsal K\", \"Mörgelin M\", \"Rippe B\", \"Rutardottir S\", \"Shohani B\", \"Wester-Rosenlöf L\"], \"date\": \"2014-01-01\", \"first\": \"Wester-Rosenlöf L\", \"last\": \"Hansson SR\", \"name\": \"PloS one\", \"pages\": \"e86353\", \"reference\": \"24489717\", \"title\": \"A1M/α1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"However, A1M treatment resulted in a transient increase in the total number of platelets 48 hours after the first injection and peripheral white blood cells, monocytes and lymphocytes 24 hours after the first injection.\", \"key\": \"afab1a4944d5e0398c4e2bde597308782cfb05ad00fa8328e27ab0a9ffbcf970ddb6c376a84a32b88be06aa9b036af8d271b36699d35d91eea31c6bee2b4445c\", \"line\": 139, \"relation\": \"positiveCorrelation\", \"source\": 25, \"target\": 51}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"For example, monocytes from SCD patients show an enhanced state of activation, with increased expression of interleukin (IL)-15 and production of TNFα and IL-1β.\", \"key\": \"c7ecd932be04932ea120e79b6a0974baf033da10f7cc030094160d65cbdaee7871a08d7087e641c0a7f170af68be16f9567b3123e31f56aa7cdbb49ffb135644\", \"line\": 112, \"relation\": \"positiveCorrelation\", \"source\": 25, \"target\": 64}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Once inside the cells, heme is catabolized by HO enzymes, generating equimolar amounts of biliverdin, carbon monoxide (CO), and Fe (Tenhunen et al., 1968). \", \"key\": \"40d896f10afef0358f30ec4331339ecc17e5cf94e0a7e3837ca7176613a88379d502102079459845c2a28fa1b7dc5f3a0088e4d4748c13ca3cae1eb9b058c0e2\", \"line\": 148, \"relation\": \"increases\", \"source\": 30, \"target\": 2}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Once inside the cells, heme is catabolized by HO enzymes, generating equimolar amounts of biliverdin, carbon monoxide (CO), and Fe (Tenhunen et al., 1968). \", \"key\": \"e5ca92c489ee579853a7dd54d8b67e7de6d7aa6cfe8235d77dbf3b6302924551b148db5fcad1291eb06a51dc1aac6bd68e86b4c1a18a29996dc51a63eefefb7c\", \"line\": 149, \"relation\": \"increases\", \"source\": 30, \"target\": 5}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"Once inside the cells, heme is catabolized by HO enzymes, generating equimolar amounts of biliverdin, carbon monoxide (CO), and Fe (Tenhunen et al., 1968). \", \"key\": \"b0bfc4e4a1ec37b30faa7982fc91d80a368c502aea30fc95418e80b9ef6ff0335fe336398361a3209176acbdeb874ed657d40fcea5d93e57b3eb333eb7f92f92\", \"line\": 146, \"relation\": \"positiveCorrelation\", \"source\": 30, \"target\": 55}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"Following i.p. E. coli infection, we observed a significant increase in plasma heme levels in LysM-Cre+/−Hmox1fl/fl mice (Fig. 1e and Supplementary Fig. 1c), which was accompanied by increased bacterial numbers in blood and liver (Fig. 1f and Supplementary Fig. 1d) and impaired survival (Fig. 1g) when compared with LysM-Cre−/−Hmox1fl/fl controls.\", \"key\": \"a9a618930011466732c5c738a18de338ed29e15691fc1872279e7e72c67ceff12c5561bf11b3371fdb48909795a667ace8db4f8b4f8e0035d8ea75fb53be7e46\", \"line\": 108, \"relation\": \"positiveCorrelation\", \"source\": 33, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"Thus, enhanced levels of plasma heme, induced by either exogenous heme administration or a lack of HO-1 expression in macrophages, resulted in an increased susceptibility to E. coli sepsis.\", \"key\": \"0530dc8594905abd8873936ef14ca5e00e3ec86c5565c014acdf50a4e34878c49134f7f68f522ecb307942ba7dabfadf188ea3ed07921e72a76ec32403c5710a\", \"line\": 116, \"relation\": \"positiveCorrelation\", \"source\": 33, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"Plasma heme amounts were comparable in mice pretreated with Fe3+ or PBS (Fig. 2d), and despite the similarly increased availability of iron in both heme- and Fe3+-treated mice (Fig. 2e), only heme-treated mice presented a significantly higher bacterial burden in the blood and liver compared with PBS- or Fe3+-treated mice (Fig. 2f).\", \"key\": \"4b0d8df1ef918e66da5caa16f41183c3401daa1279abb4ec37f5e5a787e2df830dc7c63d2f701a2035ce591f16f16d1b42a78871dcda3990e47742cd0f8f23d1\", \"line\": 133, \"relation\": \"positiveCorrelation\", \"source\": 33, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Blood\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Aichinger MC\", \"Bennett KL\", \"Brown M\", \"Colinge J\", \"Decker T\", \"Duggan M\", \"Eisenbarth SC\", \"Esterbauer H\", \"Gawish R\", \"Gorki AD\", \"Hladik A\", \"Huber KV\", \"Kerjaschki D\", \"Knapp S\", \"Korosec A\", \"Kubicek S\", \"Lakovits K\", \"Lardeau CH\", \"Maier J\", \"Martins R\", \"Quattrone F\", \"Radic-Sarikas B\", \"Saluzzo S\", \"Sharif O\", \"Sixt M\", \"Starkl P\", \"Superti-Furga G\", \"Vaahtomeri K\"], \"date\": \"2016-12-01\", \"first\": \"Martins R\", \"last\": \"Knapp S\", \"name\": \"Nature immunology\", \"pages\": \"1361-1372\", \"reference\": \"27798618\", \"title\": \"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.\", \"type\": \"PubMed\", \"volume\": \"17\"}, \"evidence\": \"These results indicate that increased heme concentrations directly lead to increased bacterial counts during sepsis and that bacterial iron requirements are met via heme-independent mechanisms.\", \"key\": \"245cae9ff5653d54c3b8e7275167c302187aae9004816b8dc15faeb4500859cfb3546ba43bdbccccc6e365c62ecb70346d51d2d75ad467e9510af86155cf3d5e\", \"line\": 141, \"relation\": \"positiveCorrelation\", \"source\": 33, \"target\": 10}, {\"annotations\": {\"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"20 hours\": true}}, \"citation\": {\"authors\": [\"Brandon AP\", \"Creighton J\", \"Dull RO\", \"Evans CA\", \"Honavar J\", \"Hu PJ\", \"Kerby JD\", \"Marques MB\", \"Morgan C\", \"Oh JY\", \"Patel RP\", \"Pittet JF\", \"Richter JR\", \"Stephens SW\", \"Wagener BM\"], \"date\": \"2018-03-01\", \"first\": \"Wagener BM\", \"last\": \"Patel RP\", \"name\": \"PLoS medicine\", \"pages\": \"e1002522\", \"reference\": \"29522519\", \"title\": \"Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study.\", \"type\": \"PubMed\", \"volume\": \"15\"}, \"evidence\": \"Pulmonary edema approximately doubled (Fig 1D), and lung bacterial CFUs significantly increased (Fig 1E) in mice resuscitated with stored RBCs compared to those that received fresh RBCs.\", \"key\": \"fe2afab571247d7edf6c8c198590bab609b6f6a8658318c2e9608e801dfc92bc13fe9b4bca90ada8353a448bce5d5134c56e66d7497ba4a75bd648ff4d19f923\", \"line\": 99, \"relation\": \"positiveCorrelation\", \"source\": 33, \"target\": 15}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Transfusion of RBCs after prolonged refrigerator storage is associated with haemolysis (Donadee et al, 2011; Hod et al, 2011) and enhances cytokine secretion in response to lipopolysaccharide (LPS) administration (Hod et al, 2010).\", \"key\": \"276cb3994bdb98b0048329293d8036662f24cd47a0d638a3e7a5436d731b8932a419ea38be46b53acd5c403f62ece3e0d536f2225f39eca8430153ab76b74541\", \"line\": 511, \"relation\": \"increases\", \"source\": 11, \"target\": 24}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"We showed that simulation of macrophages with LPS resulted in significant reduction in ferroportin mRNA and protein expression and enhanced intracellular iron deposition throughout all time points tested (Fig. 5A–D).\", \"key\": \"bbeb4571a615ff2a466a83a36847c19a9319c505c3c34e769b8fea632fe244bfb0002395f891ffdc6da16fe4dad0014cb44369a800bd7439082d3e01608415b0\", \"line\": 155, \"relation\": \"positiveCorrelation\", \"source\": 11, \"target\": 5}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"This dramatically contrasts the iron phenotype that develops in response to LPS, hallmarked by high intracellular iron levels and low ferroportin expression (10, 20, 48).\", \"key\": \"d81faeb49ccdbb336acb85a84f808da243a2efccce6806d3ff7faaf91792c4c7a63d58be3e3ce58961e36a2d31e9c0583ed1a2e3e6079cdc26cd4ac43ec79ec9\", \"line\": 252, \"relation\": \"positiveCorrelation\", \"source\": 11, \"target\": 5}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"We showed that simulation of macrophages with LPS resulted in significant reduction in ferroportin mRNA and protein expression and enhanced intracellular iron deposition throughout all time points tested (Fig. 5A–D).\", \"key\": \"703d06251f8747f8e17d491693da9d3bb12052b8b0882ef32074978773e8d341fd691b20035aa0b364b5bf9971186adcc0b91777f4e12398b3817d70468538c1\", \"line\": 154, \"relation\": \"negativeCorrelation\", \"source\": 11, \"target\": 73}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"This dramatically contrasts the iron phenotype that develops in response to LPS, hallmarked by high intracellular iron levels and low ferroportin expression (10, 20, 48).\", \"key\": \"f33e05c3a639694e053c36c25cea7ac7cc18b33bd3c2c6eb777b40e57382ec3f59e2ecfd9cef0ef584701971b0be4c942f7cbf888cee28264b68e31fa977468a\", \"line\": 253, \"relation\": \"negativeCorrelation\", \"source\": 11, \"target\": 73}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"We showed that simulation of macrophages with LPS resulted in significant reduction in ferroportin mRNA and protein expression and enhanced intracellular iron deposition throughout all time points tested (Fig. 5A–D).\", \"key\": \"f1360313f13a262605c779b4a16d6584208ae341d4fc5d929e2cf5c412095bc47cc73c7f9b9a2f52ba0fc6dbaf792ce91f2d732fdaaf9748f793d982ada4943b\", \"line\": 153, \"relation\": \"negativeCorrelation\", \"source\": 11, \"target\": 73}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"In animal experiments, the administration of lipopolysaccharide (LPS) to induce systemic inflammation leads to a significant increase in plasma concentration of cell-free hemoglobin as well [5–8].\", \"key\": \"e12f3ac4a2dd1f1d2a7ad67fa9aca3b68657863e7bf7394e5e0d5e9e1715e86879875645c9d5ef3eb603d84a8499e8889a5dfc1f792449f5ae5a5f6c1c584fda\", \"line\": 114, \"relation\": \"increases\", \"source\": 11, \"target\": 54}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Furthermore, ROS induction by haem directly depends on signal transduction involving Ga inhibitory protein and phosphoinositide 3-kinase, and partially depends on phospholipase Cb, protein kinase C, the mitogen-activated protein kinases (MAPKs) and Rho kinase in neutrophils (Porto et al, 2007).\", \"key\": \"954118da7b4207a0451671babd50651a71b803adcc128d820996c63acde52a8ba738867e417cca1b6e86d57273af8f62c73d041c16ca4cecf2485ca231db4cdb\", \"line\": 503, \"relation\": \"positiveCorrelation\", \"source\": 21, \"target\": 22}, {\"annotations\": {\"Cell\": {\"leukocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"TLR4 activation leads to MAPKs and NFκB activation, which are necessary to TNF secretion.\", \"key\": \"4448684eb426f3fdeea6991dc82511c687f5d3ec3a830c8281636050b1592f456bbcad466e31904b76ba227bef67f254c9214a9329acf0a5e1d73df525dc7229\", \"line\": 449, \"relation\": \"increases\", \"source\": 21, \"target\": 64}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Aorta\": true}, \"TextLocation\": {\"Introduction\": true}, \"TimePoint\": {\"10 min\": true}}, \"citation\": {\"authors\": [\"Chin-Dusting JP\", \"Jackson SP\", \"Salem HH\", \"Sturgeon S\", \"Woollard KJ\"], \"date\": \"2009-05-08\", \"first\": \"Woollard KJ\", \"last\": \"Jackson SP\", \"name\": \"The Journal of biological chemistry\", \"pages\": \"13110-8\", \"reference\": \"19276082\", \"title\": \"Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.\", \"type\": \"PubMed\", \"volume\": \"284\"}, \"evidence\": \"By-products of heme and iron metabolism, such as heme oxygenase-dependent generation of carbon monoxide (CO), have antioxidant and anti-inflammatory protective functions against iron-induced vascular damage (33); therefore we examined the impact of CO donors on collagen exposure and thrombus formation in the ex vivo vascular injury model.\", \"key\": \"f9b15ad82fc1a160573b8c5fe1b86c785977e2d1ddc6c51bf530711ad503e4fcf1df85e7a9ac0940588e122d6c0420f74f0a0dc1212554174a6ecedd13606a2a\", \"line\": 203, \"relation\": \"negativeCorrelation\", \"source\": 2, \"target\": 91}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \" Differently from biliverdin and CO, which have anti-inflammatory effects (Otterbein et al., 2000; Baranano et al., 2002), free Fe is highly oxidative and can promote free radicals generation through the Fenton reaction, which catalyzes hydroxyl radicals from the reaction of Fe with H2O2 (Fenton, 1894).\", \"key\": \"688298a45782c301261d36343b1ef583c22612579ea41e4eb95ae614db5fb8f0d225e633cca988872e88d53c39e461f26e2115001f9a9cc0f698855a46f64cf5\", \"line\": 159, \"relation\": \"decreases\", \"source\": 2, \"target\": 31}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Malaria\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \" CO inhibits Hb oxidation and subsequently heme release, thus blocking heme accumulation in serum and preventing heme from exerting its inflammatory effects in the course of malaria disease (Ferreira et al., 2011).\", \"key\": \"2c2ea251597a8f5eb4794439707472ce6dcf7a9614c456e9e9b5fb090720439fa4a83f93ebbb7046a662779a619bbe0c73bff613f5661bbaca186a01835e009f\", \"line\": 411, \"relation\": \"decreases\", \"source\": 2, \"target\": 10}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Within cells, heme is catabolized by the activity of heme oxygenases (inducible HO-1 and constitutive HO-2) into iron, carbon monoxide, and biliverdin.\", \"key\": \"84347dabe0fcd3fba2161605eea5193cef9687d80d3e2974186c51cd41a63daf465308b7b5753396d1f6e2682d37a1efca098dc3525ef2de256d08f8398f56c6\", \"line\": 103, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"positiveCorrelation\", \"source\": 2, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Carbon monoxide has vasodilatory, anti-proliferative, anti-inflammatory and antioxidant properties, whereas bilirubin, the product of biliverdin reductase, is an antioxidant (Baranano et al, 2002).\", \"key\": \"37a344df884a6410d41da20ad4efdc44570831aaa9874f0344ddba319a5a6c2cff1b128163d0dfcd4e6ff7345587fb6398c67a51077574ae123c401324c95964\", \"line\": 159, \"relation\": \"decreases\", \"source\": 2, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Carbon monoxide has vasodilatory, anti-proliferative, anti-inflammatory and antioxidant properties, whereas bilirubin, the product of biliverdin reductase, is an antioxidant (Baranano et al, 2002).\", \"key\": \"796de918bbc0f99a7c14fee01c6ef72079b25dad2695c21e90f2a0b20a655a616ccae875b310ecce3cd1ce5f8d0321717494961b45e826b27f0fcb8345797aa7\", \"line\": 160, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"positiveCorrelation\", \"source\": 2, \"target\": 9}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"CO also inhibited stasis in mice treated with SnPP + Hb without Hp or Hpx.\", \"key\": \"b40d471070ac3226c887adf5c454688a5524c1cd24ca0fe5f777c7374efaf2d8bcbade3f5e8c8cb5961fcf6ad360d586197ec625d156c204bb282a974adceb2c\", \"line\": 190, \"relation\": \"negativeCorrelation\", \"source\": 2, \"target\": 77}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"The beneficial effects of Hp and Hpx were lost by inhibition of HO with SnPP, but could be restored by CO administration.\", \"key\": \"0db0296d2f368a48e52bd009741d897ae5de47c30ad1491cdaea6e5ad6f199f6b6c9cceb9936510c9a31fdd6476738a513f5cbb08256e6be593dee2062a0f8a4\", \"line\": 214, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"positiveCorrelation\", \"source\": 2, \"target\": 67}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"SnPP and CO had similar inhibitory effects on NF-kB activation in the liver (data not shown).\", \"key\": \"66b925b63b5d26a7f98c58a68b8dd3c3033b6a7db4f3366fe2f824c5c694b322ecfa063a005ce729ed579b89bc0baf758330f8d7ee65ff90cfe987c136da7dc9\", \"line\": 196, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"negativeCorrelation\", \"source\": 2, \"target\": 70}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"MeSHDisease\": {\"Plaque, Atherosclerotic\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"This engenders the release of iron, which can promote further the oxidation of plaque lipids through redox cycling reactions. The result of these chemical reactions is the formation of deleterious oxidized ‘gruel’ which, among other things, leads to endothelial oxidative stress and ultimately to cytotoxicity.\", \"key\": \"120cd5c38a047a0ec959ad69b04afbddbac6bbaa700b9faaed696f211b24c141bb15a948d7ade28aa0ca692f2fb49a433b99f058003a9b951c3d2376d0d00f39\", \"line\": 275, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 39}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, by participating in Fenton chemistry, non-transferrin-bound iron (i.e., iron not bound to the physiological iron transport protein, transferrin) causes oxidative damage, cytotoxicity and enhanced endothelial expression of adhesion molecules, thereby enhancing thrombotic risk (Hershko, 2007).\", \"key\": \"7be9f7beba88c2075ccdceae2c75403706bb4830bd5f02218e7fd3104c05cf177a3f67d0c1fbc4ea872d41592fac14a34d607c98e266f606a8d948c79bf1cf4f\", \"line\": 632, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 39}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Extracellular hemoglobin and its degradation products, free heme and iron, are highly toxic due to oxidative stress induction and decrease in nitric oxide availability.\", \"key\": \"024bed557dadd3a4ed1c0c33b01192ffb92915c00f4893938bb54accd45ce81377d95cada2a0cd559866bd3899c66bd609f3916fc5982106361575ac8f93433e\", \"line\": 106, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 39}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Hb and its degradation products – free heme and iron - perpetuate oxidative stress, and together with decreased NO availability promote many SCD complications.\", \"key\": \"2d87522beb7f195b18ea1ecb52ec5b16e855da7cdf754775f1353a4c89762f128eebf7c7c1607ae58be48ba4d16cd7437ca5c3c642630aef86cea8f5b01d15b8\", \"line\": 123, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 39}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHDisease\": {\"Atherosclerosis\": true}, \"TextLocation\": {\"Discussion\": true}}, \"citation\": {\"authors\": [\"Balla G\", \"Balla J\", \"Csonka T\", \"Eaton JW\", \"Galajda Z\", \"Jeney V\", \"Méhes G\", \"Nagy E\", \"Smith A\", \"Soares MP\", \"Szentmiklósi J\", \"Varga Z\", \"Vercellotti GM\"], \"date\": \"2010-07-01\", \"first\": \"Nagy E\", \"last\": \"Balla J\", \"name\": \"Arteriosclerosis, thrombosis, and vascular biology\", \"pages\": \"1347-53\", \"reference\": \"20378845\", \"title\": \"Red cells, hemoglobin, heme, iron, and atherogenesis.\", \"type\": \"PubMed\", \"volume\": \"30\"}, \"evidence\": \"Earlier chemical investigations of gruel from advanced lesions revealed that it contains ceroid-like insoluble material composed mainly of hydoxyapatite, iron and calcium.\", \"key\": \"8b80ac0f1d27521f33df61099935c142e3cf4c8733ff68d8e124db79644e60142bd26541a3ab5351f512fd1ad6003242944456c7b7b651b05e87dc9a65bb95e0\", \"line\": 360, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 84}, {\"annotations\": {\"MeSHAnatomy\": {\"Ependyma\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Du H\", \"Gao C\", \"Hua Y\", \"Keep RF\", \"Strahle J\", \"Xi G\"], \"date\": \"2014-06-01\", \"first\": \"Gao C\", \"last\": \"Xi G\", \"name\": \"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism\", \"pages\": \"1070-5\", \"reference\": \"24667910\", \"title\": \"Role of red blood cell lysis and iron in hydrocephalus after intraventricular hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"34\"}, \"evidence\": \"Twenty-four hours after injection, T2 MRI showed a significant bilateral ventricular enlargement in the iron-injected group (17.9±5.7mm3) compared with salineinjected rats (9.2±5.7mm3, Po0.01, Figure 4).\", \"key\": \"c7daaedd765eb4f643149c37b53efab4d09b5ef9a29496594ce08bf4c06cfabdad3340684760dcf27f2299ecee875b1e25958a574f441b16a12a046f1c89ce64\", \"line\": 145, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 96}, {\"annotations\": {\"MeSHAnatomy\": {\"Ependyma\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Du H\", \"Gao C\", \"Hua Y\", \"Keep RF\", \"Strahle J\", \"Xi G\"], \"date\": \"2014-06-01\", \"first\": \"Gao C\", \"last\": \"Xi G\", \"name\": \"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism\", \"pages\": \"1070-5\", \"reference\": \"24667910\", \"title\": \"Role of red blood cell lysis and iron in hydrocephalus after intraventricular hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"34\"}, \"evidence\": \"The major findings of this study are (1) intraventricular injection of lysed RBCs but not packed RBCs resulted in hydrocephalus; (2) lysed RBCs upregulated brain HO-1 and ferritin levels; (3) intraventricular injection of iron also caused hydrocephalus; and (4) iron chelation with deferoxamine reduced lysed RBC-induced hydrocephalus.\", \"key\": \"b9d381b364f6c92c63dd5cfb090273941c80f534444dc86164260389c95e608a13e505c9ad215845dc3f6a92a2be9a79b72cdeda8fa47399d8143bb1a62f010b\", \"line\": 173, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 96}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Bozza MT\", \"Dutra FF\"], \"date\": \"2014-01-01\", \"first\": \"Dutra FF\", \"last\": \"Bozza MT\", \"name\": \"Frontiers in pharmacology\", \"pages\": \"115\", \"reference\": \"24904418\", \"title\": \"Heme on innate immunity and inflammation.\", \"type\": \"PubMed\", \"volume\": \"5\"}, \"evidence\": \"These concepts challenged the idea that the cytotoxic and inflammatory effects of heme were exclusively mediated by the oxidative capability of the Fe associated with the amphipathic property of the porphyrin ring.\", \"key\": \"fdb824d3f89a5905e9473c8c3145d145ac5d951401053b77f1b5cbf5d7d643f8f1fcc66c54b10fcddc85f1e7f9ad15111d649ae883ab2e8be01a5d89110f633c\", \"line\": 361, \"relation\": \"increases\", \"source\": 5, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).\", \"key\": \"c1e69264323eab91c750ea353a65bec0a52f7201601768a8f51dbc9b25f78cba5d590ecd7d8a344296c2b5fa74544065779615066d4f45d219f9ee242ad17648\", \"line\": 181, \"relation\": \"increases\", \"source\": 5, \"target\": 97}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"c0739f271c4eff1c62b10f2cd097a6cc2cbfe8eead9b54915fa5a81d007aaa3af1fe125d23736547cca37885364272f2d6131d8caf41dd585a6130dbd79f8c08\", \"line\": 106, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).\", \"key\": \"f9eb605b4624355fdfe70d9b78d98376e584ddb5607a17e49cb197b6bc9c8504801dd50beac1ae424bea65fc9456dfe23a2a3efc87b995691893c48552524b33\", \"line\": 182, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"decreases\", \"source\": 5, \"target\": 9}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"ROS generation by haem is at least partially dependent on the Fenton reaction, in which iron catalyses the production of toxic ROS (Wagener et al, 2003).\", \"key\": \"be79239a1f7a002bca452c6f2ef24417dbdb8c6ba07300fed4e44c02c9e7b67b338a0056b49c96117b4de01ff7dc70d95d53f463e5d8994e43c84e5b1ecd804e\", \"line\": 483, \"relation\": \"increases\", \"source\": 5, \"target\": 22}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"We confirmed that the redox active iron, which is derived from heme catabolism in macrophages, is capable of catalyzing ROS formation (Fig. 7A) (19).\", \"key\": \"1a40c2f2e6f00c6e57a224de1464cee16d7e7c3847d0c19316ed2513e2981f3970815a7a6651e85c7807a43c10c5f2a2f2a649b28598bd1a719df33339e066ba\", \"line\": 176, \"relation\": \"increases\", \"source\": 5, \"target\": 22}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Finally, ferrous iron, through Fenton-derived hydroxyl radical species production and protein kinase C function, activates platelets (Iuliano et al, 1994). \", \"key\": \"f7fb924c053f91cb1c220dd7d80550277bf6988112b18c54b9e12d47688cf3f3f9595d6c96ef5aed01a46552eded677599053d825044b95d93570534eb846433\", \"line\": 623, \"relation\": \"increases\", \"source\": 5, \"target\": 40}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"beb30c6a6431cc2de9fb1c10f2f6b955de9fdd4bfca203a40c3159e9f684277a57780f4e8a94e6147838fb5ad5fa8e1cd9ae222d293bbabfbe7af8697c59f850\", \"line\": 110, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 40}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, by participating in Fenton chemistry, non-transferrin-bound iron (i.e., iron not bound to the physiological iron transport protein, transferrin) causes oxidative damage, cytotoxicity and enhanced endothelial expression of adhesion molecules, thereby enhancing thrombotic risk (Hershko, 2007).\", \"key\": \"0b59217007c32fb2ec0e15f69320bd9a72a1f11920f9aaf49dbb93a0c9ed2bb63bae11b9e32536cde0ad6212c4a83a1ab316b9a53214ca1dd58a89ba97d2d010\", \"line\": 633, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 35}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Plasma\": true, \"Urine\": true}, \"MeSHDisease\": {\"Anemia, Hemolytic, Autoimmune\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Hod E\", \"L'Acqua C\"], \"date\": \"2015-01-01\", \"first\": \"L'Acqua C\", \"last\": \"Hod E\", \"name\": \"British journal of haematology\", \"pages\": \"175-85\", \"reference\": \"25307023\", \"title\": \"New perspectives on the thrombotic complications of haemolysis.\", \"type\": \"PubMed\", \"volume\": \"168\"}, \"evidence\": \"Thus, by participating in Fenton chemistry, non-transferrin-bound iron (i.e., iron not bound to the physiological iron transport protein, transferrin) causes oxidative damage, cytotoxicity and enhanced endothelial expression of adhesion molecules, thereby enhancing thrombotic risk (Hershko, 2007).\", \"key\": \"0f6ff7eddf81924c2472ee0aca9e545603d97cde1ff5fda99307303c25e6750b40179d4044b7c271dd4a69bbb9c3b0b334d0d9aed6b8823c1e1f6ab263eb990c\", \"line\": 635, \"relation\": \"increases\", \"source\": 5, \"target\": 99}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"294327c80813eb9694b584cdcf84e7720e0745f9eb6d51e8dc22db03acf41557a3ed3afed02d03ccbca3ab00bd299f9c29233753f4c388d676940083232c9a24\", \"line\": 118, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 99}, {\"annotations\": {\"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Within cells, heme is catabolized by the activity of heme oxygenases (inducible HO-1 and constitutive HO-2) into iron, carbon monoxide, and biliverdin.\", \"key\": \"5d9f5da6e48f99e7d74a12889f6acfdb01f5dbb464504ac7d5aa17ea472566447ab4af1540a8348279ffd02317d1ef953d8cbbd9f769e50f310fe3689dc93bc7\", \"line\": 102, \"object\": {\"modifier\": \"Degradation\"}, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"Under heme overload conditions, macrophages acquire an iron phenotype characterized by low intracellular iron and high ferroportin expression.\", \"key\": \"b08e5ac30642332234988b0e043a9ad5e9c1265c1554cc4ae0b4589ead8773d786736e93c25d5f861072cec903e5de82d77c7e0b669a3e64542b46325a562e0f\", \"line\": 244, \"relation\": \"negativeCorrelation\", \"source\": 5, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Importantly, protoporphyrin did not induce TNFα, suggesting a critical proinflammatory role for iron within the heme moiety (supplemental Figure 8).\", \"key\": \"e91b60f937013c03bc0c62151b6f9d7fb33a732d808bab3254b6159bd6ccee62effdb0e307b323f2f7f311fb74bfc18c23d82bf27b1bc3f882811a2201e24101\", \"line\": 177, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 31}, {\"annotations\": {\"MeSHAnatomy\": {\"Arteries\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Another pathogenic mechanism involves the release of iron from cell-free hemoglobin with consecutive radical formation, which in turn can modify lipids, proteins, and DNA, leading to inflammation [39].\", \"key\": \"4b1759dcad24976ed231f0ef28a07651db77dc4f3025e10a6588941ac5133bdf1438c866dbf0f353ee3fbdca5a0918ce3067957b75bf87d9c60648476e7d85a3\", \"line\": 246, \"relation\": \"increases\", \"source\": 5, \"target\": 31}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Spleen\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Likewise, NAC was able to prevent iron-induced M1 polarization in M0, M1, and M2 BMDMs (supplemental Figure 13), indicating that the alteration of macrophage plasticity in response to iron is mostly explained by its pro-oxidant properties.\", \"key\": \"714df1939f631256e76a0ea6bb2af89759d451e6e7baabcd079f38fd161e52fea66acbcf70fc856bdaed1b91ca1d91098bb10ccaa4a67894940c3c06ed65aa54\", \"line\": 232, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 14}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"MeSHAnatomy\": {\"Kidney Tubules\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"28 days\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"In old blood-transfused animals, strong Hb and iron deposition was observed in the tubule lumen and epithelial cells, respectively.\", \"key\": \"7a69b55f7d2de20c43acc62cdbecd2cf362581a2f7e2e9e04f0096d171f10961495d80f908a9422b22e2b69f671995eb245d33cc624988e290befd7c6f914a25\", \"line\": 171, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 17}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney Cortex\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Tissue iron staining revealed greater cortical iron accumulation in the kidneys of mice resuscitated with SRBCs, SRBCs combined with albumin and SRBCs combined with hemopexin than in the kidneys of mice transfused with FRBCs (Figure 6A and B).\", \"key\": \"2c253cca0d388225e67a24abdad835726b4233d7d6bf92d0bc21442ca32c19471db7f680df53eb99f3cad2af90c07d1a3d1be69c3a1ba0b81b5e04403294a6da\", \"line\": 286, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 17}, {\"annotations\": {\"MeSHAnatomy\": {\"Spleen\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Splenic iron content was greater in mice after resuscitation with SRBCs than in FRBC-transfused mice.\", \"key\": \"0b1ef32b47f791298011df2098ad05fc61a9b8b5854836c769b0cfad14184f584ef262b9e75267c217e0f6c85b665d91bd377ff8bb029f5eefcbc0454d3e3bb1\", \"line\": 300, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 17}, {\"annotations\": {\"MeSHAnatomy\": {\"Spleen\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Taken together, these results indicate that haptoglobin co-transfusion prevented stored blood transfusion-associated renal iron uptake and led to increased weight and greater iron- accumulation in the spleens of mice.\", \"key\": \"a69fd088dd972a6eb515b27f081d2676ff9368afdff0f2cc5ad650c83c19f24bf0c6fb2c3140ca52aca8f97981e38eb59c247d176d30f6234f23d9a1c93b3ffe\", \"line\": 323, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 17}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney Cortex\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Tissue iron staining revealed greater cortical iron accumulation in the kidneys of mice resuscitated with SRBCs, SRBCs combined with albumin and SRBCs combined with hemopexin than in the kidneys of mice transfused with FRBCs (Figure 6A and B).\", \"key\": \"111f659a163f0faf017c65c07515dc58c53cbd7ac8c2e9ca50e90edffec5a9fdbdcd701dcf9db4cba2752f0e7ab706a279247fd29cf938dbab9f85f2617f246e\", \"line\": 287, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 50}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney Cortex\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Tissue iron staining revealed greater cortical iron accumulation in the kidneys of mice resuscitated with SRBCs, SRBCs combined with albumin and SRBCs combined with hemopexin than in the kidneys of mice transfused with FRBCs (Figure 6A and B).\", \"key\": \"49b73fe4bab1a9e79db1afe71d31f8fe31d6c6cbb59346a8b1b4790412efc7dacdfe57ac0a78e13ddd32e0cb052847fdbf932f96790d7c00b0e0fc4ec440db42\", \"line\": 288, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 48}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney Cortex\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"Only transfusion of SRBCs and haptoglobin prevented SRBC-induced renal iron accumulation (Figure 6A and B).\", \"key\": \"cf469064f4171abb72d23f7614b4508d64e7f9a0ffcc19f1052e57a7016b7c7dba73c025962328b75880e5c0f519594ee6f6c37ae9844f8391430546c6d9e5c6\", \"line\": 294, \"relation\": \"negativeCorrelation\", \"source\": 5, \"target\": 49}, {\"annotations\": {\"MeSHAnatomy\": {\"Spleen\": true}, \"MeSHDisease\": {\"Hemorrhage\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Bloch DB\", \"Bonventre JV\", \"Colvin RB\", \"Graw JA\", \"Liu Y\", \"Malhotra R\", \"Mayeur C\", \"Rechester O\", \"Riley FE\", \"Rosales I\", \"Sabbisetti VS\", \"Warren HS\", \"Zapol WM\"], \"date\": \"2016-09-27\", \"first\": \"Graw JA\", \"last\": \"Zapol WM\", \"name\": \"Circulation\", \"pages\": \"945-60\", \"reference\": \"27515135\", \"title\": \"Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.\", \"type\": \"PubMed\", \"volume\": \"134\"}, \"evidence\": \"In comparison to mice transfused with SRBCs alone, the spleens of mice resuscitated with SRBCs and haptoglobin contained more iron (Figure 6D).\", \"key\": \"de9557c605fbaeb87159b2200ce8851abc90c313bbf224d16875d1c3e4290736fc5841b39f39f5c74236547414e3090d2ab93a220711e424859f05e80724c9d9\", \"line\": 306, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 49}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Abstract\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Extracellular hemoglobin and its degradation products, free heme and iron, are highly toxic due to oxidative stress induction and decrease in nitric oxide availability.\", \"key\": \"ea7a9c2f6fe6bc50a6747a035b19ca7e3fab0688cdf79f4b7b019209a7347342275cc61f8871c1716e31c5052dbd8d58b91d7171e01af39949b5e54c66252b3b\", \"line\": 108, \"relation\": \"decreases\", \"source\": 5, \"target\": 6}, {\"annotations\": {\"MeSHAnatomy\": {\"Erythrocytes\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Kurnikova MG\", \"Rafikov R\", \"Rafikova O\", \"Sakipov S\"], \"date\": \"2017-04-01\", \"first\": \"Sakipov S\", \"last\": \"Rafikov R\", \"name\": \"Redox biology\", \"pages\": \"516-523\", \"reference\": \"28088643\", \"title\": \"Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin.\", \"type\": \"PubMed\", \"volume\": \"11\"}, \"evidence\": \"Hb and its degradation products – free heme and iron - perpetuate oxidative stress, and together with decreased NO availability promote many SCD complications.\", \"key\": \"89f3c72f9cfdfdc571771af6cf3c1738e0c478a86f7be724b67d0ba70e40a0d5a7c6f46aa95cab1f87143fcea6df5cf37f1f44da7805cbf354782e44a47a94ea\", \"line\": 125, \"relation\": \"decreases\", \"source\": 5, \"target\": 6}, {\"annotations\": {\"Cell\": {\"bone marrow cell\": true}, \"MeSHAnatomy\": {\"Duodenum\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Using isolated duodenal loops to measure the transepithelial iron transport, we found that CEP mice presented a higher rate of iron absorption than the WT mice, although the differences between the area under the curves did not reach statistical significance (Figure 3D).\", \"key\": \"836301b0b21f8b4e5e5e00b5d8ad25c64190f75889090b1115d40fcc8d727640f8cc645703b55cf0720c136459ab3f0e76ca617d35a786614b01419640e9b30c\", \"line\": 196, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 85}, {\"annotations\": {\"Cell\": {\"bone marrow cell\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Serum iron was also increased in CEP mice, but this did not lead to elevated Tf saturation because Tf was also significantly increased, which is reminiscent of iron deficiency anemia and facilitates iron delivery to a larger number of erythroblasts (Table 1 and Figure 3G).\", \"key\": \"6e938f698557f949e4ff3df92d92c39ef6618e31efd2fed817d28e625d9466391fe2dbdbfbeda128015e370984858fc5b217fc37c2191a56529c8be58e5b2004\", \"line\": 213, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 85}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Serum\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Iron was also detected in the macrophages of the red pulp of CEP mice, while almost no iron deposit was observed in the spleen of Hjv–/– mice (Figure 4B), confirming that Hb and “free” heme are the likely source of macrophage iron accumulation.\", \"key\": \"362352a3fe935272b117919cb984fa7c2e4fc966ba5660ac117bb9f1fbfe6a855c7b97c60e68ea9de3b9c3ef68cb28f8873db275d8287b7cc54f594a455250b6\", \"line\": 228, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 85}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Kidney Cortex\": true}, \"MeSHDisease\": {\"Porphyria, Erythropoietic\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Beaumont C\", \"De Verneuil H\", \"Delaby C\", \"Deybach JC\", \"Ducrot N\", \"Ged C\", \"Gouya L\", \"Karim Z\", \"Lefebvre T\", \"Lettéron P\", \"Lyoumi S\", \"Millot S\", \"Moulouel B\", \"Pilard N\", \"Puy H\", \"de Franceschi L\"], \"date\": \"2017-02-01\", \"first\": \"Millot S\", \"last\": \"Karim Z\", \"name\": \"Haematologica\", \"pages\": \"260-270\", \"reference\": \"28143953\", \"title\": \"Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"As expected, Perl’s staining of CEP kidneys showed significant accumulation of iron in the renal cortical part, particularly in the proximal tubules (Figure 6A).\", \"key\": \"3f572538c1d80a08e073c1a114f6677967ae633955b9e571aa252979065a6547452523aec07efb3bf78df9210a764e4088792a873812a7b3d239d419701a8b24\", \"line\": 285, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 85}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"We showed that simulation of macrophages with LPS resulted in significant reduction in ferroportin mRNA and protein expression and enhanced intracellular iron deposition throughout all time points tested (Fig. 5A–D).\", \"key\": \"88d2c2921e27afb256a1009b284af70425076b5df785b4fa624ca83aad29f13a25398d35a63b4be58bc76d336ac03b0d713665736ecf4094c099d8d7ddf23c3d\", \"line\": 155, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 11}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"16 hours post-treatment\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"This dramatically contrasts the iron phenotype that develops in response to LPS, hallmarked by high intracellular iron levels and low ferroportin expression (10, 20, 48).\", \"key\": \"53f759ce66f79a438a781b667186266d050850c97bdad77d5636ecacb82b246a566b5ae29a0030acc1a133501ac5321cdc81f1847d2416216df8be5ce3b60201\", \"line\": 252, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 11}, {\"annotations\": {\"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"14 days\": true}}, \"citation\": {\"authors\": [\"Brandon AP\", \"Creighton J\", \"Dull RO\", \"Evans CA\", \"Honavar J\", \"Hu PJ\", \"Kerby JD\", \"Marques MB\", \"Morgan C\", \"Oh JY\", \"Patel RP\", \"Pittet JF\", \"Richter JR\", \"Stephens SW\", \"Wagener BM\"], \"date\": \"2018-03-01\", \"first\": \"Wagener BM\", \"last\": \"Patel RP\", \"name\": \"PLoS medicine\", \"pages\": \"e1002522\", \"reference\": \"29522519\", \"title\": \"Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study.\", \"type\": \"PubMed\", \"volume\": \"15\"}, \"evidence\": \"Fig 2 shows that free hemoglobin and free heme were higher 4 h after resuscitation with stored RBCs compared to fresh RBCs (n = 3±7 as indicated); NTBI level was also higher, but this difference did not reach statistical significance (p = 0.07).\", \"key\": \"9a38fcf4c9513c3c821ac5ae100c9ebab031a885f0f62abbcc4df886bce8baffe9e8278b27f458b3fcbd4bc6cde40222206380dea47844efa63aeeb23a7eae3e\", \"line\": 117, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 15}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Alfieris GM\", \"Blumberg N\", \"Cholette JM\", \"Eaton MP\", \"Gensini F\", \"Henrichs KF\", \"Phipps R\", \"Pietropaoli AP\", \"Powers KS\", \"Refaai MA\", \"Rubenstein JS\", \"Spinelli SL\", \"Sweeney D\"], \"date\": \"2018-07-01\", \"first\": \"Cholette JM\", \"last\": \"Blumberg N\", \"name\": \"Transfusion\", \"pages\": \"1631-1639\", \"reference\": \"29603246\", \"title\": \"Elevated free hemoglobin and decreased haptoglobin levels are associated with adverse clinical outcomes, unfavorable physiologic measures, and altered inflammatory markers in pediatric cardiac surgery patients.\", \"type\": \"PubMed\", \"volume\": \"58\"}, \"evidence\": \"There are in vitro and animal model data linking increased free Hb, heme, and iron to inflammation, 6 infection,7 platelet (PLT) activation,8,9 vasculopathy, 10 and thrombosis.\", \"key\": \"17bac9e552387e009bd1350a864bb70f156c485f266f51a664ef61c6ce0632d87a77bb79d19321e97c47887a6d5eeea2e76e68c34c2285a1eae0a3ad4988508e\", \"line\": 114, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 90}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alan B\", \"Lai D\", \"Leopold K\", \"Tangudu NK\", \"Vettorazzi S\", \"Vinchi F\", \"Vujić Spasić M\", \"Wörle K\"], \"date\": \"2018-08-10\", \"first\": \"Tangudu NK\", \"last\": \"Vujić Spasić M\", \"name\": \"Antioxidants &amp; redox signaling\", \"pages\": \"484-499\", \"reference\": \"29212341\", \"title\": \"Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.\", \"type\": \"PubMed\", \"volume\": \"29\"}, \"evidence\": \"These data suggested that during severe hemolysis, heme mediated ferroportin induction and low hepcidin in HbS mice (11) served to elevate systemic iron availability, required to sustain high erythropoietic demands in these mice.\", \"key\": \"681c26f443ec3fd2fac1bff91a75e243fad113300d485b70b336869e2d15397bd9b4f7462686153b068268e6c81915c34905c0ce99a567dadd3588c7872fbcae\", \"line\": 114, \"relation\": \"positiveCorrelation\", \"source\": 5, \"target\": 73}, {\"annotations\": {\"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Alayash AI\", \"Chintagari NR\", \"Jana S\"], \"date\": \"2016-08-01\", \"first\": \"Chintagari NR\", \"last\": \"Alayash AI\", \"name\": \"American journal of respiratory cell and molecular biology\", \"pages\": \"288-98\", \"reference\": \"26974230\", \"title\": \"Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.\", \"type\": \"PubMed\", \"volume\": \"55\"}, \"evidence\": \"Exposure to HbFe41 resulted in a drop in hyperpolarized cell percentage over untreated control, thus indicating a significant mitochondrial depolarization or compromised mitochondrial respiration.\", \"key\": \"e71944b69fd55004460ba572459f94268ecc11cd2704adc272bcdf3e7865d842f6bc4e9bd7dba4352c1439deac3399df8cca76c412efb2da0e0c04a33fb9b2b9\", \"line\": 186, \"relation\": \"negativeCorrelation\", \"source\": 27, \"target\": 26}, {\"annotations\": {\"Cell\": {\"neutrophil\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"This experiment demonstrated that under serum-free conditions, 4 hours of exposure to NaOH-dissolved heme induced complete deterioration of mitochondrial respiration at concentrations as low as 10 lmol\\u0001L\\u00031, while exposure to albumin-associated heme in the presence of 2% FCS stimulated respiratory capacity to levels above baseline.\", \"key\": \"cadc7af76ec31f484415eb4fdfbcc5d692476aa56e363a295c3522068eca00c7c3821e00e62208dc29c65fabbd6dfa2e0f5584a6d514e5d7c7f9741b9999950f\", \"line\": 142, \"relation\": \"positiveCorrelation\", \"source\": 27, \"target\": 46}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"As a component of hemoglobin, free heme is released when hemolysis or extensive cell damage occur which results in inflammatory response.\", \"key\": \"4c6c32bdc2258fc52db22885119417aca032cfda65d7e67cfd4e2972dc6b746d4c4824a4ca7156f8f9cc3823b276e7a11cf3b0677fc1957b34e681c9f4a377bd\", \"line\": 94, \"relation\": \"positiveCorrelation\", \"source\": 31, \"target\": 10}, {\"annotations\": {\"Cell\": {\"endothelial cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Chen R\", \"Chorostowska-Wynimko J\", \"Gueler F\", \"Immenschuh S\", \"Janciauskiene S\", \"Madyaningrana K\", \"Mahadeva R\", \"Tumpara S\", \"Vijayan V\", \"Welte T\", \"Wiese M\", \"Wrenger S\"], \"date\": \"2017-10-01\", \"first\": \"Janciauskiene S\", \"last\": \"Chorostowska-Wynimko J\", \"name\": \"Journal of leukocyte biology\", \"pages\": \"1127-1141\", \"reference\": \"28716864\", \"title\": \"Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.\", \"type\": \"PubMed\", \"volume\": \"102\"}, \"evidence\": \"Hemin induces expression of the adhesion molecules on endothelial cells [7, 8] and enables firm neutrophil attachment to the endothelium and initiation of an inflammatory response [9, 10].\", \"key\": \"3547cc543957107b1f40ebfeff1c175123ee9619ae353b982ff0562289a4d5225a9519cc8b60dd17289cbc08e627ddac693a72ee33d3436df01c5982214e8228\", \"line\": 95, \"relation\": \"positiveCorrelation\", \"source\": 31, \"target\": 10}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Importantly, protoporphyrin did not induce TNFα, suggesting a critical proinflammatory role for iron within the heme moiety (supplemental Figure 8).\", \"key\": \"e43282ed455a88fa0609e6f04cfbb0360f53299222e95aeed72fb1fa638565f67d5c11ddfee81cadad6309926adc3dffa98ed5149696efc9c0a5f7bae3ba9c91\", \"line\": 177, \"relation\": \"positiveCorrelation\", \"source\": 31, \"target\": 5}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.\", \"key\": \"4111e1dc77f55856c12e77c7c95e50913cb0aa5f283e0388a57faa079a1a71a406d633742d61606f8040f3739fcc89c3165dff945535e30f3969a2f6c5db10a8\", \"line\": 353, \"relation\": \"positiveCorrelation\", \"source\": 31, \"target\": 14}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.\", \"key\": \"1c9dd3b358f430d679535b89c5f7dde96ba3bc32a7a46f82c1bba7fe88a69473b799d869cb63b81dc94f7d7dc935dad7773e3f3f292a762fd165f4fd3a74ba56\", \"line\": 354, \"relation\": \"positiveCorrelation\", \"source\": 31, \"target\": 97}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Mitochondria\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"8 hours\": true}}, \"citation\": {\"authors\": [\"Buehler PW\", \"Deuel JW\", \"Humar R\", \"Ingoglia G\", \"Schaer CA\", \"Schaer DJ\", \"Vallelian F\"], \"date\": \"2018-04-01\", \"first\": \"Vallelian F\", \"last\": \"Schaer DJ\", \"name\": \"Pharmacology research &amp; perspectives\", \"pages\": \"e00392\", \"reference\": \"29610666\", \"title\": \"Revisiting the putative role of heme as a trigger of inflammation.\", \"type\": \"PubMed\", \"volume\": \"6\"}, \"evidence\": \"However, similar to Hb, heme-albumin did not induce an inflammatory response in macrophages or endothelial cells in the presence of low concentrations of serum.\", \"key\": \"9cc61ce576aafee10763acfe727d7205087aa61b3fdd21dd2d3fec2e78f6257b413bed4cc3cc3f4e4b92caf84bd2e2fcf7c68cee88a28ca8cd6036e5adaca6fd\", \"line\": 217, \"relation\": \"negativeCorrelation\", \"source\": 31, \"target\": 46}, {\"annotations\": {\"MeSHAnatomy\": {\"Knee\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"Lately, much evidence has emerged to support a central role for participation of local inflammatory pathways in the disease processes (Scanzello, 2017), particularly so after knee injury (Goldring and Otero, 2011).\", \"key\": \"819f36c53bc1faefda3910fd88c0c2d1e9d0ac8092749835475a5da50ba52a2706a91b759562f3c5b87d6c1277b47edb840591f76b9d587b3140a55dd8ded8bf\", \"line\": 115, \"relation\": \"positiveCorrelation\", \"source\": 31, \"target\": 83}, {\"annotations\": {\"MeSHAnatomy\": {\"Knee\": true}, \"MeSHDisease\": {\"Osteoarthritis, Knee\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Gram M\", \"Larsson S\", \"Lohmander LS\", \"Struglics A\", \"Åkerström B\"], \"date\": \"2018-01-01\", \"first\": \"Larsson S\", \"last\": \"Struglics A\", \"name\": \"Frontiers in physiology\", \"pages\": \"1596\", \"reference\": \"30505280\", \"title\": \"α&lt;sub&gt;1&lt;/sub&gt;-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies.\", \"type\": \"PubMed\", \"volume\": \"9\"}, \"evidence\": \"As a part of the inflammatory response after injury, oxidative stress due to formation of reactive oxygen species (ROS) is involved both in direct damage of cartilage components and as integral factors in cell signaling leading to cartilage degradation (Henrotin et al., 2003).\", \"key\": \"ab80dbd2902325012a2a27328b85026a851f3d860c435f389955fbaee3f2cbb7587500425186ef3d909928470c7920d8443d5e251f91dfed49ac9c328404eca5\", \"line\": 123, \"relation\": \"positiveCorrelation\", \"source\": 31, \"target\": 22}, {\"annotations\": {\"Cell\": {\"epithelial cell\": true}, \"Concentration\": {\"40 μM\": true}, \"MeSHAnatomy\": {\"Kidney\": true}, \"Species\": {\"Cavia porcellus\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"4 hours\": true}}, \"citation\": {\"authors\": [\"Baek JH\", \"Boretti FS\", \"Buehler PW\", \"Deuel JW\", \"Garcia-Rubio I\", \"Opitz L\", \"Schaer CA\", \"Schaer DJ\", \"Spahn DR\"], \"date\": \"2016-01-21\", \"first\": \"Deuel JW\", \"last\": \"Schaer DJ\", \"name\": \"Cell death &amp; disease\", \"pages\": \"e2064\", \"reference\": \"26794659\", \"title\": \"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.\", \"type\": \"PubMed\", \"volume\": \"7\"}, \"evidence\": \"Other studies demonstrated that heme can trigger the activation of Toll-like receptor 4 and inflammasomes, thus leading to inflammatory reactions.5,35–37\", \"key\": \"84563bbddbb0f38c8b589a5f97b3f307d97e3008480179ccc4e86fab906fcf5ac277339678481fe26a56a301157b227af2f8f2aac4be1ad71cca3bc499cd06a8\", \"line\": 275, \"relation\": \"positiveCorrelation\", \"source\": 31, \"target\": 63}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"The released heme can activate the innate immune pattern recognition receptor toll-like receptor 4 (TLR4) on inflammatory cells, platelets and endothelium, promoting a pro-inflammatory and pro-coagulant phenotype, ultimately leading to vaso-occlusion, ischemia-reperfusion physiology, tissue injury, and pain in murine models of SCD [5, 7±10].\", \"key\": \"3abcc0df6c7906dd7ee646af11f7136df36c0ec4fb5a62036d2fb1f597a1828c829420485be0c41530d33c5d0e55a551406c381ebebd85a6aa0e8588e6076844\", \"line\": 108, \"object\": {\"modifier\": \"Activity\"}, \"relation\": \"positiveCorrelation\", \"source\": 31, \"target\": 63}, {\"annotations\": {\"MeSHAnatomy\": {\"Kidney\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Fu W\", \"Ji Z\", \"Li Q\", \"Li W\", \"Wang Y\", \"Yan J\", \"Yao J\", \"Zhou Z\"], \"date\": \"2014-07-01\", \"first\": \"Li Q\", \"last\": \"Li W\", \"name\": \"Cell biochemistry and biophysics\", \"pages\": \"495-502\", \"reference\": \"24464629\", \"title\": \"Heme induces IL-1β secretion through activating NLRP3 in kidney inflammation.\", \"type\": \"PubMed\", \"volume\": \"69\"}, \"evidence\": \"IL-1b participates in a robust inflammatory response.\", \"key\": \"d5962810b5afca0c3a2f5fe8be0d7c05a01b060eae42f03270b15a634141032251b189e31da126b9388d0684803ba048256ddb7029b8918c6bf2cbd451b8fcbe\", \"line\": 116, \"relation\": \"positiveCorrelation\", \"source\": 31, \"target\": 58}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Taken together, these data suggest that Hx administration decreases heme-driven proinflammatory activation of macrophages.\", \"key\": \"6ed3ffdefb139ede99e696ae287dbf869b814de9887bc490718ca38358fdff609c9cc4ba5600baa62d58129477620443e8100a8c6d5adc469fdc1dfdcd113adc\", \"line\": 317, \"relation\": \"negativeCorrelation\", \"source\": 31, \"target\": 67}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"In conclusion, an Hx-based therapy shows beneficial effects, in that it counteracts heme-induced proinflammatory activation of macrophages and attenuates some of its pathophysiologic consequences, such as chronic inflammation, hepatic fibrosis, and apoptosis (Figure 7E).\", \"key\": \"1d1a9052b1ff23cef353d868bc75a5a15c45378c11301090ada67326ba40dec2ec87fa447b917981aa2307b1c143af202392edd76a6cc9a3d78f7aa1725f5e40\", \"line\": 323, \"relation\": \"negativeCorrelation\", \"source\": 31, \"target\": 67}, {\"annotations\": {\"Cell\": {\"macrophage\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Discussion\": true}, \"TimePoint\": {\"15 hours\": true}}, \"citation\": {\"authors\": [\"Brinkman N\", \"Cerwenka A\", \"Costa da Silva M\", \"Ingoglia G\", \"Muckenthaler MU\", \"Petrillo S\", \"Tolosano E\", \"Vinchi F\", \"Zuercher A\"], \"date\": \"2016-01-28\", \"first\": \"Vinchi F\", \"last\": \"Muckenthaler MU\", \"name\": \"Blood\", \"pages\": \"473-86\", \"reference\": \"26675351\", \"title\": \"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.\", \"type\": \"PubMed\", \"volume\": \"127\"}, \"evidence\": \"Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.\", \"key\": \"209df6fd91ae5e34d96f400d02fe4ed4056141980d1621a21f9a85f9c06d0b73fe06036f41835437cca3eb0cfff5096aaacb75f8b229105ff6382b7b65f3602d\", \"line\": 356, \"relation\": \"negativeCorrelation\", \"source\": 31, \"target\": 67}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"The released heme can activate the innate immune pattern recognition receptor toll-like receptor 4 (TLR4) on inflammatory cells, platelets and endothelium, promoting a pro-inflammatory and pro-coagulant phenotype, ultimately leading to vaso-occlusion, ischemia-reperfusion physiology, tissue injury, and pain in murine models of SCD [5, 7±10].\", \"key\": \"34bbda91d8973f088c12a4f9fb0bd19415cac5bd6959a044fbadd916c0aed1870d25e37184be08870866da4236185bb9890fcf6ac199c85b3c2cca55559578ac\", \"line\": 111, \"relation\": \"positiveCorrelation\", \"source\": 77, \"target\": 10}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"CO also inhibited stasis in mice treated with SnPP + Hb without Hp or Hpx.\", \"key\": \"9efba918b13d3d998a0d9f53652e8aa88f30c468ab50e2af64a248789e7a422ae9574d57253c344a2cc7d506a4396ce57952a9a2f1926569feece8db23e4622a\", \"line\": 190, \"relation\": \"negativeCorrelation\", \"source\": 77, \"target\": 2}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"We have previously shown that induction of HO-1 expression or liver-directed HO-1 gene therapy inhibits stasis in sickle mice exposed to H/R [38, 45].\", \"key\": \"c102a871283222a75acdf86ad0fbce197b69bd6cb439f9557fcfe0bd6c189ee85dea1e97b666699645c8349fc8a6ecec586248b7bbe7b2016435b4b485f7a02f\", \"line\": 185, \"relation\": \"negativeCorrelation\", \"source\": 77, \"target\": 66}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"48 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Infusion of exogenous hemoglobin into SS-mice can markedly increase stasis compared to the amount of spontaneous stasis [5].\", \"key\": \"cdeb591274a1b6910f831f8a568cc259f564da173e98e003b61c6b709e005b89e2a0e7ca46c8355be8964cfa8a983f6c71e91c397c8e0ec9b5c5d58ce004fa9e\", \"line\": 133, \"relation\": \"positiveCorrelation\", \"source\": 77, \"target\": 54}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"48 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Thus a single infusion of Hp or Hpx inhibited stasis for 48h.\", \"key\": \"926d764820e2af8b6ac23711db7a2fe69077300e31f4fbb131a896eb7dd2eb4991a5b72eb2cf82542055cf9c5c0cba6aa8b71b2974ff4c57472274dfdf023baa\", \"line\": 128, \"relation\": \"negativeCorrelation\", \"source\": 77, \"target\": 67}, {\"annotations\": {\"MeSHAnatomy\": {\"Blood Platelets\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"60 min\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Sickle mice co-infused with Hb + Hp, Hb + Hpx or Hb + Hp + Hpx had less stasis 1h after infusion than mice infused with Hb + albumin or Hb (Fig 1B).\", \"key\": \"db182ad156c2418fa60974f500437a9269d2794d1b346b14b27bcf18af184eb5fbd8925d3e97670cafd5d10ffafb9ba9d200b3ac963cb197a9c78204b03aa7c8\", \"line\": 141, \"relation\": \"negativeCorrelation\", \"source\": 77, \"target\": 67}, {\"annotations\": {\"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Anemia, Sickle Cell\": true}, \"Species\": {\"Mus musculus\": true}, \"TextLocation\": {\"Results\": true}, \"TimePoint\": {\"24 hours\": true}}, \"citation\": {\"authors\": [\"Abdulla F\", \"Belcher JD\", \"Brinkman N\", \"Chen C\", \"Killeen T\", \"Miescher SM\", \"Nath KA\", \"Nguyen H\", \"Nguyen J\", \"Nguyen P\", \"Steer CJ\", \"Vercellotti GM\", \"Zhang P\"], \"date\": \"2018-01-01\", \"first\": \"Belcher JD\", \"last\": \"Vercellotti GM\", \"name\": \"PloS one\", \"pages\": \"e0196455\", \"reference\": \"29694434\", \"title\": \"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.\", \"type\": \"PubMed\", \"volume\": \"13\"}, \"evidence\": \"Hp and Hpx significantly inhibited stasis in response H/R or LPS (Fig 5).\", \"key\": \"4dd0d37288c9ddc22a1c0fef71098012ade4b681316cad11e063f62b12f5c27e71e430a85cc9102cdd557deb1df8979a196885e4230688cb5a890131f38c2a67\", \"line\": 204, \"relation\": \"negativeCorrelation\", \"source\": 77, \"target\": 67}, {\"annotations\": {\"TextLocation\": {\"Introduction\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"Erythrocyte lysis after ICH can be mediated by the complement activation and formation of the membrane attack complex (MAC), which contains complement C5b, C6, C7, C8 and C9 proteins (C5b– 9).\", \"key\": \"c65d5fc953c38043c87ae176eca68bb09a8bb5b690e5613fd16cc76cb70302e9278027c4359dd4371f67f983424171b0fd4a620272bfd8c5fdab2b2c2ae4be2c\", \"line\": 104, \"relation\": \"positiveCorrelation\", \"source\": 28, \"target\": 95}, {\"annotations\": {\"MeSHDisease\": {\"Cerebral Hemorrhage\": true}, \"TextLocation\": {\"Results\": true}}, \"citation\": {\"authors\": [\"Cao S\", \"Chen G\", \"Hua Y\", \"Keep RF\", \"Xi G\", \"Zheng M\"], \"date\": \"2016-06-01\", \"first\": \"Cao S\", \"last\": \"Xi G\", \"name\": \"Stroke\", \"pages\": \"1626-31\", \"reference\": \"27125525\", \"title\": \"Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage.\", \"type\": \"PubMed\", \"volume\": \"47\"}, \"evidence\": \"Activation of the complement system and the formation of MAC resulted in an increased membrane permeability and erythrocyte lysis.\", \"key\": \"8b1800f63581e2c4c1c1f4aa7106a90296a896a79fc7814671ca60fe3491b4d7e5abfc9bc9ba2fc6122120546ea3128ba5f6b8134d331a18757ff404f8b766c5\", \"line\": 127, \"relation\": \"positiveCorrelation\", \"source\": 28, \"target\": 95}, {\"annotations\": {\"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"It is crucial, hence, to further investigate the mechanisms of sepsis-induced hemolysis with the aim of deriving possible therapeutic principles. Herein, we collected the most important previously known triggers of hemolysis during sepsis, which are (1) transfusion reactions and complement activation, (2) disseminated intravascular coagulation, (3) capillary stopped-flow, (4) restriction of glucose to red blood cells, (5) changes in red blood cell membrane properties, (6) hemolytic pathogens, and (7) red blood cell apoptosis.\", \"key\": \"12ab991c39a305fc7a3742506db617d569dc09a26f9064182eb96046c127fc7061e8962d571471181b2e853858fce97226e894b5fa071393fda7472cd7a614fd\", \"line\": 96, \"relation\": \"positiveCorrelation\", \"source\": 28, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Liver\": true}, \"MeSHDisease\": {\"Sepsis\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Effenberger-Neidnicht K\", \"Hartmann M\"], \"date\": \"2018-10-01\", \"first\": \"Effenberger-Neidnicht K\", \"last\": \"Hartmann M\", \"name\": \"Inflammation\", \"pages\": \"1569-1581\", \"reference\": \"29956069\", \"title\": \"Mechanisms of Hemolysis During Sepsis.\", \"type\": \"PubMed\", \"volume\": \"41\"}, \"evidence\": \"Thus, the complement system may be causally involved in the onset of hemolysis during sepsis [74] by directly damaging the red blood cells upon activation as a result of detecting pathogen structures [73].\", \"key\": \"70563034b4dfde65d7ff471c028d35237657a245a055db31d6ee2f7e5ba33eb1883b1f2e7dc5e545b27a84f724781701bf17c70fa5a5800adb1bf744f74a37fc\", \"line\": 349, \"relation\": \"increases\", \"source\": 28, \"target\": 95}, {\"annotations\": {\"Cell\": {\"erythrocyte\": true}, \"MeSHAnatomy\": {\"Veins\": true}, \"MeSHDisease\": {\"beta-Thalassemia\": true}, \"TextLocation\": {\"Review\": true}}, \"citation\": {\"authors\": [\"Litvinov RI\", \"Weisel JW\"], \"date\": \"2017-02-01\", \"first\": \"Litvinov RI\", \"last\": \"Weisel JW\", \"name\": \"ISBT science series\", \"pages\": \"176-183\", \"reference\": \"28458720\", \"title\": \"Role of red blood cells in haemostasis and thrombosis.\", \"type\": \"PubMed\", \"volume\": \"12\"}, \"evidence\": \"The circulating MPs can internalize free heme and transfer it to vascular endothelium, promoting vaso-occlusion, or amplify systemic inflammation via thrombin mediated activation of the complement system [57].\", \"key\": \"b0bae7b1652d50a964e55a492cc0fc578f54c173568d0a23f0453606ff062924c657ee44db82f2fd413690e7dc297d19382a53c7f8fb0d11ad3cbe021155ef5a\", \"line\": 300, \"relation\": \"increases\", \"source\": 28, \"target\": 97}], \"multigraph\": true, \"nodes\": [{\"bel\": \"a(CHEBI:\\\"N-acetyl-L-cysteine\\\")\", \"function\": \"Abundance\", \"id\": \"5fd2d2d6c0c71461451f5db5ca45d0a86243558150e59ae481c0a84cff8cdda99c1905adb131aa93fd664feb51f531b5c6526cae874af98ca519f6a18f2f1c7c\", \"name\": \"N-acetyl-L-cysteine\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(CHEBI:\\\"adenosine triphosphate\\\")\", \"function\": \"Abundance\", \"id\": \"1a64c5a28b294709d47e0e9013a1005869ad9c7b7579984fc187914b21638c2f9851b9bf937c20ae66183d58c2367f153682308f3ee7b4fcd68032cb964291f4\", \"name\": \"adenosine triphosphate\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(CHEBI:\\\"carbon monoxide\\\")\", \"function\": \"Abundance\", \"id\": \"f9a3abc538e60a3026dee8cad1fc1437008be2a35790de8c753ee79bbbcc228bb80f6053c1170690621df714e7420bc4d4144d1883eca1753cffae3c0b1a99b4\", \"name\": \"carbon monoxide\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(CHEBI:\\\"desferrioxamine B\\\")\", \"function\": \"Abundance\", \"id\": \"a49da19b69084c675adbb4db4b674aeafc2a35181871492ccfa7c50ce64a6c4abfc8c89f61961fa7652afabff064cadb1f06bd26635ec5728404604b321f72b9\", \"name\": \"desferrioxamine B\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(CHEBI:\\\"hydrogen peroxide\\\")\", \"function\": \"Abundance\", \"id\": \"4d65b5d180890b98afe0bc10614fde44ee750b2d1af6fdd925fc31ead7ee9a7248bda3d67c52aebf220b8c048d999f2d878a97a70b0e027a7294cbd3c7bf61bf\", \"name\": \"hydrogen peroxide\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(CHEBI:\\\"iron(2+)\\\")\", \"function\": \"Abundance\", \"id\": \"e426e7ad4ee4d8eb3c018acb75625d794a96811eb659d39bd8f25c4b30632fc8a938eca8397887738ecc384ec5df867e2026de113f002e5cc4490177de0905cd\", \"name\": \"iron(2+)\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(CHEBI:\\\"nitric oxide\\\")\", \"function\": \"Abundance\", \"id\": \"fd0dcffbd4e00c161d74c931890123439e35f86a92cbcf20c1efaed0bb8b8469434bbafd8364de8822b9af6368de418ed1728b1534bb8eeb47320d5a9c895548\", \"name\": \"nitric oxide\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(CHEBI:\\\"phosphatidyl-L-serine\\\")\", \"function\": \"Abundance\", \"id\": \"0e0dfe47aa48b6ed4dd6495792927789ad27b91117203b58482a6b0668bf4576c567a6c2c41f452169ea3294f583f76a38c77d3c1840aebc8746b17f45767f5b\", \"name\": \"phosphatidyl-L-serine\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(CHEBI:ATP)\", \"function\": \"Abundance\", \"id\": \"dbc5553fb6213ed82215c03a89950a37045e23683ffa96b44532f3e75d204cc547a974025c2799c6a189ad0c5045d96b16d1f5f7ac9296473ba1c647499bb3b2\", \"name\": \"ATP\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(CHEBI:antioxidant)\", \"function\": \"Abundance\", \"id\": \"532cca355e793f00fffa1df608d6c7b2ae16ca1cf9a8b72199fe64d52e06718ccdfb7bc76e319c6612692e80f7f07e2935ebf085cb0194c6e267a6253a886170\", \"name\": \"antioxidant\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(CHEBI:heme)\", \"function\": \"Abundance\", \"id\": \"719ca721f83fc39055585fbe7f31ad8173f7538a3cfa3792732de47c43a36048e922aa16d66b08e964b7d4a89e214d0d313bce30a38fe67755b9428cdec247cc\", \"name\": \"heme\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(CHEBI:lipopolysaccharide)\", \"function\": \"Abundance\", \"id\": \"66bc1a5b41c832a7d7b4b61aa44aae11a4bb778b350f17f7386e2f2a86365ef3007d5e07af494b32cae117170398c1fe5b5ee0e0e95bcef83eede21157e23d04\", \"name\": \"lipopolysaccharide\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(CHEBI:malonaldehyde)\", \"function\": \"Abundance\", \"id\": \"739f31faea80a4346f93d88fb322844d4a48cedd3887e50968fbf26d7666f2cec39be3aadacf4e570e76340d40b2e860ed74d5181306d84b7ca1c26ab4443bba\", \"name\": \"malonaldehyde\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(HM:\\\"Glucose-6-phosphate dehydrogenase deficiency\\\")\", \"function\": \"Abundance\", \"id\": \"dcb011a9a9e2f431c044d10179d0b3b83d6ab9165d34b63f15e27c4850f3ea4d07eedf3ee327ee4424e7a8bbc3c270464535792540d7ceb7f0b5fcbf43ca9af9\", \"name\": \"Glucose-6-phosphate dehydrogenase deficiency\", \"namespace\": \"HM\"}, {\"bel\": \"a(HM:\\\"macrophage M1 polarization\\\")\", \"function\": \"Abundance\", \"id\": \"e530174aaf5748285870444607e0c187f96c900e747ec2bce61d1f7ef77422e522cab40b49582af863041647b89bae36867f9d1a845342764e6b13821adb2b8b\", \"name\": \"macrophage M1 polarization\", \"namespace\": \"HM\"}, {\"bel\": \"a(HM:\\\"stored erythrocytes\\\")\", \"function\": \"Abundance\", \"id\": \"c5f07faa52d39663c7bfb6346590680850cdc80f5daec0a27d13d0b987d98745781c6e81ce6edb50f375981a5345c5027325348c3907f71521d30ab0b54f60c4\", \"name\": \"stored erythrocytes\", \"namespace\": \"HM\"}, {\"bel\": \"a(MESH:\\\"Adenosine Diphosphate\\\")\", \"function\": \"Abundance\", \"id\": \"8bb04037432bfb84172ca39c838dfcf01c8374454fdff32aba66462feaeffd5aa545da4cabf4aa4aa84e237faa299a7d355fbac635ed6537f466b8e2a6ee8311\", \"name\": \"Adenosine Diphosphate\", \"namespace\": \"MESH\"}, {\"bel\": \"a(MESH:\\\"Blood Transfusion\\\")\", \"function\": \"Abundance\", \"id\": \"b3b4ac2f07a0f5e6df3abd5f7bd0d6f120776202f4c3e417c4082961f2f3ece07bc3d7e231b573dd19b6eb0e1fdbed451fb1370fbdac4a1e42d8262b7565070f\", \"name\": \"Blood Transfusion\", \"namespace\": \"MESH\"}, {\"bel\": \"a(MESH:\\\"Cell-Derived Microparticles\\\")\", \"function\": \"Abundance\", \"id\": \"cbdd1c0e96832ed2dc8166dd4de0db4724d8bf06ba0c5e7b8f6720cf04d7c50fcf8abc5cc8cc27228f47b8b422592d1084bb0e832c29fb932d57b70741c4413d\", \"name\": \"Cell-Derived Microparticles\", \"namespace\": \"MESH\"}, {\"bel\": \"a(MESH:\\\"Complement Membrane Attack Complex\\\")\", \"function\": \"Abundance\", \"id\": \"697440f9efe6d464dff14ff66b2554c4c0fac81fd532f4039c33a96b1070ad6aaf25f4b64023470df259819a994b8fae792ef76b64d97ef8d38de60855f16b0b\", \"name\": \"Complement Membrane Attack Complex\", \"namespace\": \"MESH\"}, {\"bel\": \"a(MESH:\\\"Erythrocytes, Abnormal\\\")\", \"function\": \"Abundance\", \"id\": \"6dad8acde77b2f2b3d1f925131b538f11dd3f5b936b9e970595b5e8116ab366ced3d9d729a666bc1822c3e6c6921e8d7233fdf64546b8a67ad0e4951848716cd\", \"name\": \"Erythrocytes, Abnormal\", \"namespace\": \"MESH\"}, {\"bel\": \"a(MESH:\\\"Mitogen-Activated Protein Kinases\\\")\", \"function\": \"Abundance\", \"id\": \"86961c6e2bd820e9ad167ca01f05778410aaca1d318cfac544162c60d8cfa1f79db0548b59750206f92259e4e426945d573b8dacd03740b9599a0eaae964e629\", \"name\": \"Mitogen-Activated Protein Kinases\", \"namespace\": \"MESH\"}, {\"bel\": \"a(MESH:\\\"Reactive Oxygen Species\\\")\", \"function\": \"Abundance\", \"id\": \"431216f8a4f002a0fa83666bebdbd0cd49a0ffe231e9273c5f429fb234b0cb494c5d4db9d46d631375f41adc4b09f76693b427348a2f18e6a281f770c25d338a\", \"name\": \"Reactive Oxygen Species\", \"namespace\": \"MESH\"}, {\"bel\": \"a(MESH:\\\"haptoglobin-hemoglobin complex\\\")\", \"function\": \"Abundance\", \"id\": \"7b476fba9ca00d6770b2810f62ba5e0e75b4fec95d72ab7ad83b8c6055a4c8bb7d2c730747aeac851ef5213165f4cadb35d7b625570a7d35056e3d9f97f7d9c3\", \"name\": \"haptoglobin-hemoglobin complex\", \"namespace\": \"MESH\"}, {\"bel\": \"a(MESH:Cytokines)\", \"function\": \"Abundance\", \"id\": \"b212e0151b8087a85aaf17315ce4d0ca06e7fa2700f3e41b10ea54a20d2484f11b545e768089b4d2b117a4feb6c7438ffd569bfaecfc5b5667807e6c2d637f93\", \"name\": \"Cytokines\", \"namespace\": \"MESH\"}, {\"bel\": \"a(MESH:Monocytes)\", \"function\": \"Abundance\", \"id\": \"b5c7111e5e19891dea4fafcb9cdc48ed44402d7c029386148be62da514a0b7061634a3ca14d3f04e96bee1afb922bfa9411aeb117e3e7f0c5a602ee58a2fb794\", \"name\": \"Monocytes\", \"namespace\": \"MESH\"}, {\"bel\": \"a(MESH:ferrylhemoglobin)\", \"function\": \"Abundance\", \"id\": \"e9e7ab9bd7169afff944c21b3a5bfdd5d540f139d70efbb74aa6469f05128eec6a113dfd0c957fb11568801c62722ed4b2b11d972a64ffd74fa8406be0bbcaeb\", \"name\": \"ferrylhemoglobin\", \"namespace\": \"MESH\"}, {\"bel\": \"bp(GO:\\\"cellular respiration\\\")\", \"function\": \"BiologicalProcess\", \"id\": \"9ddd1e2f8de9532f4c9e276a14aa2dbb15c257bbe5ac1b1c60dc9d758691015a32029e530fa94ebda65285da5fa8a399da7451a7e873368708276e6ec361d1e0\", \"name\": \"cellular respiration\", \"namespace\": \"GO\"}, {\"bel\": \"bp(GO:\\\"complement activation\\\")\", \"function\": \"BiologicalProcess\", \"id\": \"7dffe42517c3d74ef8db1b8f29a0be191ff33eb743bcb3f274446e3e4e0af75347a0294e3d14b50508fa8f0e46b076f844f664d7f93566c31246a2f841df1316\", \"name\": \"complement activation\", \"namespace\": \"GO\"}, {\"bel\": \"bp(GO:\\\"endothelial cell activation\\\")\", \"function\": \"BiologicalProcess\", \"id\": \"c894e9d33edfed940a51b6b3c296739792fd65fa6d722a79d7adc2bb71d574d2b29d8567e118c9c88d2447f6fd8b362ac1ae9361950533cd5069ee34104f7689\", \"name\": \"endothelial cell activation\", \"namespace\": \"GO\"}, {\"bel\": \"bp(GO:\\\"heme catabolic process\\\")\", \"function\": \"BiologicalProcess\", \"id\": \"50f7a19da01b674033083218f27a9bae0f94de27782576c14703f73439fe44c4c01a03c5cd4547779ccb33ba65dd27fd62f327ef07d8d4d1daf111343e65e971\", \"name\": \"heme catabolic process\", \"namespace\": \"GO\"}, {\"bel\": \"bp(GO:\\\"inflammatory response\\\")\", \"function\": \"BiologicalProcess\", \"id\": \"422dfc2db00b1d942862470cbabe1e8312bf97b25050190db5ae19636adae95f4fa18c512574526825bd377b16c2278899435eb759e951ba850ad476e14f9900\", \"name\": \"inflammatory response\", \"namespace\": \"GO\"}, {\"bel\": \"bp(GO:\\\"necroptotic process\\\")\", \"function\": \"BiologicalProcess\", \"id\": \"afd362bce773bc41eb53a15034e078feddc9294931505959c995cf643d4a70245baf6f46c404e1aa29a3058c1c8a1e55da92dce5f5220c3bc180ed23b1b00b46\", \"name\": \"necroptotic process\", \"namespace\": \"GO\"}, {\"bel\": \"bp(MESH:\\\"Bacterial Load\\\")\", \"function\": \"BiologicalProcess\", \"id\": \"3fc2f7e396e9553ae5e09290108371ed24150274e9ab8ae0eda905079afec8d4489273f5921257eb5a15b038bdffde8a77f8cdfe2fb9b444b42ea08c91a4c361\", \"name\": \"Bacterial Load\", \"namespace\": \"MESH\"}, {\"bel\": \"bp(MESH:\\\"Blood Pressure\\\")\", \"function\": \"BiologicalProcess\", \"id\": \"23b5ecdb66cb0efda0b71b91cb908401ee80b6fe49d5bdbf65fdbb17a54997d02e597573b451a8f483554e3edea3e20e3872e042a8e7c9de1bcf12724b3af4c2\", \"name\": \"Blood Pressure\", \"namespace\": \"MESH\"}, {\"bel\": \"bp(MESH:\\\"Cytotoxicity, Immunologic\\\")\", \"function\": \"BiologicalProcess\", \"id\": \"d0ed8d27c859853ba0f652e37db5ff8bf969f5b0ef2850aac8b1d3ba5cccfdd88bc88c58b8e3d5def02ec5cd1f0513502839d3728f2cf4fa2691e1c0d15f03e9\", \"name\": \"Cytotoxicity, Immunologic\", \"namespace\": \"MESH\"}, {\"bel\": \"bp(MESH:\\\"Erythrocyte Aggregation\\\")\", \"function\": \"BiologicalProcess\", \"id\": \"37e965e243346eeb0987a27e17daec0bc1f89f62b4cb098c2beb95622d1d51d31f16c3d63f53eee350a056a8e39f554273da536c04e9af7b5545c949d196dcaf\", \"name\": \"Erythrocyte Aggregation\", \"namespace\": \"MESH\"}, {\"bel\": \"bp(MESH:\\\"Erythrocyte Deformability\\\")\", \"function\": \"BiologicalProcess\", \"id\": \"aafe5f8fc07e6abe467e9e2c47e0be8c08012664bc30134675ce5df8b3ab3ccc93ed0cdec5627fb8e8ab4f5e2cc991a6fb0ce0adfe41fe8358ea8c37ac60816d\", \"name\": \"Erythrocyte Deformability\", \"namespace\": \"MESH\"}, {\"bel\": \"bp(MESH:\\\"Lipid Peroxidation\\\")\", \"function\": \"BiologicalProcess\", \"id\": \"200d0f8dcc2deed3eae3e73e1ad1fecf13fdaff9aefe30936075f390afe344a7b841c8b5e7edef7a1cafc377c66bea8ff57806e4c027474403279f36c76c18bd\", \"name\": \"Lipid Peroxidation\", \"namespace\": \"MESH\"}, {\"bel\": \"bp(MESH:\\\"Oxidative Stress\\\")\", \"function\": \"BiologicalProcess\", \"id\": \"32bd3ab5e8a3a26be3209856c88741f0f0e2dff98d2587599a6a21b0f4793c5d8feb1194ea2166cf3cece076e7095530b116270e6655bc8feb35a437fda42cf6\", \"name\": \"Oxidative Stress\", \"namespace\": \"MESH\"}, {\"bel\": \"bp(MESH:\\\"Platelet Activation\\\")\", \"function\": \"BiologicalProcess\", \"id\": \"bc3ac5ceee11548085c1a7e0d96d4010c7e723996372d0d939fcf3692d8c2e70ca67a0cb96b5e091f3c69e850885005c1f2765ff9cbd2a675bfcce404bddda86\", \"name\": \"Platelet Activation\", \"namespace\": \"MESH\"}, {\"bel\": \"bp(MESH:Apoptosis)\", \"function\": \"BiologicalProcess\", \"id\": \"39c21a5bf990cacd109cd022171f1f8d53f15707601351a2acf509f4f1a1c21650a3be4e5ddc8df4e09a2d236cc4cc03242239c0b4cde5940d3950792f6b9449\", \"name\": \"Apoptosis\", \"namespace\": \"MESH\"}, {\"bel\": \"bp(MESH:Hemostasis)\", \"function\": \"BiologicalProcess\", \"id\": \"39971f238507c6db6f4eaedaa774ebd16438e7c7ef1516eeb59982e95a41ed04db788a2181a49de811930fdf73aa452ffe608495eb2855d7c4daccf9abc94c2c\", \"name\": \"Hemostasis\", \"namespace\": \"MESH\"}, {\"bel\": \"bp(MESH:Phagocytosis)\", \"function\": \"BiologicalProcess\", \"id\": \"24a222f2ff316c1e82d9d6384fa23bcf65146b96e43cad2dc483dbb7b91380d0503cf56322a6472aa8b8fe74fde67a96f94aca55fb98bca131743ae81c45a68d\", \"name\": \"Phagocytosis\", \"namespace\": \"MESH\"}, {\"bel\": \"complex(a(CHEBI:\\\"carbon monoxide\\\"), a(CHEBI:\\\"iron(2+)\\\"), a(CHEBI:biliverdin))\", \"function\": \"Complex\", \"id\": \"2033560c512aad562132957023ac38c2b0bf31137d200c6e7dee8afb38cbb8240d9ffcdd2a2a0d03fea5c2e3303f87bf09ebf273445d38431c6e5c9458076703\", \"members\": [{\"bel\": \"a(CHEBI:\\\"carbon monoxide\\\")\", \"function\": \"Abundance\", \"id\": \"f9a3abc538e60a3026dee8cad1fc1437008be2a35790de8c753ee79bbbcc228bb80f6053c1170690621df714e7420bc4d4144d1883eca1753cffae3c0b1a99b4\", \"name\": \"carbon monoxide\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(CHEBI:\\\"iron(2+)\\\")\", \"function\": \"Abundance\", \"id\": \"e426e7ad4ee4d8eb3c018acb75625d794a96811eb659d39bd8f25c4b30632fc8a938eca8397887738ecc384ec5df867e2026de113f002e5cc4490177de0905cd\", \"name\": \"iron(2+)\", \"namespace\": \"CHEBI\"}, {\"bel\": \"a(CHEBI:biliverdin)\", \"function\": \"Abundance\", \"id\": \"1c1df7b129d5a63a47fc79a36894f16edf9e46eeda375a544fab22d339b8ec13a98effcc5a7a66757ea24e35cb0e93dc91496e8cf42cc4d1ba0235d8b5dcbfab\", \"name\": \"biliverdin\", \"namespace\": \"CHEBI\"}]}, {\"bel\": \"complex(a(CHEBI:\\\"carbon monoxide\\\"), p(HGNC:HBB))\", \"function\": \"Complex\", \"id\": \"ae2f7698761a915940cc24177e2f7f73fbfb887bc31eef83f7c1a9fea312d2f9b8df27b9249655819e10b2a83aadb68a7c0dd1d4e7e4742d848a5103fede242c\", \"members\": [{\"bel\": \"a(CHEBI:\\\"carbon monoxide\\\")\", \"function\": \"Abundance\", \"id\": \"f9a3abc538e60a3026dee8cad1fc1437008be2a35790de8c753ee79bbbcc228bb80f6053c1170690621df714e7420bc4d4144d1883eca1753cffae3c0b1a99b4\", \"name\": \"carbon monoxide\", \"namespace\": \"CHEBI\"}, {\"bel\": \"p(HGNC:HBB)\", \"function\": \"Protein\", \"id\": \"75606239f93ac271516eb110566907523dfdbf0a1937760050e049e79942bd684a190c3dd54b45444c2c5b5217192e72df697c824cbb392f90f2fa4005d9adb1\", \"name\": \"HBB\", \"namespace\": \"HGNC\"}]}, {\"bel\": \"complex(a(CHEBI:heme), p(HGNC:ALB))\", \"function\": \"Complex\", \"id\": \"4772101b39469c4d573f8ff81be0d88042756eaa418755a910b68db7b83a2a50f43e61c8dd75f346dabe02998a32212f48335df3e1b7785118c3ada766556566\", \"members\": [{\"bel\": \"a(CHEBI:heme)\", \"function\": \"Abundance\", \"id\": \"719ca721f83fc39055585fbe7f31ad8173f7538a3cfa3792732de47c43a36048e922aa16d66b08e964b7d4a89e214d0d313bce30a38fe67755b9428cdec247cc\", \"name\": \"heme\", \"namespace\": \"CHEBI\"}, {\"bel\": \"p(HGNC:ALB)\", \"function\": \"Protein\", \"id\": \"888f5bd8bd1586fa3a22b3c9fa459dee00628c3ba399e7c4d2e42f7800e9f98cdfd9d801d90f0ba999670ad8d0a443f970f7dfa1633e91d49ffc34ebe6980340\", \"name\": \"ALB\", \"namespace\": \"HGNC\"}]}, {\"bel\": \"complex(a(CHEBI:heme), p(MGI:Hpx))\", \"function\": \"Complex\", \"id\": \"a28e94760af121bf3833287a964c8f5f9e882de2e94edbb8657b283c46da1e75360b14c9031560bf441a5aef08ec3ba78e079ea29f268174dadca7b5e901eddc\", \"members\": [{\"bel\": \"a(CHEBI:heme)\", \"function\": \"Abundance\", \"id\": \"719ca721f83fc39055585fbe7f31ad8173f7538a3cfa3792732de47c43a36048e922aa16d66b08e964b7d4a89e214d0d313bce30a38fe67755b9428cdec247cc\", \"name\": \"heme\", \"namespace\": \"CHEBI\"}, {\"bel\": \"p(MGI:Hpx)\", \"function\": \"Protein\", \"id\": \"ccdc2439745a084dbbe73e6559429f702bfbdd9823ad4837b3232123b8c4a6c91ffd44740d989f368c570e462c58632040fcfa2d5e947abff06413ab3ce7ec44\", \"name\": \"Hpx\", \"namespace\": \"MGI\"}]}, {\"bel\": \"complex(a(MESH:\\\"Blood Transfusion\\\"), p(MGI:Alb))\", \"function\": \"Complex\", \"id\": \"fb8693d468eec27e016980bcbf1c5543ad58d59028f6af59bf81cddf47cd216c5e8c5526495c0405f9a8038bb36f003e947c803cbf5cddf2d4fad95d41af6960\", \"members\": [{\"bel\": \"a(MESH:\\\"Blood Transfusion\\\")\", \"function\": \"Abundance\", \"id\": \"b3b4ac2f07a0f5e6df3abd5f7bd0d6f120776202f4c3e417c4082961f2f3ece07bc3d7e231b573dd19b6eb0e1fdbed451fb1370fbdac4a1e42d8262b7565070f\", \"name\": \"Blood Transfusion\", \"namespace\": \"MESH\"}, {\"bel\": \"p(MGI:Alb)\", \"function\": \"Protein\", \"id\": \"cd5261842e80d489daec82231b57bf29e0a4bea4a25d4af7a40c4d62d0a689daac3a9020ab8c40f68bcd6436873e640f2062cbd41e82dbce5c116fb7ebb61cbd\", \"name\": \"Alb\", \"namespace\": \"MGI\"}]}, {\"bel\": \"complex(a(MESH:\\\"Blood Transfusion\\\"), p(MGI:Hp))\", \"function\": \"Complex\", \"id\": \"bf37e1e48ffee9efe1e66cab8b5e0c0a2775579a0debfeeb9c4d4b8751f7864ca14d8d9886fb210bd8facc323c73aa66604048d5e83763f13c997fc8d8699fe7\", \"members\": [{\"bel\": \"a(MESH:\\\"Blood Transfusion\\\")\", \"function\": \"Abundance\", \"id\": \"b3b4ac2f07a0f5e6df3abd5f7bd0d6f120776202f4c3e417c4082961f2f3ece07bc3d7e231b573dd19b6eb0e1fdbed451fb1370fbdac4a1e42d8262b7565070f\", \"name\": \"Blood Transfusion\", \"namespace\": \"MESH\"}, {\"bel\": \"p(MGI:Hp)\", \"function\": \"Protein\", \"id\": \"ef6b27651769abfe3e0b315e005cda4bbf0d64e50c65cb3ec3a5605a08018dd0bb6b8b25ca42f8ea3ccc0630388908ccd832178ba97d5ffa830e6aff4f9c9092\", \"name\": \"Hp\", \"namespace\": \"MGI\"}]}, {\"bel\": \"complex(a(MESH:\\\"Blood Transfusion\\\"), p(MGI:Hpx))\", \"function\": \"Complex\", \"id\": \"64630a0c3606394eeda5b51f2a6cbaf7e904728c55c6bb681afafb7721f3358ce6c3fba89b0e739c08e85a1baefc91e0e1e1e113b9865c5ced87d4b09f4cea7d\", \"members\": [{\"bel\": \"a(MESH:\\\"Blood Transfusion\\\")\", \"function\": \"Abundance\", \"id\": \"b3b4ac2f07a0f5e6df3abd5f7bd0d6f120776202f4c3e417c4082961f2f3ece07bc3d7e231b573dd19b6eb0e1fdbed451fb1370fbdac4a1e42d8262b7565070f\", \"name\": \"Blood Transfusion\", \"namespace\": \"MESH\"}, {\"bel\": \"p(MGI:Hpx)\", \"function\": \"Protein\", \"id\": \"ccdc2439745a084dbbe73e6559429f702bfbdd9823ad4837b3232123b8c4a6c91ffd44740d989f368c570e462c58632040fcfa2d5e947abff06413ab3ce7ec44\", \"name\": \"Hpx\", \"namespace\": \"MGI\"}]}, {\"bel\": \"g(HGNC:AMBP)\", \"function\": \"Gene\", \"id\": \"a332aecfe627dd82c9338a6f3b2cef7648bc153a13a75ddf60088f027d38efdea5ff8363e74c7a0188eb6626a50a8c45f380db6ddef96728147ab139003ed0ce\", \"name\": \"AMBP\", \"namespace\": \"HGNC\"}, {\"bel\": \"g(HGNC:CD163)\", \"function\": \"Gene\", \"id\": \"ea0f40b6fdeb26b2c15f176ab059ab3f277d3fbf313339337c05be67030977ba127ac55b928b43c43b9593a4286a42f361c21453810a9a85e815cbe84fd77c38\", \"name\": \"CD163\", \"namespace\": \"HGNC\"}, {\"bel\": \"g(HGNC:FTH1)\", \"function\": \"Gene\", \"id\": \"00fc8a3d6041a98b3dce0172e39a4395fcfe2cb1d0335115abda9e0e7485c262aebbf227a28a553095f49575ceeb296845956ce269f3cc04f80632bba0f81ae0\", \"name\": \"FTH1\", \"namespace\": \"HGNC\"}, {\"bel\": \"g(HGNC:HBB)\", \"function\": \"Gene\", \"id\": \"22a3758f2021c530b05e5f0d230e275aa042e0dd0f7f975d9c8ac4048d2c5a4875e6a4a86848699f7a62d4cc6d36586d6fb0d974d8b3f40e9132e4e6555d65d7\", \"name\": \"HBB\", \"namespace\": \"HGNC\"}, {\"bel\": \"g(HGNC:HMOX1)\", \"function\": \"Gene\", \"id\": \"5622991ccfd2bd08ff1bbb6f5804132021998b11d6ae5741285ded646024f2b52de6c79b3a5ef732345f7d128ddcd95f9ce8de11116d8b043f33c136cb232e07\", \"name\": \"HMOX1\", \"namespace\": \"HGNC\"}, {\"bel\": \"g(HGNC:HP)\", \"function\": \"Gene\", \"id\": \"5cb546906bd2d9a36b39a73586e944c4876b27a5d0895c43bbda5788668ccd665749c5ef7a3c8c47f121d1760f8496babe2b9b427d79757f7eb245ce91c55f4b\", \"name\": \"HP\", \"namespace\": \"HGNC\"}, {\"bel\": \"g(HGNC:HPX)\", \"function\": \"Gene\", \"id\": \"ac029c993d30145dfeea3ccecd48a6cbad28a53829399119515d5d77b8e0fdcf19706d3f80ed5436210642ba7a238ea4f9ffbedecd97417d29ee4563036047cc\", \"name\": \"HPX\", \"namespace\": \"HGNC\"}, {\"bel\": \"g(HGNC:IL1B)\", \"function\": \"Gene\", \"id\": \"c17fbb40fec9a356de1d0e81634700aa160b03b4eda8b4b82fed589901a2413038ca143646788dd319bcabc87f84c6c16fe3c4d630c90f0e6e1524a5c6b4df07\", \"name\": \"IL1B\", \"namespace\": \"HGNC\"}, {\"bel\": \"g(HGNC:IL6)\", \"function\": \"Gene\", \"id\": \"3b189c2d121b1ff060be3682dde340a8e33d52387003b99a7d6a81589bf8dcee2275b49b447608e5b09cf7161eb75577adbecf3ed019a6b1cac94a4e039d16c4\", \"name\": \"IL6\", \"namespace\": \"HGNC\"}, {\"bel\": \"g(HGNC:MYD88)\", \"function\": \"Gene\", \"id\": \"89ac5cec3e645f2807a6010d023f7b2e9d5ac9981cd8b52ccc66b4926f436d66493e09d850cf231416f39bf267ae2d86c330dda60fd5c2dd46d7cdb87eb310ec\", \"name\": \"MYD88\", \"namespace\": \"HGNC\"}, {\"bel\": \"g(HGNC:NFKB1)\", \"function\": \"Gene\", \"id\": \"5d17876a1ebbc987f2ac040a68ad6a5b331f0775eb1d51a80c545febb9776938c80825d3a71d91c33d0cb8558f1ae9cbb20676338f89709976f90ba6411a6b79\", \"name\": \"NFKB1\", \"namespace\": \"HGNC\"}, {\"bel\": \"g(HGNC:NLRP3)\", \"function\": \"Gene\", \"id\": \"efaa6ef717585a160de973f5869c44f65498dc544909539972c26e75c410baa480b2b3224fb2be189b23ed59feb66e640f9198549772c234600284bdf08b0457\", \"name\": \"NLRP3\", \"namespace\": \"HGNC\"}, {\"bel\": \"g(HGNC:TLR4)\", \"function\": \"Gene\", \"id\": \"8f0deae7a74d73f21f7d74bcd82fa6e486697e8bfee9f44b04be6d61da3bdc017170a539c20dcca5be43cff74b65b114fd06dd9b5e24e33ca98dd284c2c0701f\", \"name\": \"TLR4\", \"namespace\": \"HGNC\"}, {\"bel\": \"g(HGNC:TNF)\", \"function\": \"Gene\", \"id\": \"e47a25230245f058c0a7b39983313938d3bfb3a2d8e16428d60c1569bd005a230a1ef5de97fc5157765e3c0ecc9ff4d4346dd4d55ffd32f2b66323d5b7ce22bf\", \"name\": \"TNF\", \"namespace\": \"HGNC\"}, {\"bel\": \"g(MGI:Casp1)\", \"function\": \"Gene\", \"id\": \"5aefce3e446597ae4454e7f31248caa1f88aee2ea17b713e5e49ecbf4338ea676cea3f9731a8e686b04b2cbd72c5229bd65a302885f7450ffbd1fbe3b07e7ea4\", \"name\": \"Casp1\", \"namespace\": \"MGI\"}, {\"bel\": \"g(MGI:Hmox1)\", \"function\": \"Gene\", \"id\": \"61e10a7bbe2d6345bce4f2b77de9b39fb80921b23e9d101c2a838e9173a7279bd3f354c8c5427561418bd5771502a57bdd31ac845b07537df95db650926a4bf0\", \"name\": \"Hmox1\", \"namespace\": \"MGI\"}, {\"bel\": \"g(MGI:Hpx)\", \"function\": \"Gene\", \"id\": \"d53e119de82623157f549cd0ed8a0ca4a8b66fd98133f63596419860684237f573e4839400f3dad29abe31f362f0165b5974f784300e0a9dda4051f84f01659b\", \"name\": \"Hpx\", \"namespace\": \"MGI\"}, {\"bel\": \"g(MGI:Icam1)\", \"function\": \"Gene\", \"id\": \"fcea9d10aca51ef8a04a8ef5c3435c980fe994d22e120339d60261107bc331099349e1d3b3272793d6604fce34f8557908df77e370d88fc43c648734ef43821e\", \"name\": \"Icam1\", \"namespace\": \"MGI\"}, {\"bel\": \"g(MGI:Il1b)\", \"function\": \"Gene\", \"id\": \"fb1a1404ba4a9260929bf69d9617a83f765352bfe031d337f67513e8d6ae5818bb43660b57a2f6ba8c535205097bdb93822921ac5b91dc88e2de3946e757e8eb\", \"name\": \"Il1b\", \"namespace\": \"MGI\"}, {\"bel\": \"g(MGI:Nfkb1)\", \"function\": \"Gene\", \"id\": \"e10cb0d294bc2addd4ad43f195a5b0f9caef84bfd7061065e0c2f11b578775c5bb38c294b9abbdf5a4468477fa9c5a0f5024e652942e59118130e7ef88fb8e22\", \"name\": \"Nfkb1\", \"namespace\": \"MGI\"}, {\"bel\": \"g(MGI:Nlrp3)\", \"function\": \"Gene\", \"id\": \"68adb2042d226b948cbdf76e2d852e8eab790e8635daa19d4a84c90bc0f00537f17642f36b61fbfb87735d706a3549fc51024c97561be69b35e740018087d334\", \"name\": \"Nlrp3\", \"namespace\": \"MGI\"}, {\"bel\": \"g(MGI:Prdx2)\", \"function\": \"Gene\", \"id\": \"3daa7e9e07e0ca76480cf556ffe29639d9ef55c28f29f80ddc3264c649f77139b673f5d0e4267dbb0a249cfef6b2d66674373a5ad911dc8c69b89b255f15f5d7\", \"name\": \"Prdx2\", \"namespace\": \"MGI\"}, {\"bel\": \"g(MGI:Slc40a1)\", \"function\": \"Gene\", \"id\": \"1790ad6f39681a031814e36377a79c10e9d86c69a47818ed01303add8e809979d5fabc67b67086ec43c6ad4a08ba8f4f8edc8d0f67032a7607ab6a1b629fc202\", \"name\": \"Slc40a1\", \"namespace\": \"MGI\"}, {\"bel\": \"g(MGI:Vcam1)\", \"function\": \"Gene\", \"id\": \"8aa447e337a10c6f9b5aff80775b5d9e0c4852f642dabfd3bc1334943e9250a0a9dcfad6de2ab6482820af780ac2c7f168677e10ac5b328cf2170a5b5b933d45\", \"name\": \"Vcam1\", \"namespace\": \"MGI\"}, {\"bel\": \"g(RGD:Hmox1)\", \"function\": \"Gene\", \"id\": \"daeb86c1080e76cbc4a019d786a939054368f2ec38588cfcbd14c5746e8b74336a2f21bab2d2599ee72afc4a5a28bf08c98aa31bcbf23672b55c8bcd1dc6061a\", \"name\": \"Hmox1\", \"namespace\": \"RGD\"}, {\"bel\": \"p(HGNC:CD59, var(\\\"p.Cys89Tyr\\\"))\", \"function\": \"Protein\", \"id\": \"64620dfc08ca7bd4d4f47fb3573acdb4f660f66c533370c939430b0d0423dd6b0ac97faf239f79242306e0783ce579f66d1dd18f43b6495e7614e570bf87a276\", \"name\": \"CD59\", \"namespace\": \"HGNC\", \"variants\": [{\"identifier\": \"p.Cys89Tyr\", \"kind\": \"hgvs\"}]}, {\"bel\": \"path(HM:\\\"vaso-occlusive crisis\\\")\", \"function\": \"Pathology\", \"id\": \"7007ee304406d4320c9dcbefa93caf0b8ca48c68e148031ff1268674b1581667e2815de7ed2d14f5ac673c886c0493c40b8b821f94db58cf6f8ac9093dca5a48\", \"name\": \"vaso-occlusive crisis\", \"namespace\": \"HM\"}, {\"bel\": \"path(HP:\\\"Hemolytic-uremic syndrome\\\")\", \"function\": \"Pathology\", \"id\": \"b401e152d6544ccbbfb8379873b9d853c8f3811659ec2fe908e3ef40c0f0f18914079f51db8a81442a629950c5b65d134658cad58b60f31981d9130a8f4bd6f0\", \"name\": \"Hemolytic-uremic syndrome\", \"namespace\": \"HP\"}, {\"bel\": \"path(HP:\\\"Paroxysmal nocturnal hemoglobinuria\\\")\", \"function\": \"Pathology\", \"id\": \"b435a1d59be1cdaa0b4ed194d90883cdd83744b9266a0dfabcd67b3b3602ac6e83e987e8037ee732aa09bf34ebca2af45464d443827dd1d6b2f249563b69e007\", \"name\": \"Paroxysmal nocturnal hemoglobinuria\", \"namespace\": \"HP\"}, {\"bel\": \"path(MESH:\\\"Anemia, Sickle Cell\\\")\", \"function\": \"Pathology\", \"id\": \"edec8b7dad84d51e332f9eadc2a53b392a4a9b5a362b9cbe0276afc5a2618ad33d944f511fe99ba7d9be1b08a451229d57e7aa4606f64d46c1900e28980d0c79\", \"name\": \"Anemia, Sickle Cell\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:\\\"Brain Edema\\\")\", \"function\": \"Pathology\", \"id\": \"c3bdad023455029800950166f687761800d1fad85ac9885402c305207a8975f5a36a02d4ca1fd66eca2dce6668b46cdc290fc18d48cd06581fea7eff3768e06c\", \"name\": \"Brain Edema\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:\\\"Disseminated Intravascular Coagulation\\\")\", \"function\": \"Pathology\", \"id\": \"9c3182afb90d8cc0cd420ae4e6e7a59db2d13a782e8722c2fc3312a4d6414f9fd118cfa1ffce692c19b67933061917762019568c38d1341dfd5eb53da97abc0f\", \"name\": \"Disseminated Intravascular Coagulation\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:\\\"Knee Injuries\\\")\", \"function\": \"Pathology\", \"id\": \"497f92a9e805c1dbc4a671f562f5d4cf59f83ca78d5472dc6e8d150d191756bb002075d87895b03582f82bb01efd7a240ea6fcfa90bb3e61597e393e4fff768f\", \"name\": \"Knee Injuries\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:\\\"Plaque, Atherosclerotic\\\")\", \"function\": \"Pathology\", \"id\": \"4a0d1a83798630251d8e4e76c6bb2bece4082ec517af77934fd30aa8d989f249ab4b6d97f6a7d2efa7dc64140bb1261ce4e8bce3c9f2d407e9818900d1002906\", \"name\": \"Plaque, Atherosclerotic\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:\\\"Porphyria, Erythropoietic\\\")\", \"function\": \"Pathology\", \"id\": \"757f56c7852b0c51d44e1eb761d88e1c67ba95cc9ad2f2d37cf44d66fbbabd3506b4e7986ffeb830cd161cde165978557f57e74d339348feaf0f47b2e7327662\", \"name\": \"Porphyria, Erythropoietic\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:\\\"Pre-Eclampsia\\\")\", \"function\": \"Pathology\", \"id\": \"19da9c3d7cd76ce5ac5f6430c95b3eb30bf6b792a1b80f8c642e329101db9f583e5e8f00fe8fb80cc87d29b4f75c82774455fb4590d0feedf2ebdfa496feca8a\", \"name\": \"Pre-Eclampsia\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:\\\"Reperfusion Injury\\\")\", \"function\": \"Pathology\", \"id\": \"dbad6279f7d2dc927ad3faf3349552c0c7089af0c6b97b825e2b755ba1b23e12e508eebdffc14fad5cdfc66af6f409136f7f68dc9b09f9ec4c6423633828ea30\", \"name\": \"Reperfusion Injury\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:\\\"Thrombotic Microangiopathies\\\")\", \"function\": \"Pathology\", \"id\": \"5a4ed637b8e8e5cfd83125e6ad779ca5c10cc46906884e01d9dbeb597484a1c41e83210a37d5ab2a55fda308ea5505cf3020f64a4dbe1d81bdb402e995511657\", \"name\": \"Thrombotic Microangiopathies\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:\\\"Tricuspid Valve Insufficiency\\\")\", \"function\": \"Pathology\", \"id\": \"b404b65a845ee76eb856597ecb7cbc0cc48d06cc43a93548aae3388567e9dcf9c31e333c8fcf8876d9182793bf6132c9e240816e7cba4f0d67a14cb431947eca\", \"name\": \"Tricuspid Valve Insufficiency\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:\\\"Vascular Diseases\\\")\", \"function\": \"Pathology\", \"id\": \"ce091dc04570084e2b728b46cb56349db1241447bf122a9be809c1cc5dfb911c7bd086753ac6e471825bfa801065a31091ee847d482f4f615b6c3abe09ef75b3\", \"name\": \"Vascular Diseases\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:\\\"Vascular System Injuries\\\")\", \"function\": \"Pathology\", \"id\": \"2c1dc10562090ab803cf25bbb0eaa83a64b75c8750bd549df2e66f6f3545a54bd009fd5c1a689c5489abb49876de701c8542c0c371e00e4420f455faa8fff57a\", \"name\": \"Vascular System Injuries\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:Atherosclerosis)\", \"function\": \"Pathology\", \"id\": \"18fdde6cb24c9d4214eeebf2aa06f1137477ccfb0b31f46c6aab8020e5c4c9787a0d193d08631001c015c81f4f49a5372064be5fd1f4da59ef8653cbe6333b14\", \"name\": \"Atherosclerosis\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:Fever)\", \"function\": \"Pathology\", \"id\": \"c7c3671a2b0c61b4ba09160e95c6ffb5fded355754843caa4f15a50b9b110c1963a26d66a9ed641ebb551206132a8e541ca666cbb7786a4fd2bb4f5861b7aa39\", \"name\": \"Fever\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:Hematoma)\", \"function\": \"Pathology\", \"id\": \"5d7d50aa06632981313824480b1e9fc3888f43eebcefd6d5719284883f354dd2f3a830dd5a516f830fd94783d1a4a574113a475bf0ec4c53b186d7ca7c03fd95\", \"name\": \"Hematoma\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:Hemolysis)\", \"function\": \"Pathology\", \"id\": \"7cfbd58cfcd389d302278ecd54992b3d6039896ac077344c4c47bcafd5379ca16ef441da8e1f3105595a30c4dd7331ca2a6f864432425107f7850f8dbe210b09\", \"name\": \"Hemolysis\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:Hydrocephalus)\", \"function\": \"Pathology\", \"id\": \"aea880bd7e611b57e3241d3a3cacf9bd6927ed92e76eea04c18fb94d1f666091146c4330e8dd35913744f94e21907d91821d7c109ad7fdfe1537b9f14949c8a5\", \"name\": \"Hydrocephalus\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:Inflammation)\", \"function\": \"Pathology\", \"id\": \"3196cc4c6a20279c822cae925a9b271d0224f2c8d468e3069a3ee460662be286b61db2f144c550686a9c624e58af4ffa7570f4f2384e1cb8ee40496f8cb3fa5e\", \"name\": \"Inflammation\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:Pneumonia)\", \"function\": \"Pathology\", \"id\": \"928af46e81998338b2b6585ab5611a7825d0cdce2c71347e01e437d5e113af6067c9cdc4ae5a66e45d2f7957e6a0a9b752d46106c6d25ab46a97c045a4e71808\", \"name\": \"Pneumonia\", \"namespace\": \"MESH\"}, {\"bel\": \"path(MESH:Thrombosis)\", \"function\": \"Pathology\", \"id\": \"b8739fcb57aeef4e74a351a9a6298e8d50bd9a172d37973c9c286907a2c6f131a06ff7070db9641962cc62043cd6e64ab2361b9c3e0adde501b1f69294ea5490\", \"name\": \"Thrombosis\", \"namespace\": \"MESH\"}, {\"bel\": \"rxn(reactants(p(HGNC:HBB)), products(a(CHEBI:methemoglobin)))\", \"function\": \"Reaction\", \"id\": \"34d27a2351b59e91a628fc7c7db7545aad43ba29fdad776860225f87cfa360fe578ee564b21db01839a6157d08542befd347b3349c9f623f37879f82816499de\", \"products\": [{\"bel\": \"a(CHEBI:methemoglobin)\", \"function\": \"Abundance\", \"id\": \"7805bca22642b820fb0a026eb5c67eb4512f0a021ec5c97c5f505f5706c0ef4cb986edf806c547d40110c084b98e15c3520dd558cb96c5071b4dd9709e641130\", \"name\": \"methemoglobin\", \"namespace\": \"CHEBI\"}], \"reactants\": [{\"bel\": \"p(HGNC:HBB)\", \"function\": \"Protein\", \"id\": \"75606239f93ac271516eb110566907523dfdbf0a1937760050e049e79942bd684a190c3dd54b45444c2c5b5217192e72df697c824cbb392f90f2fa4005d9adb1\", \"name\": \"HBB\", \"namespace\": \"HGNC\"}]}]}, \"#prcaembydgsjvozk\", 1000, 650, {'Protein': '#1F77B4', 'Pathology': '#FF7F0E', 'BiologicalProcess': '#2CA02C', 'miRNA': '#D62728', 'Complex': '#98DF8A', 'Composite': '#9467BD', 'Reaction': '#000000', 'Gene': '#FFBB78', 'Abundance': '#AEC7E8', 'RNA': '#FF9896'});\n",
       "});"
      ],
      "text/plain": [
       "<IPython.core.display.Javascript object>"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "to_jupyter(graph)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "# pickle_out = open('thrombosis_nodes_with_pathways.pickle','wb')\n",
    "# pickle.dump(graph_nodes_key_players, pickle_out)\n",
    "# pickle_out.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "# thrombosis_dict = pickle.load(open('thrombosis_nodes_with_pathways.pickle', 'rb'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "#key_nodes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "# test = set(graph_nodes_key_players)\n",
    "# list_test = list(test)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {
    "scrolled": false
   },
   "outputs": [],
   "source": [
    "# for node in list_test:\n",
    "#     if 'namespace' in node and node.namespace == 'MGI':\n",
    "#         no_MGI = list_test.remove(node)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "# print(no_MGI)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[<BEL a(CHEBI:heme)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Fever)>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL a(MESH:Monocytes)>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL path(MESH:Hemolysis)>, <BEL g(HGNC:HPX)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(MESH:Cytokines)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL path(MESH:\"Anemia, Sickle Cell\")>, <BEL g(HGNC:HPX)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL path(MESH:\"Reperfusion Injury\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"necroptotic process\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"necroptotic process\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(MESH:Apoptosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(MESH:Apoptosis)>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:antioxidant)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(HM:\"stored erythrocytes\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL complex(a(CHEBI:\"carbon monoxide\"), a(CHEBI:\"iron(2+)\"), a(CHEBI:biliverdin))>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL complex(a(CHEBI:\"carbon monoxide\"), a(CHEBI:\"iron(2+)\"), a(CHEBI:biliverdin))>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL path(MESH:\"Pre-Eclampsia\")>, <BEL g(HGNC:HPX)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(MESH:\"Erythrocyte Deformability\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(HGNC:HPX)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:ATP)>, <BEL g(HGNC:HPX)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL path(HM:\"vaso-occlusive crisis\")>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL path(HM:\"vaso-occlusive crisis\")>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(MESH:\"Complement Membrane Attack Complex\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(MESH:\"Complement Membrane Attack Complex\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL path(MESH:\"Vascular System Injuries\")>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL complex(a(MESH:\"Blood Transfusion\"), p(MGI:Hpx))>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL complex(a(MESH:\"Blood Transfusion\"), p(MGI:Hpx))>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(MESH:Phagocytosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL complex(a(CHEBI:heme), p(MGI:Hpx))>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL path(MESH:\"Vascular Diseases\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL a(CHEBI:\"adenosine triphosphate\")>, <BEL complex(a(CHEBI:heme), p(HGNC:ALB))>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL bp(GO:\"cellular respiration\")>, <BEL complex(a(CHEBI:heme), p(HGNC:ALB))>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:HMOX1)>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:HMOX1)>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:HMOX1)>, <BEL complex(a(CHEBI:heme), p(HGNC:ALB))>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(MGI:Hmox1)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(MGI:Slc40a1)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Erythrocyte Deformability\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL rxn(reactants(p(HGNC:HBB)), products(a(CHEBI:methemoglobin)))>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"endothelial cell activation\")>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Cytotoxicity, Immunologic\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:Apoptosis)>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(MESH:\"Erythrocytes, Abnormal\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(CHEBI:malonaldehyde)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Slc40a1)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Prdx2)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Prdx2)>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(HGNC:AMBP)>, <BEL g(HGNC:IL6)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(HGNC:AMBP)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Fever)>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL a(MESH:Monocytes)>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:Hydrocephalus)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(HGNC:HPX)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL a(MESH:\"Complement Membrane Attack Complex\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:Hemolysis)>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:Hemolysis)>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:Hemolysis)>, <BEL bp(GO:\"complement activation\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:Hemolysis)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:Hemolysis)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:Hemolysis)>, <BEL g(HGNC:HPX)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:Hemolysis)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:Hematoma)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL bp(MESH:\"Bacterial Load\")>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL g(MGI:Slc40a1)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL g(HGNC:HBB)>, <BEL a(MESH:\"haptoglobin-hemoglobin complex\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL g(HGNC:HBB)>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL g(HGNC:HBB)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL g(HGNC:HBB)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL g(HGNC:HBB)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL g(HGNC:CD163)>, <BEL a(MESH:\"haptoglobin-hemoglobin complex\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:NLRP3)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Erythrocyte Deformability\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL rxn(reactants(p(HGNC:HBB)), products(a(CHEBI:methemoglobin)))>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"endothelial cell activation\")>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Cytotoxicity, Immunologic\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:Apoptosis)>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(MESH:\"Erythrocytes, Abnormal\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(CHEBI:malonaldehyde)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Slc40a1)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Prdx2)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Prdx2)>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(HGNC:AMBP)>, <BEL g(HGNC:IL6)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(HGNC:AMBP)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL g(HGNC:HMOX1)>, <BEL path(MESH:\"Plaque, Atherosclerotic\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL g(HGNC:HMOX1)>, <BEL complex(a(CHEBI:\"carbon monoxide\"), p(HGNC:HBB))>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL g(HGNC:HMOX1)>, <BEL complex(a(CHEBI:\"carbon monoxide\"), p(HGNC:HBB))>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL g(HGNC:HMOX1)>, <BEL bp(GO:\"heme catabolic process\")>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL g(HGNC:HMOX1)>, <BEL bp(GO:\"heme catabolic process\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL g(HGNC:HMOX1)>, <BEL path(MESH:\"Tricuspid Valve Insufficiency\")>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL g(HGNC:HMOX1)>, <BEL path(MESH:Hematoma)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL g(HGNC:HMOX1)>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL g(HGNC:HMOX1)>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL g(HGNC:HMOX1)>, <BEL complex(a(CHEBI:heme), p(HGNC:ALB))>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(MESH:\"Erythrocytes, Abnormal\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(CHEBI:malonaldehyde)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(CHEBI:antioxidant)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Thrombosis)>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(HGNC:HPX)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(MESH:\"Blood Transfusion\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(MESH:\"Blood Transfusion\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(MESH:\"Blood Transfusion\")>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(MESH:\"Blood Transfusion\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL complex(a(MESH:\"Blood Transfusion\"), p(MGI:Hpx))>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL complex(a(MESH:\"Blood Transfusion\"), p(MGI:Hpx))>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL complex(a(MESH:\"Blood Transfusion\"), p(MGI:Alb))>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL complex(a(MESH:\"Blood Transfusion\"), p(MGI:Alb))>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL complex(a(MESH:\"Blood Transfusion\"), p(MGI:Alb))>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL complex(a(MESH:\"Blood Transfusion\"), p(MGI:Hp))>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL complex(a(MESH:\"Blood Transfusion\"), p(MGI:Hp))>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:\"Porphyria, Erythropoietic\")>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:\"Porphyria, Erythropoietic\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(CHEBI:lipopolysaccharide)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(HM:\"stored erythrocytes\")>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(HM:\"stored erythrocytes\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:\"Vascular Diseases\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:\"Vascular Diseases\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL a(CHEBI:\"N-acetyl-L-cysteine\")>, <BEL g(HGNC:IL6)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL a(CHEBI:\"N-acetyl-L-cysteine\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(HGNC:HPX)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(HGNC:HPX)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(HGNC:HPX)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(HGNC:HPX)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(MGI:Hpx)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(MGI:Hpx)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(MGI:Hpx)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL complex(a(CHEBI:heme), p(HGNC:ALB))>, <BEL bp(GO:\"cellular respiration\")>, <BEL a(MESH:ferrylhemoglobin)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL complex(a(CHEBI:heme), p(HGNC:ALB))>, <BEL a(CHEBI:\"hydrogen peroxide\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:\"Knee Injuries\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:\"Knee Injuries\")>, <BEL g(HGNC:HBB)>, <BEL a(MESH:\"haptoglobin-hemoglobin complex\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:\"Knee Injuries\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:\"Knee Injuries\")>, <BEL g(HGNC:HBB)>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:\"Knee Injuries\")>, <BEL g(HGNC:HBB)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:\"Knee Injuries\")>, <BEL g(HGNC:HBB)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:\"Knee Injuries\")>, <BEL g(HGNC:HBB)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:\"Knee Injuries\")>, <BEL g(HGNC:AMBP)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:\"Knee Injuries\")>, <BEL g(HGNC:AMBP)>, <BEL g(HGNC:IL6)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:\"Knee Injuries\")>, <BEL g(HGNC:AMBP)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Erythrocyte Deformability\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL rxn(reactants(p(HGNC:HBB)), products(a(CHEBI:methemoglobin)))>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"endothelial cell activation\")>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Cytotoxicity, Immunologic\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:Apoptosis)>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(MESH:\"Erythrocytes, Abnormal\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(CHEBI:malonaldehyde)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Slc40a1)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Prdx2)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Prdx2)>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(HGNC:AMBP)>, <BEL g(HGNC:IL6)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(HGNC:AMBP)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Fever)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Thrombosis)>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:IL1B)>, <BEL a(MESH:Monocytes)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL path(HM:\"vaso-occlusive crisis\")>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL path(HM:\"vaso-occlusive crisis\")>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL path(HM:\"vaso-occlusive crisis\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL bp(MESH:Apoptosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL g(HGNC:HPX)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL a(MESH:\"Blood Transfusion\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL a(MESH:\"Blood Transfusion\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL a(MESH:\"Blood Transfusion\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL a(MESH:\"Blood Transfusion\")>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL complex(a(MESH:\"Blood Transfusion\"), p(MGI:Hpx))>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL complex(a(MESH:\"Blood Transfusion\"), p(MGI:Hpx))>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:\"Porphyria, Erythropoietic\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:\"Porphyria, Erythropoietic\")>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL bp(MESH:\"Blood Pressure\")>, <BEL g(HGNC:HPX)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(MESH:\"Erythrocytes, Abnormal\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL a(CHEBI:malonaldehyde)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL bp(MESH:\"Oxidative Stress\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL bp(MESH:\"Lipid Peroxidation\")>, <BEL a(CHEBI:malonaldehyde)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Pneumonia)>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL g(MGI:Hmox1)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL g(MGI:Hmox1)>, <BEL g(MGI:Il1b)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL g(MGI:Hmox1)>, <BEL g(MGI:Casp1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL g(MGI:Hmox1)>, <BEL g(MGI:Nlrp3)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL g(MGI:Slc40a1)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL g(MGI:Nfkb1)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Fever)>, <BEL g(HGNC:IL1B)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Fever)>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL bp(GO:\"necroptotic process\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL bp(GO:\"necroptotic process\")>, <BEL a(CHEBI:\"desferrioxamine B\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL bp(GO:\"complement activation\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL g(HGNC:HPX)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL bp(MESH:Hemostasis)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(HP:\"Paroxysmal nocturnal hemoglobinuria\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(HP:\"Paroxysmal nocturnal hemoglobinuria\")>, <BEL bp(GO:\"complement activation\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(HP:\"Paroxysmal nocturnal hemoglobinuria\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(HP:\"Paroxysmal nocturnal hemoglobinuria\")>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(HM:\"Glucose-6-phosphate dehydrogenase deficiency\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:\"Thrombotic Microangiopathies\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:\"Disseminated Intravascular Coagulation\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(HP:\"Hemolytic-uremic syndrome\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL bp(MESH:\"Erythrocyte Deformability\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL bp(MESH:\"Erythrocyte Deformability\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"phosphatidyl-L-serine\")>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"phosphatidyl-L-serine\")>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"phosphatidyl-L-serine\")>, <BEL a(MESH:\"Erythrocytes, Abnormal\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(MESH:\"Cell-Derived Microparticles\")>, <BEL bp(GO:\"complement activation\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL bp(MESH:\"Erythrocyte Aggregation\")>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL a(HM:\"stored erythrocytes\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL p(HGNC:CD59, var(\"p.Cys89Tyr\"))>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL p(HGNC:CD59, var(\"p.Cys89Tyr\"))>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL g(MGI:Il1b)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL g(MGI:Casp1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL g(MGI:Nlrp3)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL a(MESH:\"haptoglobin-hemoglobin complex\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL a(CHEBI:\"nitric oxide\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HP)>, <BEL a(MESH:\"haptoglobin-hemoglobin complex\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HP)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL a(MESH:Monocytes)>, <BEL g(HGNC:IL1B)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL a(MESH:Monocytes)>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL a(MESH:Monocytes)>, <BEL g(HGNC:AMBP)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL a(MESH:Monocytes)>, <BEL g(HGNC:AMBP)>, <BEL g(HGNC:IL6)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL a(MESH:Monocytes)>, <BEL g(HGNC:AMBP)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Fever)>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL a(MESH:Monocytes)>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL path(MESH:Thrombosis)>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL bp(MESH:\"Platelet Activation\")>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL g(HGNC:AMBP)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL g(HGNC:AMBP)>, <BEL g(HGNC:IL6)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL a(MESH:Cytokines)>, <BEL g(HGNC:AMBP)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Fever)>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL path(MESH:Hemolysis)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(MESH:\"Adenosine Diphosphate\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(MGI:Hmox1)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HBB)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Thrombosis)>, <BEL g(HGNC:HP)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL a(MESH:Monocytes)>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(MGI:Icam1)>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(MGI:Vcam1)>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(RGD:Hmox1)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(MGI:Prdx2)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:NLRP3)>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:NLRP3)>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:NLRP3)>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:NLRP3)>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:NLRP3)>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:NLRP3)>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:NLRP3)>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:IL1B)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:NLRP3)>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(MGI:Hpx)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:NLRP3)>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:NLRP3)>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:NLRP3)>, <BEL path(MESH:\"Brain Edema\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:IL1B)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:IL1B)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:IL1B)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:IL1B)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:IL1B)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:IL1B)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL a(MESH:\"Mitogen-Activated Protein Kinases\")>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL path(MESH:Atherosclerosis)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:MYD88)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(MGI:Hpx)>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:NFKB1)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(MGI:Hpx)>, <BEL a(HM:\"macrophage M1 polarization\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(MGI:Hpx)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(MGI:Hpx)>, <BEL a(CHEBI:\"carbon monoxide\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:AMBP)>, <BEL a(MESH:\"Reactive Oxygen Species\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>, <BEL a(CHEBI:heme)>, <BEL g(HGNC:FTH1)>, <BEL a(CHEBI:\"iron(2+)\")>, <BEL bp(GO:\"inflammatory response\")>, <BEL g(HGNC:TLR4)>, <BEL g(HGNC:TNF)>, <BEL path(MESH:Inflammation)>]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "print(graph_nodes_key_players)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
